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ABSTRACT 
 
Notwithstanding advances in modern chemical methods, the selective installation of 
sterically encumbered carbon stereocenters, in particular all-carbon quaternary centers, 
remains an unsolved problem in organic chemistry.  The prevalence of all-carbon 
quaternary centers in biologically active natural products and pharmaceutical 
compounds provides a strong impetus to address current limitations in the state of the 
art of their generation.  This thesis presents four related projects, all of which share in 
the goal of constructing highly-congested carbon centers in a stereoselective manner, 
and in the use of transition-metal catalyzed alkylation as a means to address that goal. 
The first research described is an extension of allylic alkylation methodology 
previously developed in the Stoltz group to small, strained rings.  This research 
constitutes the first transition metal-catalyzed enantioselective α-alkylation of 
cyclobutanones.  Under Pd-catalysis, this chemistry affords all–carbon α-quaternary 
cyclobutanones in good to excellent yields and enantioselectivities.   
Next is described our development of a (trimethylsilyl)ethyl β-ketoester class of 
enolate precursors, and their application in palladium–catalyzed asymmetric allylic 
alkylation to yield a variety of α-quaternary ketones and lactams.  Independent 
coupling partner synthesis engenders enhanced allyl substrate scope relative to allyl β-
ketoester substrates; highly functionalized α-quaternary ketones generated by the union 
of our fluoride-triggered β-ketoesters and sensitive allylic alkylation coupling partners 
serve to demonstrate the utility of this method for complex fragment coupling. 
Lastly, our development of an Ir-catalyzed asymmetric allylic alkylation of cyclic 
β-ketoesters to afford highly congested, vicinal stereocenters comprised of tertiary and 
all-carbon quaternary centers with outstanding regio-, diastereo-, and enantiocontrol is 
detailed.  Implementation of a subsequent Pd-catalyzed alkylation affords dialkylated 
products with pinpoint stereochemical control of both chiral centers.  The chemistry is 
then extended to include acyclic β-ketoesters and similar levels of selective and 
functional group tolerance are observed.  Critical to the successful development of this 
method was the employment of iridium catalysis in concert with N-aryl-
phosphoramidite ligands.   
    
xiv 
TABLE OF CONTENTS 
 
 
 Dedication ......................................................................................................... iii 
 Acknowledgements ............................................................................................ iv 
 Abstract ........................................................................................................... xiii 
 Table of Contents .............................................................................................. xiv 
 List of Figures .................................................................................................... xxi 
 List of Schemes ............................................................................................... xxiv 
 List of Tables ................................................................................................. xxxvi 
 List of Abbreviations ..................................................................................... xxxix 
 
CHAPTER 1  1 
Enantioselective Construction of α-Quaternary Cyclobutanones by Catalytic 
Asymmetric Allylic Alkylation 
 1.1  Introduction ........................................................................................................................... 1 
  1.1.1 Palladium catalyzed allylic alkylation ................................................................. 1 
  1.1.2 Palladium catalyzed allylic alkylation of cyclobutanones .................................... 5 
 1.2  Preparation of cyclobutanones β-ketoester substrates and reaction optimization .................... 7 
  1.2.1 Cyclobutanones β-ketoester substrates synthesis ................................................. 7 
  1.2.2 Optimization of cyclobutanones allylic alkylation .............................................. 9 
 1.3  Exploration of the reaction scope ......................................................................................... 11 
  1.3.1 Reaction scope with respect to enolate α-substitution ....................................... 11 
  1.3.2 Reaction scope with respect to allyl substitution ............................................... 13 
 1.4 Derivatization of reaction products ....................................................................................... 14 
 1.5 Concluding remarks ............................................................................................................. 15 
 1.6 Experimental section ............................................................................................................ 16 
  1.6.1 Materials and methods ...................................................................................... 16 
  1.6.2 Representative procedures for the synthesis of 2-oxocyclobutanecarboxylates .. 18 
  1.6.3  Representative procedures for the synthesis of 2-H-2-oxocyclobutane- 
     carboxylates ...................................................................................................... 19 
  1.6.4  Spectroscopic data for novel cyclobutanone β-ketoester substrates ................... 20 
  1.6.5  Representative procedure for the asymmetric decarboxylative allylic alkylation of  
    2-oxocyclobutanecarboxylates .......................................................................... 31 
  1.6.6  Spectroscopic data for novel α-quaternary cyclobutanone products .................. 32 
    
xv 
  1.6.7  Procedures for derivatization of α-quaternary cyclobutanones and determination of  
    absolute stereochemical configuration .................................................................. 42 
  1.6.8  Determination of enantiomeric excess .............................................................. 49 
1.7  References and Notes .......................................................................................................... 51 
 
APPENDIX 1  60 
Spectra Relevant to Chapter 1 
 
CHAPTER 2  137 
Development of (Trimethylsilyl)Ethyl Ester Protected Enolates and Applications in 
Palladium–Catalyzed Enantioselective Allylic Alkylation: Intermolecular Cross-
Coupling of Functionalized Electrophiles 
2.1 Introduction  ....................................................................................................................... 137 
2.1.1  Latent enolates: silyl enol ethers ...................................................................... 137 
2.1.2  Latent enolates: β-ketoesters ............................................................................ 138 
2.1.3 Latent enolates: TMSE β-ketoesters .................................................................. 139 
2.2 Synthesis of and Reaction Optimization with TMSE β-ketoesters ........................................ 141 
 2.2.1 Substrate synthesis .......................................................................................... 141 
 2.2.2 TMSE-β-ketoester allylic alkylation optimization ............................................. 142 
2.3  Palladium-Catalyzed Allylic Alkylation with TMSE β-Ketoesters ......................................... 146 
 2.3.1 Reaction scope with respect to nucleophile .................................................... 146 
 2.3.2 Reaction scope with respect to electrophile .................................................... 148 
2.4 Coupling of TMSE β-Ketoesters with Functionally Complex Electrophilic Partners .............. 149 
2.5 Concluding Remarks ........................................................................................................... 152 
2.6 Experimental Section .......................................................................................................... 154 
2.6.1 Materials and Methods .................................................................................... 154 
2.6.2  General Procedure for TMSE β-Ketoester Substrate Synthesis .......................... 156 
2.6.3  Procedures for the syntheses of TMSE β-ketoester intermediate 88 and ketoester  
  77b ................................................................................................................. 157 
2.6.4 Spectroscopic data for TMSE β-ketoester substrates ......................................... 159 
2.6.5 General procedure for allyl carbonate substrate syntheses .............................. 164 
2.6.6 Spectroscopic data for allyl carbonate substrates ............................................. 165 
2.6.7 Procedure for the synthesis allyl carbonate 82 ................................................ 167 
    
xvi 
2.6.8 Optimization of reaction parameters ............................................................... 169 
2.6.9 General procedure for Pd-catalyzed allylic alkylation ..................................... 170  
2.6.10 Spectroscopic data for Pd-catalyzed allylic alkylation products ....................... 172 
2.6.11 Determination of enantiomeric excess and optical rotations ........................... 179 
2.7 References and Notes  ........................................................................................................ 180 
 
APPENDIX 2   183 
Spectra Related to Chapter 2 
 
CHAPTER 3   226 
Construction of Vicinal Tertiary and All-Carbon Quaternary Stereocenters via Ir-
Catalyzed Regio-, Diastereo-, and Enantioselective Allylic Alkylation and 
Applications in Sequential Pd-Catalysis  
3.1 Introduction   .................................................................................................................... 226 
3.1.1 State of the art in the asymmetric construction of vicinal quaterary and tertiary 
carbon centers ................................................................................................ 226 
3.2  Reaction Optimzation and Development ........................................................................... 228 
3.2.1 Discovery and optimization of iridium catalyzed regio-, diastereo- and 
enantioselective allylic alkylation of cyclic ketones ........................................ 228 
3.2.2 Further development of the reaction conditions .............................................. 231 
3.3 Survey of Reaction Scope .................................................................................................... 231 
3.3.1 Exploration of the reaction scope with respect to allyl electrophile ................. 231 
3.3.2 Exploration of the reaction scope with respect to ketoester nucleophile .......... 232 
3.4 Employment of TMSE β-Ketoester to Enable Sequential Catalysis ........................................ 233 
3.5 Concluding Remarks ........................................................................................................... 236 
3.6 Experimental Section .......................................................................................................... 237 
3.6.1 Materials and Methods .................................................................................... 237 
3.6.2  Optimization of reaction parameters ............................................................... 239 
3.6.3  General procedure for the Ir-catalyzed asymmetric allylic alkylation of  
  β-ketoesters ..................................................................................................... 240 
3.6.4 Spectroscopic data for Ir-catalyzed allylic alkylation products ........................ 242 
3.6.5 General procedure for Pd-catalyzed allylic alkylation ..................................... 256 
3.6.6 Determination of the relative configuration of compound 106a ...................... 259 
3.6.7 Spectroscopic data for new phosphinooxazoline ligands ................................ 260 
    
xvii 
3.6.8 Determination of enantiomeric excess ............................................................ 263 
3.7 References and Notes  ........................................................................................................ 265 
 
APPENDIX 3  272 
Spectra Related to Chapter 3 
 
APPENDIX 4  319 
X-Ray Crystallography Reports Relevant to Appendix 3 
 
CHAPTER 4  330 
Enantio-, Diastereo- and Regioselective Iridium-Catalyzed Asymmetric Allylic 
Alkylation of Acyclic β-Ketoesters 
4.1 Introduction  ....................................................................................................................... 330 
4.1.1 State of the art in the asymmetric construction of vicinal quaternary and tertiary 
carbon centers ................................................................................................ 330 
4.2 Development and Optimization of an Iridium-Catalyzed Allylic Alkylation of Linear β-
Ketoesters  ....................................................................................................................... 332 
4.3 Exploration of the Reaction Scope and Substituent Effects .................................................. 334 
4.3.1 Exploration of the iridium-catalyzed allylic alkylation of linear β-ketoesters with 
respect to allyl electrophile ............................................................................. 334 
4.3.2 Investigation of allyl electrophile substituent effects on reaction selectivity ..... 336 
4.3.3 Exploration of the iridium-catalyzed allylic alkylation of linear β-ketoesters with 
respect to β-ketoester nucleophile ................................................................... 337 
4.4 Elaboration of the Allylic Alkylation Products ..................................................................... 339  
4.5 Concluding Remarks ........................................................................................................... 340 
4.6 Experimental Section .......................................................................................................... 341 
4.6.1 Materials and Methods .................................................................................... 341 
4.6.2  Optimization of reaction parameters ............................................................... 343 
4.6.3  General procedure for the Ir-catalyzed asymmetric allylic alkylation of  
  acyclic β-ketoesters ......................................................................................... 345 
4.6.4 Spectroscopic data for Ir-catalyzed allylic alkylation products ........................ 374 
    
xviii 
4.6.5 Procedures for derivatization of allylic alkylation products and spectroscopic data 
of derivatives .................................................................................................. 373 
4.6.6 Determination of the absolute confirmation of compound 112f ...................... 376 
4.6.7 Determination of enantiomeric excess ............................................................ 378 
4.7 References and Notes  ........................................................................................................ 382 
 
APPENDIX 5  384 
Stereochemical Model and Mechanistic Discussion for Iridium Catalyzed Allylic 
Alkylation  
A5.1  Introduction .................................................................................................... 384 
A5.2 Stereochemical Model for Diastereoselectivity in Iridium-Catalyzed Allylic 
Alkylation ....................................................................................................... 385 
A5.3 References and Notes ..................................................................................... 388 
 
APPENDIX 6  390 
Spectra Related to Chapter 4 
 
APPENDIX 7  466 
X-Ray Crystallography Reports Relevant to Chapter 4 
 
APPENDIX 8  480 
Development of an α-Arylation Reaction of TMSE β-Ketoesters 
A8.1 Introduction ...................................................................................................................... 480 
A8.1.1 Background and state of the art in the α-arylation of cyclic ketones ................ 480 
A8.1.2 State of the art in the asymmetric α-arylation of cyclic ketones ....................... 482 
A8.2 Background: Extension of Carboxylate Protected Enolate Cross Coupling Strategy to  
  α-Arylation ..................................................................................................... 484 
 A8.2.1 Use of allyl β-ketoester protected enolates in non-allylic alkylation processes . 484 
A8.2.2 New pathways into catalysis via a carboxylate protected prochiral enolate  
  strategy ........................................................................................................... 487 
A8.3 Initial Evaluation of TMSE β-Ketoester in α-Arylation ...................................................... 489 
A8.3.1 Symyx assisted reaction development: early experiments ................................ 489 
    
xix 
A8.3.2 Symyx assisted reaction development: beyond the initial experiments ............ 491 
A8.4 Optimization of The Palladium catalyzed α-Arylation of TMSE β-Ketoesters ................... 493 
A8.5 Outlook and Future Directions for carboxylate protected enolates in α-Arylation ............ 499 
A8.5.1 Hypotheses that remain to be tested in α-arylation of TMSE β-ketoesters ........ 499 
A8.5.2 Deacylative in situ access to prochiral enolates .............................................. 500 
A8.6  Concluding Remarks ....................................................................................................... 502 
A8.7 Experimental Section ....................................................................................................... 503 
 A8.7.1 Materials and Methods .................................................................................... 503 
 A8.6.2 Procedure for Symyx assisted screening of α-arylation .................................... 504 
 A8.6.3 Procedure for manual screening of α-arylation ................................................ 508 
A8.7   References and Notes ..................................................................................................... 509 
 
APPENDIX 9  511 
Studies Toward the Enantioselective Total Synthesis of (+)-Lingzhiol 
A9.1 Introduction ...................................................................................................................... 511  
A9.1.1 Isolation studies of the lingzhiols .................................................................... 511 
A9.1.2 Biological studies on and bioactivity profile of lingzhiol ................................. 512 
A9.2 Retrosynthetic Analysis of (+)-Lingzhiol .......................................................... 513 
A9.3  Model Studies to Investigate Key (3+2) Cycloaddition in the Synthesis of (+)-Lingzhiol .... 514 
A9.3.1 Retrosynthetic plan for lingzhiol model system ............................................... 514 
A9.3.2 Synthesis of lingzhiol model system and testing of key (3+2) cycloaddition .... 515 
A9.4  Revised  Model Studies to Investigate Key (3+2) Cycloaddition in the Synthesis of  
  (+)-Lingzhiol ................................................................................................... 519 
A9.4.1 Rationale and revised plan for (+)-lingzhiol model system .............................. 519 
 A9.4.2 Synthesis of the revised model system for (+)-lingzhiol .................................... 520 
A9.5  Revised Strategy for the Synthesis of (+)-Lingzhiol ........................................................... 523 
A9.6  Concluding Remarks ....................................................................................................... 525 
A9.7  Experimental Section ....................................................................................................... 525 
 A9.7.1 Materials and Methods .................................................................................... 525 
 A9.7.2 Procedures for the preparation of and spectroscopic data for compounds in 
    scheme A9.3.2.1 ............................................................................................. 526 
 A9.7.3 Procedures for the preparation of and spectroscopic data for compounds in  
   scheme A9.3.2.2 ............................................................................................. 528 
 A9.7.4 Procedures for the preparation of and spectroscopic data for compounds in  
    
xx 
   scheme A9.3.2.3 ............................................................................................. 530 
 A9.7.5 Procedures for the preparation of and spectroscopic data for compounds in 
    scheme A9.3.2.4 ............................................................................................ 532 
 A9.7.6 Procedures for the preparation of and spectroscopic data for compounds in  
   scheme A9.4.2.1 ............................................................................................. 533 
 A9.7.7 Procedures for the preparation of and spectroscopic data for compounds in 
    scheme A9.4.2.2 ............................................................................................ 537 
A9.8 References and Notes ....................................................................................................... 541 
 
APPENDIX 10  544 
Spectra Related to Appendix 9 
 
  Comprehensive Bibliography .......................................................................... 567 
  Index .............................................................................................................. 587 
  About the Author ............................................................................................ 590 
    
xxi 
LIST OF FIGURES 
 
CHAPTER 1 
Figure 1.1.2.1  (A) Representative cycbutanoid natural products; (B) ring, conformational 
and torsional strain in cyclobutanone enolates ............................................. 6 
Figure 1.2.1.1  Construction of allyl 1-benzyl-2-oxocyclobutane-carboxylate (36) ............... 9 
Figure 1.2.2.1  General initial reaction parameters and select ligands  ............................... 10 
Figure 1.2.2.2  Solvent and temperature optimization of the palladium catalyzed allylic 
alkylation reaction ...................................................................................... 11 
Figure 1.3.1.1  Reaction scope with respect to α-quaternary substitution (R1) ..................... 13 
Figure 1.3.2.1  Reaction scope with respect to allyl substitution (R2) .................................. 14 
Figure 1.4.1  Derivatization of α-quaternary cyclobutanones .......................................... 15 
 
APPENDIX 1 
Figure A1.1 1H NMR (500 MHz, CDCl3) of compound 48 ................................................ 61 
Figure A1.2 Infrared spectrum (thin film/NaCl) of compound 48 ....................................... 62 
Figure A1.3 13C NMR (125 MHz, CDCl3) of compound 48 ............................................... 62 
Figure A1.4 1H NMR (500 MHz, CDCl3) of compound 39a .............................................. 63 
Figure A1.5 Infrared spectrum (thin film/NaCl) of compound 39a ..................................... 64 
Figure A1.6 13C NMR (125 MHz, CDCl3) of compound 39a .............................................. 64 
Figure A1.7 1H NMR (500 MHz, CDCl3) of compound 39b .............................................. 65 
Figure A1.8 Infrared spectrum (thin film/NaCl) of compound 39b ..................................... 66 
Figure A1.9 13C NMR (125 MHz, CDCl3) of compound 39b ............................................. 66 
Figure A1.10 1H NMR (500 MHz, CDCl3) of compound 39c .............................................. 67 
Figure A1.11 Infrared spectrum (thin film/NaCl) of compound 39c ..................................... 68 
Figure A1.12 13C NMR (125 MHz, CDCl3) of compound 39c .............................................. 68 
Figure A1.13 1H NMR (500 MHz, CDCl3) of compound 39d .............................................. 69 
Figure A1.14 Infrared spectrum (thin film/NaCl) of compound 39d ..................................... 70 
Figure A1.15 13C NMR (125 MHz, CDCl3) of compound 39d ............................................. 70 
Figure A1.16 1H NMR (500 MHz, CDCl3) of compound 39e .............................................. 71 
Figure A1.17 Infrared spectrum (thin film/NaCl) of compound 39e ..................................... 72 
Figure A1.18 13C NMR (125 MHz, CDCl3) of compound 39e .............................................. 72 
Figure A1.19 1H NMR (500 MHz, CDCl3) of compound 39f ............................................... 73 
Figure A1.20 Infrared spectrum (thin film/NaCl) of compound 39f ...................................... 74 
Figure A1.21 13C NMR (125 MHz, CDCl3) of compound 39f .............................................. 74 
    
xxii 
Figure A1.22 1H NMR (500 MHz, CDCl3) of compound 39g .............................................. 75 
Figure A1.23 Infrared spectrum (thin film/NaCl) of compound 39g ..................................... 76 
Figure A1.24 13C NMR (125 MHz, CDCl3) of compound 39g .............................................. 76 
Figure A1.25 1H NMR (500 MHz, CDCl3) of compound 39h .............................................. 77 
Figure A1.26 Infrared spectrum (thin film/NaCl) of compound 39h ..................................... 78 
Figure A1.27 13C NMR (125 MHz, CDCl3) of compound 39h ............................................. 78 
Figure A1.28 1H NMR (500 MHz, CDCl3) of compound 41a .............................................. 79 
Figure A1.29 Infrared spectrum (thin film/NaCl) of compound 41a ..................................... 80 
Figure A1.30 13C NMR (125 MHz, CDCl3) of compound 41a .............................................. 80 
Figure A1.31 1H NMR (500 MHz, CDCl3) of compound 41b .............................................. 81 
Figure A1.32 Infrared spectrum (thin film/NaCl) of compound 41b ..................................... 82 
Figure A1.33 13C NMR (125 MHz, CDCl3) of compound 41b ............................................. 82 
Figure A1.34 1H NMR (500 MHz, CDCl3) of compound 41c .............................................. 83 
Figure A1.35 Infrared spectrum (thin film/NaCl) of compound 41c ..................................... 84 
Figure A1.36 13C NMR (125 MHz, CDCl3) of compound 41c .............................................. 84 
Figure A1.37 1H NMR (500 MHz, CDCl3) of compound 36 ................................................ 85 
Figure A1.38 Infrared spectrum (thin film/NaCl) of compound 36 ....................................... 86 
Figure A1.39 13C NMR (125 MHz, CDCl3) of compound 36 ............................................... 86 
Figure A1.40 1H NMR (500 MHz, CDCl3) of compound 41d .............................................. 87 
Figure A1.41 Infrared spectrum (thin film/NaCl) of compound 41d ..................................... 88 
Figure A1.42 13C NMR (125 MHz, CDCl3) of compound 41d ............................................. 88 
Figure A1.43 1H NMR (500 MHz, CDCl3) of compound 41e .............................................. 89 
Figure A1.44 Infrared spectrum (thin film/NaCl) of compound 41e ..................................... 90 
Figure A1.45 13C NMR (125 MHz, CDCl3) of compound 41e .............................................. 90 
Figure A1.46 1H NMR (500 MHz, CDCl3) of compound 41f ............................................... 91 
Figure A1.47 Infrared spectrum (thin film/NaCl) of compound 41f ...................................... 92 
Figure A1.48 13C NMR (125 MHz, CDCl3) of compound 41f .............................................. 92 
Figure A1.49 1H NMR (500 MHz, CDCl3) of compound 40a .............................................. 93 
Figure A1.50 Infrared spectrum (thin film/NaCl) of compound 40a ..................................... 94 
Figure A1.51 13C NMR (125 MHz, CDCl3) of compound 40a .............................................. 94 
Figure A1.52 1H NMR (500 MHz, CDCl3) of compound 40b .............................................. 95 
Figure A1.53 Infrared spectrum (thin film/NaCl) of compound 40b ..................................... 96 
Figure A1.54 13C NMR (125 MHz, CDCl3) of compound 40b ............................................. 96 
Figure A1.55 1H NMR (500 MHz, CDCl3) of compound 40c .............................................. 97 
Figure A1.56 Infrared spectrum (thin film/NaCl) of compound 40c ..................................... 97 
    
xxiii 
Figure A1.57 13C NMR (125 MHz, CDCl3) of compound 40c .............................................. 98 
Figure A1.58 1H NMR (500 MHz, CDCl3) of compound 40d .............................................. 99 
Figure A1.59 Infrared spectrum (thin film/NaCl) of compound 40d ................................... 100 
Figure A1.60 13C NMR (125 MHz, CDCl3) of compound 40d ........................................... 100 
Figure A1.61 1H NMR (500 MHz, CDCl3) of compound 40e ............................................ 101 
Figure A1.62 Infrared spectrum (thin film/NaCl) of compound 40e ................................... 102 
Figure A1.63 13C NMR (125 MHz, CDCl3) of compound 40e ............................................ 102 
Figure A1.64 1H NMR (500 MHz, CDCl3) of compound 40f ............................................. 103 
Figure A1.65 Infrared spectrum (thin film/NaCl) of compound 40f .................................... 104 
Figure A1.66 13C NMR (125 MHz, CDCl3) of compound 40f ............................................ 104 
Figure A1.67 1H NMR (500 MHz, CDCl3) of compound 40g ............................................ 105 
Figure A1.68 Infrared spectrum (thin film/NaCl) of compound 40g ................................... 106 
Figure A1.69 13C NMR (125 MHz, CDCl3) of compound 40g ............................................ 106 
Figure A1.70 1H NMR (500 MHz, CDCl3) of compound 40h ............................................ 107 
Figure A1.71 Infrared spectrum (thin film/NaCl) of compound 40h  .................................. 108 
Figure A1.72 13C NMR (125 MHz, CDCl3) of compound 40h ........................................... 108 
Figure A1.73 1H NMR (500 MHz, CDCl3) of compound 42a ............................................ 109 
Figure A1.74 Infrared spectrum (thin film/NaCl) of compound 42a ................................... 110 
Figure A1.75 13C NMR (125 MHz, CDCl3) of compound 42a ............................................ 110 
Figure A1.76 1H NMR (500 MHz, CDCl3) of compound 42b ............................................ 111 
Figure A1.77 Infrared spectrum (thin film/NaCl) of compound 42b ................................... 112 
Figure A1.78 13C NMR (125 MHz, CDCl3) of compound 42b ........................................... 112 
Figure A1.79 1H NMR (500 MHz, CDCl3) of compound 42c ............................................ 113 
Figure A1.80 Infrared spectrum (thin film/NaCl) of compound 42c ................................... 114 
Figure A1.81 13C NMR (125 MHz, CDCl3) of compound 42c ............................................ 114 
Figure A1.82 1H NMR (500 MHz, CDCl3) of compound 38 .............................................. 115 
Figure A1.83 Infrared spectrum (thin film/NaCl) of compound 38 ..................................... 116 
Figure A1.84 13C NMR (125 MHz, CDCl3) of compound 38 ............................................. 116 
Figure A1.85 1H NMR (500 MHz, CDCl3) of compound 42d ............................................ 117 
Figure A1.86 Infrared spectrum (thin film/NaCl) of compound 42d ................................... 118 
Figure A1.87 13C NMR (125 MHz, CDCl3) of compound 42d ........................................... 118 
Figure A1.88 1H NMR (500 MHz, CDCl3) of compound 49 .............................................. 119 
Figure A1.89 Infrared spectrum (thin film/NaCl) of compound 49 ..................................... 120 
Figure A1.90 13C NMR (125 MHz, CDCl3) of compound 49 ............................................. 120 
Figure A1.91 1H NMR (500 MHz, CDCl3) of compound 42e ............................................ 121 
    
xxiv 
Figure A1.92 Infrared spectrum (thin film/NaCl) of compound 42e ................................... 122 
Figure A1.93 13C NMR (125 MHz, CDCl3) of compound 42e ............................................ 122 
Figure A1.94 1H NMR (500 MHz, CDCl3) of compound 42f ............................................. 123 
Figure A1.95 Infrared spectrum (thin film/NaCl) of compound 42f .................................... 124 
Figure A1.96 13C NMR (125 MHz, CDCl3) of compound 42f ............................................ 124 
Figure A1.97 1H NMR (500 MHz, CDCl3) of compound 44 .............................................. 125 
Figure A1.98 Infrared spectrum (thin film/NaCl) of compound 44 ..................................... 126 
Figure A1.99 13C NMR (125 MHz, CDCl3) of compound 44 ............................................. 126 
Figure A1.100 1H NMR (500 MHz, CDCl3) of compound 45 .............................................. 127 
Figure A1.101 Infrared spectrum (thin film/NaCl) of compound 45 ..................................... 128 
Figure A1.102 13C NMR (125 MHz, CDCl3) of compound 45 ............................................. 128 
Figure A1.103 1H NMR (500 MHz, CDCl3) of compound 46 .............................................. 129 
Figure A1.104 Infrared spectrum (thin film/NaCl) of compound 46 ..................................... 130 
Figure A1.105 13C NMR (125 MHz, CDCl3) of compound 46 ............................................. 130 
Figure A1.106 1H NMR (500 MHz, CDCl3) of compound  47 ............................................. 131 
Figure A1.107 Infrared spectrum (thin film/NaCl) of compound 47 ..................................... 132 
Figure A1.108 13C NMR (125 MHz, CDCl3) of compound 47 ............................................. 132 
Figure A1.109 1H NMR (500 MHz, CDCl3) of compound 51 .............................................. 133 
Figure A1.110 Infrared spectrum (thin film/NaCl) of compound 51 ..................................... 134 
Figure A1.111 13C NMR (125 MHz, CDCl3) of compound 51 ............................................. 134 
Figure A1.112 1H NMR (500 MHz, CDCl3) of compound 52 .............................................. 135 
Figure A1.113 Infrared spectrum (thin film/NaCl) of compound 52 ..................................... 136 
Figure A1.114 13C NMR (125 MHz, CDCl3) of compound 52 ............................................. 136 
 
CHAPTER 2 
Figure 2.1.1.1 Drawbacks of silyl enol ether synthesis ........................................................ 138 
Figure 2.1.2.1  Allyl β-ketoester approach to latent enolate chemistry ................................. 139 
Figure 2.1.3.1 Non-allyl β-ketoester approach to latent enolate chemistry .......................... 140 
Figure 2.1.3.2 TMSE β-ketoester approach to latent enolate chemistry ............................... 141 
 Figure 2.3.1.1 Exploration of functional group and scaffold diversity in the fluoride triggered 
palladium-catalyzed allylic alkylation reaction with respect to nucleophile . 148 
 Figure 2.3.2.1 Exploration of functional group and scaffold diversity in the fluoride triggered 
palladium-catalyzed allylic alkylation reaction with respect to electrophile ... 14 
Figure 2.4.1 Complex allyl architechtures ....................................................................... 150 
Figure 2.4.2 Union of complex fragments by asymmetric allylic alkylation ..................... 153 
    
xxv 
APPENDIX 2 
Figure A2.1 1H NMR (500 MHz, CDCl3) of compound 74 .............................................. 184 
Figure A2.2 Infrared spectrum (thin film/NaCl) of compound 74 ..................................... 185 
Figure A2.3 13C NMR (125 MHz, CDCl3) of compound 74 ............................................. 185 
Figure A2.4 1H NMR (500 MHz, CDCl3) of compound 88 .............................................. 186 
Figure A2.5 Infrared spectrum (thin film/NaCl) of compound 88 ..................................... 187 
Figure A2.6 13C NMR (125 MHz, CDCl3) of compound 88 ............................................. 187 
Figure A2.7 1H NMR (500 MHz, CDCl3) of compound 77b ............................................ 188 
Figure A2.8 Infrared spectrum (thin film/NaCl) of compound 77b ................................... 189 
Figure A2.9 13C NMR (125 MHz, CDCl3) of compound 77b ........................................... 189 
Figure A2.10 1H NMR (500 MHz, CDCl3) of compound 77a ............................................ 190 
Figure A2.11 Infrared spectrum (thin film/NaCl) of compound 77a ................................... 191 
Figure A2.12 13C NMR (125 MHz, CDCl3) of compound 77a ............................................ 191 
Figure A2.13 1H NMR (500 MHz, CDCl3) of compound 77c ............................................ 192 
Figure A2.14 Infrared spectrum (thin film/NaCl) of compound 77c ................................... 193 
Figure A2.15 13C NMR (125 MHz, CDCl3) of compound 77c ............................................ 193 
Figure A2.16 1H NMR (500 MHz, CDCl3) of compound 77d ............................................ 194 
Figure A2.17 Infrared spectrum (thin film/NaCl) of compound 77d ................................... 195 
Figure A2.18 13C NMR (125 MHz, CDCl3) of compound 77d ........................................... 195 
Figure A2.19 1H NMR (500 MHz, CDCl3) of compound 77e ............................................ 196 
Figure A2.20 Infrared spectrum (thin film/NaCl) of compound 77e ................................... 197 
Figure A2.21 13C NMR (125 MHz, CDCl3) of compound 77e ............................................ 197 
Figure A2.22 1H NMR (500 MHz, CDCl3) of compound 77f ............................................. 198 
Figure A2.23 Infrared spectrum (thin film/NaCl) of compound 77f .................................... 199 
Figure A2.24 13C NMR (125 MHz, CDCl3) of compound 77f ............................................ 199 
Figure A2.25 1H NMR (500 MHz, CDCl3) of compound 77g ............................................ 200 
Figure A2.26 Infrared spectrum (thin film/NaCl) of compound 77g ................................... 201 
Figure A2.27 13C NMR (125 MHz, CDCl3) of compound 77g ............................................ 201 
Figure A2.28 1H NMR (500 MHz, CDCl3) of compound 80b ............................................ 202 
Figure A2.29 Infrared spectrum (thin film/NaCl) of compound 80b ................................... 203 
Figure A2.30 13C NMR (125 MHz, CDCl3) of compound 80b ........................................... 203 
Figure A2.31 1H NMR (500 MHz, CDCl3) of compound 80d ............................................ 204 
Figure A2.32 Infrared spectrum (thin film/NaCl) of compound 80d ................................... 205 
Figure A2.33 13C NMR (125 MHz, CDCl3) of compound 80d ........................................... 205 
Figure A2.34 1H NMR (500 MHz, CDCl3) of compound 83 .............................................. 206 
    
xxvi 
Figure A2.35 Infrared spectrum (thin film/NaCl) of compound 83 ..................................... 206 
Figure A2.36 13C NMR (125 MHz, CDCl3) of compound 83 ............................................. 206 
Figure A2.37 1H NMR (500 MHz, CDCl3) of compound 92 .............................................. 206 
Figure A2.38 Infrared spectrum (thin film/NaCl) of compound 92 ..................................... 207 
Figure A2.39 13C NMR (125 MHz, CDCl3) of compound 92 ............................................. 207 
Figure A2.40 1H NMR (500 MHz, CDCl3) of compound 82 .............................................. 208 
Figure A2.41 Infrared spectrum (thin film/NaCl) of compound 82 ..................................... 209 
Figure A2.42 13C NMR (125 MHz, CDCl3) of compound 82 ............................................. 209 
Figure A2.43 1H NMR (500 MHz, CDCl3) of compound 81a ............................................ 210 
Figure A2.44 Infrared spectrum (thin film/NaCl) of compound 81a ................................... 211 
Figure A2.45 13C NMR (125 MHz, CDCl3) of compound 81a ............................................ 211 
Figure A2.46 1H NMR (500 MHz, CDCl3) of compound 79g ............................................ 212 
Figure A2.47 Infrared spectrum (thin film/NaCl) of compound 79g ................................... 213 
Figure A2.48 13C NMR (125 MHz, CDCl3) of compound 79g ............................................ 213 
Figure A2.49 1H NMR (500 MHz, CDCl3) of compound 81b ............................................ 214 
Figure A2.50 Infrared spectrum (thin film/NaCl) of compound 81b ................................... 215 
Figure A2.51 13C NMR (125 MHz, CDCl3) of compound 81b ........................................... 215 
Figure A2.52 1H NMR (500 MHz, CDCl3) of compound 81d ............................................ 216 
Figure A2.53 Infrared spectrum (thin film/NaCl) of compound 81d ................................... 217 
Figure A2.54 13C NMR (125 MHz, CDCl3) of compound 81d ........................................... 217 
Figure A2.55 1H NMR (500 MHz, CDCl3) of compound 84 .............................................. 218 
Figure A2.56 Infrared spectrum (thin film/NaCl) of compound 84 ..................................... 219 
Figure A2.57 13C NMR (125 MHz, CDCl3) of compound 84 ............................................. 219 
Figure A2.58 1H NMR (500 MHz, CDCl3) of compound 85 .............................................. 220 
Figure A2.59 Infrared spectrum (thin film/NaCl) of compound 85 ..................................... 221 
Figure A2.60 13C NMR (125 MHz, CDCl3) of compound 85 ............................................. 221 
Figure A2.61 1H NMR (500 MHz, CDCl3) of compound 86 .............................................. 222 
Figure A2.62 Infrared spectrum (thin film/NaCl) of compound 86 ..................................... 223 
Figure A2.63 13C NMR (125 MHz, CDCl3) of compound 86 ............................................. 223 
Figure A2.61 1H NMR (500 MHz, CDCl3) of compound 87 .............................................. 222 
Figure A2.62 Infrared spectrum (thin film/NaCl) of compound 87 ..................................... 223 
Figure A2.63 13C NMR (125 MHz, CDCl3) of compound 87 ............................................. 223 
 
CHAPTER 3 
 Figure 3.1.1.1  Ir-catalyzed allylic substitution ....................................................................... 228 
    
xxvii 
Figure 3.2.1.1 Selected phosphoramidite and PHOX ligands .............................................. 229 
Figure 3.3.1.1 Substrate scope of Ir-catalyzed allylic alkylation of β-aetoesters ................... 232 
Figure 3.3.2.1 Substrate scope of Ir-catalyzed allylic alkylation of β-ketoesters ................... 233 
Figure 3.4.1 Conceptualization of sequential catalysis ..................................................... 234 
Figure 3.4.2 Development of Pd-catalyzed diastereoselective decarboxylative allylic 
alkylation of TMSE-β-ketoesters ................................................................... 236 
 
APPENDIX 3 
Figure A3.1 1H NMR (500 MHz, CDCl3) of compound 100a .......................................... 273 
Figure A3.2 Infrared spectrum (thin film/NaCl) of compound 100a ................................. 274 
Figure A3.3 13C NMR (125 MHz, CDCl3) of compound 100a .......................................... 274 
Figure A3.4 1H NMR (500 MHz, CDCl3) of compound 100b .......................................... 275 
Figure A3.5 Infrared spectrum (thin film/NaCl) of compound 100b ................................. 276 
Figure A3.6 13C NMR (125 MHz, CDCl3) of compound 100b ......................................... 276 
Figure A3.7 1H NMR (500 MHz, CDCl3) of compound 100c .......................................... 277 
Figure A3.8 Infrared spectrum (thin film/NaCl) of compound 100c ................................. 278 
Figure A3.9 13C NMR (125 MHz, CDCl3) of compound 100c .......................................... 278 
Figure A3.10 1H NMR (500 MHz, CDCl3) of compound 100d .......................................... 279 
Figure A3.11 Infrared spectrum (thin film/NaCl) of compound 100d ................................. 280 
Figure A3.12 13C NMR (125 MHz, CDCl3) of compound 100d ......................................... 280 
Figure A3.13 1H NMR (500 MHz, CDCl3) of compound 100e .......................................... 281 
Figure A3.14 Infrared spectrum (thin film/NaCl) of compound 100e ................................. 282 
Figure A3.15 13C NMR (125 MHz, CDCl3) of compound 100e .......................................... 282 
Figure A3.16 1H NMR (500 MHz, CDCl3) of compound 100f ........................................... 283 
Figure A3.17 Infrared spectrum (thin film/NaCl) of compound 100f .................................. 284 
Figure A3.18 13C NMR (125 MHz, CDCl3) of compound 100f .......................................... 284 
Figure A3.19 1H NMR (500 MHz, CDCl3) of compound 100g .......................................... 285 
Figure A3.20 Infrared spectrum (thin film/NaCl) of compound 100g ................................. 286 
Figure A3.21 13C NMR (125 MHz, CDCl3) of compound 100g .......................................... 286 
Figure A3.22 1H NMR (500 MHz, CDCl3) of compound 100h .......................................... 287 
Figure A3.23 Infrared spectrum (thin film/NaCl) of compound 100h ................................. 288 
Figure A3.24 13C NMR (125 MHz, CDCl3) of compound 100h ......................................... 288 
Figure A3.25 1H NMR (500 MHz, CDCl3) of compound 100i ........................................... 289 
Figure A3.26 Infrared spectrum (thin film/NaCl) of compound 100i .................................. 290 
Figure A3.27 13C NMR (125 MHz, CDCl3) of compound 100i .......................................... 290 
    
xxviii 
Figure A3.28 1H NMR (500 MHz, CDCl3) of compound 103a .......................................... 291 
Figure A3.29 Infrared spectrum (thin film/NaCl) of compound 103a ................................. 292 
Figure A3.30 13C NMR (125 MHz, CDCl3) of compound 103a .......................................... 292 
Figure A3.31 1H NMR (500 MHz, CDCl3) of compound 103b .......................................... 293 
Figure A3.32 Infrared spectrum (thin film/NaCl) of compound 103b ................................. 294 
Figure A3.33 13C NMR (125 MHz, CDCl3) of compound 103b ......................................... 294 
Figure A3.34 1H NMR (500 MHz, CDCl3) of compound 103c .......................................... 295 
Figure A3.35 Infrared spectrum (thin film/NaCl) of compound 103c ................................. 296 
Figure A3.36 13C NMR (125 MHz, CDCl3) of compound 103c .......................................... 296 
Figure A3.37 1H NMR (500 MHz, CDCl3) of compound 103d .......................................... 297 
Figure A3.38 Infrared spectrum (thin film/NaCl) of compound 103d ................................. 298 
Figure A3.39 13C NMR (125 MHz, CDCl3) of compound 103d ......................................... 298 
Figure A3.40 1H NMR (500 MHz, CDCl3) of compound 103e .......................................... 299 
Figure A3.41 Infrared spectrum (thin film/NaCl) of compound 103e ................................. 300 
Figure A3.42 13C NMR (125 MHz, CDCl3) of compound 103e .......................................... 300 
Figure A3.43 1H NMR (500 MHz, CDCl3) of compound 103f ........................................... 301 
Figure A3.44 Infrared spectrum (thin film/NaCl) of compound 103f .................................. 302 
Figure A3.45 13C NMR (125 MHz, CDCl3) of compound 103f .......................................... 302 
Figure A3.46 1H NMR (500 MHz, CDCl3) of compound 106a and 107a ........................... 303 
Figure A3.47 Infrared spectrum (thin film/NaCl) of compound 106a and 107a ................. 304 
Figure A3.48 13C NMR (125 MHz, CDCl3) of compound 106a and 107a .......................... 304 
Figure A3.49 1H NMR (500 MHz, CDCl3) of compound 106b .......................................... 305 
Figure A3.50 Infrared spectrum (thin film/NaCl) of compound 106b ................................. 306 
Figure A3.51 13C NMR (125 MHz, CDCl3) of compound 106b ......................................... 306 
Figure A3.52 1H NMR (500 MHz, CDCl3) of compound 106c .......................................... 307 
Figure A3.53 Infrared spectrum (thin film/NaCl) of compound 106c ................................. 308 
Figure A3.54 13C NMR (125 MHz, CDCl3) of compound 106c .......................................... 308 
Figure A3.55 1H NOESY (600 MHz, CDCl3) of compound 108 ......................................... 309 
Figure A3.56 Infrared spectrum (thin film/NaCl) of compound 108 ................................... 310 
Figure A3.57 13C NMR (125 MHz, CDCl3) of compound 108 ........................................... 310 
Figure A3.58 1H NMR (500 MHz, CDCl3) of compound L14 ............................................ 311 
Figure A3.59 Infrared spectrum (thin film/NaCl) of compound L14 ................................... 312 
Figure A3.60 13C NMR (125 MHz, CDCl3) of compound L14 ............................................ 312 
Figure A3.61 19F NMR (300 MHz, CDCl3) of compound L14 ............................................ 313 
Figure A3.62 31P NMR (500 MHz, CDCl3) of compound L14 ............................................ 314 
    
xxix 
Figure A3.63 1H NMR (500 MHz, CDCl3) of compound L14 ............................................ 315 
Figure A3.64 Infrared spectrum (thin film/NaCl) of compound L15 ................................... 316 
Figure A3.65 13C NMR (125 MHz, CDCl3) of compound L15 ............................................ 316 
Figure A3.65 19F NMR (300 MHz, CDCl3) of compound L15 ............................................ 317 
Figure A3.67 31P NMR (500 MHz, CDCl3) of compound L15 ............................................ 318 
 
ADDENDIX 4 
Figure A4.1.1.  ORTEP drawing of 100f ............................................................................... 320  
 
CHAPTER 4 
Figure 4.1.1.1 Representative Ir-catalyzed asymmetric allylic alkylation ........................... 331 
Figure 4.3.2.1 Hammett plot of the log of product ratios (112:113) from Table 2 versus 
Hammett σ-values ...................................................................................... 337 
 
APPENDIX 5 
Figure A5.2.1  Selected iridium-phosphoramidite complexes: 118 Feringa type; 119 N-
arylphosphoramidite (or You) type; 120 (π-allyl)-Ir complex with You type 
ligand ................................................................................................................  
   385 
Figure A5.2.2  Approach of the enolate nucloephile in the Ir-catalyzed allylic alkylation ... 387 
Figure A5.2.3  Proposed catalytic cycle for iridium-N-arylphosphoramidite complex catalyzed 
allylic alkylation .......................................................................................... 388 
 
APPENDIX 6 
Figure A6.1 1H NMR (500 MHz, CDCl3) of compound 112a .......................................... 391 
Figure A6.2 Infrared spectrum (thin film/NaCl) of compound 112a ................................. 392 
Figure A6.3 13C NMR (125 MHz, CDCl3) of compound 112a .......................................... 392 
Figure A6.4 1H NMR (500 MHz, CDCl3) of compound 112b .......................................... 393 
Figure A6.5 Infrared spectrum (thin film/NaCl) of compound 112b ................................. 394 
Figure A6.6 13C NMR (125 MHz, CDCl3) of compound 112b ......................................... 394 
Figure A6.7 1H NMR (500 MHz, CDCl3) of compound 112c .......................................... 395 
Figure A6.8 Infrared spectrum (thin film/NaCl) of compound 112c ................................. 396 
Figure A6.9 13C NMR (125 MHz, CDCl3) of compound 112c .......................................... 396 
    
xxx 
Figure A6.10 1H NMR (500 MHz, CDCl3) of compound 112d .......................................... 397 
Figure A6.11 Infrared spectrum (thin film/NaCl) of compound 112d ................................. 398 
Figure A6.12 13C NMR (125 MHz, CDCl3) of compound 112d ......................................... 398 
Figure A6.13 1H NMR (500 MHz, CDCl3) of compound 112e .......................................... 399 
Figure A6.14 Infrared spectrum (thin film/NaCl) of compound 112e ................................. 400 
Figure A6.15 13C NMR (125 MHz, CDCl3) of compound 112e .......................................... 400 
Figure A6.16 1H NMR (500 MHz, CDCl3) of compound 112f ........................................... 401 
Figure A6.17 Infrared spectrum (thin film/NaCl) of compound 112f .................................. 402 
Figure A6.18 13C NMR (125 MHz, CDCl3) of compound 112f .......................................... 402 
Figure A6.19 1H NMR (500 MHz, CDCl3) of compound 112g .......................................... 403 
Figure A6.20 Infrared spectrum (thin film/NaCl) of compound 112g ................................. 404 
Figure A6.21 13C NMR (125 MHz, CDCl3) of compound 112g .......................................... 404 
Figure A6.22 1H NMR (500 MHz, CDCl3) of compound 112h .......................................... 405 
Figure A6.23 Infrared spectrum (thin film/NaCl) of compound 112h ................................. 406 
Figure A6.24 13C NMR (125 MHz, CDCl3) of compound 112h ......................................... 406 
Figure A6.25 1H NMR (500 MHz, CDCl3) of compound 113h .......................................... 407 
Figure A6.26 Infrared spectrum (thin film/NaCl) of compound 113h ................................. 408 
Figure A6.27 13C NMR (125 MHz, CDCl3) of compound 113h ......................................... 408 
Figure A6.28 1H NMR (500 MHz, CDCl3) of compound 112i ........................................... 409 
Figure A6.29 Infrared spectrum (thin film/NaCl) of compound 112i .................................. 410 
Figure A6.30 13C NMR (125 MHz, CDCl3) of compound 112i .......................................... 410 
Figure A6.31 1H NMR (500 MHz, CDCl3) of compound 112j ........................................... 411 
Figure A6.32 Infrared spectrum (thin film/NaCl) of compound 112j .................................. 412 
Figure A6.33 13C NMR (125 MHz, CDCl3) of compound 112j .......................................... 412 
Figure A6.34 1H NMR (500 MHz, CDCl3) of compound 112k .......................................... 413 
Figure A6.35 Infrared spectrum (thin film/NaCl) of compound 112k ................................. 414 
Figure A6.36 13C NMR (125 MHz, CDCl3) of compound 112k .......................................... 414 
Figure A6.37 1H NMR (500 MHz, CDCl3) of compound 112l ........................................... 415 
Figure A6.38 Infrared spectrum (thin film/NaCl) of compound 112l .................................. 416 
Figure A6.39 13C NMR (125 MHz, CDCl3) of compound 112l .......................................... 416 
Figure A6.40 1H NMR (500 MHz, CDCl3) of compound 112m ......................................... 417 
Figure A6.41 Infrared spectrum (thin film/NaCl) of compound 112m ................................ 418 
Figure A6.42 13C NMR (125 MHz, CDCl3) of compound 112m ........................................ 418 
Figure A6.43 1H NMR (500 MHz, CDCl3) of compound 112n .......................................... 419 
Figure A6.44 Infrared spectrum (thin film/NaCl) of compound 112n ................................. 420 
    
xxxi 
Figure A6.45 13C NMR (125 MHz, CDCl3) of compound 112n ......................................... 420 
Figure A6.46 1H NMR (500 MHz, CDCl3) of compound 112o .......................................... 421 
Figure A6.47 Infrared spectrum (thin film/NaCl) of compound 112o ................................. 422 
Figure A6.48 13C NMR (125 MHz, CDCl3) of compound 112o ......................................... 422 
Figure A6.49 1H NMR (500 MHz, CDCl3) of compound 112p .......................................... 423 
Figure A6.50 Infrared spectrum (thin film/NaCl) of compound 112p ................................. 424 
Figure A6.51 13C NMR (125 MHz, CDCl3) of compound 112p ......................................... 424 
Figure A6.52 1H NMR (500 MHz, CDCl3) of compound 112q .......................................... 425 
Figure A6.53 Infrared spectrum (thin film/NaCl) of compound 112q ................................. 426 
Figure A6.54 13C NMR (125 MHz, CDCl3) of compound 112q ......................................... 426 
Figure A6.55 1H NOESY (600 MHz, CDCl3) of compound 113q ....................................... 427 
Figure A6.56 Infrared spectrum (thin film/NaCl) of compound 113q ................................. 428 
Figure A6.57 13C NMR (125 MHz, CDCl3) of compound 113q ......................................... 428 
Figure A6.58 1H NMR (500 MHz, CDCl3) of compound 112r ........................................... 429 
Figure A6.59 Infrared spectrum (thin film/NaCl) of compound 112r ................................. 430 
Figure A6.60 13C NMR (125 MHz, CDCl3) of compound 112r .......................................... 430 
Figure A6.61 1H NMR (500 MHz, CDCl3) of compound 112s ........................................... 431 
Figure A6.61 Infrared spectrum (thin film/NaCl) of compound 112s ................................. 432 
Figure A6.63 13C NMR (125 MHz, CDCl3) of compound 112s .......................................... 432 
Figure A6.64 1H NMR (500 MHz, CDCl3) of compound 112t ........................................... 433 
Figure A6.65 Infrared spectrum (thin film/NaCl) of compound 112t .................................. 434 
Figure A6.66 13C NMR (125 MHz, CDCl3) of compound 112t .......................................... 434 
Figure A6.67 1H NMR (500 MHz, CDCl3) of compound 112t’ .......................................... 435 
Figure A6.68 Infrared spectrum (thin film/NaCl) of compound 112t’ ................................. 436 
Figure A6.69 13C NMR (125 MHz, CDCl3) of compound 112t’ ......................................... 436 
Figure A6.70 1H NMR (500 MHz, CDCl3) of compound 112u .......................................... 437 
Figure A6.71 Infrared spectrum (thin film/NaCl) of compound 112u ................................. 438 
Figure A6.72 13C NMR (125 MHz, CDCl3) of compound 112u ......................................... 438 
Figure A6.73 1H NMR (500 MHz, CDCl3) of compound 112v .......................................... 439 
Figure A6.74 Infrared spectrum (thin film/NaCl) of compound 112v ................................. 440 
Figure A6.75 13C NMR (125 MHz, CDCl3) of compound 112v .......................................... 440 
Figure A6.76 1H NMR (500 MHz, CDCl3) of compound 112w ......................................... 441 
Figure A6.77 Infrared spectrum (thin film/NaCl) of compound 112w ................................ 442 
Figure A6.78 13C NMR (125 MHz, CDCl3) of compound 112w ......................................... 442 
Figure A6.79 1H NMR (500 MHz, CDCl3) of compound 112x .......................................... 443 
    
xxxii 
Figure A6.80 Infrared spectrum (thin film/NaCl) of compound 112x ................................. 444 
Figure A6.81 13C NMR (125 MHz, CDCl3) of compound 112x .......................................... 444 
Figure A6.82 1H NMR (500 MHz, CDCl3) of compound 112y .......................................... 445 
Figure A6.83 Infrared spectrum (thin film/NaCl) of compound 112y ................................. 446 
Figure A6.84 13C NMR (125 MHz, CDCl3) of compound 112y .......................................... 446 
Figure A6.85 1H NMR (500 MHz, CDCl3) of compound 112y’ ......................................... 447 
Figure A6.86 Infrared spectrum (thin film/NaCl) of compound 112y’ ................................ 448 
Figure A6.87 13C NMR (125 MHz, CDCl3) of compound 112y’ ......................................... 448 
Figure A6.88 1H NMR (500 MHz, CDCl3) of compound 112z .......................................... 449 
Figure A6.89 Infrared spectrum (thin film/NaCl) of compound 112z ................................. 450 
Figure A6.90 13C NMR (125 MHz, CDCl3) of compound 112z .......................................... 450 
Figure A6.91 1H NMR (500 MHz, CDCl3) of compound 113z .......................................... 451 
Figure A6.92 Infrared spectrum (thin film/NaCl) of compound 113z ................................. 452 
Figure A6.93 13C NMR (125 MHz, CDCl3) of compound 113z .......................................... 452 
Figure A6.94 1H NMR (500 MHz, CDCl3) of compound 114 ............................................ 453 
Figure A6.95 Infrared spectrum (thin film/NaCl) of compound 114 ................................... 454 
Figure A6.96 13C NMR (125 MHz, CDCl3) of compound 114 ........................................... 454 
Figure A6.97 1H NMR (500 MHz, CDCl3) of compound 116 ............................................ 455 
Figure A6.98 Infrared spectrum (thin film/NaCl) of compound 116 ................................... 456 
Figure A6.99 13C NMR (125 MHz, CDCl3) of compound 116 ........................................... 456 
Figure A6.100 HSQC NMR (500 MHz, CDCl3) of compound 116 ...................................... 457 
Figure A6.101 GCOSY NMR (500 MHz, CDCl3) of compound 116 .................................... 458 
Figure A6.102 1H NOESY NMR (500 MHz, CDCl3) of compound 116 ................................ 459 
Figure A6.103 1H NMR (500 MHz, CDCl3) of compound 115 ............................................ 460 
Figure A6.104 Infrared spectrum (thin film/NaCl) of compound 115 ................................... 461 
Figure A6.105 13C NMR (125 MHz, CDCl3) of compound 115 ........................................... 461 
Figure A6.106 1H NMR (500 MHz, CDCl3) of compound 117a .......................................... 462 
Figure A6.107 Infrared spectrum (thin film/NaCl) of compound 117a ................................. 463 
Figure A6.108 13C NMR (125 MHz, CDCl3) of compound 117a .......................................... 463 
Figure A6.109 1H NMR (500 MHz, CDCl3) of compound 117b .......................................... 464 
Figure A6.110 Infrared spectrum (thin film/NaCl) of compound 117b ................................. 465 
Figure A6.111 13C NMR (125 MHz, CDCl3) of compound 117b ......................................... 465 
 
    
xxxiii 
ADDENDIX 7 
Figure A7.1.1.  ORTEP drawing of 117 ................................................................................ 467  
  
APPENDIX 8 
Figure A8.1.1.1  Natural products containing benzylic quaternary stereocenters .................. 480 
Figure A8.2.2.1 Proposed catalytic cycle for the α-arylation of cyclic ketones using in situ 
generated enolates ....................................................................................... 488 
Figure A8.2.2.2 Proposed catalytic cycle for the α-arylation of cyclic ketones using in situ 
generated enolates ....................................................................................... 489 
Figure A8.3.1.1 Summarized results of screen 1 at 60 °C ...................................................... 491 
Figure A8.3.2.1 Summarized results of screen 2 at 60 °C ...................................................... 493 
Figure A8.4.1 Elaborated ligand search .............................................................................. 495 
Figure A8.4.2 Optimization of fluoride donor, reaction time and temperature ................... 496 
Figure A8.4.3 Further optimization of ligand, solvent and temperature .............................. 497 
Figure A8.4.4 Further optimization of ligand, solvent and temperature .............................. 498 
Figure A8.4.5 Importance of metal source to ligand ratio ................................................... 499 
 
APPENDIX 9 
 Figure A9.1.1.1 The structures of (+)-lingzhiol and (–)-lingzhiol ............................................ 512 
 Figure A9.4.1.1 A hypothesis regarding the electronics of exocyclic olefin 182 .................... 520 
  
APPENDIX 10 
Figure A10.1 1H NMR (500 MHz, CDCl3) of compound 181 ............................................ 545 
Figure A10.2 13C NMR (125 MHz, CDCl3) of compound 181 ........................................... 546 
Figure A10.3 1H NMR (300 MHz, CDCl3) of compound 174 ............................................ 547 
Figure A10.4 1H NMR (300 MHz, CDCl3) of compound 173 ............................................ 548 
Figure A10.5 1H NMR (500 MHz, CDCl3) of compound 172 ............................................ 549 
Figure A10.6 13C NMR (125 MHz, CDCl3) of compound 172 ........................................... 550 
Figure A10.7 1H NMR (500 MHz, CDCl3) of compound 183 ............................................ 551 
Figure A10.8 13C NMR (125 MHz, CDCl3) of compound 183 ........................................... 552 
Figure A10.9 1H NMR (300 MHz, CDCl3) of compound 187 ............................................ 553 
    
xxxiv 
Figure A10.10 1H NMR (300 MHz, CDCl3) of compound 188’ ........................................... 554 
Figure A10.11 1H NMR (300 MHz, CDCl3) of compound 189 ............................................ 555 
Figure A10.12 1H NMR (500 MHz, CDCl3) of compound 190 ............................................ 556 
Figure A10.13 1H NMR (500 MHz, CDCl3) of compound 191 ............................................ 557 
Figure A10.14 13C NMR (125 MHz, CDCl3) of compound 191 ........................................... 558 
Figure A10.15 1H NMR (500 MHz, CDCl3) of compound 192 ............................................ 559 
Figure A10.16 1H NMR (500 MHz, CDCl3) of compound 193 ............................................ 560 
Figure A10.17 13C NMR (125 MHz, CDCl3) of compound 193 ........................................... 561 
Figure A10.18 1H NMR (500 MHz, CDCl3) of compound 194 ............................................ 562 
Figure A10.19 13C NMR (125 MHz, CDCl3) of compound 194 ........................................... 563 
Figure A10.20 1H NMR (500 MHz, CDCl3) of compound 195 ............................................ 564 
Figure A10.21 13C NMR (125 MHz, CDCl3) of compound 195 ........................................... 565 
Figure A10.22 1H NMR (300 MHz, CDCl3) of compound 196 ............................................ 566 
 
 
 
LIST OF SCHEMES 
 
 
CHAPTER 1 
 
Scheme 1.1.1.1  Palladium catalyzed allylic alkylation pioneered by Tsuji and coworkers ........ 2 
Scheme 1.1.1.2  State of the art in asymmetric alkylation of prochiral enolates, 2003 ................ 3 
Scheme 1.1.1.3  Stoltz and coworkers approach to asymmetric allylic alkylation ...................... 4 
Scheme 1.1.1.4  Asymmetric allylic alkylation by Trost (A) and Jacobsen (B) ............................. 5 
Scheme 1.1.2.1 Selected modern methods for the synthesis of cycbutanoids according to (A) 
Baudoin, (B) Toste, and (C) Echavarren ............................................................ 7 
 
CHAPTER 2 
 
Scheme 2.2.1.1  TMSE β-ketoester substrate synthesis ............................................................ 142 
Scheme 2.2.1.2 Fluoride-triggered deprotection of TMSE β-ketoester substrate  .................... 142 
 
CHAPTER 4 
    
xxxv 
 
Scheme 4.4.1  Rapid generation of molecular and stereochemical complexity employing 
    allylic alkylation products ............................................................................ 340 
 
APPENDIX 8 
 
Scheme A8.1.1.1 Initial Reports of Direct α-Arylation of Ketones by Buchwald (A) and Hartwig  
  (B) ................................................................................................................ 481 
Scheme A8.1.1.2 Improved Catalyst Systems for α-Arylation by Hartwig (A) and Buchwald (B)482 
Scheme A8.1.2.1 Current State of the Art in Catalytic Asymmetric α-Arylation to Form α-
Quaternary Ketones ..................................................................................... 484 
Scheme A8.2.1.1 Proposed catalytic cycle of asymmetric allylic alkylation ............................. 486 
Scheme A8.2.1.2 A. Asymmetric protonation of allyl β-ketoesters; B. Stereoselective conjugate 
addition–allylation cascade reaction ............................................................ 487 
Scheme A8.3.1.1 Initial screens for α-arylation reactivity ........................................................ 490 
Scheme A8.3.2.1 Revised screens for α-arylation reactivity ..................................................... 492 
Scheme A8.5.2.1 Conceptual schemes for deacylative enolate formation: A. previous research by 
Tunge and coworkers; B. proposed allylic alkylation via deacylative pathway; 
C. proposed  α-arylation via deacylative pathway ........................................ 501 
 
 
APPENDIX 9 
 
Scheme A9.2.1  First-generation retrosynthetic analysis for (+)-lingzhiol ............................... 514 
Scheme A9.3.1.1 First-generation retrosynthetic analysis for (+)-lingzhiol model system ......... 515 
Scheme A9.3.2.1 A. Foreseeable difficulties in advancing methyl Grignard addition to ketone 
176; B. Synthesis of olefin 181 ..................................................................... 516 
Scheme A9.3.2.2 Optimization studies for the tandem hydroboration/oxidation elimination of 
181 .............................................................................................................. 517 
Scheme A9.3.2.3 Synthesis of oxime 172 and attempts at (3+2) cycloaddition ........................ 518 
    
xxxvi 
Scheme A9.3.2.4.  The intramolecular (3+2) cycloaddition of nitrone 182 to form  
   tetracycle 183 .............................................................................................. 519 
Scheme A9.4.2.1 Synthesis of revised model for (3+2) cycloaddition studies ........................... 521 
Scheme A9.4.2.2 Synthesis of revised model for (3+2) cycloaddition studies ........................... 522 
Scheme A9.4.2.3 Studies toward the dehydration of tertiary alcohol 196 ................................ 523 
Scheme A9.5.1  Second-generation retrosynthetic analysis toward the synthesis of 
   (+)-lingzhiol ................................................................................................. 524 
Scheme A9.5.2  Second-generation retrosynthetic analysis toward the synthesis of  
   (+)-lingzhiol ................................................................................................. 525 
 
 
LIST OF TABLES 
 
CHAPTER 1 
 
Table 1.2.2.1 Initial optimization of the palladium catalyzed allylic alkylation reaction ...... 10 
Table 1.6.8.1 Determination of enantiomeric excess ......................................................... 149  
  
CHAPTER 2 
  
Table 2.2.2.1 TMSE β-ketoester allylic alkylation initial optimization experiments ............ 144 
Table 2.2.2.2 TMSE β-ketoester allylic alkylation solvent effects on reaction yield ............ 145 
Table 2.2.2.3 TMSE β-ketoester allylic alkylation solvent effects on reaction selectivity ..... 146 
Table 2.6.8.1 Optimization of reaction parameters ............................................................ 169 
Table 2.6.11.1 Determination of enantiomeric excess and optical rotations ........................ 179 
 
CHAPTER 3 
 
 Table 3.2.1.1 Optimization of reaction parameters ............................................................ 230 
Table 3.6.2.1 Optimization of reaction parameters ............................................................ 239 
Table 3.6.8.1 Determination of enantiomeric excess ......................................................... 263 
 
APPENDIX 4 
 
    
xxxvii 
 Table A4.1 Crystal Data and Structure Analysis Details for allylation ketoester 100f ...... 320 
 Table A4.2    Atomic coordinates  ( x 104) and equivalent  isotropic displacement 
parameters (Å2x 103) for 100f.  U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor ............................................................................ 322 
Table A4.3    Bond lengths [Å] and angles [°] for 100f ...................................................... 323 
Table A4.4    Anisotropic displacement parameters  (Å2x 104 ) for 100f.  The anisotropic 
displacement factor exponent takes the form: -2p2 [ h2 a*2U 11  + ... + 2 h k 
a* b* U12 ] .................................................................................................. 327 
 
Table A4.5    Hydrogen coordinates ( x 103) and isotropic  displacement parameters (Å2x 
103) for 100f ............................................................................................... 328 
Table A4.6    Hydrogen bonds for 100f  [Å and °]. ............................................................ 328 
 
CHAPTER 4 
 
Table 4.2.1  Optimization of the Ir-catalyzed asymmetric allylic alkylation ..................... 334 
Table 4.3.1.1  Exploration of the reaction scope with respect to allyl electrophile .............. 336 
Table 4.3.3.1  Exploration of the reaction scope with respect to β-ketoester nucleophile .... 339 
Table 4.6.2.1  Optimization of reaction parameters ............................................................ 343 
Table 4.6.7.1  Determination of enantiomeric excess…………………………………………378 
  
APPENDIX 7 
 
 Table A7.1 Crystal Data and Structure Analysis Details for diol 117 .............................. 464 
 Table A7.2    Atomic coordinates  ( x 104) and equivalent  isotropic displacement 
parameters (Å2x 103) for 117.  U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor ............................................................................ 469 
Table A7.3    Bond lengths [Å] and angles [°] for 117 ....................................................... 470 
Table A7.4    Anisotropic displacement parameters  (Å2x 104 ) for 117.  The anisotropic 
displacement factor exponent takes the form: -2π2 [ h2 a*2U 11  + ... + 2 h k 
a* b* U12 ] .................................................................................................. 474 
 
Table A7.5    Hydrogen coordinates ( x 103) and isotropic  displacement parameters (Å2x 
    
xxxviii 
103) for 117 ................................................................................................. 475 
 Table A7.6   Hydrogen bonds for 117  [Å and °]. ............................................................. 476 
 Table A7.7   Torsion angles [°] for 117  [Å and °]. ........................................................... 478 
  
 
 
 
 
    
xxxix 
LIST OF ABBREVIATIONS 
 
 
 [α]D  angle of optical rotation of plane-polarized light 
Å   angstrom(s) 
p-ABSA  para-acetamidobenzenesulfonyl azide 
Ac   acetyl 
AIBN  azobisisobutyronitrile 
APCI  atmospheric pressure chemical ionization 
app  apparent 
aq   aqueous 
Ar   aryl group 
At   benztriazolyl 
atm  atmosphere(s) 
BINAP  2,2'-bis(diphenylphosphino)-1,1'-binaphthyl 
Bn   benzyl 
Boc  tert-butoxycarbonyl 
bp   boiling point 
br   broad 
Bu   butyl 
n-Bu  butyl or norm-butyl 
t-Bu  tert-butyl 
Bz   benzoyl 
c   concentration of sample for measurement of optical rotation 
    
xl 
13C   carbon-13 isotope 
/C   supported on activated carbon charcoal 
°C   degrees Celcius 
ca.   approximately (Latin: circum) 
calc’d  calculated 
Cbz  benzyloxycarbonyl 
CCDC  Cambridge Crystallographic Data Centre 
CDI  1,1’-carbonyldiimidazole 
cf.   consult or compare to (Latin: confer) 
cm–1  wavenumber(s) 
cod  1,5-cyclooctadiene 
comp  complex 
conc.  concentrated 
Cy   cyclohexyl 
CSA  camphor sulfonic acid 
d   doublet 
d   dextrorotatory 
DABCO  1,4-diazabicyclo[2.2.2]octane 
dba  dibenzylideneacetone 
DBU  1,8-diazabicyclo[5.4.0]undec-7-ene 
DCE  1,2-dichloroethane 
de   diastereomeric excess 
DIAD  diisopropyl azodicarboxylate 
    
xli 
DIBAL  diisobutyl aluminum hydride 
DMAP  4-dimethylaminopyridine 
DME  1,2-dimethoxyethane 
DMF  N,N-dimethylformamide 
DMSO  dimethylsulfoxide 
dppb  1,3-bis(diphenylphosphino)butane 
dppf  1,3-bis(diphenylphosphino)ferrocene 
dppe  1,3-bis(diphenylphosphino)ethane 
dppp  1,3-bis(diphenylphosphino)propane 
dr   diastereomeric ratio 
ee   enantiomeric excess 
E   methyl carboxylate (CO2CH3) 
E+   electrophile 
E   trans (entgegen) olefin geometry 
e.g.  for example (Latin: exempli gratia) 
EI   electron impact 
eq   equation 
ESI  electrospray ionization 
Et   ethyl 
et al.  and others (Latin: et alii) 
EtOAc  ethyl acetate 
FAB  fast atom bombardment 
g   gram(s) 
    
xlii 
h   hour(s) 
1H   proton 
hν   light 
HPLC  high performance liquid chromatography 
HRMS  high resolution mass spectrometry 
Hz   hertz 
IBX  2-iodoxybenzoic acid 
IC50  half maximal inhibitory concentration (50%) 
i.e.   that is (Latin: id est) 
iNOS  human-inducible nitric oxide synthase 
IR   infrared spectroscopy 
J   coupling constant 
k   rate constant 
kcal  kilocalorie(s) 
kg   kilogram(s) 
KHMDS  potassium bis(trimethylsilyl)amide 
L   liter or neutral ligand 
l   levorotatory 
LDA  lithium diisopropylamide 
LHMDS  lithium bis(trimethylsilyl)amide 
LTMP  lithium 2,2,6,6-tetramethylpiperidide 
m   multiplet or meter(s) 
M   molar or molecular ion 
    
xliii 
m   meta 
µ   micro 
m-CPBA  meta-chloroperbenzoic acid 
Me   methyl 
mg   milligram(s) 
MHz  megahertz 
min  minute(s) 
mL   milliliter(s) 
MM  mixed method 
mol  mole(s) 
MOM  methoxymethyl 
mp   melting point 
Ms   methanesulfonyl (mesyl) 
MS  molecular seives 
m/z   mass-to-charge ratio 
N   normal or molar 
NBS  N-bromosuccinimide 
nm   nanometer(s) 
NMR  nuclear magnetic resonance 
NOE  nuclear Overhauser effect 
NOESY  nuclear Overhauser enhancement spectroscopy 
Nu—  nucleophile 
o   ortho 
    
xliv 
[O]   oxidation 
OAc  Acetate 
p   para 
Ph   phenyl 
pH   hydrogen ion concentration in aqueous solution 
pKa  acid dissociation constant 
PMB  para-methoxybenzyl 
ppm  parts per million 
Pr   propyl 
i-Pr  isopropyl 
py   pyridine 
q   quartet 
R   alkyl group 
R   rectus 
RCM  ring-closing metathesis 
ref   reference 
Rf   retention factor 
RNA  ribonucleic acid 
s   singlet or seconds 
S   sinister 
sat.   saturated 
Selectfluor  1-Chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane 
bis(tetrafluoroborate) 
    
xlv 
SFC  supercritical fluid chromatography 
t   triplet 
TBAF  tetra-n-butylammonium fluoride 
TBAT  tetra-n-butylammonium difluorotriphenylsilicate 
TBD  1,5,7-triazabicyclo[4.4.0]dec-5-ene  
TBHP  tert-butyl hydroperoxide 
TBS  tert-butyldimethylsilyl 
temp  temperature 
Tf   trifluoromethanesulfonyl 
tR   retention time 
THF  tetrahydrofuran 
TLC  thin layer chromatography 
TMP  2,2,6,6-tetramethylpiperidine 
TMS  trimethylsilyl 
TMSE  2(trimethylsilyl)ethyl 
TOF  time-of-flight 
tol   tolyl 
Ts   para-toluenesulfonyl (tosyl) 
UV  ultraviolet 
w/v  weight per volume 
v/v   volume per volume 
X   anionic ligand or halide 
Z   cis (zusammen) olefin geometry 
Chapter 1 – Enantioselective Construction of α-Quaternary Cyclobutanones by Catalytic 
Asymmetric Allylic Alkylation 
 
1 
 
CHAPTER 1 
Enantioselective Construction of α-Quaternary Cyclobutanones by 
Catalytic Asymmetric Allylic Alkylation1 
 
1.1 INTRODUCTION  
1.1.1 Palladium catalyzed allylic alkylation 
 The synthesis of stereogenic all-carbon quaternary centers remains a formidable 
challenge, notwithstanding the strides made by modern organic chemistry in this regard.1  
Contemporary advances in enolate alkylation have made it a fundamental strategy for the 
construction of C–C bonds.2  Allylic alkylation of tetrasubstituted enolates to give rise to 
 α-quaternary carbonyl compounds has emerged as an efficient solution to this problem.3 
The Tsuji research group was among the first to study this class of transformations and 
pioneering investigations undertaken nearly three decades ago by, which culminated in a 
series of disclosures describing novel decarboxylative entry into the palladium-catalyzed 
allylic alkylation of cyclic ketones (Scheme 1.1.1.1).4  
A simple mechanistic framework for the transformation begins with the oxidative 
addition of Pd0 into the allyl group of an allyl enol carbonate (1), allyl β-ketoesters (2) or 
 
1 This work was performed in collaboration with Christian Eidamshaus and Jimin Kim, postdoctoral 
researchers in the Stoltz group.  This work has been published. See: Reeves, C. M, Eidamshaus, C.; Kim, 
J.; Stoltz, B. M.  Angew. Chem. Int. Ed. 2013, 52, 6718. 
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silyl enol ethers (3) in the presence of an allyl source (4), and gives a palladium π-allyl 
species (6), and the corresponding free carboxylate species.  Spontaneous 
decarboxylation of the free carboxylate yields a tetrasubstituted enolate (5) that may enter 
into a catalytic cycle and furnish α-quaternary ketones (7).  This method of enolate 
formation is particularly attractive in that the so-called “thermodynamic” enolate can be 
selectively generated in situ, in the absence of exogenous base under kinetic control.  
Furthermore, excellent positional fidelity is observed between the site of enolization and 
the site of allylic alkylation.  
 
Scheme 1.1.1.1 Palladium catalyzed allylic alkylation pioneered by Tsuji and coworkers 
 
 
 
Although methods for the alkylation of a number of enolate types (e.g., ester, 
ketone, amide, etc.) with a variety of alkylating agents exist, catalytic enantioselective 
variants of these transformations are relatively rare.5  Of the catalytic asymmetric 
methods available, there have been few examples of general techniques for the 
asymmetric alkylation of carbocyclic systems, and still fewer that have the capacity to 
O O
O
O O
O
OTMS
Pd(0)
O
1
2
3
5
O
6
+
7
2
O
O
[Pd]
–CO2
4
–TMSF
–Oallyl
Chapter 1 – Enantioselective Construction of α-Quaternary Cyclobutanones by Catalytic 
Asymmetric Allylic Alkylation 
 
3 
deliver all-carbon quaternary stereocenters. 6   While the Merck phase transfer 
methylation, and Koga alkylation of 2-alkyltetralone-derived silyl enol ethers represent 
notable exceptions,4 the breadth of application and utility of these reactions has been 
limited.  In fact, at the outset of investigations by the Stoltz group in this area, there were 
no examples of catalytic enantioselective alkylations of monocyclic 2-substituted 
cycloalkanone enolates in the absence of either α’-blocking groups or α-enolate 
stabilizing groups (e.g., 8, R = aryl, ester, etc., Figure 1.1.1.2).   
 
Scheme 1.1.1.2.  State of the art in asymmetric alkylation of prochiral enolates, 2003.   
 
 
 
 
In 2003, we initiated a program for the catalytic enantioselective synthesis of all-
carbon quaternary stereocenters by allylic alkylation of prochiral cyclic ketone enolates.  
We adapted a protocol originally developed by Tsuji7 to incorporate a chiral ligand 
scaffold, and found that the phosphinooxazoline (PHOX) ligands (e.g., L1, Scheme 
1.1.1.3)8 were optimal for both chemical yields and enantioselectivity.9  The allylic 
alkylation protocol developed in the Stoltz laboratory is robust enough to prevail upon 
several different enolate precursor classes, namely allyl enol carbonates (10), enol silanes 
(11), and β-ketoesters (12) to deliver the desired α-quaternary cyclic ketone products (13) 
in good to excellent yields and enantioselectivies.9,10 
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Scheme 1.1.1.3.  Stoltz and coworkers’ approach to asymmetric allylic alkylation   
 
 
 
In addition, the reaction is highly tolerant of a broad range of functionality and 
substitution on both the enolate precursors and allyl fragments.  Enolates derived from 
cyclic ketones,9 enones,10 vinylogous esters,11 vinylogous thioesters,12 tetralones,10 and 
dioxanones13 function with similar levels of selectivity in the catalytic asymmetric 
chemistry.  We have also developed a scale-up protocol employing 2.5 mol % Pd that 
allows access to >10 g of enantioenriched material in excellent yields.14  
Concurrent to our work in this area, 10,15 Trost and coworkers have published a 
series of papers that complement our studies in asymmetric alkylation, and which employ 
symmetric bidentate C-2 symmetric bisphosphine ligands (L2, Scheme 1.1.1.4a). 16  
Shortly after this report, Jacobsen and coworkers, as well, have revealed a unique 
enantioselective method involving the chromium-catalyzed reaction of tin-enolates (16) 
with a variety of non-activated alkyl halides (Scheme 1.1.1.4b).6 
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Scheme 1.1.1.4.  Asymmetric allylic alkylation by Trost (A) and Jacobsen (B) 
 
 
 
1.1.2 Palladium-catalyzed allylic alkylation of cyclobutanones 
In the domain of asymmetric allylic alkylation, cyclobutanones have received far 
less attention relative to their five-, six- and seven-membered congeners, despite the fact 
that these compounds and their derivatives are prevalent in important biologically-active 
natural products17 (18–22, Figure 1.1.2.1A).  Additionally, cyclobutanes have been shown 
to serve as highly valuable synthetic intermediates for a variety of transformations.18  The 
dearth of reports describing the asymmetric alkylation of cyclobutanones may be 
attributed to the fact that these compounds possess an estimated 26–28.6 kcal/mol of 
ring-strain19 and, in turn, exhibit enhanced carbonyl electrophilicity.20  The propensity of 
cyclobutanones to alleviate this strain via electrophilic ring opening is often a limiting 
challenge during their manipulation.  Moreover, the energetic requirements for 
enolization of cyclobutanones (23) are compounded by a concomitant increase in ring-
strain to 31–34 kcal/mol (calculated for cyclobutene 24, Figure 1.1.2.1B)18 as well as 
enforced deviation from the more favorable puckered conformation (25→26, Figure 
1.1.2.1C).21  In the case of α-substituted cyclobutanones, enolization is further impeded 
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by the development of torsional strain between the putative enolate substituents (26, 
Figure 1.1.2.1C).22  
 
Figure 1.1.2.1.  (A) Representative cycbutanoid natural products; (B) ring, conformational and 
torsional strain in cyclobutanone enolates 
 
 
 
Given these data, it is not surprising that previous methods for the preparation of 
enantioenriched cyclobutanes have relied primarily on either [2+2] cycloaddition 
reactions23 or ring expansion from various cyclopropane derivatives.24  Recent reports 
from Baudoin on annulating C–H activation25  (Scheme 1.1.2.1A) as well as disclosures 
from Toste26 (Scheme 1.1.2.1B) and Echavarren27 (Scheme 1.1.2.1C) that employ gold(I) 
catalysis to affect cyclopropanoid rearrangements have emerged as significant new 
methods for the construction of cyclobutanes, and show the power of transition metals in 
this regard.  Organocatalytic approaches to cyclobutanone synthesis have also gained 
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traction recently. 28   Despite these advances, transformations that produce chiral 
cyclobutanones remain limited in scope, and very few methods exist for the catalytic 
construction of chiral cyclobutanones from achiral starting materials.9b,29 In order to 
address these limitations and to further develop the nucleophilic chemistry of these 
unusually reactive compounds, we report herein the first direct transition metal-catalyzed 
asymmetric α-alkylation of cyclobutanones to form all-carbon quaternary centers.   
 
Scheme 1.1.2.1.  Selected modern methods for the synthesis of cycbutanoids according to (A) 
Baudoin, (B) Toste, and (C) Echavarren 
 
 
 
1.2 PREPARATION OF CYCLOBUTANONE β-KETOESTER SUBSTRATES AND 
REACTION OPTIMIZATION 
1.2.1 Cyclobutanone β-ketoester substrate synthesis 
A longstanding interest of our research group has been the transition metal-
catalyzed asymmetric α-functionalization of carbonyl compounds to form all-carbon 
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quaternary centers.30  In the course of our studies, we have developed a series of 
phosphinooxazoline (PHOX) ligands with varied steric and electronic properties that 
exhibit a range of reactivity and selectivity.  We have found that the use of electron 
deficient ligands (e.g. L6 and L7) often results in superior asymmetric induction in 
certain cases where electron-rich or electron-neutral ligands perform poorly. 31  
Examination of ligand electronic effects would, therefore, help to inform our 
development of a method for the asymmetric allylic alkylation of cyclobutanones.   
We first established a simple and efficient reaction sequence to access allyl 1-
alkyl-2-oxocyclobutanecarboxylate substrates (36) (Scheme 1).  Diazotization of 
commercially available 1,3-cyclopentane dione (34) with para-
acetamidobenzenesulfonyl azide (p-ABSA)32 delivered the corresponding diazodiketone 
(35) in consistently good yields.  Microwave-promoted Wolff rearrangement of diketone 
35 in the presence of an allylic alcohol33 (e.g., allyl alcohol, 37), followed by alkylation 
with an alkyl halide (e.g., benzyl bromide) furnished the allyl 1-alkyl-2-
oxocyclobutanecarboxylates in good yields over two steps.  With a quick and efficient 
method to access the desired substrates at hand, we next examined reaction parameters to 
identify optimal conditions for reactivity and enantioselectivity.  
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Figure 1.2.1.1 Construction of allyl 1-benzyl-2-oxocyclobutane-carboxylate (36) 
 
 
 
1.2.2 Optimization of cyclobutanone allylic alkylation 
Our initial experiments revealed that treatment of allyl 1-benzyl-2-
oxocyclobutanecarboxylate (36) with catalytic Pd2(pmdba)3 in the presence of (S)-t-
BuPHOX (L1) in THF delivered the desired α-quaternary (S)-2-allyl-2-
benzylcyclobutanone (38)34 in 90% yield, albeit in moderate enantioselectivity (Figure 
1.2.2.1, Table 1.2.2.1, Entry 1).  The use of electron-deficient ligands L6 or L7 resulted 
in considerably improved enantioinduction (Table 1.2.2.1, Entries 2 and 5).  Although the 
reaction proceeds well in a number of solvents, toluene was identified as optimal for 
inducing asymmetry.  This solvent effect is likely due to an enhanced binding between 
the enolate and the electrophilic sigma-allyl-Pd(II) center in the catalytic cycle, which 
may reinforce a tight ion pair and lead to an inner-sphere mechanism.35  Finally, at 
temperatures just below ambient, the reaction was found to proceed at a reasonable rate 
and with high enantioselectivity.   
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Figure 1.2.2.1.  General initial reaction parameters and select ligands  
 
 
 
 
Table 1.2.2.1.  Initial optimization of the palladium-catalyzed allylic alkylation reaction 
 
Entry Ligand Solvent T [°C] ee [%] 
 
1 
 
L1 
 
THF 
 
25 
 
58 
2 L6 THF 25 75 
3 L6 p-dioxane 25 84 
4 L6 benzene 25 84 
5 L7 toluene 25 84 
6 L6 toluene 25 85 
     
     
In order to fully explore the effects of solvent on the reactions selectivity, we 
made use of the reaction automation system in the Caltech Center for Catalysis and 
Chemical Synthesis.  A Symyx systems robot was employed to expedite a panel of 
experiments that varied solvent and temperature, while holding constant reaction 
variables that were found be to optimal during preliminary screening (i.e., ligand L6 and 
relatively non-polar solvent).36  These studies illustrated that while the reaction was most 
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selective when carried out in relatively non-polar solvent, a number of different non-polar 
solvents or solvent combinations could be employed without significant detriment to the 
reaction selectivity (Figure 1.2.2.2).  Finally, these studies revealed that, in most cases, 
decreasing the temperature at which the reaction was carried out resulted in an increase in 
selectivity.   
 
Figure 1.2.2.2.  Solvent and temperature optimization of the palladium catalyzed allylic alkylation 
reaction 
 
 
1.3 EXPLORATION OF THE REACTION SCOPE 
1.3.1 Reaction scope with respect to enolate α-substitution 
With these optimized conditions identified, we next explored the influence of 
different α-substituents (R1, Figure 1.3.1.1) on the efficacy of the allylic alkylation 
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process.  To aid in the isolation of these highly volatile products, we chose coupling 
fragments of higher molecular weights, bearing substitution at both the α-position and 
allyl fragment  (i.e. 2-phenylallyl and 1-alkyl-2-oxocyclobutanecarboxylate).  We were 
pleased to find that α-alkyl substituents were well tolerated with enantiomeric excess up 
to 99% (Figure 1.3.1.1, 40a–40b).  α-Benzyl substituents were found to give the 
respective α-quaternary cyclobutanones with uniformly excellent enantioselectivity 
regardless of the electronic nature of the benzyl moiety (compounds 40c–40e).  In 
addition to alkyl- and benzyl- substituents, allyl-, TMS-protected propargyl and 
heteroaryl substituted 2-carboxyallyl cyclobutanones proved to be eligible substrates in 
the asymmetric allylic alkylation reaction providing cyclobutanones 40f–40h in high 
yields and enantiomeric excess. 
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Figure 1.3.1.1.  Reaction scope with respect to α-quaternary substitution (R1) 
 
 
 
1.3.2 Reaction scope with respect to allyl coupling partner substitution 
Having surveyed the scope of the process with respect to various substituents at 
the quaternary center, we were poised to investigate the influence of different allyl 
substitution on the process (R2, Figure 1.3.2.1).  In accord with previous studies on the 
palladium-catalyzed asymmetric allylic alkylation, the catalytic system was found to be 
relatively inactive when terminally-substituted or cyclic allyl fragments were employed.15   
As such, we limited our survey to carboxyallyl fragments bearing substituents at the 2-
allyl position.  Gratifyingly, diverse substituents were well tolerated (Figure 1.3.2.1).  All 
α-quaternary cyclobutanones were obtained in moderate to high yield and with 
outstanding enantiopurity.  Particularly interesting are compounds 42a, 42c, and 42d 
featuring a butadiene, a vinyl chloro and a benzyl ether moiety, respectively.  Each of 
these diverse functional groups may potentially serve as handles for various 
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derivatization reactions  (e.g., cycloaddition, annulation or transition metal-catalyzed 
cross-coupling).   
 
Figure 1.3.2.1.  Reaction scope with respect to allyl substitution (R2) 
 
 
 
1.4 DERIVATIZATION OF REACTION PRODUCTS 
Myriad studies have shown cyclobutanoids to be highly valuable synthetic 
intermediates, allowing access to enantioenriched oxazepines, 37  piperidines, 38 
tetrahydropyrans,39 α- and β-quaternary cyclopentanones,17 benzannulated polycycles40 as 
well as β-quaternary linear ketones.17 Cyclobutanones may participate directly in a 
variety of robust classical transformations, such as Baeyer-Villiger oxidation and 
Beckmann rearrangement,17 as well as transition metal-catalyzed ring expansion,41 ring 
contraction42 and ring-opening processes.43  To demonstrate the utility of our asymmetric 
synthesis of cyclobutanones within this domain, we carried out a number of 
transformations on the chiral cyclobutanones generated in this study.  Ring expansion by 
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Baeyer-Villiger oxidation, treatment with trimethylsilyldiazomethane and Beckmann 
rearrangement all proceeded smoothly to deliver dialkyl γ-lactone 44, α-quaternary 
cyclopentanone 45 and dialkyl γ-lactam 46, respectively.  Additionally, ring-closing 
metathesis of diallyl-substituted cyclobutanone 40f cleanly furnished quaternary [4.5]-
spirocycle 47.  
 
Figure 1.4.1.  Derivatization of α-quaternary cyclobutanones 
 
 
 
1.5 CONCLUDING REMARKS 
In summary, we have developed the first transition metal-catalyzed 
enantioselective α-alkylation of cyclobutanones.  This method employs palladium 
catalysis and an electron-deficient PHOX type ligand to afford α-quaternary 
cyclobutanones in good to excellent yields and enantioselectivities.  A wide variety of 
substituents are tolerated at both the α-keto and 2-allyl positions.  The mild nature of our 
method is reflected in its compatibility with otherwise highly electrophilic 
cyclobutanones.  We have further demonstrated the utility of chiral cyclobutanones as 
synthetic building blocks to access a variety of enantioenriched derivative compounds 
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including dialkyl γ-lactams, dialkyl γ-lactones, α-quaternary cyclopentanones and 
quaternary [4.5]-spirocycles.  We believe that this novel synthetic method will enable the 
expeditious synthesis of complex bioactive natural products and pharmaceutical 
components by providing unique access to previously unknown and inaccessible 
enantioenriched α-quaternary cyclobutanones.  Efforts toward this end are currently 
underway in our laboratory. 
 
1.6 EXPERIMENTAL SECTION 
1.6.1 Materials and Methods 
Unless otherwise stated, reactions were performed in flame-dried glassware under 
an inert atmosphere of argon or nitrogen using dry, deoxygenated solvents.  Reaction 
progress was monitored by thin-layer chromatography (TLC).  THF, Et2O, CH2Cl2, 
toluene, benzene, CH3CN, and dioxane were dried by passage through an activated 
alumina column under argon.  Triethylamine was distilled over CaH2 prior to use.  Brine 
solutions are saturated aqueous solutions of sodium chloride.  1,3-Cyclopentanedione was 
purchased from AK Scientific, Inc., reagent grade acetone was purchased from Aldrich 
and distilled from anhydrous Ca2SO4 and stored over molecular sieves (3 Å) under an 
atmosphere of argon.  para-Acetamidobenzenesulfonyl azide (p-ABSA) was prepared 
following a procedure by Davies et al. 44  2-Phenylprop-2-en-1-ol, 2-(4-
methoxyphenyl)prop-2-en-1-ol and 2-(3-fluorophenyl)prop-2-en-1-ol were prepared 
according to the method by Gouverneur and Brown.45 2-Diazocyclopentane-1,3-dione 
was prepared through diazotization of 1,3-cyclopentanedione with p-ABSA following a 
procedure by Coquerel and Rodriguez.46  Phosphinooxazoline (PHOX) ligands were 
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prepared by methods described in our previous work.9, 47  Tris(4,4’-
methoxydibenzylideneacetone)dipalladium(0) (Pd2(pmdba)3) was prepared according to 
the method of Ibers48 or Fairlamb.49 All other reagents were purchased from Sigma-
Aldrich, Acros Organics, Strem, or Alfa Aesar and used as received unless otherwise 
stated.  Reaction temperatures were controlled by an IKAmag temperature modulator 
unless otherwise indicated. Stirring was accomplished with Teflon® coated magnetic stir 
bars. Microwave-assisted reactions were performed in a Biotage Initiator 2.5 microwave 
reactor.  Glove box manipulations were performed under a N2 atmosphere.  TLC was 
performed using E. Merck silica gel 60 F254 precoated glass plates (0.25 mm) and 
visualized by UV fluorescence quenching, p-anisaldehyde, or KMnO4 staining.  Silicycle 
SiliaFlash P60 Academic Silica gel (particle size 0.040-0.063 mm) was used for flash 
column chromatography.  1H NMR spectra were recorded on a Varian Inova 500 MHz 
spectrometer and are reported relative to residual CHCl3 (δ 7.26 ppm), C6H6 (δ 7.16 ppm), 
or CH2Cl2 (δ 5.32 ppm).  13C NMR spectra were recorded on a Varian Inova 500 MHz 
(126 MHz) or Varian Mercury 300 MHz (75 MHz) spectrometer and are reported relative 
to CHCl3 (δ 77.16 ppm) or C6H6 (δ 128.06 ppm).  Data for 1H NMR are reported as 
follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), integration).  
Multiplicities are reported as follows: s = singlet, d = doublet, t = triplet, q = quartet, p = 
pentet, h = heptet, m = multiplet, br s = broad singlet, br d = broad doublet, app = 
apparent.  Data for 13C are reported in terms of chemical shifts (δ ppm).  IR spectra were 
obtained using a Perkin Elmer Spectrum BXII spectrometer using thin films deposited on 
NaCl plates and reported in frequency of absorption (cm–1).  Optical rotations were 
measured with a Jasco P-2000 polarimeter operating on the sodium D-line (589 nm) 
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using a 100 mm path-length cell and are reported as: [α]DT (concentration in g/100 mL, 
solvent, ee).  Analytical UHPLC-LCMS was performed with an Agilent 1290 Infinity 
Series UHPLC/Agilent 6140 Quadrupole LCMS utilizing an Agilent Eclipse Plus C18 
RRHD 1.8 µm column (2.1 x 50 mm), part number 959757-902.  High-resolution mass 
spectra (HRMS) were obtained from the Caltech Mass Spectral Facility (EI+ or FAB+) or 
on an Agilent 6200 Series TOF with an Agilent G1978A Multimode source in 
electrospray ionization (ESI), atmospheric pressure chemical ionization (APCI), or mixed 
(MM: ESI-APCI) ionization mode. 
 
1.6.2 Representative procedure for the preparation of 2-
oxocyclobutanecarboxylates  
 
 
2-Phenylallyl 2-oxocyclobutanecarboxylate.  To a 20 mL microwave vial charged with 
a magnetic stir bar were added 2-diazocyclopentane-1,3-dione (35, 500 mg, 4.03 mmol), 
toluene (13.5 mL) and 2-phenylprop-2-en-1-ol (47, 540 mg, 4.03 mmol).  The vial was 
sealed with a microwave crimp cap and heated to 180 °C for one hour using a Biotage 
Initiator microwave reactor (sensitivity set to low; reaction mixture heated gradually over 
first 2 min by increasing the temperature in 20 °C increments).  After 30 min of stirring, 
the mixture was cooled to ambient temperature and the pressure was released by puncture 
of the crimp cap with a needle.  The reaction vessel was then subsequently irradiated at 
180 °C for an additional 30 min.  The vessel was then cooled to ambient temperature, the 
O
O
Oµ-waves, toluene
180 °C, 1 h
O O
N2
35 48
HO
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vial uncapped and mixture directly loaded onto a silica gel column followed by elution 
with hexanes to 20% EtOAc in hexanes to afford of 48 (635 mg, 68% yield) as a 
colorless oil. Rf = 0.2 (20% EtOAc in hexanes); 1H NMR (300 MHz, CDCl3) δ 7.44−7.30 
(m, 5H), 5.57−5.55 (m, 1H), 5.40−5.39 (m, 1H), 5.06–5.05 (m, 2H), 4.26–4.20 (m, 1H), 
3.20−3.15 (m, 2H), 2.48−2.34 (m, 1H), 2.29–2.16 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 
199.5, 166.5, 142.0, 137.8, 128.5, 128.1, 126.0, 115.4, 66.5, 64.5, 47.1, 13.6; IR (Neat 
Film, NaCl) 3448, 3084, 3057, 3024, 2970, 1956, 1790, 1732, 1633, 1600, 1574, 1497, 
1445, 1387, 1310, 1177, 1046, 915, 780 cm–1; HRMS (MM: ESI-APCI) m/z calc'd for 
C14H15O3 [M+H]+: 231.1016; found 231.1018. 
 
With the exception of compound 48, all 2-carboxyallylcyclobutanone derivatives were 
directly used in the following steps without rigorous characterization due to their 
instability. 
 
1.6.3 Representative procedure for the alkylation of 2-H-2-
oxocyclobutanecarboxylates 
 
 
2-Phenylallyl 1-ethyl-2-oxocyclobutanecarboxylate (39a).  To a solution of 48 (233 
mg, 1.01 mmol) in acetone (14 mL) were added K2CO3 (224 mg, 1.62 mmol) and freshly 
distilled EtI (787 mg, 5.05 mmol).  The mixture was heated to reflux until full 
consumption of the starting material was indicated by TLC analysis (alkylation reaction 
O
O
O
48
Ph
K2CO3, acetone
reflux, 24 h
EtI (excess) O Et
O
O
39a
Ph
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times typically ranged from 12 to 24 hours).  Upon completion, the mixture was cooled to 
25 °C, the solids were removed by filtration through filter paper and the mixture was 
concentrated in vacuo.  The crude material was purified by flash column chromatography 
(SiO2, hexanes to 10% EtOAc in hexanes to 20% EtOAc in hexanes) to provide 39a (105 
mg, 40% yield) as a colorless oil.  Rf = 0.3 (20% EtOAc in hexanes); 1H NMR (300 MHz, 
CDCl3) δ 7.42−7.28 (m, 5H), 5.55 (s, 1H), 5.38 (s, 1H), 5.06 (dd, J = 9.0, 1.0 Hz, 2H), 
2.56−2.17 (m, 3H), 1.88-1.63 (m, 3H), 0.69 (t, J = 7.5 Hz, 3H); 13C NMR (75 MHz, 
CDCl3) δ 209.4, 171.5, 142.2, 137.8, 128.5, 128.1, 126.1, 116.5, 66.5, 63.7, 35.5, 30.4, 
27.1, 8.6; IR (Neat Film, NaCl) 3084, 2972, 2880, 1738, 1709, 1460, 1444, 1231, 1207, 
1138 cm–1; HRMS (EI+) m/z calc'd for C16H19O3 [M+H]+: 259.1334; found 259.1326. 
 
1.6.4 Spectroscopic data for novel cyclobutanone β-ketoester substrates 
2-Phenylallyl 1-methyl-2-oxocyclobutanecarboxylate (39b) 
 
 
Compound 39b was isolated by flash column chromatography (SiO2, hexanes to 10% 
EtOAc in hexanes) as a colorless oil. 32% yield. Rf = 0.5 (20% EtOAc in hexanes); 1H 
NMR (500 MHz, CDCl3) δ 7.40–7.29 (m, 5H), 5.54–553 (m, 1H), 5.35−5.34 (m, 1H), 
5.06 (dq, J = 11.2, 1.0 Hz, 1H), 3.20 (ddd, J = 18.3, 11.3, 7.6 Hz, 1H), 3.10 (ddd, J = 
18.3, 9.9, 6.3 Hz, 1H), 2.53 (td, J = 11.3, 6.3 Hz, 1H), 1.84 (ddd, J = 11.5, 9.9, 7.6 Hz, 
1H), 1.45 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 204.3, 170.0, 142.3, 137.9, 128.5, 
128.1, 126.0, 115.2, 69.4, 66.5, 45.3, 23.1, 18.4; IR (Neat Film, NaCl) 2970, 2930, 1788, 
O Me
O
O
Ph
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1729, 1452, 1274, 1145, 1049 cm–1; HRMS (EI+) m/z calc'd for C15H16O3 [M]+: 244.1100; 
found 244.1103. 
 
2-Phenylallyl 1-benzyl-2-oxocyclobutanecarboxylate (39c) 
 
 
Compound 39c was isolated by flash column chromatography (SiO2, hexanes to 10% 
EtOAc in hexanes) as a colorless oil. 37% yield. Rf = 0.4 (10% EtOAc in hexanes); 1H 
NMR (500 MHz, CDCl3) δ 7.33−7.14 (m, 8H), 7.04−7.02 (m, 2H), 5.47 (s, 1H), 5.28–
5.27 (m, 1H), 5.01−4.95 (m, 2H), 3.12, 3.10 (AB system, JAB = 14.2 Hz, 2H), 2.95 (ddd, J 
= 18.3, 11.1, 7.3 Hz, 1H), 2.62 (ddd, J = 18.3, 10.3, 6.3 Hz, 1H), 2.39 (ddd, J = 11.9, 
11.1, 6.3 Hz, 1H), 1.93 (ddd, J = 11.9, 10.3, 7.3 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 
203.7, 168.7, 142.1, 137.8, 135.9, 129.7, 128.51, 128.49, 128.1, 126.9, 126.0, 115.5, 75.0, 
66.7, 45.2, 37.9, 19.2; IR (Neat Film, NaCl) 3029, 2924, 1788, 1725, 1496, 1270, 1191, 
1046 cm–1;  HRMS (MM: ESI-APCI) m/z calc'd for C42H40NaO6 [2M+Na]+: 663.2717; 
found 663.2692. 
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2-Phenylallyl 1-(4-fluorobenzyl)-2-oxocyclobutanecarboxylate (39d) 
 
 
Compound 39d was isolated by flash column chromatography (SiO2, 3% EtOAc in 
hexanes to 6% EtOAc in hexanes) as a colorless oil. 22% yield. Rf = 0.4 (20% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3) δ  7.40−7.29 (m, 5H), 7.08−7.04 (m, 2H), 6.95–
6.91 (m, 2H), 5.54 (s, 1H), 5.34 (d, J = 0.9 Hz, 1H), 5.05 (s, 2H), 3.18, 3.16 (AB system, 
JAB = 14.3 Hz, 2H), 3.05 (ddd, J = 18.4, 11.2, 7.4 Hz, 1H), 2.73 (ddd, J = 18.4, 10.2, 6.2 
Hz, 1H), 2.46 (ddd, J = 11.8, 11.2, 6.2 Hz, 1H), 1.97 (ddd, J = 11.8, 10.2, 7.4 Hz, 1H); 
13C NMR (126 MHz, CDCl3) δ 203.4, 168.6, 161.9 (d, 1JCF = 245.6 Hz), 142.1, 137.8, 
131.6 (d, 4JCF = 3.7 Hz), 131.2 (d, 3JCF = 8.0 Hz), 128.5, 128.1, 126.0, 115.7, 115.3 (d, 2JCF 
= 21.2 Hz), 75.0, 66.8, 45.2, 37.0, 19.3;  IR (Neat Film, NaCl) 3052, 2968, 2928, 1784, 
1717, 1506, 1219, 1186, 1042, 912 cm–1;  HRMS (MM: ESI-APCI) m/z calc'd for 
C21H2019FO3 [M+H]+: 339.1391; found 339.1387. 
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2-Phenylallyl 1-(4-methoxybenzyl)-2-oxocyclobutanecarboxylate (39e) 
 
 
To a solution of NaI (1.88 g, 12.54 mmol) in acetone (20 mL) was added 4-
methoxybenzyl chloride (1.55 mL, 11.38 mmol). The mixture was stirred at 25 °C  for 2 
hours before K2CO3 (504 mg, 3.65 mmol) and 48 (524 mg, 2.28 mmol) were added. The 
resulting mixture was heated to reflux for 16 hours until full conversion of the starting 
material was indicated by TLC analysis. The mixture was cooled to room temperature, 
the solids removed by filtration and concentrated in vacuo. The crude material was 
purified by flash column chromatography (SiO2, hexanes to 10% EtOAc in hexanes to 
20% EtOAc in hexanes) to provide 39e (506 mg, 63% yield) as a colorless oil. Rf = 0.5 
(20% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.41−7.39 (m, 2H), 7.36–7.29 
(m, 3H), 7.04−7.01 (m, 2H), 6.80−6.77 (m, 2H), 5.54 (s, 1H), 5.36−5.35 (m, 1H), 5.08–
5.02 (m, 2H), 3.77 (s, 3H), 3.13 (s, 2H), 3.00 (ddd, J = 18.3, 11.1, 7.2 Hz, 1H), 2.68 (ddd, 
J = 18.3, 10.3, 6.4 Hz, 1H), 2.45 (ddd, J = 11.8, 11.1, 6.4 Hz, 1H), 2.00 (ddd, J = 11.8, 
10.3, 7.2 Hz, 1H);  13C NMR (126 MHz, CDCl3) δ  203.9, 168.8, 158.5, 142.1, 137.8, 
130.7, 128.5, 128.1, 127.8, 126.0, 115.5, 113.9, 75.2, 66.7, 55.2, 45.0, 37.1, 19.1;  IR 
(Neat Film, NaCl) 2957, 2933, 2836, 1788, 1725, 1513, 1248, 1179, 1037 cm–1;  HRMS 
(FAB+) m/z calc'd for C22H23O4 [M+H]+: 351.1596; found 351.1601. 
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2-Phenylallyl 1-allyl-2-oxocyclobutanecarboxylate (39f) 
 
 
Compound 39f was isolated by flash column chromatography (SiO2, 3% EtOAc in 
hexanes to 4% EtOAc in hexanes) as a colorless oil.  68% yield.  Rf = 0.2 (10% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 7.49–7.27 (m, 5H), 5.64 (ddt, J = 17.5, 9.7, 7.1 
Hz, 1H), 5.56 (q, J = 0.8 Hz, 1H), 5.38 (q, J = 1.2 Hz, 1H), 5.12–5.08 (m, 2H), 5.07 (dd, 
J = 1.4, 0.7 Hz, 2H), 3.14 (ddd, J = 18.4, 11.0, 7.4 Hz, 1H), 3.02 (ddd, J = 18.4, 10.1, 6.4 
Hz, 1H), 2.70 (ddt, J = 14.3, 7.1, 1.2 Hz, 1H), 2.59–2.44 (m, 2H), 1.99 (ddd, J = 11.9, 
10.1, 7.4 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 203.4, 168.6, 142.3, 137.9, 131.9, 
128.5, 128.1, 126.1, 119.2, 115.5, 73.6, 66.6, 45.0, 36.7, 19.5; IR (Neat Film, NaCl) 
3072, 2967, 1786, 1725, 1638, 1497, 1440, 1387, 1193, 1142, 1043, 919, 779 cm–1; 
HRMS (MM: ESI-APCI)  m/z calc'd for C17H19O3 [M+H]+: 271.1329; found 271.1330. 
 
2-Phenylallyl 2-oxo-1-(3-(trimethylsilyl)prop-2-yn-1-yl)cyclobutanecarboxylate (39g) 
 
 
Compound 39g was isolated by flash column chromatography (SiO2, 3% EtOAc in 
hexanes to 7% EtOAc in hexanes) as a colorless oil.  63% yield.  Rf = 0.3 (10% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3) δ  7.42–7.27 (m, 5H), 5.54 (q, J = 0.7 Hz, 1H), 
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5.35 (td, J = 1.3, 0.7 Hz, 1H), 5.10–4.98 (m, 2H), 3.18 (ddd, J = 18.4, 11.0, 7.4 Hz, 1H), 
3.06 (ddd, J = 18.4, 10.4, 6.5 Hz, 1H), 2.82 (d, J = 17.3 Hz, 1H), 2.69 (d, J = 17.3 Hz, 
1H), 2.48 (ddd, J = 11.8, 11.0, 6.5 Hz, 1H), 2.27 (ddd, J = 11.8, 10.4, 7.4 Hz, 1H), 0.13 
(s, 9H); 13C NMR (126 MHz, CDCl3) δ 201.9, 168.1, 142.1, 137.8, 128.5, 128.1, 126.0, 
115.4, 100.9, 87.9, 72.1, 66.8, 46.3, 22.8, 19.7, -0.1; IR (Neat Film, NaCl) 3058, 2959, 
2177, 1949, 1794, 1732, 1634, 1575, 1496, 1444, 1422, 1315, 1250, 1194, 1161, 1116, 
1028, 906, 843, 778, 760, 708 cm–1; HRMS (APCI)  m/z calc'd for C20H25O3Si [M+H]+: 
341.1567; found 341.1582. 
 
2-Phenylallyl 1-(benzofuran-2-ylmethyl)-2-oxocyclobutanecarboxylate (39h) 
 
 
Compound 39h was isolated by flash column chromatography (SiO2, 5% EtOAc in 
hexanes to 10% EtOAc in hexanes) as a colorless oil. 27% yield. Rf = 0.6 (20% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3) δ  7.48−7.46 (m, 1H), 7.40−7.38 (m, 3H), 
7.33−7.29 (m, 3H), 7.25−7.18 (m, 2H), 6.37 (d, J = 0.8 Hz, 1H), 5.55 (m, 1H), 5.37 (m, 
1H), 5.09 (s, 2H), 3.43 (d, J = 15.6 Hz, 1H), 3.28 (dd, J = 15.6, 0.8 Hz, 1H), 3.18 (ddd, J 
= 18.4, 11.2, 7.6 Hz, 1H), 2.97 (ddd, J = 18.4, 10.2, 6.1 Hz, 1H), 2.58 (ddd, J = 11.9, 
11.2, 6.1 Hz, 1H), 2.11 (ddd, J = 11.9, 10.2, 7.6 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 
202.2, 168.1, 154.8, 153.6, 142.1, 137.7, 128.5, 128.4, 128.1, 126.0, 123.8, 122.7, 120.6, 
115.7, 110.9, 104.9, 73.1, 67.0, 45.8, 30.9, 19.9;  IR (Neat Film, NaCl) 3582, 3056, 3033, 
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2963, 2928, 1790, 1726, 1601, 1586, 1455, 1253, 1193, 1045 cm–1;  HRMS (MM: ESI-
APCI) m/z calc'd for C23H21O4 [M+H]+: 361.1434; found 361.1427. 
 
2-Methylenebut-3-en-1-yl 1-benzyl-2-oxocyclobutanecarboxylate (41a) 
 
 
Compound 41a was isolated by flash column chromatography (SiO2, 1% EtOAc in 
hexanes to 8% EtOAc in hexanes) as a colorless oil.  51% yield. Rf = 0.4 (10% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 7.33–7.20 (m, 3H), 7.19–7.05 (m, 2H), 6.36 
(ddd, J = 17.9, 11.1, 0.8 Hz, 1H), 5.28–5.09 (m, 4H), 4.89–4.78 (m, 2H), 3.24 (dd, J = 
18.6, 14.2 Hz, 2H), 3.14 (ddd, J = 18.3, 11.0, 7.2 Hz, 1H), 2.75 (ddd, J = 18.3, 10.3, 6.4 
Hz, 1H), 2.58 (ddd, J = 11.8, 11.0, 6.4 Hz, 1H), 2.06 (ddd, J = 11.8, 10.3, 7.2 Hz, 1H); 
13C NMR (126 MHz, CDCl3) δ 203.7, 168.7, 140.0, 136.0, 135.9, 129.7, 128.5, 127.0, 
118.4, 114.8, 75.1, 64.6, 45.2, 38.0, 19.2; IR (Neat Film, NaCl) 3987, 3027, 2929, 1789, 
1725, 1598, 1495, 1454, 1393, 1266, 1192, 1044, 909, 743 cm–1; HRMS (MM: ESI-
APCI)  m/z calc'd for C17H19O3 [M+H]+: 271.1329; found 271.1330. 
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2-Methylallyl 1-benzyl-2-oxocyclobutanecarboxylate (41b) 
 
 
Compound 41b was isolated by flash column chromatography (SiO2, 3% EtOAc in 
hexanes) as a colorless oil. 44% yield. Rf = 0.4 (10% EtOAc in hexanes); 1H NMR (500 
MHz, CDCl3) δ   7.32−7.24 (m, 3H), 7.19−7.17 (m, 2H), 4.97 (d, J = 15.1 Hz, 2H), 4.60, 
4.56 (AB system, JAB = 13.1 Hz, 2H), 3.28, 3.26 (AB system, JAB = 14.2 Hz, 2H), 3.16 
(ddd, J = 18.3, 11.0, 7.2 Hz, 1H), 2.77 (ddd, J = 18.3, 10.4, 6.5 Hz, 1H), 2.61 (ddd, J = 
11.8, 11.0, 6.5 Hz, 1H), 2.09 (ddd, J = 11.8, 10.4, 7.2 Hz, 1H) 1.70 (d, J = 0.5 Hz, 3H); 
13C NMR (126 MHz, CDCl3) δ  203.9, 168.7, 139.3, 134.0, 129.7, 128.5, 127.0, 113.4, 
75.1, 68.7, 45.2, 38.0, 19.4, 19.2; IR (Neat Film, NaCl) 3030, 2974, 2925, 1790, 1727, 
1454, 1271, 1193, 1047, 907 cm–1; HRMS (MM: ESI-APCI) m/z calc'd for C18H19O3 
[M+H]+ 259.1329; found 259.1340. 
 
2-Chloroallyl 1-benzyl-2-oxocyclobutanecarboxylate (41c) 
 
 
Compound 41c was isolated by flash column chromatography (SiO2, 2% EtOAc in 
hexanes to 5% EtOAc in hexanes) as a colorless oil. 63% yield. Rf = 0.3 (10% EtOAc in 
hexanes); 1H NMR (300 MHz, CDCl3) δ  7.33−7.24 (m, 3H), 7.18–7.16 (m, 2H), 
5.44−5.40 (m, 2H), 4.71 (m, 2H), 3.26 (s, 2H), 3.17 (ddd, J = 18.3, 11.0, 7.2 Hz, 1H), 
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2.77 (ddd, J = 18.3, 10.3, 6.5 Hz, 1H), 2.61 (ddd, J = 11.8, 11.0, 6.5 Hz, 1H), 2.01 (ddd, J 
= 11.8, 10.3, 7.2 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ  203.4, 168.2, 135.7, 135.2, 
129.7, 128.6, 127.1, 115.3, 74.9, 66.7, 45.3, 38.0, 19.2; IR (Neat Film, NaCl) 3578, 2918, 
1792, 1734, 1637, 1439, 1268, 1191, 1045 cm–1; HRMS (ESI) m/z calc'd for C15H15ClO3 
[M]+: 278.0710; found 278.0714. 
 
Allyl 1-benzyl-2-oxocyclobutanecarboxylate (36) 
 
 
Compound 36 was isolated by flash column chromatography (SiO2, 3% EtOAc in 
hexanes to 6% EtOAc in hexanes) as a colorless oil. 87% yield. Rf = 0.3 (10% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 7.30−7.27 (m, 2H), 7.25−7.22 (m, 1H), 
7.17−7.14 (m, 2H), 5.88 (ddt, J = 17.2, 10.5, 5.7 Hz, 1H), 5.31 (dq, J = 17.2, 1.4 Hz, 1H), 
5.24 (dq, J = 10.5, 1.4 Hz, 1H), 4.64 (dq, J = 5.7, 1.4 Hz, 2H), 3.26, 3.22 (AB system, JAB 
= 14.2 Hz, 2H), 3.14 (ddd, J = 18.3, 11.0, 7.2 Hz, 1H), 2.75 (ddd, J = 18.3, 10.3, 6.5 Hz, 
1H), 2.59 (ddd, J = 11.8, 11.0, 6.5 Hz, 1H), 2.07 (ddd, J = 11.8, 10.3, 7.2 Hz, 1H); 13C 
NMR (126 MHz, CDCl3) δ 203.9, 168.6, 136.0, 131.5, 129.7, 128.5, 127.0, 118.7, 75.1, 
66.1, 45.1, 38.1, 19.3;  IR (Neat Film, NaCl) 2916, 2848, 1781, 1715, 1438, 1181, 1040 
cm–1;  HRMS (MM: ESI-APCI) m/z calc'd for C15H17O3 [M+H]+: 245.1172; found 
245.1178. 
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4-(Benzyloxy)-2-methylenebutyl 1-benzyl-2-oxocyclobutanecarboxylate (41d) 
 
 
Compound 41d was isolated by flash column chromatography (SiO2, 1% EtOAc in 
Hexanes to 3% EtOAc in hexanes) as a colorless oil. 51% yield.  Rf = 0.5 (10% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 7.47–7.12 (m, 10H), 5.11 (q, J = 1.0 Hz, 1H), 
5.04 (h, J = 1.1 Hz, 1H), 4.67, 4.61 (AB system, JAB = 13.3 Hz, 2H), 4.53 (s, 2H), 3.60 (t, 
J = 6.6, 2H), 3.26 (s, 2H), 3.14 (ddd, J = 18.2, 11.0, 7.2 Hz, 1H), 2.76 (ddd, J=18.3, 10.3, 
6.4 Hz, 1H), 2.60 (ddd, J = 11.8, 11.0, 6.5 Hz, 1H), 2.42–2.33 (m, 2H), 2.08 (ddd, J = 
11.8, 10.3, 7.2 Hz, 1H);  13C NMR (126 MHz, CDCl3) δ 203.9, 168.7, 140.7, 138.2, 
136.0, 129.7, 128.6, 128.4, 127.7, 127.6, 127.0, 114.4, 75.1, 73.0, 68.5, 68.0, 45.2, 38.1, 
33.5, 19.3; IR (Neat Film, NaCl) 3029, 2920, 2849, 1784, 1717, 1495, 1451, 1360, 1268, 
1187, 1095, 904, 732 cm–1; HRMS (MM: ESI-APCI)  m/z calc'd for C24H27O4 [M+H]+: 
379.1904; found 379.1926. 
 
2-(3-Methoxyphenyl)allyl 1-benzyl-2-oxocyclobutanecarboxylate (41e) 
 
 
Compound 41e was isolated by flash column chromatography (SiO2, 3% EtOAc in 
Hexanes to 7% EtOAc in Hexanes) as a colorless oil.  79% yield.  Rf = 0.35 (10% EtOAc 
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in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.41–7.16 (m, 4H), 7.16–7.09 (m, 2H), 7.05–
6.90 (m, 2H), 6.91–6.82 (m, 1H), 5.60–5.53 (m, 1H), 5.37 (q, J = 1.2 Hz, 1H), 5.12–5.01 
(m, 2H), 3.84 (s, 3H), 3.24, 3.21 (AB system, JAB = 14.13 Hz, 2H), 3.06 (ddd, J = 18.3, 
11.1, 7.3 Hz, 1H), 2.72 (ddd, J = 18.3, 10.2, 6.3 Hz, 1H), 2.51 (ddd, J = 11.9, 11.1, 6.3 
Hz, 1H), 2.04 (ddd, J = 11.8, 10.2, 7.3 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 203.7, 
168.7, 159.7, 142.1, 139.4, 136.0, 129.7, 129.5, 128.5, 126.9, 118.5, 115.8, 113.6, 111.8, 
75.1, 66.8, 55.3, 45.2, 37.9, 19.2; IR (Neat Film, NaCl) 2957, 2833, 1786, 1720, 1575, 
1494, 1453, 1387, 1221, 1180, 1039, 783 cm–1; HRMS (MM: ESI-APCI)  m/z calc'd for 
C22H23O4 [M+H]+: 351.1591; found 351.1582. 
 
2-(4-Fluorophenyl)allyl 1-benzyl-2-oxocyclobutanecarboxylate (41f) 
 
 
Compound 41f was isolated by flash column chromatography (SiO2, 3% EtOAc in 
hexanes to 6% EtOAc in hexanes) as a colorless oil.  93% yield.  Rf = 0.3 (10% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3) δ  7.40–7.36 (m, 2H), 7.30–7.23 (m, 3H), 7.14–
7.11 (m, 2H), 7.07–7.02 (m, 2H), 5.51 (s, 1H), 5.36 (s, 1H), 5.07–5.01 (m, 2H),  3.23, 
3.20 (AB system, JAB = 14.2 Hz, 2H), 3.06 (ddd, J = 18.3, 11.0, 7.3 Hz, 1H), 2.74 (ddd, J 
= 18.3, 10.3, 6.4 Hz, 1H), 2.51 (ddd, J = 11.9, 11.0, 6.4 Hz, 1H), 2.05 (ddd, J = 11.9, 
10.3, 7.3 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 203.5, 168.6, 162.7 (d, 1JCF = 247.5 
Hz), 141.1, 135.9, 133.9 (d, 4JCF = 3.9 Hz), 129.6, 128.5, 127.7 (d, 3JCF = 8.6 Hz), 126.9, 
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115.7, 115.4 (d, 2JCF = 21.4 Hz), 75.0, 66.7, 45.1, 37.8, 19.2; IR (Neat Film, NaCl) 3060, 
3029, 2967, 2928, 1790, 1728, 1634, 1602, 1511, 1454, 1386, 1233, 1193, 1162, 1047, 
917, 840, 744 cm–1; HRMS (MM: ESI-APCI)  m/z calc'd for C21H2019FO3 [M+H]+: 
339.1391; found 339.1397. 
 
1.6.5 Representative procedure for the asymmetric decarboxylative allylic 
alkylation of 2-oxocyclobutanecarboxylates 
  
(S)-2-Ethyl-2-(2-phenylallyl)cyclobutanone (40a) 
 
 
To a 20 mL scintillation vial with a stir bar were added Pd2(pmdba)3 (16.4 mg, 0.015 
mmol), L6 (21.9 mg, 0.037 mmol) and toluene (9 mL) in a nitrogen-filled glove box. The 
dark purple mixture was stirred at ambient glove box temperature (ca. 30 °C) for 35 min 
at which point the mixture had become red-orange. 2-Carboxyallylcyclobutanone 39a 
(80.0 mg, 0.31 mmol) was then added.  The resulting yellow-greenish reaction mixture 
was stirred at 20 °C until full conversion of the starting material was indicated by TLC 
analysis (reaction times typically ranged from 18 to 36 hours).  The vial was removed 
from the glove box, uncapped and directly purified by flash column chromatography 
(SiO2, pentane to 15% Et2O in pentane) afforded 40a (41 mg, 62% yield) as colorless oil.  
Rf = 0.3 (15% Et2O in pentane); 1H NMR (300 MHz, CDCl3) δ 7.46–7.25 (m, 5H), 5.55 
(d, J = 0.9 Hz, 1H), 5.38 (d, J = 1.1 Hz, 1H), 5.16–4.92 (m, 2H), 2.51 (ddd, J = 14.7, 
O Et
O
O
Ph
O Et
Ph
Pd2(pmdba)3 (5 mol%)
(S)-L2 (12.5 mol%)
toluene, 20 °C
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10.5, 2.0 Hz, 1H), 2.42–2.30 (m, 1H), 2.29–2.14 (m, 1H), 1.93–1.77 (m, 2H), 1.73–1.59 
(m, 1H), 0.69 (t, J = 7.4 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ  215.1, 145.2, 141.9, 
128.3, 127.6, 126.5, 116.5, 63.8, 42.8, 40.6, 23.5, 21.6, 8.4; IR (Neat Film, NaCl) 3078, 
2966, 1699, 1464, 1443, 905 cm–1; HRMS (FAB+) m/z calc'd for C15H17O [(M+H)−H2]+: 
213.1279; found 213.1274; [α]D26.0 +8.50 (c 1.00, CHCl3, 99% ee). 
 
1.6.6 Spectroscopic data for novel α-quaternary cyclobutanone products 
(S)-2-Methyl-2-(2-phenylallyl)cyclobutanone (40b)  
 
 
Cyclobutanone 40b was isolated by flash column chromatography (SiO2, 10% Et2O in 
pentane) as a colorless oil. 92% yield. Rf = 0.3 (10% Et2O in pentane); 1H NMR (500 
MHz, CDCl3) δ 7.31−7.19 (m, 5H), 5.25 (d, J = 1.5 Hz, 1H), 5.04−5.03 (m, 1H), 
2.93−2.66 (m, 3 H), 2.56 (d, J = 14.1 Hz, 1H), 1.82 (ddd, J = 11.4, 10.5, 6.9 Hz, 1H), 
1.47 (ddd, J = 11.4, 10.2, 6.6 Hz, 1H), 1.09 (s, 3H); 13C NMR (126 MHz, CDCl3) δ  215.1, 
145.2, 141.9, 128.3, 127.6, 126.5, 116.5, 63.8, 42.8, 40.6, 23.5, 21.6;  IR (Neat Film, 
NaCl) 2080, 2865, 1774, 1443, 1059 cm–1;  HRMS (FAB+) m/z calc'd for C14H17O 
[M+H]+: 201.1279; found 201.1286; [α]D26.0 −83.9 (c 1.00, CHCl3, 90% ee). 
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(R)-2-Benzyl-2-(2-phenylallyl)cyclobutanone (40c) 
 
 
Cyclobutanone 40c was isolated by flash column chromatography (SiO2, 5% Et2O in 
petroleum ether) as a colorless oil. 81% yield. Rf = 0.6 (10% EtOAc in hexanes); 1H 
NMR (500 MHz, CDCl3) δ 7.36–7.26 (m, 8H), 7.13−7.11 (m, 2H), 5.37 (d, J = 1.4 Hz, 
1H), 5.15−5.14 (m, 1H), 2.94 (t, J = 14.9 Hz, 2H), 2.72 (t, J = 14.2 Hz, 2H), 2.61 (ddd, J 
= 18.1, 9.6, 7.2 Hz, 1H ), 2.32 (ddd, J = 18.1, 10.0, 7.5 Hz, 1H), 1.86−1.77 (m, 2H);  13C 
NMR (126 MHz, CDCl3) δ  214, 145.0, 141.8, 137.3, 130.0, 128.4, 128.3, 127.7, 126.5, 
126.4, 116.9, 68.8, 43.7, 41.2, 39.9, 20.0;  IR (Neat Film, NaCl) 3028, 2918, 1770, 1494, 
1453, 1074, 905 cm–1; HRMS (EI+) m/z calc'd for C20H21O [M+H]+: 277.1587;  found 
277.1587;  [α]D26.0 −2.91 (c 1.14, CHCl3, 95% ee). 
 
(R)-2-(4-Fluorobenzyl)-2-(2-phenylallyl)cyclobutanone (40d) 
 
 
Cyclobutanone 40d was isolated by flash column chromatography (SiO2, hexanes to 3% 
Et2O in hexanes) as a colorless oil. 71% yield.  Rf = 0.3 (25% EtOAc in hexanes); 1H 
NMR (500 MHz, CDCl3)  δ 7.36−7.26 (m, 5H), 7.09–7.05 (m, 2H), 6.97−6.93 (m, 2H), 
5.37 (d, J = 1.4 Hz, 1H), 5.14 (d, J = 0.9 Hz, 1H), 2.93−2.89 (m, 2H), 2.74−2.67 (m, 2H), 
2.33 (ddd, J = 18.1, 10.7, 6.9 Hz, 1H), 2.62 (ddd, J = 18.1, 10.4, 6.5 Hz, 1H), 1.83 (ddd, J 
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= 11.7, 10.4, 6.9 Hz, 1H), 1.75 (ddd, J = 11.7, 10.7, 6.5 Hz, 1H);  13C NMR (126 MHz, 
CDCl3) δ 214.7, 161.7 (d, 1JCF = 244.8 Hz), 144.9, 141.8, 132.9 (d, 4JCF = 3.8 Hz), 131.5 
(d, 3JCF = 8.3 Hz), 128.8, 127.2, 126.4, 117.0, 115.1 (d, 2JCF = 21.1 Hz), 68.7, 43.7, 40.2, 
39.9, 19.9; IR (Neat Film, NaCl) 3047, 2918, 2848, 1772, 1599, 1508, 1221, 1158, 1060 
836 cm–1;  HRMS (MM: ESI-APCI)  m/z calc'd for C20H2019FO [M+H]+: 294.1420; found 
294.1408;  [α]D26.0 –9.9 (c 0.59, CHCl3, 94% ee). 
 
(R)-2-(4-Methoxybenzyl)-2-(2-phenylallyl)cyclobutanone (40e) 
 
 
Cyclobutanone 40e was isolated by flash column chromatography (SiO2, 10% EtOAc in 
hexanes) as a colorless oil. 83% yield.  Rf = 0.3 (10% EtOAc in hexanes); 1H NMR (300 
MHz, CDCl3) δ 7.37−7.26 (m, 5H), 7.06−7.01 (m, 2H), 6.83–6.78 (m, 2H), 5.37 (d, J = 
1.2 Hz, 1H), 5.14 (s, 1H), 3.78 (s, 3H), 2.91 (dd, J = 14.5, 3.1 Hz, 2H), 2.69 (dd, J = 14.5, 
1.9 Hz, 2H), 2.64−2.53 (m, 1H), 2.37-2.26 (m, 1H) 1.78 (ddd, J = 10.1, 7.2, 2.6 Hz, 2H); 
13C NMR (126 MHz, CDCl3) δ 215.1, 158.2, 145.0, 141.8, 131.0, 129.2, 128.3, 127.6, 
126.4, 116.8, 113.6, 68.9, 55.1, 43.6, 40.3, 39.8;  IR (Neat Film, NaCl) 3080, 2913, 2835, 
1770, 1611, 1513, 1248, 1179, 1035, 907 cm–1; HRMS (EI+) m/z calc'd for C21H22O2 
[M]+: 306.1620;  found 306.1614;  [α]D26.0 −0.60 (c 1.00, CHCl3, 95% ee). 
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(R)-2-Allyl-2-(2-phenylallyl)cyclobutanone (40f) 
 
 
Cyclobutanone 40f was isolated by flash column chromatography (SiO2, 3% EtOAc in 
hexanes to 4% EtOAc in hexanes) as a colorless oil. 86% yield.  Rf = 0.2 (10% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 7.42–7.25 (m, 5H), 5.84–5.71 (m, 1H), 5.37 (d, 
J = 1.5 Hz, 1H), 5.14 (d, J = 1.0 Hz, 1H), 5.15–5.05 (m, 2H), 2.91, 2.70 (AB system, JAB 
= 14.4 Hz, 2H), 2.87–2.65 (m, 2H), 2.36 (ddt, J = 13.9, 7.1, 1.2 Hz, 1H), 2.27 (ddt, J = 
13.9, 7.6, 1.1 Hz, 1H), 1.85 (ddd, J = 11.7, 10.4, 6.8 Hz, 1H), 1.77–1.64 (m, 1H); 13C 
NMR (126 MHz, CDCl3) δ 214.5, 145.1, 141.8, 133.3, 128.3, 128.3, 126.5, 118.7, 116.9, 
67.5, 43.3, 39.7, 39.1, 20.3; IR (Neat Film, NaCl) 3078, 2921, 1774, 1625, 1493, 1443, 
1387, 1059, 1000, 908, 779 cm–1; HRMS (MM: ESI-APCI)  m/z calc'd for C16H19O 
[M+H]+: 227.1430; found 227.1418; αD25 –13.98 (c 0.51, CHCl3, 92% ee). 
 
(S)-2-(2-Phenylallyl)-2-[3-(trimethylsilyl)prop-2-yn-1-yl]cyclobutanone (40g) 
 
 
Cyclobutanone 40g was isolated by flash column chromatography (SiO2, 1% EtOAc in 
hexanes to 3% EtOAc in hexanes) as a colorless oil.  90% yield.  Rf = 0.2 (10% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 7.51–7.08 (m, 5H), 5.37 (d, J = 1.4 Hz, 1H), 
O
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5.13 (d, J = 1.1 Hz, 1H), 2.93–2.86 (m, 2H), 2.82–2.75 (m, 2H), 2.42, 2.37 (AB system, 
JAB = 17.0 Hz, 2H), 1.96–1.85 (m, 2H) 0.15 (s, 9H);  13C NMR (126 MHz, CDCl3) δ 
212.6, 144.5, 141.4, 128.4, 127.7, 126.4, 116.9, 102.7, 87.2, 66.6, 43.9, 38.9, 25.8, 20.9, 
0.0;  IR (Neat Film, NaCl) 2957, 2169, 1776, 1713, 1444, 1249, 1177, 1061, 1031, 834, 
760 cm–1;  HRMS (MM: ESI-APCI) m/z calc'd for C19H25OSi [M+H]+: 297.1681; found 
297.1683;  [α]D25 +10.76 (c 0.29, CHCl3, 93% ee). 
 
(S)-2-(Benzofuran-2-ylmethyl)-2-(2-phenylallyl)cyclobutanone (40h) 
 
 
Cyclobutanone 40h was isolated by flash column chromatography (SiO2, hexanes to 10% 
EtOAc in hexanes) as a colorless oil. 82% yield. Rf = 0.5 (10% EtOAc in hexanes); 1H 
NMR (500 MHz, CDCl3) δ 7.50−7.48 (m, 1H), 7.42−7.40 (m, 1H), 7.38−7.36 (m, 2H), 
7.33−7.28 (m, 3H), 7.25−7.18 (m, 2H), 6.44 (s, 1H), 5.40 (d, J = 1.34 Hz, 1H), 5.17 (m, 
1H), 3.07 (d, J = 15.2 Hz, 1H), 2.98 (dd, J = 14.3, 0.9 Hz, 1H), 2.96 (d, J = 15.0 Hz, 1H), 
2.82 (d, J = 14.3 Hz, 1H), 2.79−2.64 (m, 2H), 1.96−1.86 (m, 2H);  13C NMR (126 MHz, 
CDCl3) δ 213.2, 155.0, 154.7, 144.7, 141.6, 128.5, 128.4, 127.8, 126.4, 123.6, 122.6, 
120.5, 117.2, 110.9, 105.0, 67.2, 43.8, 39.6, 33.7, 20.9;  IR (Neat Film, NaCl) 3054, 
2917, 2849, 1770, 1598, 1585, 1453, 1251, 1104, 1061, 905 cm–1; HRMS (MM ESI-
APCI) m/z calc'd for C22H21O2 [M+H]+: 317.1536;  found 317.1530;  [α]D26 +56.4 (c 1.00, 
CHCl3, 92% ee). 
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(S)-2-Benzyl-2-(2-methylenebut-3-en-1-yl)cyclobutanone (42a) 
 
 
Cyclobutanone 42a was isolated by flash column chromatography (SiO2, hexanes to 5% 
Et2O in hexanes) as a colorless oil.  92% yield.  Rf = 0.3 (10% EtOAc in hexanes); 1H 
NMR (500 MHz, CDCl3) δ 7.33–7.27 (m, 3H), 7.25–7.20 (m, 2H), 7.19–7.12 (m, 1H), 
6.59–6.19 (m, 1H), 5.24–5.06 (m, 2H), 5.05 (s, 2H), 3.01 (d, J = 13.6 Hz, 1H), 2.80 (d, J 
= 13.6 Hz, 1H), 2.68 (ddd, J = 18.1, 10.3, 6.8 Hz, 1H), 2.57 (dd, J = 14.4, 1.0 Hz, 1H), 
2.45 (ddd, J = 18.1, 10.3, 6.9 Hz, 1H), 2.40 (d, J = 14.4 Hz, 1H), 1.95 (qdd, J = 11.6, 
10.2, 6.8 Hz, 1H);  13C NMR (126 MHz, CDCl3) δ 215.2, 142.4, 139.4, 137.3, 130.1, 
128.3, 126.6, 119.2, 114.5, 68.6, 43.9, 41.4, 35.5, 20.2;  IR (Neat Film, NaCl) 3022, 
2921, 2843, 1768, 1590, 1493, 1452, 1384, 1065, 989, 898, 755 cm–1;  HRMS (MM: ESI-
APCI)  m/z calc'd for C16H18O [M+H]+: 227.1430; found 227.1433; [α]D25 +0.44 (c 1.60, 
CHCl3, 91% ee). 
 
(S)-2-Benzyl-2-(2-methylallyl)cyclobutanone (42b) 
 
 
Cyclobutanone 42b was isolated by flash column chromatography (SiO2, 2% Et2O in 
hexanes to 5% Et2O in hexanes) as a colorless oil. 82% yield.  Rf = 0.3 (10% EtOAc in 
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hexanes); 1H NMR (300 MHz, CDCl3) δ 7.41–7.12 (m, 5H), 4.91 (t, J = 1.7 Hz, 1H), 4.78 
(dd, J = 2.0 Hz, 1.0, 1H), 2.88, 2.65 (AB system, JAB = 13.7 Hz, 2H), 2.77 (ddd, J = 18.1, 
9.6, 6.9 Hz, 1H), 2.43–2.33 (m, 1H), 2.33, 2.22 (AB system, JAB = 14.2 Hz,  2H), 1.97 
(ddd, J = 9.4, 7.2, 3.1, 2H), 1.80–1.72 (m, 3H); 13C NMR (126 MHz, CDCl3) δ 215.3, 
141.8, 137.4, 130.1, 128.3, 126.5, 114.8, 68.2, 43.6, 43.2, 40.6, 24.0, 20.7; IR (Neat Film, 
NaCl) 3072, 3027, 2964, 2919, 1772, 1322, 1131, 1062, 894 cm–1;  HRMS (MM: ESI-
APCI)  m/z calc'd for C15H18O [M]+: 214.1358, found 214.1346;  [α]D26 –2.4° (c 0.48, 
CHCl3, 90% ee).   
(R)-2-Benzyl-2-(2-chloroallyl)cyclobutanone (42c) 
 
 
Cyclobutanone 42c was isolated by flash column chromatography (SiO2, hexanes to 3% 
EtOAc in hexanes) as a colorless oil. 67% yield. Rf = 0.3 (10% EtOAc in hexanes); 1H 
NMR (500 MHz, CDCl3) δ 7.33−7.21 (m, 3H), 7.18−7.15 (m, 2H), 5.33 (d, J = 1.3 Hz, 
1H), 5.22−5.21 (m, 1H), 2.97 (d, J = 13.7 Hz, 1H), 2.90−2.76 (m, 1H), 2.82 (d, J = 13.7 
Hz, 1H), 2.74 (dd, J = 14.7, 1.0 Hz, 1H), 2.59 (d, J = 14.7 Hz, 1H), 2.43 (ddd, J = 18.1, 
10.8, 7.3 Hz, 1H), 2.19 (ddd, J = 11.8, 10.2, 7.2 Hz, 1H), 2.04 (ddd, J = 11.8, 10.8, 6.1 
Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 213.7, 138.4, 136.7, 130.1, 128.4, 126.8, 116.4, 
67.5, 44.1, 43.8, 40.5, 20.7;  IR (Neat Film, NaCl) 3028, 2919, 2848, 1772, 1631, 1494, 
1453, 1063, 888 cm–1; HRMS (MM ESI-APCI) m/z calc'd for C14H1635ClO [M+H]+: 
235.0884; found 235.0883; [α]D26 +1.51 (c 0.56, CHCl3, 94% ee).  
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(S)-2-Allyl-2-benzylcyclobutanone (38) 
 
 
Cyclobutanone 38 was isolated by flash column chromatography (SiO2, 2% Et2O in 
hexanes to 5% Et2O in hexanes) as a colorless oil.  82% yield.  Rf = 0.4 (10% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 7.30−7.27 (m, 2H), 7.24−7.21 (m, 1H), 
7.16−7.15 (m, 2H), 5.81 (ddt, J = 17.2, 10.0, 7.4 Hz, 1H), 5.16−5.10 (m, 2H), 2.97 (d, J = 
13.7 Hz, 1H), 2.78 (ddd, J = 18.2, 10.3, 6.5 Hz, 1H), 2.72 (d, J = 13.7 Hz, 1H), 2.49 (ddd, 
J = 18.2, 10.6, 6.8 Hz, 1H), 2.39 (ddt, J = 13.9, 7.4, 1.1 Hz, 1H), 2.67 (ddt, J = 13.9, 7.4, 
1.1 Hz, 1H), 1.94 (ddd, J = 11.5, 10.6, 6.5 Hz, 1H), 1.86 (ddd, J = 11.5, 10.3, 6.8 Hz, 
1H); 13C NMR (126 MHz, CDCl3) δ 214.9, 137.3, 133.2, 130.0, 128.3, 126.5, 118.7, 68.4, 
42.9, 40.3, 39.5, 19.8; IR (Neat Film, NaCl) 3029, 2918, 1771, 1495, 1437, 1454, 1076, 
920 cm–1;  HRMS (MM: ESI-APCI)  m/z calc'd for C14H16O [M]+: 200.1201; found 
200.1199;  [α]D26 +4.69 (c 0.55, CHCl3, 88% ee).   
 
(S)-2-Benzyl-2-[4-(benzyloxy)-2-methylenebutyl]cyclobutanone (42d) 
 
 
Cyclobutanone 42d was isolated by flash column chromatography (SiO2, 1% EtOAc in 
hexanes to 3% EtOAc in hexanes) as a colorless oil (95% yield).  Rf = 0.2 (10% EtOAc in 
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hexanes); 1H NMR (500 MHz, CDCl3) δ 7.41–7.12 (m, 10H), 5.01 (q, J = 1.4 Hz, 1H), 
4.93–4.92 (m, 1H), 4.54 (s, 2H), 3.59 (td, J = 6.8, 0.7, 2H), 2.95, 2.73 (AB system, JAB = 
13.7, 2H), 2.83–2.71 (m, 1H), 2.51–2.27 (m, 5H), 2.04–1.92 (m, 2H); 13C NMR (126 
MHz, CDCl3) δ 215.2, 142.6, 138.4, 137.4, 130.1, 128.4, 128.3, 127.7, 127.6, 126.5, 
115.1, 72.9, 68.7, 68.3, 43.6, 41.5, 40.6, 37.0, 20.7; IR (Neat Film, NaCl) 3022, 2923, 
2853, 1768, 1641, 1494, 1452, 1360, 1099, 899, 735 cm -1; HRMS (MM: ESI-APCI)  m/z 
calc'd for C23H27O2 [M+H]+: 335.2006; found 335.2020;  
 
 
Enantiomeric excess determined for the corresponding Baeyer-Villiger product, which 
was obtained by the general procedure below.  Lactone 49 was isolated by flash column 
chromatography (SiO2, 4% EtOAc in hexanes) as a colorless oil (93% yield). Rf = 0.2 
(20% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.40–7.18 (m, 10H), 5.09 (q, J = 
1.5 Hz, 1H), 4.98 (dd, J = 1.7, 0.9 Hz, 1H), 4.51 (s, 2H), 3.61 (t, J = 6.5 Hz, 2H), 3.09 (d, 
J = 14.1 Hz, 1H), 2.75 (d, J = 14.1 Hz, 1H), 2.61–2.38 (m, 4H), 2.23 (ddd, J = 17.6, 9.4, 
5.9 Hz, 1H), 2.17–2.03 (m, 2H), 1.68 (ddd, J = 17.6, 10.0, 8.6 Hz, 1H); 13C NMR (126 
MHz, CDCl3) δ 176.9, 141.8, 138.4, 135.5, 130.5, 128.5, 128.3, 127.7, 127.5, 127.1, 
117.1, 87.8, 72.8, 68.5, 46.7, 45.6, 37.0, 29.3, 29.2; IR (Neat Film, NaCl) 3524, 3062, 
3029, 2919, 2855, 1958, 1770, 1642, 1603, 1495, 1454, 1416, 1361, 1271, 1232, 1177, 
1101, 1080, 1029, 932, 741 cm–1; HRMS (MM: ESI-APCI)  m/z calc'd for C23H27O3 
[M+H]+: 351.1955; found 351.1951; αD25 +21.17 (c 0.44, CHCl3, 89% ee). 
 
H2O2 
(50 % in H2O)
OO
NaOH (1 M), 
MeOH
49
Bn
OBn
O Bn
42d
OBn
93% yield
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(R)-2-Benzyl-2-(2-[3-methoxyphenyl]allyl)cyclobutanone (42e) 
 
 
Cyclobutanone 42e was isolated by flash column chromatography (SiO2, 1% EtOAc in 
hexanes to 3% EtOAc in hexanes) as a colorless oil. 91% yield.  Rf = 0.2 (10% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 7.37–7.19 (m, 4H), 7.19–7.10 (m, 2H), 6.98 
(ddd, J = 7.7, 1.7, 0.9 Hz, 1H), 6.91 (dd, J = 2.5, 1.6 Hz, 1H), 6.85 (ddd, J = 8.2, 2.6, 0.9 
Hz, 1H), 5.41 (d, J = 1.4 Hz, 1H), 5.17 (q, J = 1.1 Hz, 1H), 3.83 (s, 3H), 3.03–2.86 (m, 
2H), 2.86–2.68 (m, 2H), 2.63 (ddd, J = 18.1, 9.7, 7.1 Hz, 1H), 2.35 (ddd, J = 18.1, 10.1, 
7.4 Hz, 1H), 1.96–1.72 (m, 2H); 13C NMR (126 MHz, CDCl3) δ 215.0, 159.6, 144.9, 
143.5, 137.3, 130.1, 129.4, 128.4, 126.6, 119.0, 117.1, 112.9, 112.4, 68.9, 55.3, 43.8, 
41.2, 40.0, 20.0; IR (Neat Film, NaCl) 2913, 2829, 1766, 1595, 1572, 1488, 1451, 1286, 
1221, 1170, 1039, 898, 873, 779 cm–1; HRMS (MM: ESI-APCI)  m/z calc'd for C21H23O2 
[M+H]+: 307.1693; found 307.1693; αD25 –4.78 (c 0.45, CHCl3, 92% ee). 
 
(R)-2-Benzyl-2-(2-(4-fluorophenyl)allyl)cyclobutanone (42f) 
 
 
Cyclobutanone 42f was isolated by flash column chromatography (SiO2, 3% EtOAc in 
hexanes to 7% EtOAc in hexanes) as a colorless oil.  94% yield.  Rf = 0.3 (10% EtOAc in 
O Bn
42e
OMe
O Bn
42f
F
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hexanes); 1H NMR (500 MHz, CDCl3) δ 7.25–7.12 (m, 5H), 7.05–7.03 (m, 2H), 6.95–
6.90 (m, 2H), 5.25 (d, J = 1.3 Hz, 1H), 5.05 (s, 1H), 2.88 (d, J = 13.7 Hz, 1H), 2.82 (dd, J 
= 14.4, 1.0 Hz, 1H), 2.66 (d, J = 13.7 Hz, 1H), 2.59 (d, J = 14.4 Hz, 1H), 2.54–2.47 (m, 
1H), 2.29–2.22 (m, 1H), 1.73 (t, J = 8.6 Hz, 2H);  13C NMR (126 MHz, CDCl3) δ 214.6, 
162.3 (d, 1JCF = 246.8 Hz), 144.0, 137.8 (d, 4JCF = 3.3 Hz), 137.1, 130.0, 128.3, 128.0 (d, 
3JCF = 7.9 Hz), 126.6, 116.9, 115.2 (d, 2JCF = 21.3 Hz), 68.6, 43.7, 41.2, 40.5, 20.0;  IR 
(Neat Film, NaCl) 2913, 1766, 1597, 1505, 1219, 1055, 837 cm–1;  HRMS (MM: ESI-
APCI) m/z calc'd for C20H2019FO [M+H]+: 295.1493; found 295.1502; [α]D25 +3.53 (c 
0.16, CHCl3, 94% ee).  
 
1.6.7 Procedures for derivatization of α-quaternary cyclobutanones and 
determination of absolute stereochemical configuration 
 
 
(R)-5-Benzyl-5-(2-phenylallyl)dihydrofuran-2(3H)-one (44). To a stirred solution of 
cyclobutanone 40c (43 mg, 0.23 mmol) in MeOH (4.6 mL) was added NaOH (1 M in H2O, 
0.23 μL, 0.23 mmol) followed by H2O2 (50 wt% in H2O, 17 mg, 0.46 mmol). The resulting 
mixture was stirred at room temperature for 1 h. The reaction mixture was then acidified to 
pH 7 with 1 N aqueous HCl and extracted with dichloromethane (2 mL x 5). The combined 
organic layers were dried over MgSO4 and concentrated in vacuo. The crude oil was 
purified by flash column chromatography (SiO2, 15% EtOAc in hexanes) to afford lactone 
44 (37 mg, 0.17 mmol, 80% yield) as a colorless oil. Rf = 0.2 (20% EtOAc in hexanes); 1H 
O
Ph
Ph
H2O2 (50 % in H2O) OO
Ph
Ph
NaOH (1 M), MeOH
40c 4480% yield
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NMR (300 MHz, CDCl3) δ 7.41−7.18 (m, 10H), 5.46 (d, J = 1.4 Hz, 1H), 5.27 (s, 1H), 
3.08−2.92 (m, 3H), 2.79 (d, J = 14.1 Hz, 1H), 2.17 (ddd, J = 17.4, 9.8, 6.4 Hz, 1H), 2.04-
−1.86 (m, 2H), 1.76−1.62 (m, 1H);  13C NMR (126 MHz, CDCl3) δ 176.7, 143.4, 141.7, 
135.4, 130.6, 128.6, 128.5, 127.8, 127.0, 126.3, 119.2, 87.7, 46.1, 45.3, 29.3, 28.8; IR 
(Neat Film, NaCl) 3029, 2918, 1771, 1495, 1437, 1454, 1076, 920 cm–1;  HRMS (MM: 
ESI-APCI)  m/z calc'd for C20H21O2 [M+H]+: 293.1536; found 293.1536;  [α]D26 –0.60 (c 
1.00, CHCl3, 89% ee).  
 
 
(S)-2-(2-Phenylallyl)-2-(3-(trimethylsilyl)prop-2-yn-1-yl)cyclopentanone (45). To a 
solution of 40g  (0.1023 g, 0.345 mmol) in Et2O (3.5 mL), cooled to 0 °C with a water/ice 
bath, under an atmosphere of N2, was added BF3 etherate (0.112 mL, 0.379 mmol) 
dropwise followed by trimethylsilyldiazomethane (0.345 mL, 2 M solution in hexane) 
dropwise. The mixture was allowed to warm to 25 °C and stirred for 18 hours, at which 
point the reaction was determined to be complete by TLC analysis. To the mixture was 
added 3 mL of saturated aqueous NaHCO3. After stirring for 30 min, this mixture was 
extracted with Et2O (5 mL x 3), dried over MgSO4 and concentrated in vacuo. The crude 
product was purified by flash column chromatography (SiO2, 1% EtOAc in hexanes to 
5% EtOAc in hexanes) to afford α-trimethylsilylcyclopentanone as a colorless oil. The 
identity of the α-trimethylsilylcyclopentanone was confirmed by 1H NMR analysis; the 
product was taken on without further characterization.  Rf = 0.3 (10% EtOAc in hexanes); 
O
Ph
1. TMSCHN2, BF3•Et2O
Et2O, 0 °C to 25 °C
Ph2. HCl (aq.), DCM
TMS
TMS
O
40g 45
69% yield
over two steps
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To a solution of α-trimethylsilylcyclopentanone (61 mg, 0.159 mmol) in 2 ml 
dichloromethane was added 2 mL of 1 N aqueous HCl in H2O at 25 °C. The mixture was 
stirred for 24 hours at which point the reaction was determined to be complete by TLC 
analysis.  The mixture was diluted with dichloromethane (2 ml) and then extracted with 
dichloromethane (5 mL x 3).  The collected organic layers were then washed with brine 
(5 mL), dried over MgSO4, filtered and concentrated in vacuo.  The crude oil was 
purified by flash column chromatography  (SiO2, hexanes to 1% EtOAc in hexanes) to 
afford cyclopentanone 45 (47 mg, 0.153 mmol, 69% yield over two steps) as a colorless 
oil. Rf = 0.3 (10% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.58–7.12 (m, 5H), 
5.32 (d, J = 1.6 Hz, 1H), 5.14–4.97 (m, 1H), 2.83–2.73 (m, 2H), 2.22 (dd, J = 16.9, 38.9 
Hz, 2H), 2.16–2.08 (m, 1H), 2.03–1.91 (m, 2H), 1.89–1.71 (m, 3H), 0.14 (s, 9H); 13C 
NMR (126 MHz, CDCl3) δ  221.0, 145.1, 141.6, 128.3, 127.6, 126.5, 117.4, 103.7, 87.1, 
52.2, 39.8, 38.4, 31.4, 27.4, 18.7, 0.0; IR (Neat Film, NaCl) 3080, 2958, 1738, 1623, 
1494, 1447, 1404, 1308, 1249, 1154, 1046, 1029, 973, 904, 841, 778, 759 cm–1;  HRMS 
(EI+)  m/z calc'd for C20H26OSi [M]+: 310.1753; found 310.1765;  [α]D25 +4.13 (c 0.50, 
CHCl3, 93% ee).  
 
(R)-5-Allyl-5-(2-phenylallyl)pyrrolidin-2-one (46).  To a solution of cyclobutanone 42f 
(65 mg, 0.221 mmol) in 7 mL absolute ethanol was added hydroxylamine hydrochloride 
(76 mg, 1.104 mmol), followed by pyridine (0.27 ml, 3.31 mmol) and the mixture was 
stirred at 25 °C for 24 hours.  The crude mixture was concentrated in vacuo and loaded 
O
Ph
1. HONH2•HCl, 
Pyridine, EtOH
H
N Ph
2. p-TsCl, Et3N,
 DMAP, DCM
O
F
F
42f 46
22% yield
over two steps
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directly onto a flash column.  Flash column chromatography (SiO2, 8% EtOAc in hexanes 
to 11% EtOAc in hexanes) afforded the corresponding oxime, whose identity was 
confirmed by 1H NMR and which was taken on without further characterization; Rf = 0.2 
(25% EtOAc in hexanes); To a mixture of 4-toluenesulfonyl chloride (83 mg, 0.43 
mmol), triethylamine (0.06 mL, 0.43 mmol) and catalytic 4-dimethylaminopyridine in 2.5 
mL of dichloromethane under an atmosphere of N2 was added dropwise a solution of 
oxime (54 mg, 0.175 mmol) in 1 mL of dichloromethane. The mixture was stirred at 25 
°C for 4 hours.  The crude mixture was washed with H2O (5 mL), washed with brine (5 
mL), dried over Na2SO4 and concentrated in vacuo.  The crude oil was purified by flash 
column chromatography  (SiO2, 3% EtOAc in hexanes to EtOAc) to afford lactam 46 (16 
mg, 0.05 mmol, 22% yield over two steps) as a pale yellow oil.  Rf = 0.4 (EtOAc); 1H 
NMR (500 MHz, CDCl3) δ 7.34–7.07 (m, 7H), 7.07–6.96 (m, 2H), 5.35 (d, J = 1.3 Hz, 
1H), 5.26 (s, 1H), 5.15 (q, J = 1.0 Hz, 1H), 2.87–2.63 (m, 4H), 2.06–1.85 (m, 3H), 1.69–
1.55 (m, 1H); 13C NMR (126 MHz, CDCl3) δ = 176.9, 162.4 (d, 1JCF = 247.4 Hz), 143.7, 
138.0 (d, 4JCF = 3.4 Hz), 136.1, 130.3, 128.5, 127.8 (d, 3JCF = 8.0 Hz), 127.0, 118.6, 115.7 
(d, 2JCF = 21.4 Hz), 62.0, 47.0, 46.5, 30.9, 30.1; IR (Neat Film, NaCl) 3196, 3081, 2927, 
1690, 1601, 1507, 1452, 1260, 1224, 1159, 1087, 906, 842, 750 cm–1; HRMS (EI+)  m/z 
calc'd for C20H20ONF [M]+: 309.1529; found 309.1517;  [α]D25 +53.19 (c 0.08, CHCl3, 
94% ee). 
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(R)-6-phenylspiro[3.4]oct-6-en-1-one (47). To a flask charged with Grubbs-Hoveyda an 
atmosphere of argon was added a solution of cyclobutanone 40f (50 mg, 0.221 mmol) in 
5 mL benzene.  The reaction mixture was heated to 50 °C and stirred for one hour, at 
which point the reaction was determined to be complete by TLC analysis.  The reaction 
vessel was cooled to 25 °C and 1 mL of ethyl vinyl ether was added.  After 30 min of 
stirring, the crude mixture was purified directly by flash column chromatography (SiO2, 
hexanes to 3% EtOAc in hexanes) to afford spirocycle 9 (43 mg, 0.215 mmol, 97% yield) 
as a colorless oil.  Rf = 0.3 (10% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3)  δ 
7.37–7.31 (m, 2H), 7.32–7.21 (m, 2H), 7.24–7.15 (m, 1H), 5.97 (p, J = 2.4 Hz, 1H), 3.19 
(dq, J = 16.0, 2.2 Hz, 1H), 3.04 (t, J = 8.61 Hz, 2H), 3.04–2.97 (m, 1H), 2.81 (dq, J = 
16.0, 1.7 Hz, 1H), 2.63 (dtd, J = 17.5, 2.5, 1.4 Hz, 1H), 2.09 (td, J = 8.9, 2.5 Hz, 2H); 13C 
NMR (126 MHz, CDCl3) δ  214.1, 140.0, 135.6, 128.4, 127.3, 125.6, 122.9, 67.9, 43.6, 
43.1, 42.8, 28.3; IR (Neat Film, NaCl) 2890, 2924, 1765, 1595, 1491, 1385, 1298, 1241, 
1056, 747 cm–1; HRMS (MM: ESI-APCI) m/z calc'd for C14H15O [M+H]+: 199.1117; 
found 199.1120;  [α]D25 –41.23 (c 0.30, CHCl3, 92% ee).  
 
O
benzene, 50 °CPh
O Ph
MesN NMes
Ru
Cl
Cl
Grubbs-Hoveyda 2 (5 mol%)
O
40f 47
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(S)-5-allyl-5-methyldihydrofuran-2(3H)-one (53). Dihydrofuranone 53 was generated 
from 2-carboxyallylcyclobutanone 51, via cyclobutanone 52, following the general 
procedures described above (see SI 3, SI 10 and SI 16).  When compared with known 
compound (5S)-(+)-5-allyl-5-methyldihydrofuran-2(3H)-one, the optical rotation value 
for 53 was found to be of the same sign and of nearly identical magnitude ([α]D25 +2.96 (c 
1.5, CH3OH), literature value: [α]D17 +3.33 (c 1.27, CH3OH)). 50  The absolute 
configurations of all other compounds described herein were established by analogy to 
52.  Cyclobutanone 51 was isolated by flash column chromatography (SiO2, 3% Et2O in 
pentane to 7% Et2O in pentane) as a colorless oil.  84% yield. Rf = 0.4 (15% EtOAc in 
hexanes); 1H NMR (300 MHz, CDCl3)  δ 5.90 (ddt, J = 17.2, 10.5, 5.6 Hz, 1H), 5.38–5.14 
(m, 2H), 4.63 (dt, J = 5.6, 1.4 Hz, 2H), 3.42–3.06 (m, 2H), 2.65 (td, J = 11.3, 6.3 Hz, 
1H), 1.88 (ddd, J = 11.6, 9.9, 7.5 Hz, 1H), 1.49 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 
204.6, 169.8, 131.6, 118.4, 65.9, 45.2, 23.1, 18.6; IR (Neat Film, NaCl) 2933, 1792, 
1730, 1457, 1376, 1274, 1193, 1147, 1050, 983 cm–1; HRMS (MM: ESI-APCI) m/z calc'd 
for C9H12O2 [M+H]+: 153.0910; found 153.0905.  Cyclobutanone 52 was isolated by flash 
column chromatography (SiO2, 1% Et2O in pentane to 5% Et2O in pentane) as a colorless 
oil.  56% yield. Rf = 0.3 (10% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3)  δ 5.76 
(ddt, J = 16.6, 10.5, 7.3 Hz, 1H), 5.14–5.05 (m, 2H), 3.08–2.89 (m, 2H), 2.31 (ddt, J = 
13.8, 7.2, 1.2 Hz, 1H), 2.21 (ddt, J = 13.8, 7.5, 1.1 Hz, 1H), 1.98 (ddd, J = 11.3, 10.3, 6.7 
Hz, 1H), 1.73 (ddd, J = 11.3, 10.1, 6.9 Hz, 1H), 1.19 (s, 3H); 13C NMR (126 MHz, 
H2O2 
(50 % in H2O)
OO
NaOH (1 M), 
MeOH 53
O Me
O
O
Pd2(pmdba)3 
(5 mol%)
(S)-L2 
(12.5 mol%)
toluene,
  20 °C51
O Me
52
Me
56% yield 81% yield
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CDCl3) δ  214.1, 140.0, 135.6, 128.4, 127.3, 125.6, 122.9, 67.9, 43.6, 43.1, 42.8, 28.3; IR 
(Neat Film, NaCl) 2929, 2854, 1728, 1323, 1261, 1170, 1129, 1060, 1019, 799 cm–1; 
HRMS (MM: ESI-APCI) m/z calc'd for C8H12O [M+H]+: 125.0961; found 125.0955.  
Enantiomeric excess was determined for the corresponding Baeyer-Villiger product 53, 
which was isolated as by flash column chromatography (SiO2, 10% Et2O in pentane) as a 
colorless oil (81% yield). Spectroscopic and physical data for 53 were identical to those 
reported in the literature.7 ([α]D25 +2.96 (c 1.5, CH3OH), 83% ee). 
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1.6.8 Determination of enantiomeric excess 
Table 1.6.8 Determination of enantiomeric excess 
 
 
 
entry compound assay method and conditions
retention time
of major isomer
(min)
retention time
of minor isomer
(min)
%ee
1
2
3
4
5
6
7
8
O Me
Ph
O Et
Ph
O
Ph
Ph
90
99
95
O
Ph
O
Ph
O
Ph
F
OMe
O
Ph
O
Ph
97
92
93
92
93
TMS
O
SFC, 10% MeOH in CO2,
 2.5 mL/min, AS-H col. 6.025.31
SFC, 3% MeOH in CO2, 
2.5 mL/min, AS-H col. 3.082.68
SFC, 3% MeOH in CO2, 
3 mL/min, OJ-H col. 8.91 7.93
SFC, 2% MeOH in CO2, 
3 mL/min, OJ-H col. 11.4510.43
SFC, 2% MeOH in CO2, 
2.5 mL/min, AS-H col. 8.388.82
HPLC, 2% iPrOH in
hexanes, 0.6 mL/min, 
AD col.
8.949.74
3.37 3.15SFC, 1% MeOH in CO22.5 mL/min, AS-H col.
SFC, 2% MeOH in CO2
3.0 mL/min, OJ-H col. 2.68 4.32
Chapter 1 – Enantioselective Construction of α-Quaternary Cyclobutanones by Catalytic 
Asymmetric Allylic Alkylation 
 
50 
Table 1.6.8 Determination of enantiomeric excess (continued) 
 
 
 
 
 
9
10
11
12
13
14
15
O Bn
Me
O Bn
Cl
O Bn
90
93
86
O Bn
Bn
O Bn
O Bn
89
91
94
92
OMe
F
OBn
SFC, 1% MeOH in CO2,
3 mL/min, OB-H col. 2.532.76
GC, 110 °C, isotherm
 1 mL/min, GTA col. 11.3410.41
SFC, 1% MeOH in CO2, 
2.5 mL/min, OB-H col. 2.933.38
SFC, 1% MeOH in CO2, 
3 mL/min, AS-H col. 6.787.29
SFC, 1% MeOH in CO2
2.5 mL/min, OB-H col. 3.40 2.83
O
O
SFC, 1% MeOH in CO2,
2.5 mL/min, AS-H col. 16.17 14.84
SFC, 10% MeOH in CO2,
3.0 mL/min, AD-H col. 6.09 7.29
entry compound assay method and conditions
retention time
of major isomer
(min)
retention time
of minor isomer
(min)
%ee
16 83GC, 130 °C, isotherm 1 mL/min, GTA col. 13.3210.15
Me
O
O
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Figure A1.2  Infrared spectrum (thin film/NaCl) of compound 48 
 
Figure A1.3  13C NMR (75 MHz, CDCl3) of compound 48 
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Figure A1.5  Infrared spectrum (thin film/NaCl) of compound 39a 
 
Figure A1.6  13C NMR (125 MHz, CDCl3) of compound 39a 
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Figure A1.8  Infrared spectrum (thin film/NaCl) of compound 39b. 
Figure A1.9  13C NMR (125 MHz, CDCl3) of compound 39b. 
66
Appendix 1 – Spectra Relevant to Chapter 1 
 
0
1
2
3
4
5
6
7
8
9
10
pp
m
  
Fi
gu
re
 A
1.
10
  1
H
 N
M
R
 (5
00
 M
H
z,
 C
D
C
l 3)
 o
f c
om
po
un
d 
39
c.
 
O
Bn
O
O
Ph
39
c
67
Appendix 1 – Spectra Relevant to Chapter 1 
 
020406080100120140160180200220
ppm
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1.11  Infrared spectrum (thin film/NaCl) of compound 39c. 
Figure A1.12  13C NMR (125 MHz, CDCl3) of compound 39c. 
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Figure A1.14  Infrared spectrum (thin film/NaCl) of compound 39d. 
Figure A1.15  13C NMR (125 MHz, CDCl3) of compound 39d. 
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Figure A1.17  Infrared spectrum (thin film/NaCl) of compound 39e. 
Figure A1.18  13C NMR (125 MHz, CDCl3) of compound 39e. 
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Figure A1.20  Infrared spectrum (thin film/NaCl) of compound 39f. 
Figure A1.21  13C NMR (125 MHz, CDCl3) of compound 39f. 
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Figure A1.23  Infrared spectrum (thin film/NaCl) of compound 39g. 
Figure A1.24  13C NMR (125 MHz, CDCl3) of compound 39g. 
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Figure A1.26  Infrared spectrum (thin film/NaCl) of compound 39h. 
Figure A1.27  13C NMR (125 MHz, CDCl3) of compound 39h. 
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Figure A1.29  Infrared spectrum (thin film/NaCl) of compound 41a. 
Figure A1.30  13C NMR (125 MHz, CDCl3) of compound 41a. 
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Figure A1.32  Infrared spectrum (thin film/NaCl) of compound 41b. 
Figure A1.33  13C NMR (125 MHz, CDCl3) of compound 41b. 
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Figure A1.35  Infrared spectrum (thin film/NaCl) of compound 41c. 
Figure A1.36  13C NMR (125 MHz, CDCl3) of compound 41c. 
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Figure A1.38  Infrared spectrum (thin film/NaCl) of compound 36. 
Figure A1.39  13C NMR (125 MHz, CDCl3) of compound 36. 
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Figure A1.41  Infrared spectrum (thin film/NaCl) of compound 41d. 
Figure A1.42  13C NMR (125 MHz, CDCl3) of compound 41d. 
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Figure A1.44  Infrared spectrum (thin film/NaCl) of compound 41e. 
Figure A1.45  13C NMR (125 MHz, CDCl3) of compound 41e. 
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Figure A1.47  Infrared spectrum (thin film/NaCl) of compound 41f. 
Figure A1.48  13C NMR (125 MHz, CDCl3) of compound 41f. 
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Figure A1.50  Infrared spectrum (thin film/NaCl) of compound 40a. 
Figure A1.51  13C NMR (75 MHz, CDCl3) of compound 40a. 
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Figure A1.53  Infrared spectrum (thin film/NaCl) of compound 40b. 
Figure A1.54  13C NMR (125 MHz, CDCl3) of compound 40b. 
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Figure A1.56  Infrared spectrum (thin film/NaCl) of compound 40c. 
Figure A1.57  13C NMR (125 MHz, CDCl3) of compound 40c. 
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Figure A1.59  Infrared spectrum (thin film/NaCl) of compound 40d. 
Figure A1.60  13C NMR (125 MHz, CDCl3) of compound 40d. 
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Figure A1.62  Infrared spectrum (thin film/NaCl) of compound 40e. 
Figure A1.63  13C NMR (125 MHz, CDCl3) of compound 40e. 
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Figure A1.65  Infrared spectrum (thin film/NaCl) of compound 40f. 
Figure A1.66  13C NMR (125 MHz, CDCl3) of compound 40f. 
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Figure A1.68  Infrared spectrum (thin film/NaCl) of compound 40g. 
Figure A1.69  13C NMR (125 MHz, CDCl3) of compound 40g. 
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Figure A1.71  Infrared spectrum (thin film/NaCl) of compound 40h. 
Figure A1.72  13C NMR (125 MHz, CDCl3) of compound 40h. 
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Figure A1.74  Infrared spectrum (thin film/NaCl) of compound 42a. 
Figure A1.75  13C NMR (125 MHz, CDCl3) of compound 42a. 
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Figure A1.77  Infrared spectrum (thin film/NaCl) of compound 42b. 
Figure A1.78  13C NMR (125 MHz, CDCl3) of compound 42b. 
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Figure A1.80  Infrared spectrum (thin film/NaCl) of compound 42c. 
Figure A1.81  13C NMR (125 MHz, CDCl3) of compound 42c. 
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Figure A1.83  Infrared spectrum (thin film/NaCl) of compound 38. 
Figure A1.84  13C NMR (125 MHz, CDCl3) of compound 38. 
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Figure A1.86  Infrared spectrum (thin film/NaCl) of compound 42d. 
Figure A1.87  13C NMR (125 MHz, CDCl3) of compound 42d. 
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Figure A1.89  Infrared spectrum (thin film/NaCl) of compound 49. 
Figure A1.90  13C NMR (125 MHz, CDCl3) of compound 49. 
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Figure A1.92  Infrared spectrum (thin film/NaCl) of compound 42e. 
Figure A1.93  13C NMR (125 MHz, CDCl3) of compound 42e. 
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Figure A1.95  Infrared spectrum (thin film/NaCl) of compound 42f. 
Figure A1.96  13C NMR (125 MHz, CDCl3) of compound 42f. 
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Figure A1.98  Infrared spectrum (thin film/NaCl) of compound 44. 
Figure A1.99  13C NMR (125 MHz, CDCl3) of compound 44. 
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Figure A1.101  Infrared spectrum (thin film/NaCl) of compound 45. 
Figure A1.102  13C NMR (125 MHz, CDCl3) of compound 45. 
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Figure A1.104  Infrared spectrum (thin film/NaCl) of compound 46. 
Figure A1.105  13C NMR (125 MHz, CDCl3) of compound 46. 
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Figure A1.107  Infrared spectrum (thin film/NaCl) of compound 47. 
Figure A1.108  13C NMR (125 MHz, CDCl3) of compound 47. 
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Figure A1.110  Infrared spectrum (thin film/NaCl) of compound 51. 
Figure A1.111  13C NMR (125 MHz, CDCl3) of compound 51. 
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Figure A1.113  Infrared spectrum (thin film/NaCl) of compound 52. 
Figure A1.114  13C NMR (125 MHz, CDCl3) of compound 52. 
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CHAPTER 2 
Development of (Trimethylsilyl)Ethyl Ester-Protected Enolates and 
Applications in Palladium–Catalyzed Enantioselective Allylic Alkylation: 
Intermolecular Cross-Coupling of Functionalized Electrophiles1 
 
2.1 INTRODUCTION  
2.1.1 Latent enolates: silyl enol ethers 
Latent or protected enolates such as silyl enol ethers, silyl ketene acetals, allyl 
enol carbonates, allyl β-keto esters and others, have found broad use in organic synthesis 
owing to their mild release and ease of use.51,15  Perhaps the most well studied class of 
protected enolates employ oxygen-bound protecting groups (i.e. silyl enol ethers).  
Unfortunately, the utility of this class of compounds is often limited by poor 
regioselectivity when forming fully substituted enol derivatives.52  Although much effort 
has been devoted to the identification of conditions that allow for selective generation of 
so-called “thermodynamic” enolate isomers, selectivity often drops precipitously when 
sterically demanding α-substitution is introduced (Figure 2.1.1.1).53  For example, in 
previous studies by the Stoltz group, it was found that while formation of the 
 
1 This work was performed in collaboration with Douglas C. Behenna, staff scientist in the Stoltz group.  
This work has been published. See: Reeves, C. M.; Behenna, D. C.; Stoltz, B. M. Org. Lett. 2014, 16, 2314. 
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thermodynamic silyl enol ether derived from 2-methyl cyclohexanone (Figure 2.1.1.1, 
57) proceeded in 84% yield, while the corresponding ethyl substituted enol ether (Figure 
2.1.1.1, 58) was formed in only 41% yield.  
 
Figure 2.1.1.1. Drawbacks of silyl enol ether synthesis   
 
 
 
2.1.2 Latent enolates: β-ketoesters 
The problem of thermodynamic enolate masking would be solved, ideally, by the 
development of enolate precursors that are readily prepared and, when triggered, release 
the “thermodynamic” enolate under kinetic control. In the context of allylic alkylation 
reactions, carboxylate-protected enolates (i.e., allyl β-ketoesters, 61, Figure 2.1.2.1) 
represent a significant advance toward such a solution.  Allyl β-ketoesters enjoy 
relatively uncomplicated, selective synthesis54 from simple ketones (i.e. 59) and undergo 
deprotection upon treatment with a transition metal capable of oxidative addition.  
Oxidative addition affords a transition metal allyl species, in the case at hand, a palladium 
π-allyl species 63, and a free carboxylate 62. The resulting carboxylate may then 
spontaneously release CO2  to give prochiral enolate 64.55  This enolate may then enter 
into a catalytic cycle and undergo α-functionalization.     
 
O
NaI (1.25 equiv), TMSCl (1.15 equiv)
Et3N (1.25 equiv), MeCN
OTMS
R R
OTMS
R
+
• mixtures of kinetic X and thermodynamic X product ranging
  from 4 – 10 : 1
• separated by spinning band distillation
• or by subjecting the product mixture to Segusa–Ito conditions
OTMSOTMS
40.5% yield84.2% yield
54 55 56
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Figure 2.1.2.1. Allyl β-ketoester approach to latent enolate chemistry 
 
 
 
Despite these advantages, allyl β-ketoesters are not without their own limitations. 
Facile nucleophilic attack of the incipient enolate at the transition metal-allyl species 
generated during deprotection often precludes applications that do not involve allylic 
alkylation.56  Moreover, with traditional carboxylate-protected enolates, any functionality 
borne by the allyl fragment (60, R2, Figure 2.1.2.1) must be compatible with the 
conditions required for substrate synthesis (i.e. strong base and reactive electrophiles).  
Tunge and coworkers have demonstrated the utility of acyl-protected enolates, which 
may undergo deprotection via a retro-Claisen condensation to reveal fully-substituted 
enolates, that participate in catalysis.57  However, these reactions often require the use of 
elevated temperatures and alkoxide base to proceed. 
 
2.1.3 Latent enolates: TMSE β-ketoesters 
Conceptually, we envisioned a new class of β-ketoester enolate precursors 
bearing an alkyl ester substituent labile to cleavage (Figure 2.1.3.1, 66). Ideally, facile 
deprotection would liberate this alkyl fragment to reveal a free carboxylate species, 
which, upon spontaneous decarboxylation, would yield the desired tetrasubstituted, 
prochiral enolate (67). Electrophilic trapping of this enolate species in the presence of a 
O
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chiral catalyst would, in turn, give rise to enantioenriched α–functionalizaed carbonyl 
products (68).    
 
Figure 2.1.3.1. Non-allyl β-ketoester approach to latent enolate chemistry 
 
 
 
In considering novel carboxylate-protected enolates, our design criteria called for 
a substrate that could be synthesized efficiently, deprotected under mild conditions and 
facilitate the convergent union of complex fragments in a synthetic setting.  Our approach 
to this problem was to develop the (trimethylsilyl)ethyl β-ketoester (TMSE β-ketoester) 58 
substrate class (i.e., 69, Figure 2.1.3.2). These compounds boast similar ease of 
preparation as compared with allyl β-ketoesters, but are not susceptible to transition 
metal-mediated deprotection. We hypothesized that use of TMSE β-ketoesters may 
enhance the breadth of functional group tolerance at the allyl coupling partner in 
asymmetric allylic alkylations, relative to allyl β-ketoesters, by virtue of the fact that the 
allyl fragment is not subjected to the conditions of substrate synthesis (Figure 2.1.3.2).  
We further reasoned that by eliminating allyl from the reaction mixture, we would 
obviate the problem of competing reaction pathways in non-allyl enolate trapping 
chemistry, and greatly expand the range of reactions in which carboxylate-protected 
enolates may participate. 
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Figure 2.1.3.2. TMSE β-ketoester approach to latent enolate chemistry 
 
 
 
In this chapter, we describe the preparation and development of this substrate 
class and the evaluation thereof in the enantioselective palladium-catalyzed allylic 
alkylation of 6- and 7-membered ketone and lactam scaffolds.  Furthermore, we go on to 
show how the use of these substrates can enable the union of complex fragments bearing 
functionality that would be incompatible with incorporation into traditional allyl β-
ketoester substrates.  
 
2.2  SYNTHESIS OF AND REACTION OPTIMIZATION WITH TMSE β-
KETOESTERS 
2.2.1 Substrate synthesis 
The initial task pursuant to the goals laid out in Section 2.1.3 was to develop an 
efficient synthesis of TMSE β-ketoester 69.  We were pleased to find that α-methyl 
TMSE β-ketoester (74) could be prepared in a single synthetic operation from 
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commercially available cyclohexanone (59), 2-(trimethylsilyl)ethyl chloroformate (73) 
and methyl iodide (MeI) in good overall yield (Scheme 2.2.1.1).   
 
Scheme 2.2.1.1. TMSE β-ketoester substrate synthesis 
 
 
 
In order to evaluate the substrate’s capacity to engage in transition metal-
mediated catalysis as anticipated, TMSE-β-ketoester 74 was subjected to treatment with 
tetrabutylammonium difluorotriphenylsilicate (TBAT) in THF at ambient temperature 
(Scheme 2.2.1.2).  The reaction was quenched with saturated aqueous ammonium 
chloride, and full deprotection to 2-methyl-cyclohexanone 75 was observed after 30 min. 
This experiment lended proof of principal that our TMSE-β-ketoesters could indeed 
undergo mild deprotection and encourgaed further investigation of the substrate class.  
 
Scheme 2.2.1.2. Fluoride-triggered deprotection of TMSE β-ketoester substrate  
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2.2.2 TMSE-β-ketoester allylic alkylation optimization 
With TMSE β-ketoester 74 in hand, our investigation into this substrate class 
commenced in the context of Pd-catalyzed allylic alkylation.  We were pleased to find 
that exposure of β-ketoester 74 to allyl bromide, TBAT, [Pd2(dba)3] and (S)-t-Bu-
PHOX8,59 in toluene at  40 °C generated the desired α-quaternary ketone 7 in modest 
yield and good enantioselectivity (entry 1, Table 2.2.2.1).  We next explored the scope of 
allyl sources that could be used in the reaction and found that a variety of diverse allyl 
sources were competent in the chemistry, including allyl sulfonates, allyl acetates and 
allyl carbonates (entries 2–5).  Allyl methyl carbonate proved to be the most efficient, 
selective and prudent allyl source, in particular, with respect to the number of the allyl 
equivalents required for optimal reactivity (entry 6).  Reaction parameters including 
relative stoichiometry (entries 7–9), solvent (entries 10–13) and temperature (entry 14) 
were all subsequently explored and we found that a slight excess of mixed carbonate in 
THF at 25 °C delivering the desired ketone in 81% yield and 86% enantioselectivity 
(entry 14).  
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Table 2.2.2.1. TMSE β-ketoester allylic alkylation initial optimization experiments 
 
 
(a) Yield determined by comparison to tridecane internal standard. (b) % ee Determined by chiral 
GC analysis of the crude reaction mixture.  (c) Reaction performed at 25 °C. 
 
A more rigorous investigation of the solvent effects on the reaction was 
subsequently conducted.  Using preliminarily optimized reaction parameters, we 
conducted screening experiment wherein the base substrate 74 was treated with TBAT 
(1.25 equiv), Pd2(dba)3 (5 mol%), ligand L1 (12.5 mol%) and methyl allyl carbonate (1.1 
equiv) in a wide variety of solvent combinations. The results of these experiments are 
shown below in Tables 2.2.2.2 and 2.2.2.3.  The results of these experiments show that 
reaction yield is highly variable based on the solvent employed (Table 2.2.2.2), while 
reaction selectivity remains relatively uniform (Table 2.2.2.3). With respect to variablility 
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in yield, the primary factor at play in these expeirments is hypothesized to be the relative 
solubility of the fluoride source used, TBAT. In toluene, TBAT is only sparingly soluble, 
in MTBE still only somewhat soluble, whereas TBAT is completely soluble in THF and 
p-dioxane, even at higher concentrations, thus accounting for lower observed yields in 
cases where low-dielectric solvents are employed.  The majority of mass balance in low-
yielding experiments is accounted for in recovered starting material. The fluctuation in 
enantioselectivity may be rationalized via the working mechanistic hypothesis for this 
transformation; in particular, that enantioselective allylic alkylation occurs via an inner-
sphere pathway,35 and this pathway is reinforced by less polar solvents.  
 
Table 2.2.2.2. TMSE β-ketoester allylic alkylation solvent effects on reaction yield 
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0.0 
20.0 
40.0 
60.0 
80.0 
100.0 
Diox 
1:2 
Diox 
1:1 
Diox 
2:1 
THF 
1:2 
THF 
1:1 
THF 
2:1 
MTBE 
1:2 
MTBE 
1:1 
MTBE 
2:1 
34.6 
27.2 
99.0 
80.1 84.9 
15.5 13.9 20.4 
26.9 28.5 
15.2 
98.5 
67.6 
31.4 
%yield 
solvent combination 
Chapter 2 – Development of TMSE Ester-Protected Enolates and Applications in Palladium–
Catalyzed Enantioselective Allylic Alkylation 
 
 
146 
Table 2.2.2.3. TMSE β-ketoester allylic alkylation solvent effects on reaction selectivity 
 
2.3 PALLADIUM-CATALYZED ALLYLIC ALYLATION WITH TMSE-β-KETOESTERS 
2.3.1 Reaction scope with respect to nucleophile  
Having identified optimal reaction conditions, we turned our attention to 
exploring reaction scope, beginning with tolerance of variability with respect to the 
nucleophile’s α-substitution, ring size, and carbonyl functionality (Figure 2.3.1.1).  
Simple α-alkyl substitutions, such as α-benzyl substituted β-ketoester 77a (R1 = Bn, X = 
CH2, Y = CH2, n = 1, Figure 2), functioned consistently well in the chemistry; the desired 
benzyl substituted α-quaternary ketone 79a was obtained in high yield and 
enantioselectivity.  In addition to simple α-alkyl substrates (i.e. compounds 74 and 77a), 
heteroatom-substituted substrate 77b (R1 = F, X = Y = CH2, n = 1) proved to be a viable 
coupling partner and provided the corresponding α-fluoro-allylic alkylation product 79b 
in good yield and excellent ee. Subjecting methyl ester-bearing substrate 77c (R1 = 
CH2CH2CO2Me, X = Y = CH2, n = 1) to our optimized conditions resulted in an efficient 
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and selective reaction, furnishing enantioenriched ketone 79c in 93% yield and 89% ee.  
Substrates constituted from 7-membered rings, including ketone 77d (R1 = Me, X = Y = 
CH2, n = 2) and vinylogous ester 77e (R1 = Me, X = CH, Y = CO(i-Bu), n = 2), were 
shown to be suitable coupling partners, affording α-quaternary ketone 79d and α-
quaternary vinylogous ester 79e products in 95% and 89% yield and 87% and 92% ee, 
respectively.  Finally, 6- and 7-membered lactams were investigated.  We were pleased to 
find that under slightly modified reaction conditions (40 °C), the desired α-functionalized 
lactam products 79f and 79g were obtained in good to excellent yields and excellent ee’s.  
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Figure 2.3.1.1. Exploration of functional group and scaffold diversity in the fluoride-triggered 
palladium-catalyzed allylic alkylation reaction with respect to nucleophile 
 
(a) Reaction conditions: 3 (1.0 equiv), 5 (1.1 equiv), [Pd2(dba)3] (5 mol%), (S)-t-Bu-PHOX (12.5 
mol%), TBAT (1.25 equiv) in THF (0.033M) at 25 °C for 12–48 h. (b) Reaction performed on 
substrates 77f and 77g at 40 °C. (c) All reported yields are for isolated products. 
 
2.3.2 Reaction scope with respect to electrophile 
Having surveyed the scope of the reaction with respect to nucleophile α-
substitution and scaffold type, we next probed the allylic alkylation with respect to 
substitution at the 2-allyl position. We were pleased to find that a variety of functional 
groups could be introduced through the use of differentially substituted allyl carbonates 
(80, R2 ≠ H, Figure 2.3.2.1).  Simple alkyl substitution at the internal allyl position was 
well tolerated as 2-methylallyl ketone 81a was obtained in 89% yield and 89% ee.  2-
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Chloroallyl methyl carbonate (80, R2 = Cl) also participated well in the chemistry, 
furnishing the corresponding α-quaternary ketone 81b in 72% yield and 96% ee.  Allyl 
fragments bearing electron-neutral and electron-deficient aryl groups also functioned well 
in the reaction, delivering the desired allylic alkylation products 81c and 81d, 
respectively, in excellent yields and ee’s. 
 
Figure 2.3.2.1. Exploration of functional group and scaffold diversity in the fluoride-triggered 
palladium-catalyzed allylic alkylation reaction with respect to electrophile 
 
 
(a) Reaction conditions: 3 (1.0 equiv), 5 (1.1 equiv), [Pd2(dba)3] (5 mol%), (S)-t-Bu-PHOX (12.5 
mol%), TBAT (1.25 equiv) in THF (0.033M) at 25 °C for 12–48 h. (b) All reported yields are for 
isolated products. 
 
2.4 COUPLING OF TMSE β-KETOESTERS WITH FUNCTIONALLY COMPLEX 
ELECTROPHILIC PARTNERS 
While the new fluoride-triggered chemistry described thus far permits alternative 
access to structures previously available by allylic alkylation, a distinct advantage offered 
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by TMSE-β-ketoesters in allylic alkylation chemistry is the ability to introduce allyl-
coupling partners that would be unstable to the conditions of allyl β-ketoester substrate 
synthesis.  To illustrate this feature of the new chemistry, we synthesized mixed 
carbonates 82 and 83 as coupling partners for palladium-catalyzed allylic alkylation 
(Figure 2.4.1).  Allyl carbonate 82, derived from leucine, bears an epimerizable 
stereocenter that is racemized upon treatment with strong base.60  Since strong base (i.e. 
LDA, LHMDS, etc.) is typically required for enolization and acylation in the preparation 
of standard allyl β-ketoesters, employing electrophiles bearing base labile functionality 
has not previously been possible.  Alternatively, allyl carbonate 83, which was 
synthesized by allylic oxidation of (S)-carvone, also bears functionality that would be 
unstable to the conditions required for standard allyl β-ketoester substrate synthesis.  In 
particular, we envisioned that attempts to acylate a ketone enolate with an allyl chloro- or 
allyl cyanoformate bearing enone 83 would be complicated by undesired conjugate 
addition and enolate chemistries (e.g. Aldol reaction, Michael addition, etc.).  In both 
cases, our new TMSE β-ketoester chemistry allows for the independent preparation and, 
thus, physical separation of nucleophilic and electrophilic components until the fragment 
coupling stage.  
 
Figure 2.4.1. Complex allyl architechtures 
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Subjecting allyl carbonate 82 and TMSE β-ketoester 77a (R1 = Bn, X = Y = CH2, 
n = 1, Figure 2.4.2) to our fluoride-modified allylic alkylation conditions with achiral 
ligand L8 revealed modest substrate-controlled diastereoselection of 1.7:1 (entry 1, 
Figure 2.4.2A).  Use of (S)-t-Bu-PHOX (L1) resulted in a highly efficient and 
diastereoselective reaction giving the desired amino ester 84 in 95% yield and greater 
than 25:1 dr, with no detectable epimerization at the amino ester side chain (entry 2).  
The inherent diastereoselectivity could be completely reversed under catalyst control by 
using (R)-t-Bu-PHOX (L9), without significant loss in selectivity or reactivity (entry 3).  
Likewise, upon exposing carbonate 83 and ketoester 77a to slightly modified allylic 
alkylation conditions (40 °C vs. 25 °C) with achiral ligand L8, we again observed an 
efficient reaction and slight inherent diastereoselectivity (entry 4, Figure 2.4.2B).  This 
bias could be enhanced by using ligand L1 to obtain α-quaternary ketone 86 in 6:1 dr and 
87% yield, or overturned by use of L9 to obtain 87 in 5:1 dr and 77% yield (entries 5 and 
6). 
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Figure 2.4.2. Union of complex fragments by asymmetric allylic alkylationa 
 
(a) Reaction conditions: 77a (1.0 equiv), 82 or 83 (1.1 equiv), [Pd2(dba)3] (5 mol%), Ligand (12.5 
mol%), TBAT (1.25 equiv) in THF (0.033M) at the indicated temperature for 24–48 h. (b) 
Diastereoselectivity determined by 1H NMR analysis of the crude reaction mixture.  (c) Yields are 
reported for combined diastereomeric mixture. 
 
2.5 CONCLUDING REMARKS 
In conclusion, we have developed a new class of substrates for enolate alkylation 
chemistry that benefit from ease of preparation and mild deprotection conditions that are 
orthogonal to those used for traditional allyl β-ketoesters.  We examined the application 
of these compounds in palladium-catalyzed asymmetric allylic alkylation chemistry and 
found that a wide range of functional groups and substrate scaffolds are well tolerated, 
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including 6- and 7-membered ketones and lactams.  We have further demonstrated the 
value of these compounds for uniting complex coupling partners that would be 
incompatible to preparation via standard allyl β-ketoester based allylic alkylation.  We 
envision that this technology will also enable the convergent cross-coupling of 
synthetically challenging fragments for complex molecule synthesis.  Further studies 
exploring the application of TMSE β-ketoesters in diverse reaction methodologies and 
complex natural product synthesis are ongoing in our laboratory.  
 
2.6 EXPERIMENTAL SECTION 
2.6.1 Materials and Methods 
Unless otherwise stated, reactions were performed in flame-dried glassware under 
an argon or nitrogen atmosphere using dry, deoxygenated solvents.  Solvents were dried 
by passage through an activated alumina column under argon.61 Reaction progress was 
monitored by thin-layer chromatography (TLC).  TLC was performed using E. Merck 
silica gel 60 F254 precoated glass plates (0.25 mm) and visualized by UV fluorescence 
quenching, p-anisaldehyde, or KMnO4 staining.  Silicycle SiliaFlash® P60 Academic 
Silica gel (particle size 40–63 nm) was used for flash chromatography.  1H NMR spectra 
were recorded on Varian Inova 300 MHz and 500 MHz spectrometers and are reported 
relative to residual CHCl3 (δ 7.26 ppm) or C6HD5 (δ 7.16 ppm).  13C NMR spectra were 
recorded on a Varian Inova 500 MHz spectrometer (125 MHz) and are reported relative 
to CHCl3 (δ 77.16 ppm) or C6HD5 (δ 128.06 ppm). Data for 1H NMR are reported as 
follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), integration).  
Multiplicities are reported as follows: s = singlet, d = doublet, t = triplet, q = quartet, p = 
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pentet, sept = septuplet, m = multiplet, br s = broad singlet, br d = broad doublet, app = 
apparent.  Data for 13C NMR are reported in terms of chemical shifts (δ ppm).  19F NMR 
spectra were recorded on a Varian Mercury 300 spectrometer at 282 MHz, and are 
reported relative to the external standard F3CCO2H (δ –76.53 ppm).  IR spectra were 
obtained by use of a Perkin Elmer Spectrum BXII spectrometer or Nicolet 6700 FTIR 
spectrometer using thin films deposited on NaCl plates and reported in frequency of 
absorption (cm-1).  Optical rotations were measured with a Jasco P-2000 polarimeter 
operating on the sodium D-line (589 nm), using a 100 mm path-length cell and are 
reported as: [α]DT (concentration in g/100 mL, solvent).  Analytical HPLC was performed 
with an Agilent 1100 Series HPLC utilizing a Chiralpak (AD-H or AS) or Chiralcel (OD-
H, OJ-H, or OB-H) columns (4.6 mm x 25 cm) obtained from Daicel Chemical 
Industries, Ltd. Analytical SFC was performed with a Mettler SFC supercritical CO2 
analytical chromatography system utilizing Chiralpak (AD-H, AS-H or IC) or Chiralcel 
(OD-H, OJ-H, or OB-H) columns (4.6 mm x 25 cm) obtained from Daicel Chemical 
Industries, Ltd. Analytical chiral GC analysis was performed with an Agilent 6850 GC 
utilizing a GTA (30 m x 0.25 mm) column (1.0 mL/min carrier gas flow).  High 
resolution mass spectra (HRMS) were obtained from Agilent 6200 Series TOF with an 
Agilent G1978A Multimode source in electrospray ionization (ESI+), atmospheric 
pressure chemical ionization (APCI+), or mixed ionization mode (MM: ESI-APCI+). 
Reagents were purchased from Sigma-Aldrich, Gelest, Strem, or Alfa Aesar and 
used as received unless otherwise stated. 2-(trimethylsilyl)ethyl chloroformate (78) was 
prepared according to a known procedure.62 Allyl carbonates 82 and 83 were prepared 
from methyl chloroformate and the corresponding allyl alcohols by adaptation of a 
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known procedure. 63  β-Ketoesters 74 and 77a–77g were prepared by adaptation of 
procedures by Stoltz and co-workers.64,15 Data reported herein is for new compounds 
only.  
 
2.6.2  General procedure for TMSE β-ketoester substrate synthesis  
 
 
2-(Trimethylsilyl)ethyl 1-methyl-2-oxocyclohexane-1-carboxylate (74). A flame-dried 
1L round bottom flask was charged with 28.02 g (152.83 mmol, 2.5 equiv) of LiHMDS 
and a magnetic stirring bar in a nitrogen-filled glove box. The flask was sealed, removed 
from the glove-box, fitted with a N2 line, and suspended in a dry ice/acetone bath. 300 
mL of THF was added slowly to the flask and allowed to stir until the LiHMDS had  
completely dissolved. 6.00 g (61.13 mmol, 1.0 equiv) of cyclohexanone 59 in 130 mL of 
THF was added via cannula over 30 min, and the flask was removed from the cooling 
bath and allowed to warm to 23 °C while continuing to stir. After 30 min, the flask was 
suspended in a dry ice/acetone bath and 12.15 g (67.24 mmol, 1.1 equiv) of 
chloroformate 73 in 130 mL of THF was added over 30 min via cannula. This mixture 
was allowed to warm to 23 °C and stirred for 6 h. The flask was then suspended in a 
water/ice bath and 21.69 g (152.83 mmol, 2.5 equiv) of methyl iodide was added 
dropwise. This mixture was allowed to warm to 23 °C and stirred for 6 h, at which time 
an additional 21.69 g (152.83 mmol, 2.5 equiv) of methyl iodide was added dropwise. 
O
LiHMDS (2.5 equiv)
O O
O
Me
TMS
O
O
TMS
Cl
70% yield
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74THF, –78 °C → 0 °C → 23 °C
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The mixture was then stirred at 23 °C until full consumption of starting material and 
acylated intermediate was observed by TLC analysis. 300 mL of saturated aqueous 
NH4Cl was then added slowly to the mixture and stirring continued for 2 h. The mixture 
was then extracted with EtOAc (100 mL x 3), the collected organic fractions washed with 
brine, dried over MgSO4, filtered and concentrated in vacuo. The crude residue was 
purified by flash column chromatography (SiO2, hexanes to 3% EtOAc in hexanes) to 
give 11.05 g (43.08 mmol) of ketoester 74 as a pale yellow oil. 70.1% yield. Rf = 0.3 
(10% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 4.29–4.12 (m, 2H), 2.57–2.37 
(m, 3H), 2.05–1.95 (m, 1H), 1.76–1.57 (m, 3H), 1.48–1.37 (m, 1H), 1.26 (s, 3H), 1.01–
0.92 (m, 2H), 0.02 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 208.3, 173.2, 63.6, 57.1, 40.7, 
38.2, 27.5, 22.6, 21.2, 17.3, -1.6; IR (Neat Film, NaCl) 3438, 2952, 2897, 2866, 1717, 
1452, 1378, 1336, 1251, 1215, 1121, 1084, 1061, 1041, 938, 861, 834, 763 cm–1; HRMS 
(MM: ESI-APCI+) m/z calc'd for C13H25O3Si [M + H]+: 257.1567; found 257.1556. 
 
2.6.3 Procedures for the syntheses of TMSE β-ketoester intermediate 88 and 
ketoester 77b 
 
 
2-(Trimethylsilyl)ethyl 1-H-2-oxocyclohexane-1-carboxylate (88). A flame-dried 500 
mL round bottom flask was charged with 4.67 g (25.47 mmol, 1.3 equiv) of LiHMDS 
and a magnetic stirring bar in a nitrogen-filled glove-box. The flask was sealed, removed 
O
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from the glove-box, fitted with a N2 line, and suspended in a dry ice/acetone bath. 100 
mL of THF was added slowly to the flask and allowed to stir until the LiHMDS had been 
completely dissolved. 2.00 g (20.38 mmol, 1.0 equiv)  of cyclohexanone 59 in 50 mL of 
THF was added via cannula over 30 min, and the flask was removed from the cooling 
bath and allowed to warm to 23 °C while continuing to stir. After 30 min, the flask was 
suspended in a dry ice/acetone bath and 4.10 g (22.42 mmol, 1.1 equiv) of chloroformate 
73 in 50 mL of THF was added over 30 min via cannula. This mixture was allowed to 
warm to 23 °C and stirred until full consumption of starting material was observed (ca. 6 
h). 100 mL of saturated aqueous NH4Cl was then added slowly and the mixture stirred for 
20 min before being extracted with EtOAc (30 mL x 3). The collected organic fractions 
were washed with brine, dried over MgSO4, filtered and concentrated in vacuo. The crude 
residue was purified by flash column chromatography (SiO2, hexanes to 2% EtOAc in 
hexanes), to give 3.20 g (43.08 mmol) of ketoester 88 as a colorless oil. 64.6% yield. Rf = 
0.5 (20% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 12.29 (s, 1H), 4.27–4.21 (m, 
2H), 2.23 (dtt, J = 24.7, 6.3, 1.6 Hz, 4H), 1.76–1.51 (m, 4H), 1.17–0.86 (m, 2H), 0.04 (s, 
9H); 13C NMR (126 MHz, CDCl3) δ  172.9, 171.9, 97.8, 62.4, 29.1, 22.5, 22.4, 21.9, 17.3, 
-1.5; IR (Neat Film, NaCl) 2952, 2899, 2860, 1742, 1718, 1654, 1618, 1453, 1398, 1360, 
1297, 1258, 1219, 1175, 1079, 1060, 936, 859, 837 cm–1; HRMS (MM: ESI-APCI–) m/z 
calc'd for C12H21O3Si [M – H]–: 241.1265; found 241.1270. 
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2-(Trimethylsilyl)ethyl 1-fluoro-2-oxocyclohexane-1-carboxylate (77b). A flame dried 
100 mL round bottom flask was charged with a magnetic stirring bar, 0.35 g 88 (1.44 
mmol, 1.0 equiv), 5 mL of acetonitrile and cooled to 0 °C. To this mixture was added  
0.027 g TiCl4 (0.144 mmol, 0.10 equiv) dropwise over 15 min. To this stirring solution 
was added 0.64 g Selectfluor (1.73 mmol, 1.2 equiv) in 20 mL of acetonitrile over 25 
min. The mixture was then allowed to warm to 23 °C and stirred for 8 h. A 1:1 mixture of 
H2O/EtOAc (20 mL) was added, and the mixture was extracted with EtOAc (20 mL x 3), 
dried over MgSO4 and adsorbed onto 1 g SiO2 by concentration in vacuo. The crude 
product was isolated by flash column chromatography (SiO2, 3% Et2O in pentane to 12% 
Et2O in pentane) to give 0.29 g of 77b as a colorless oil. 79.0% yield. Rf = 0.2 (20% 
EtOAc in hexanes); 1H NMR (300 MHz, CDCl3) δ 4.41–4.26 (m, 2H), 2.84–2.36 (m, 
3H), 2.21–2.04 (m, 1H), 2.00–1.79 (m, 4H), 1.15–0.97 (m, 2H), 0.04 (s, 9H); 13C NMR 
(75 MHz, CDCl3) δ  202.0 (d, 4JCF = 19.5 Hz), 167.0 (d, 2JCF = 24.6 Hz), 96.4 (d, 1JCF = 
197.0 Hz), 65.0, 39.7, 36.0 (d, 3JCF = 21.7 Hz), 26.6 , 21.0 (d, 5JCF = 6.0 Hz), 17.3 , -1.6; 
19F NMR (282 MHz, CDCl3) δ –173.70; IR (Neat Film, NaCl) 2953, 1732, 1452, 1287, 
1251, 1223, 1157, 1093, 1051, 860, 838 cm–1; HRMS (MM: ESI-APCI+) m/z calc'd for 
C12H21FO3SiNa [M + Na]+: 283.1136; found 283.1145. 
 
2.6.4 Spectroscopic data for TMSE β-ketoester substrates 
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2-(Trimethylsilyl)ethyl 1-benzyl-2-oxocyclohexane-1-carboxylate (77a) 
 
 
Ketoester 77a was prepared by the general procedure and was isolated by flash column 
chromatography (SiO2, hexanes to 5% EtOAc in hexanes) as a colorless oil. 79.4% yield. 
Rf = 0.3 (20% EtOAc in hexanes); 1H NMR (300 MHz, CDCl3) δ 7.48–7.04 (m, 5H), 
4.16 (td, J = 9.8, 7.1 Hz, 2H), 3.13 (dd, J = 125.3, 13.7 Hz, 2H), 2.60–2.35 (m, 2H), 2.05 
(ddd, J = 12.4, 6.1, 3.0 Hz, 1H), 1.83–1.59 (m, 4H), 1.57–1.40 (m, 1H), 0.92 (ddd, J = 
8.9, 7.2, 1.0 Hz, 2H), 0.07 (s, 9H); 13C NMR (75 MHz, CDCl3) δ  208.9, 172.8, 138.3, 
132.0, 129.5, 128.2, 65.2, 63.8, 42.9, 42.0, 37.5, 29.2, 24.1, 18.8, 0.0; IR (Neat Film, 
NaCl) 3029, 2952, 2856, 1713, 1496, 1453, 1439, 1250, 1221, 1177, 1132, 1086, 1053, 
988, 932, 860, 838, 765, 744 cm–1; HRMS (MM: ESI-APCI+) m/z calc'd for C19H29O3Si 
[M + H]+: 333.1880; found 333.1863. 
 
2-(Trimethylsilyl)ethyl 1-(3-methoxy-3-oxopropyl)-2-oxocyclohexane-1-carboxylate 
(77c) 
 
Ketoester 77c was prepared according to the general procedure, using methyl acrylate in 
place of methyl iodide, and isolated by flash column chromatography (SiO2, 5% EtOAc 
in hexanes to 10% EtOAc in hexanes) as a colorless oil. 81.2% yield. Rf = 0.3 (25% 
O O
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EtOAc in hexanes); 1H NMR (300 MHz, CDCl3) δ 4.28–4.08 (m, 2H), 3.62 (s, 3H), 2.41 
(dddd, J = 14.6, 12.9, 6.5, 2.7 Hz, 4H), 2.27–2.06 (m, 2H), 2.02–1.92 (m, 1H), 1.92–1.84 
(m, 1H), 1.76–1.51 (m, 3H), 1.40 (ddd, J = 13.5, 12.1, 4.2 Hz, 1H), 1.03–0.91 (m, 2H), 
0.00 (s, 9H); 13C NMR (75 MHz, CDCl3) δ  207.6, 173.5, 171.8, 63.9, 60.0, 51.6, 41.0, 
36.3, 29.7, 29.4, 27.5, 22.5, 17.4, -1.6; IR (Neat Film, NaCl) 3432, 2952, 2899, 2866, 
1740, 1713, 1437, 1377, 1340, 1308, 1250, 1175, 1137, 1093, 1075, 1062, 1040, 943, 
861, 838, 763, 695 cm–1; HRMS (MM: ESI-APCI+) m/z calc'd for C16H28O5SiNa [M + 
Na]+: 351.1598; found 351.1602. 
 
2-(Trimethylsilyl)ethyl 1-methyl-2-oxocycloheptane-1-carboxylate (77d) 
 
Ketoester 77d was prepared by the general procedure and purified by flash column 
chromatography (SiO2, hexanes to 5%  EtOAc in hexanes) as a colorless oil. 78% yield. 
Rf = 0.4 (20% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 4.25–4.14 (m, 2H), 
2.78–2.68 (m, 1H), 2.49 (ddd, J = 12.2, 8.6, 2.5 Hz, 1H), 2.19–2.10 (m, 1H), 1.88–1.71 
(m, 3H), 1.71–1.48 (m, 3H), 1.43–1.34 (m, 1H), 1.33 (s, 3H), 1.06–0.94 (m, 2H), 0.03 (s, 
9H);13C NMR (126 MHz, CDCl3) δ  210.5, 173.7, 63.6, 58.8, 42.0, 35.4, 30.1, 25.8, 24.7, 
21.5, 17.3, -1.6; IR (Neat Film, NaCl) 2949, 2861, 1736, 1710, 1458, 1378, 1250, 1232, 
1152, 1105, 1062, 942, 860, 838 cm–1; HRMS (EI+) m/z calc'd for C14H26O3Si [M + 
Na]+: 293.1543; found 293.1543. 
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2-(Trimethylsilyl)ethyl 4-isobutyl-1-methyl-2-oxocyclohept-3-ene-1-carboxylate (77e) 
 
 
Vinylogous ester 77e was prepared by the general procedure, starting from 3-
isobutoxycyclohept-2-en-1-one, and purified by flash column chromatography (SiO2, 
hexanes to 10%  EtOAc in hexanes) as a colorless oil. 85% yield. Rf = 0.3 (20% EtOAc in 
hexanes); 1H NMR (500 MHz, C6D6) δ 5.66–5.53 (m, 1H), 4.32–4.07 (m, 2H), 3.16–3.00 
(m, 2H), 2.57 (dddd, J = 17.7, 10.1, 3.9, 1.2 Hz, 1H), 2.50–2.37 (m, 1H), 2.20 (ddd, J = 
17.7, 7.0, 3.6 Hz, 1H), 1.77–1.67 (m, 2H), 1.66 (s, 3H), 1.59–1.41 (m, 2H), 0.88 (ddd, J = 
10.0, 7.0, 2.1 Hz, 2H), 0.71 (dd, J = 6.7, 4.2 Hz, 6H), -0.13 (s, 9H); 13C NMR (126 MHz, 
C6D6) δ  197.1, 173.9, 171.7, 105.6, 74.0, 62.9, 58.9, 33.9, 33.7, 27.6, 24.1, 18.7, 18.7, 
17.0, -2.1; IR (Neat Film, NaCl) 2951, 1684, 1452, 1386, 1327, 1281, 1251, 1139, 1053, 
859, 839, 718, 693, 658 cm–1; HRMS (EI+) m/z calc'd for C28H33O3Si [M + H]+: 
341.2143; found 341.2139. 
 
2-(Trimethylsilyl)ethyl 1-benzoyl-3-methyl-2-oxopiperidine-3-carboxylate (77f) 
 
 
Amide ester 77f was prepared by the general procedure, starting from N-benzoyl-2-
piperidone, and purified by flash column chromatography (SiO2, 5%  EtOAc in hexanes 
O Me
O
O
TMS
(i-Bu)O
77e
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to 25%  EtOAc in hexanes) as a colorless oil. 89% yield. Rf = 0.3 (35% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 7.76–7.72 (m, 2H), 7.47 (ddt, J = 8.0, 6.9, 1.3 
Hz, 1H), 7.41–7.36 (m, 2H), 4.38–4.24 (m, 2H), 3.91–3.82 (m, 1H), 3.78 (dtd, J = 12.9, 
5.2, 1.4 Hz, 1H), 2.47 (dddd, J = 13.8, 5.7, 4.3, 1.4 Hz, 1H), 2.06–1.91 (m, 2H), 1.85–
1.74 (m, 1H), 1.46 (s, 3H), 1.14–1.05 (m, 2H), 0.07 (s, 9H); 13C NMR (126 MHz, CDCl3) 
δ  175.0, 173.1, 173.0, 135.9, 131.6, 129.0 128.0, 64.4, 52.9, 46.8, 33.7, 22.4, 20.2, 17.5, 
-1.5; IR (Neat Film, NaCl) 3062, 2953, 2896, 1726, 1703, 1683, 1449, 1389, 1277, 1251, 
1192, 1140, 1062, 932, 859, 838, 723, 694 cm–1; HRMS (MM: ESI-APCI+) m/z calc'd for 
C19H27NO4SiNa [M + Na]+: 384.1602; found 384.1611. 
 
2-(Trimethylsilyl)ethyl 1-benzoyl-3-methyl-2-oxoazepane-3-carboxylate (77g) 
 
 
Amide ester 77g was prepared by the general procedure, starting from 1-benzoylazepan-
2-one, and purified by flash column chromatography (SiO2, 5%  EtOAc in hexanes to 
25%  EtOAc in hexanes) as a colorless oil. 77% yield. Rf = 0.3 (35% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3) δ 7.72–7.68 (m, 2H), 7.50–7.45 (m, 1H), 7.39 (ddt, J = 8.2, 
6.6, 1.1 Hz, 2H), 4.47–4.39 (m, 1H), 4.38–4.31 (m, 2H), 3.15 (ddd, J = 15.7, 11.2, 1.2 
Hz, 1H), 2.22 (dtd, J = 14.8, 3.6, 1.8 Hz, 1H), 2.01–1.90 (m, 2H), 1.89–1.77 (m, 1H), 
1.61 (dddt, J = 20.7, 12.0, 5.0, 3.2 Hz, 3H), 1.44 (s, 3H), 1.14–1.06 (m, 2H), 0.08 (s, 9H); 
13C NMR (126 MHz, CDCl3) δ  175.6, 174.9, 173.1, 136.4, 131.5, 128.1, 127.9, 64.3, 
BzN
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55.0, 44.0, 34.4, 27.9, 26.9, 25.0, 17.5, -1.5; IR (Neat Film, NaCl) 2956, 1729, 1661, 
1614, 1455, 1383, 1249, 1169, 1115, 860, 838 cm–1; HRMS (MM: ESI-APCI+) m/z 
calc'd for C20H29NO4SiNa [M + Na]+: 398.1758; found 398.1775. 
 
2.6.5 General procedure for allyl carbonate substrate syntheses 
 
 
2-Chloroallyl methyl carbonate (80b). To a flame-dried 50 mL round bottom flask 
charged with a magnetic stirring bar, 1.00 g 2-chloroallyl alcohol (89) (10.8 mmol, 1.0 
equiv), 2.56 g of pyridine (32.4 mmol, 3.0 equiv), 0.016 g of dimethylaminopyridine 
(0.14 mmol, 0.013 equiv) and 22 mL of DCM at 0 °C, was added 3.06 g of methyl 
chloroformate (32.43 mmol, 3 equiv), dropwise over 10 min.  The solution was allowed 
to warm to 23 °C and stirred for 12 h.  The mixture was then diluted with 40 mL of 
DCM, washed consecutively with 50 mL H2O and 50 mL brine before being dried over 
MgSO4 and directly subjected to flash column chromatography (SiO2, pentane to 5% 
Et2O in pentane).  1.23 g of 2-Chloroallyl methyl carbonate was isolated as a colorless 
oil. 75.6% yield.  Rf = 0.6 (20% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 5.49 
(dt, J = 2.0, 1.2 Hz, 1H), 5.41 (dt, J = 1.8, 0.9 Hz, 1H), 4.68–4.67 (m, 2H), 3.80 (d, J = 
1.2 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ  155.1, 135.2, 115.2, 69.0, 55.1; IR (Neat 
Film, NaCl) 3008, 2959, 2255, 1752, 1639, 1444, 1383, 1358, 1265, 1182, 1116, 974, 
HO
Cl
methyl chloroformate (3 equiv)
pyridine (3 equiv)
DMAP (0.013 equiv), DCM
89 76% yield
O O
O
Cl80b
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908, 790, 745 cm–1; HRMS (MM: ESI-APCI+) m/z calc'd for C5H8ClO3 [M + H]+: 
151.0156; found 151.0150. 
2.6.6. Spectroscopic data for allyl carbonate substrates 
 
 
2-(4-Fluorophenyl)allyl methyl carbonate (80d) was prepared by the general procedure 
from 2-(4-fluorophenyl)allyl alcohol and isolated as a colorless oil by flash column 
chromatography (SiO2, pentane to 5%  Et2O in pentane). 87% yield. Rf = 0.4 (20% EtOAc 
in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.44–7.36 (m, 2H), 7.09–6.99 (m, 2H), 5.51 
(s, 1H), 5.39 (tt, J = 1.2, 0.5 Hz, 1H), 5.00 (dd, J = 1.3, 0.6 Hz, 2H), 3.79 (s, 3H); 13C 
NMR (126 MHz, CDCl3) δ  162.65 (d, 1JCF = 247.0 Hz), 155.54, 141.1, 133.85, 127.74 
(d, 3JCF = 7.8 Hz), 115.85 (d, 4JCF = 1.4 Hz), 115.41 (d, 2JCF = 21.9 Hz), 69.09 , 54.89; 19F 
NMR (282 MHz, CDCl3) δ –126.95; IR (Neat Film, NaCl) 3007, 2959, 1893, 1750, 
1634, 1603, 1511, 1447, 1372, 1260, 1164, 1102, 969, 918, 839, 791, 742 cm–1; HRMS 
(MM: ESI-APCI+) m/z calc'd for C11H12FO3 [M + H]+: 211.0765; found 211.0772. 
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(R)-Methyl (2-(4-methyl-5-oxocyclohex-3-en-1-yl)allyl) carbonate (83) 
 
 
Enone carbonate 83 was prepared by the general method from known allylic alcohol (R)-
5-(3-hydroxyprop-1-en-2-yl)-2-methylcyclohex-2-en-1-one (i.e. (R)-10-hydroxy 
carvone)65 and isolated as a colorless oil by flash column chromatography (SiO2, 5% 
EtOAc in henxanes to 20% EtOAc in hexanes). 91% yield. Rf = 0.2 (20% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 6.74 (ddd, J = 5.9, 2.7, 1.4 Hz, 1H), 5.22 (dt, J = 
1.3, 0.7 Hz, 1H), 5.07 (dd, J = 1.4, 0.7 Hz, 1H), 4.64 (ddt, J = 3.8, 1.2, 0.5 Hz, 2H), 3.79 
(s, 3H), 2.97–2.74 (m, 1H), 2.63 (ddd, J = 16.1, 3.8, 1.6 Hz, 1H), 2.52 (dddt, J = 18.2, 
6.0, 4.5, 1.5 Hz, 1H), 2.39 (dd, J = 16.1, 13.2 Hz, 1H), 2.31 (ddt, J = 18.2, 10.8, 2.5 Hz, 
1H), 1.78 (dt, J = 2.6, 1.3 Hz, 3H);13C NMR (126 MHz, CDCl3) δ  198.9, 155.5, 144.7, 
144.0, 135.6, 114.3, 69.1, 54.9, 42.9, 38.2, 31.3, 15.7; IR (Neat Film, NaCl) 2958, 2928, 
2893, 1750, 1671, 1444, 1364, 1266, 1107, 984, 954, 913, 791 cm–1; HRMS (MM: ESI-
APCI+) m/z calc'd for C12H17O4 [M + H]+: 225.1121; found 225.1118. 
 
 
 
 
 
 
MeO
O
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2.6.7 Procedure for the synthesis allyl carbonate 82 
 
 
Methyl N-(2-(((methoxycarbonyl)oxy)methyl)allyl)-L-leucinate (92). Known hydroxy 
carbonate 9066 was prepared by the general method.  Following the procedure of Altmann 
and co-workers,67 0.77 g of 90 (5.27 mmol, 1.0 equiv) was added to flame-dried round 
bottom flask charged with a magnetic stirring bar and 0.66 mL of acetonitrile.  The 
solution was cooled to 0 °C and 1.80 g of triphenylphosphine (6.83 mmol, 1.3 equiv) and 
0.66 mL of carbontetrachloride (6.85 mmol, 1.3 equiv) were added sequentially.  The 
resulting slurry was allowed to warm to 23 °C and stirred for 2 h before being subjected 
directly to flash column chromatography.  The resulting crude oil, 91 was determined to 
be ca. 95% pure by 1H NMR analysis and used without further purification  
(yield not determined).  Following a known procedure,68 0.47 g of crude allylic chloride 
intermediate 91 (2.855 mmol, 1.5 equiv) was combined with 0.28 g of NaI (1.90 mmol, 
1.0 equiv), 0.346 g of (L)-leucine methyl ester hydrochloride (1.90 mmol, 1.0 equiv), 
0.061 g of tetrabutylammonium bromide (0.19 mmol, 0.1 equiv), 1.01 g Na2CO3 (9.52 
mmol, 5 equiv) and 20 mL acetonitrile in a 50 mL round bottom flask equipped with a 
magnetic stirring bar.  The flask was fitted with a reflux condenser and the mixture stirred 
at 82 °C for 14 h.  The vessel was then cooled to 23 °C and the mixture diluted with 50 
mL Et2O, washed with H2O (20 mL x 2), dried over MgSO4 and concentrated in vacuo.  
MeO2CO OH
PPh3 (1.3 equiv)
CCl4 (1.3 equiv)
MeCN
MeO2CO Cl NaI (1 equiv)
TBAB (0.1 equiv)
Na2CO3 (5 equiv)
MeCN
(1 equiv)
MeO O
O
HN
O
OMe
92
i-Pr
NH3Cl
O
OMei-Pr
9190
66% yield
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The crude oil was purified by flash column chromatography (SiO2, 5% EtOAc in hexanes 
to 15% EtOAc in hexanes) to give 0.52 g of amino ester 92 as a colorless oil.  66.1% 
yield from crude 91.  Rf = 0.2 (40% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 
5.23–5.08 (m, 2H), 4.66 (t, J = 1.0 Hz, 2H), 3.79 (s, 3H), 3.71 (s, 3H), 3.25 (t, J = 7.3 Hz, 
1H), 3.19 (dd, J = 80.0, 13.8 Hz, 1H), 1.74 (dq, J = 13.5, 6.7 Hz, 1H), 1.51 (br s, 2H), 
1.43 (t, J = 7.2 Hz, 2H), 0.89 (dd, J = 9.2, 6.6 Hz, 6H);13C NMR (126 MHz, CDCl3) δ  
176.5, 155.7, 141.7, 115.0, 68.9, 59.1, 54.9, 51.7, 50.4, 42.9, 24.9, 22.9, 22.2; IR (Neat 
Film, NaCl) 2956, 2868, 1750, 1737, 1443, 1368, 1267, 1196, 1151, 980, 943, 792 cm–1; 
HRMS (MM: ESI-APCI+) m/z calc'd for C13H24NO5 [M + H]+: 274.1649; found 
274.1659. 
 
Methyl N-(2-(((methoxycarbonyl)oxy)methyl)allyl)-N-methyl-L-leucinate (82). To a 
10 mL round bottom flask containing a magnetic stirring bar and a solution of 0.37 g 92 
(1.35 mmol, 1.0 equiv) in 4 mL of methanol was added 0.056 g of formaldehyde (1.88 
mmol, 1.4 equiv) as a 37% solution in H2O.  The mixture was stirred at 23 °C for 12 h at 
which point 0.11 g sodium cyanoborohydride was carefully added.  After an additional 
12 h of stirring, the mixture was diluted with H2O (5 mL), extracted with EtOAc (5 mL x 
3), dried over MgSO4, concentrated in vacuo and subjected directly to purification by 
flash column chromatography (SiO2, 10% EtOAc in hexanes to 25% EtOAc in hexanes) 
to yield 0.25 g of carbonate 82 as a colorless oil. 63.8% yield.  Rf = 0.5 (33% EtOAc in 
hexanes); 1H NMR (300 MHz, CDCl3) δ 5.30–5.07 (m, 2H), 4.63 (t, J = 1.0 Hz, 2H), 3.79 
MeO O
O
HN
O
OMe
92
i-Pr
HCHO (1.4 equiv)
MeOH
then NaBH3CN
MeO O
O
MeN
O
OMe
82
i-Pr
64% yield
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(s, 3H), 3.69 (s, 3H), 3.34 (dd, J = 8.3, 7.0 Hz, 1H), 3.18 (dd, J = 75.0, 13.8 Hz, 2H), 2.22 
(s, 3H), 1.73–1.61 (m, 1H), 1.61–1.46 (m, 2H), 0.90 (dd, J = 17.5, 6.6 Hz, 6H);13C NMR 
(126 MHz, CDCl3) δ  173.3, 155.6, 141.2, 115.4, 68.5, 63.8, 57.3, 54.7, 50.9, 38.4, 37.0, 
24.7, 22.9, 21.9; IR (Neat Film, NaCl) 2955, 2870, 2803, 1751, 1658, 1444, 1385, 1368, 
1269, 1193, 1157, 1126, 1072, 978, 945, 792 cm–1; HRMS (MM: ESI-APCI+) m/z calc'd 
for C14H26NO5 [M + H]+: 288.1805; found 288.1795. 
 
2.6.8 Optimization of reaction parameters 
Table 2.6.8.1. Optimization of reaction parameters  
 
 
 
General Procedure for Optimization Experiments: Inside a nitrogen-filled glove-box, 
an oven-dried 0.5 dram vial was charged with a magnetic stirring bar, 0.0046 g 
O O
O
Me
O
Me [Pd2(dba)3] (5 mol %)
 (S)-t-Bu-PHOX(12.5 mol %)
 
TBAT (1.25 equiv)
solvent, 40 °C
entry equiv allyl ee (%)byield (%)a
2
3
4
5
6
7
8
9
1.0
1.0
1.0
1.0
0.75
1.0
1.5
2.0
77
84
82
83
82
84
82
84
43
45
15
78
51
78
74
73
sovent
1,4-dioxane
1,4-dioxane
1,4-dioxane
1,4-dioxane
1,4-dioxane
1 1.0 8355toluene
10
11
12
1.1
1.1
1.1
toluene
MTBE
THF
8681
13 1.1
83
82
84
tol/hex 93
14c 1.1 THF
X
Br
OTs
OMs
OAc
OCO2Allyl
OCO2Me
OCO2Me
OCO2Me
OCO2Me
OCO2Me
OCO2Me
OCO2Me
OCO2Me
OCO2Me
1,4-dioxane
1,4-dioxane
1,4-dioxane
33
65
83
45
X
74 7
TMS
76
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[Pd2(dba)3] (0.005 mmol, 0.05 equiv), 0.0047 g (S)-t-Bu-PHOX (0.0125 mmol, 0.125 
equiv), 0.067 g TBAT (0.125 mmol, 1.25 equiv), 0.018 g tridecane (0.10 mmol, 1.0 
equiv) and 3.0 mL THF.  This mixture was stirred at 25 °C for 30 min at which time 
0.026 g of β-ketoester 74 (0.10 mmol, 1.0 equiv) and 0.013 g of allyl methyl carbonate 
(0.11 mmol, 1.1 equiv) were added, neat.  The vial was capped and stirring continued for 
12 h at which time the vial was removed from the glove-box, uncapped and the magnetic 
stirring bar removed.  The reaction mixture was diluted with hexanes (2 mL) and passed 
through a pipette plug (SiO2) with 4 mL of hexanes followed by 4 mL of Et2O.  From the 
combined organic fractions, a sample was prepared and the mixture analyzed by GC. 
 
2.6.9 General procedure for Pd-catalyzed allylic alkylation  
Please note that the absolute configuration for all products 79 and 81 has been inferred by 
analogy to previous studies. For isolated yields, see the main text of vide supra. For 
respective GC, HPLC or SFC conditions, as well as optical rotation data, please refer to 
Table 2.6.11.  
 
(S)-2-benzyl-2-(2-methylallyl)cyclohexan-1-one (81a). Inside a nitrogen filled glove-
box, an oven-dried 20 mL scintillation vial was charged with a magnetic stirring bar, 
0.011 g [Pd2(dba)3] (0.012 mmol, 0.05 equiv), 0.011 g (S)-t-Bu-PHOX (0.029 mmol, 
0.125 equiv), 0.15 g TBAT (0.28 mmol, 1.25 equiv) and 7 mL THF. This mixture was 
[Pd2(dba)3] (5 mol%)
(S)-t-Bu-PHOX (12.5 mol%)
TBAT (1.25 equiv), THF, 25 °C
O O
O
TMS
Bn
O
Bn
Me
MeO
O
O
Me
77a
80a (1.1 equiv)
81a
89% yield
Chapter 2 – Development of TMSE Ester-Protected Enolates and Applications in Palladium–
Catalyzed Enantioselective Allylic Alkylation 
 
 
170 
stirred at 25 °C for 30 min at which time 0.075 g of β-ketoester 77a (0.23 mmol, 1.0 
equiv) and 0.033 g of allyl methyl carbonate (0.25 mmol, 1.1 equiv) were added, neat.  
The vial was capped and stirring continued for 16 h at which time the vial was removed 
from the glove-box, uncapped and magnetic stirring bar removed.  The reaction mixture 
was concentrated in vacuo.  The resulting crude semisolid was purified by flash column 
chromatography (SiO2, hexanes to 2% EtOAc in hexanes) to give ketone 81a as a 
colorless oil.  89% yield.  89% ee, [α]D25 –20.1 (c 1.2, CHCl3); Rf = 0.3 (10% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 7.27–7.23 (m, 2H), 7.22–7.17 (m, 1H), 7.15–
7.11 (m, 2H), 4.86 (dd, J = 2.0, 1.4 Hz, 1H), 4.69 (dd, J = 2.0, 1.0 Hz, 1H), 2.93 (dd, J = 
114.0, 13.7 Hz, 2H), 2.60–2.49 (m, 1H), 2.44–2.38 (m, 1H), 2.37 (s, 3H), 1.92–1.84 (m, 
1H), 1.81–1.69 (m, 2H), 1.67 (dd, J = 1.5, 0.8 Hz, 3H), 1.64–1.56 (m, 2H); 13C NMR 
(126 MHz, CDCl3) δ 214.8, 142.2, 137.8, 130.9, 127.9, 126.2, 114.7, 52.5, 43.2, 41.7, 
39.7, 35.7, 26.7, 24.6, 20.8;  IR (Neat Film, NaCl) 3026, 2935, 2863, 1700, 1448, 1123, 
893, 746 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C17H23O [M + H]+: 243.1743, 
found 243.1745; SFC conditions: 1% MeOH, 2.5 mL/min, Chiralpak OD–H column, λ = 
210 nm, tR (min): major = 5.79, minor = 6.48. 
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2.6.10 Spectroscopic data for Pd-catalyzed allylic alkylation products      
(S)-3-Allyl-1-benzoyl-3-methylazepan-2-one (79g) 
 
 
Lactam 79g was prepared by the general procedure and isolated by flash column 
chromatography (SiO2, 5%  EtOAc in hexanes to 25%  EtOAc in hexanes) as a colorless 
oil. 91% yield. 90% ee, [α]D25 –35.2 (c 1.7, CHCl3); Rf = 0.2 (30% EtOAc in hexanes); 1H 
NMR (500 MHz, CDCl3) δ 7.52–7.48 (m, 2H), 7.47–7.42 (m, 1H), 7.39–7.35 (m, 2H), 
5.72 (dddd, J = 17.1, 10.3, 7.6, 7.1 Hz, 1H), 5.13–5.06 (m, 2H), 4.13–4.05 (m, 1H), 3.91 
(ddd, J = 14.8, 8.8, 2.0 Hz, 1H), 2.40 (dddt, J = 71.6, 13.7, 7.6, 1.2 Hz, 2H), 1.91–1.78 
(m, 4H), 1.78–1.67 (m, 2H), 1.29 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 182.5, 174.7, 
137.0, 133.7, 131.0, 128.1, 127.4, 118.7, 47.7, 44.7, 42.6, 35.1, 28.0, 24.9, 23.3;  IR (Neat 
Film, NaCl) 3072, 2830, 1676, 1448, 1279, 1244, 1224, 1148, 1117, 1096, 971, 951, 919, 
790, 726, 695 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C17H21NO2 [M + H]+: 
272.1645, found 272.1660; HPLC conditions: 5% IPA, 1.0 mL/min, Chiralpak OJ–H 
column, λ = 220 nm, tR (min): major = 5.60, minor = 5.00. 
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(R)-2-Benzyl-2-(2-chloroallyl)cyclohexan-1-one (81b) 
 
 
Ketone 81b was prepared according to the general procedure and isolated by flash 
column chromatography (SiO2, 5% EtOAc in hexanes to 10% EtOAc in hexanes) as a 
colorless oil. 72% yield. 96% ee, [α]D25 –7.0 (c 1.4, CHCl3); Rf = 0.4 (10% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 7.39–7.16 (m, 2H), 7.20–7.08 (m, 3H), 5.30 (d, 
J = 1.3 Hz, 1H), 5.17 (t, J = 1.2 Hz, 1H), 2.99 (dd, J = 40.6, 14.1 Hz, 2H), 2.69 (dd, J = 
56.9, 15.6 Hz, 2H), 2.66–2.34 (m, 2H), 1.97–1.63 (m, 6H); 13C NMR (126 MHz, CDCl3) 
δ 213.5, 137.0, 130.7, 128.1, 127.7, 126.5, 116.6, 52.5, 43.9, 41.3, 39.7, 35.1, 26.5, 20.9;  
IR (Neat Film, NaCl) 2939, 2858, 1705, 1631, 1494, 1452, 1429, 1118, 1088, 889, 701 
cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C16H20ClO [M + H]+: 263.1197, found 
263.1199; SFC conditions: 3% MeOH, 2.5 mL/min, Chiralpak OD-H column, λ = 210 
nm, tR (min): major = 6.09, minor = 7.04. 
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(R)-2-Benzyl-2-(2-(4-fluorophenyl)allyl)cyclohexan-1-one (81d) 
 
 
Ketone 81d was prepared according to the general procedure, and isolated by flash 
column chromatography (SiO2, 1% EtOAc in hexanes to 3% EtOAc in hexanes) as a 
colorless oil. 91% yield. 95% ee, [α]D25 –9.9 (c 2.0, CHCl3); Rf = 0.3 (10% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 7.37–7.12 (m, 5H), 7.11–6.85 (m, 4H), 5.26 (d, 
J = 1.3 Hz, 1H), 5.09 (d, J = 1.5 Hz, 1H), 2.86 (dd, J = 102.0, 13.7 Hz, 2H), 2.87–2.73 
(m, 2H), 2.31 (tt, J = 6.2, 2.5 Hz, 2H), 1.83–1.50 (m 6H) ; 13C NMR (126 MHz, CDCl3) δ 
214.3 , 162.2 (d, 1JCF = 246.2 Hz), 144.5, 139.2 (d, 4JCF = 3.3 Hz), 137.8, 130.7, 128.2 (d, 
3JCF = 7.9 Hz), 127.9, 126.3, 117.6, 115.0 (d, 2JCF = 21.3 Hz), 53.3, 41.7, 40.9, 39.7, 35.1, 
26.1, 20.8; 19F NMR (282 MHz, CDCl3) δ –128.24;  IR (Neat Film, NaCl) 3027, 2939, 
2864, 1703, 1602, 1508, 1453, 1223, 1159, 1126, 905, 841, 750 cm-1; HRMS (MM: ESI-
APCI+) m/z calc’d for C22H24FO [M + H]+: 323.1806, found 323.1809; SFC conditions: 
10% MeOH, 2.5 mL/min, Chiralpak OJ-H column, λ = 210 nm, tR (min): major = 8.59, 
minor = 10.15. 
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Methyl N-(2-(((R)-1-benzyl-2-oxocyclohexyl)methyl)allyl)-N-methyl-L-leucinate (84) 
 
 
Ketone 84 was prepared by the general procedure and isolated by flash column 
chromatography (SiO2, 2%  EtOAc in hexanes to 5%  EtOAc in hexanes) as a colorless 
oil. 95% yield. >25:1 dr, [α]D25 –20.57 (c 1.75, CHCl3); Rf = 0.5 (30% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 7.25–7.21 (m, 2H), 7.21–7.16 (m, 1H), 7.15–
7.11 (m, 2H), 5.12 (q, J = 1.3 Hz, 1H), 4.94–4.88 (m, 1H), 3.67 (s, 3H), 3.33 (t, J = 7.6 
Hz, 1H), 3.05–2.90 (m, 2H), 2.93 (dd, J = 176.8, 13.7 Hz, 2H), 2.67–2.54 (m, 2H), 2.40–
2.31 (m, 1H), 2.25 (dd, J = 15.1, 1.1 Hz, 1H), 2.20 (s, 3H), 1.90 (ddq, J = 8.0, 4.3, 1.9 
Hz, 1H), 1.81–1.47 (m, 8H), 0.90 (dd, J = 11.9, 6.6 Hz, 6H); 13C NMR (126 MHz, CDCl3) 
δ 214.9, 173.3, 143.0, 138.1, 130.9, 127.8, 126.1, 116.5, 62.9, 61.8, 52.6, 50.8, 41.2, 
39.5, 38.9, 38.4, 36.8, 36.5, 26.9, 24.8, 23.0, 22.2, 20.8; IR (Neat Film, NaCl) 2949, 2868, 
1732, 1703, 1641, 1452, 1189, 1152, 1122, 1019, 910, 702 cm-1; HRMS (MM: ESI-
APCI+) m/z calc’d for C25H37NO3 [M + H]+: 400.2836, found 400.2860.  
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Methyl N-(2-(((S)-1-benzyl-2-oxocyclohexyl)methyl)allyl)-N-methyl-L-leucinate (85) 
 
 
Ketone 85 was prepared by the general procedure, using ligand L9 instead of L1, and 
isolated by flash column chromatography (SiO2, 2%  EtOAc in hexanes to 5%  EtOAc in 
hexanes) as a colorless oil. 95% yield. 1:21 dr, [α]D25 +12.94 (c 1.25, CHCl3); Rf = 0.5 
(30% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.25–7.21 (m, 2H), 7.21–7.16 
(m, 1H), 7.16–7.12 (m, 2H), 5.11 (d, J = 1.5 Hz, 1H), 4.89 (d, J = 1.7 Hz, 1H), 3.68 (s, 
3H), 3.29 (dd, J = 7.7, 7.0 Hz, 1H), 3.03–2.93 (m, 2H), 2.92 (dd, J = 197.9, 13.7 Hz, 2H), 
2.68–2.58 (m, 2H), 2.34 (dt, J = 13.8, 4.9 Hz, 1H), 2.27–2.21 (m, 1H), 2.19 (s, 3H), 1.91 
(d, J = 12.8 Hz, 1H), 1.85–1.56 (m, 8H), 0.89 (dd, J = 12.4, 6.3 Hz, 6H); 13C NMR (126 
MHz, CDCl3) δ 214.8, 173.2, 143.2, 138.2, 131.0, 127.8, 126.1, 116.5, 63.3, 61.6, 52.5, 
50.8, 41.1, 39.5, 39.3, 38.2, 36.7, 36.7, 26.9, 24.9, 22.8, 22.5, 20.8;  IR (Neat Film, NaCl) 
3027, 2950, 2867, 1734, 1702, 1641, 1602, 1495, 1452, 1192, 1154, 1125, 1030, 909, 749, 
702 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C25H37NO3 [M + H]+: 400.2846, 
found 400.2855.  
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(R)-5-(3-((S)-1-Benzyl-2-oxocyclohexyl)prop-1-en-2-yl)-2-methylcyclohex-2-en-1-one 
(86) 
 
 
Ketone 86 was prepared by the general procedure, at 40 °C, and isolated by flash column 
chromatography (SiO2, 3%  EtOAc in hexanes to 15%  EtOAc in hexanes) as a colorless 
oil. 87% combined yield (86 and 87). Characterization data reported for major 
diastereomer. 6:1 dr, [α]D25 +49.25 (c 0.25, CHCl3); Rf = 0.1 (30% EtOAc in hexanes); 1H 
NMR (500 MHz, CDCl3) δ 7.25–7.18 (m, 3H), 7.12–7.02 (m, 2H), 6.72 (dq, J = 4.2, 1.3 
Hz, 1H), 4.97–4.91 (m, 1H), 4.82 (d, J = 1.2 Hz, 1H), 3.03–2.83 (m, 2H), 2.64–2.49 (m, 
2H), 2.49–2.37 (m, 4H), 2.38–2.09 (m, 3H), 1.85–1.78 (m, 2H), 1.77 (dt, J = 2.6, 1.3 Hz, 
3H), 1.76–1.61 (m, 4H); 13C NMR (126 MHz, CDCl3) δ 214.7, 199.8, 147.4, 144.7, 
137.3, 135.3, 130.6, 128.0, 126.5, 113.1, 52.5, 43.6, 42.2, 41.8, 39.5, 39.4, 35.6, 31.9, 
26.7, 20.8, 15.7;  IR (Neat Film, NaCl) 2923, 2863, 1702, 1672, 1494, 1450, 1365, 1248, 
1109, 901, 750, 703 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C23H28O2Na [M + 
Na]+: 359.1982, found 359.1988. 
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(R)-5-(3-((S)-1-Benzyl-2-oxocyclohexyl)prop-1-en-2-yl)-2-methylcyclohex-2-en-1-one 
(87) 
 
 
Ketone 87 was prepared by the general procedure, at 40 °C, and isolated by flash column 
chromatography (SiO2, 3%  EtOAc in hexanes to 15%  EtOAc in hexanes) as a colorless 
oil. 77% combined yield (86 and 87). Characterization data reported for major 
diastereomer. 6:1 dr, [α]D25 –10.60 (c 0.50, CHCl3); Rf = 0.1 (30% EtOAc in hexanes); 1H 
NMR (500 MHz, CDCl3) δ 7.25–7.18 (m, 3H), 7.12–7.02 (m, 2H), 6.73 (dq, J = 4.2, 1.3 
Hz, 1H), 4.98 (s, 1H), 4.84 (s, 1H), 3.01–2.86 (m, 2H), 2.59–2.38 (m, 4H), 2.36–2.11 (m, 
3H), 1.88–1.81 (m, 2H), 1.76 (dt, J = 2.6, 1.3 Hz, 3H), 1.76–1.61 (m, 4H); 13C NMR (126 
MHz, CDCl3) δ 214.6, 199.8, 147.1, 144.5, 137.5, 135.4, 130.6, 128.0, 126.4, 112.7, 
52.5, 43.7, 42.6, 41.7, 39.6, 39.2, 35.9, 31.9, 26.8, 20.8, 15.7;  IR (Neat Film, NaCl) 2923, 
2863, 1702, 1672, 1494, 1450, 1365, 1248, 1109, 901, 750, 703 cm-1; HRMS (MM: ESI-
APCI+) m/z calc’d for C23H28O2Na [M + Na]+: 359.1982, found 359.1985. 
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2.6.11 Determination of enantiomeric excess and optical rotations 
Table 2.6.11.1. Determination of enantiomeric excess and optical rotations 
 
entry compound analytic conditions ee (%)
1
2
3
4
5
6
7
8
GC
G-TA, 105 °C, isotherm
tR (min): major 7.80, minor 8.24
86
88
91
89
87
92
96
90
GC
G-TA, 110 °C, isotherm
tR (min): major 6.45, minor 7.23
HPLC
Chiralcel OD-H, λ = 220 nm
1% IPA/hexanes, 1.0 mL/min
tR(min): major 6.12, minor 7.16
SFC
Chiralpak AD-H, λ = 254 nm
5% MeOH/CO2, 2.5 mL/min,
tR (min):  major 5.54, minor 6.23
HPLC
Chiralcel OJ-H, λ = 220 nm
5% IPA/hexanes, 1.0 mL/min
tR(min): major 5.60, minor 5.00
O
Me
O
Bn
O
F
O
CO2Me
O Me
O Me
i-BuO
BzN
O
Me
BzN
O Me
polarimetry
[α]D²⁵&&–11.7
(c&0.6,&CHCl3)
GC
G-TA, 120 °C, isotherm
tR (min): major 15.3, minor 22.18
GC
G-TA, 110 °C, isotherm
tR (min): major 5.039, minor 5.41
SFC
Chiralpak OJ-H, λ = 210 nm
3% IPA/CO2, 2.5 mL/min,
tR (min):  major 5.74, minor 4.71
[α]D²⁵&–13.6
(c&1.3,&CHCl3)
[α]D²⁵&–68.74
(c&1.5,&CHCl3)
[α]D²⁵&10.51
(c&1.6,&CHCl3)
[α]D²⁵&–22.13
(c&1.4,&CHCl3)
[α]D²⁵&–65.6
(c&1.0,&CHCl3)
[α]D²⁵&–76.5
(c&2.1,&CHCl3)
[α]D²⁵&–35.2
(c&1.7,&CHCl3)
9
10
11
12
89
96
93
95
SFC
Chiralpak OD-H, λ = 210 nm
1% MeOH/CO2, 2.5 mL/min,
tR (min): major 5.79, minor 6.48
SFC
Chiralpak OD-H, λ  = 210 nm
3% MeOH/CO2, 2.5 mL/min
tR (min): major 6.09, minor 7.04
SFC
Chiralpak OJ-H, λ = 210 nm
4% IPA/CO2, 4.0 mL/min
tR (min): major 7.86, minor 8.66
SFC
Chiralcel OJ-H, λ  = 210 nm
10% MeOH/CO2, 2.5 mL/min
tR (min): major 8.59, minor 10.15
O
Bn
Me
O
Bn
F
O
Bn
Cl
O
Bn
[α]D²⁵&–20.1
(c&1.2,&CHCl3)
[α]D²⁵&–7.0
(c&1.4,&CHCl3)
[α]D²⁵&–10.5
(c&0.8,&CHCl3)
[α]D²⁵&–9.9
(c&2.0,&CHCl3)
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 020406080100120140160180200220 ppm
Figure A2.2  Infrared spectrum (thin film/NaCl) of compound 74. 
Figure A2.3  13C NMR (125 MHz, CDCl3) of compound 74. 
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 020406080100120140160180200220 ppm
Figure A2.5  Infrared spectrum (thin film/NaCl) of compound 88. 
Figure A2.6  13C NMR (125 MHz, CDCl3) of compound 88. 
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 020406080100120140160180200220 ppm
Figure A2.8  Infrared spectrum (thin film/NaCl) of compound 77b. 
Figure A2.9  13C NMR (75 MHz, CDCl3) of compound 77b. 
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 020406080100120140160180200220 ppm
Figure A2.11  Infrared spectrum (thin film/NaCl) of compound 77a. 
Figure A2.12  13C NMR (125 MHz, CDCl3) of compound 77a. 
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 020406080100120140160180200220 ppm
Figure A2.14  Infrared spectrum (thin film/NaCl) of compound 77c. 
Figure A2.15  13C NMR (75 MHz, CDCl3) of compound 77c. 
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 020406080100120140160180200220 ppm
Figure A2.17  Infrared spectrum (thin film/NaCl) of compound 77d. 
Figure A2.18  13C NMR (125 MHz, CDCl3) of compound 77d. 
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Figure A2.20  Infrared spectrum (thin film/NaCl) of compound 77e. 
Figure A2.21  13C NMR (125 MHz, CDCl3) of compound 77e. 
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 020406080100120140160180200220 ppm
Figure A2.23  Infrared spectrum (thin film/NaCl) of compound 77f. 
Figure A2.24  13C NMR (125 MHz, CDCl3) of compound 77f. 
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Figure A2.26  Infrared spectrum (thin film/NaCl) of compound 77g. 
Figure A2.27  13C NMR (125 MHz, CDCl3) of compound 77g. 
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 020406080100120140160180200220 ppm
Figure A2.29  Infrared spectrum (thin film/NaCl) of compound 80b. 
Figure A2.30  13C NMR (125 MHz, CDCl3) of compound 80b. 
203
Appendix 2 – Spectra Related to Chapter 2 
 
0
1
2
3
4
5
6
7
8
9
10
pp
m
  
Fi
gu
re
 A
2.
31
  1
H
 N
M
R
 (5
00
 M
H
z,
 C
D
C
l 3)
 o
f c
om
po
un
d 
80
d.
 
O
O
F
O
80
d
204
Appendix 2 – Spectra Related to Chapter 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 020406080100120140160180200220 ppm
Figure A2.32  Infrared spectrum (thin film/NaCl) of compound 80d. 
Figure A2.33  13C NMR (125 MHz, CDCl3) of compound 80d. 
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 020406080100120140160180200220 ppm
Figure A2.35  Infrared spectrum (thin film/NaCl) of compound 83. 
Figure A2.36  13C NMR (125 MHz, CDCl3) of compound 83. 
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Figure A2.38  Infrared spectrum (thin film/NaCl) of compound 92. 
Figure A2.39  13C NMR (125 MHz, CDCl3) of compound 92. 
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 020406080100120140160180200220 ppm
Figure A2.41  Infrared spectrum (thin film/NaCl) of compound 82. 
Figure A2.42  13C NMR (125 MHz, CDCl3) of compound 82. 
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Figure A2.44  Infrared spectrum (thin film/NaCl) of compound 81a. 
Figure A2.45  13C NMR (125 MHz, CDCl3) of compound 81a. 
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Figure A2.47  Infrared spectrum (thin film/NaCl) of compound 79g. 
Figure A2.48  13C NMR (125 MHz, CDCl3) of compound 79g. 
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 020406080100120140160180200220 ppm
Figure A2.50  Infrared spectrum (thin film/NaCl) of compound 81b. 
Figure A2.51  13C NMR (125 MHz, CDCl3) of compound 81b. 
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 020406080100120140160180200220 ppm
Figure A2.53  Infrared spectrum (thin film/NaCl) of compound 81d. 
Figure A2.54  13C NMR (125 MHz, CDCl3) of compound 81d. 
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 020406080100120140160180200220 ppm
Figure A2.56  Infrared spectrum (thin film/NaCl) of compound 84. 
Figure A2.57  13C NMR (125 MHz, CDCl3) of compound 84. 
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 020406080100120140160180200220 ppm
Figure A2.59  Infrared spectrum (thin film/NaCl) of compound 85. 
Figure A2.60  13C NMR (125 MHz, CDCl3) of compound 85. 
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 020406080100120140160180200220 ppm
Figure A2.62  Infrared spectrum (thin film/NaCl) of compound 86 and 87. 
Figure A2.63  13C NMR (125 MHz, CDCl3) of compound 86 and 87. 
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CHAPTER 3 
Construction of Vicinal Tertiary and All-Carbon Quaternary 
Stereocenters via Ir-Catalyzed Regio-, Diastereo-, and Enantioselective 
Allylic Alkylation and Applications in Sequential Pd-Catalysis1  
 
3.1 INTRODUCTION  
3.1.1 State of the art in the asymmetric construction of vicinal quaterary and 
tertiary carbon centers 
 The asymmetric construction of sterically-encumbered, vicinal stereogenic centers 
is of great interest to synthetic chemists due to the prevalence of such structural 
arrangements in natural products and bioactive compounds.69  The limited number of 
methods that provide selective access to vicinal tertiary and all-carbon quaternary 
stereocenters highlights the challenging nature of this task.  Enantioselective approaches 
for accessing this structural dyad have generally relied on asymmetric Michael additions70 
and Claisen rearrangements.71  Among the methods available for forging this motif, only 
a relatively small number have been reported to do so by employing transition metals in a 
 
1 This work was performed in collaboration with Wen-Bo Lui, postdoctoral researcher in the Stoltz group, 
and Scott Virgil, manager of the Caltech Center for Catalysis and Chemical Synthesis.  This work has been 
published. See: Liu, W. -B.; Reeves, C. M.; Virgil, S. C.; Stoltz, B. M. J. Am. Chem. Soc. 2013, 135, 
10626. 
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catalytic, asymmetric fashion.72,73  Thus, further investigations into the development of 
metal-catalyzed methods to directly and selectively generate such stereochemical arrays 
should prove valuable.  
Allylic alkylation chemistry represents a successful strategy for the assembly of 
highly congested chemical architectures by C–C bond formation74 and, within this 
domain, Ir-catalyzed processes are among the most selective and highest yielding.75,76 
Initial reports from the Helmchen77 and Hartwig78 groups demonstrated the utility of Ir-
catalyzed allylic substitutions for the synthesis of enantioenriched 3,3-disubstituted 
(branched) allyl compounds.75  As this research area has developed, Ir/phosphoramidite 
catalysts79 have emerged as privileged scaffolds for the regio- and enantioselective allylic 
alkylation of achiral nucleophiles, such as malonate derivatives and ketone enolates 
(Figure 3.1.1.1, 94 → 93).80  However, methods for Ir-catalyzed intermolecular allylic 
alkylation that employ prochiral nucleophiles and display high (1) regio-, (2) diastereo-, 
and (3) enantioselectively remain elusive (Figure 3.1.1.1, 94 → 96).81  Prior to our 
investigation, only two reports, 82  from the laboratories of Takemoto and Hartwig, 
detailed successful examples in attaining all three of these goals; however, in these 
accounts, the nucleophiles investigated were limited to amino acid derivatives and 
azlactones.83  
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Figure 3.1.1.1. Ir-catalyzed allylic substitution  
 
 
 
In this chapter, we detail the development of a highly regio-, diastereo-, and 
enantioselective Ir-catalyzed α-allylic alkylation of cyclic β-ketoesters that forges vicinal 
tertiary and all-carbon quaternary centers in one step and in excellent yields.  Moreover, 
we describe the deployment of our novel 2-(trimethylsilyl)ethyl β-ketoester (TMSE β-
ketoester) (see Chapter 2), which functions as an oxycarbonyl-protected enolate, enabling 
sequential catalyst-controlled α-allylic alkylations and, in turn, the ability to select the 
diastereomer produced within the nascent stereochemical dyad.  
 
3.2  REACTION DEVELOPMENT AND OPTIMIZATION 
3.2.1 Discovery and optimization of iridium catalyzed regio-, diastereo- and 
enantioselective allylic alkylation of cyclic ketones 
Our preliminary studies focused on probing the effects of different ligands, bases, 
additives, and solvents on the efficiency and selectivity of the reaction.  Cyclic β-
ketoester 97, cinnamyl carbonate 98, and [Ir(cod)Cl]2/phosphoramidite complexes84 were 
chosen as standard reaction components at the outset of our investigations.85  Selected 
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results of these experiments are summarized in Table 3.2.1.1. Our investigations 
commenced with commonly used phosphoramidite ligand L1086 and we were pleased to 
find that the proposed reaction proceeded smoothly under the conditions described (Table 
3.2.1.1), delivering α-quaternary β-ketoester 100a in >95% conversion and in 96% ee.  
Unfortunately, no diastereoselectivity was observed in this case (Table 3.2.1.1, entry 1).  
Use of ligand L11, a diastereoisomer of L10, again produced a high-yielding reaction, 
but in significantly diminished ee (32%) and modest 1:2 dr (entry 2).  Inspired by the 
You group’s use of Ir-N-arylphosphoramidite complexes (derived from [Ir(cod)Cl]2 and 
L12)87 to effect the diastereo- and enantioselective intramolecular allylation of indoles 
and pyrroles,88 we envisioned that analogous Ir complexes may prove valuable for the 
generation of all-carbon quaternary stereocenters.  We were delighted to discover that the 
use of N-aryl-phosphoramidite ligand L12 furnished the desired product in 98% ee, >20:1 
dr, and 95:5 branched to linear ratio (entry 3).  
 
Figure 3.2.1.1.  Selected phosphoramidite and PHOX ligands 
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Table 3.2.1.1.  Optimization of reaction parameters.a     
 
 
a Reactions performed with 0.1 mmol of 98a, 0.2 mmol of 97a at 0.1 M in THF at 20 °C and 
allowed to proceed to complete consumption of 98a.  b Determined by 1H NMR and UHPLC-MS 
analysis of the crude mixture.  c Determined by chiral HPLC analysis of the major diastereomer.  d 
(ee) of the alternate diastereomer.  e (ee) of the major diastereomer.  f Measured after 60 h at 60% 
conversion.  g 1 mol % [Ir(cod)Cl]2 and 2 mol % L12 were used. 
 
Extensive exploration of various bases, including organic and inorganic bases, 
revealed that the use of LiOt-Bu afforded the desired product in comparable selectivities 
as NaH (entries 4–8).  Previous reports demonstrating the marked effect of LiCl on the 
regioselectivity79b,80j,81b in Ir-catalyzed allylic alkylations prompted us to investigate this 
and related additives.  As a result of these efforts (entries 9–10), the combination of LiBr 
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and THF, at 25 °C, was found to provide 100a in >20:1 dr, 95:5 branched:linear ratio, 
and with >99% ee (entry 10). 
 
3.2.2 Further development of the reaction conditions  
Under these superior conditions, several more ligands were examined.  Use of 
ligand L1388b afforded 100a in 96% ee and 12:1 dr (entry 11). Employment of N-aryl-
phosphoramidite scaffolds proved critical to maintaining high diastereoselectivity in the 
reaction.  Phosphinooxazoline (PHOX) type ligands (e.g. L1), first used in Ir-catalyzed 
allylation by Helmchen,77 were also examined, but we found these to be poorly suited for 
our reaction (entry 12).  Finally, we found that the catalyst loading could be reduced to 1 
mol % (entry 13) without loss of selectivity. 
 
3.3 SURVEY OF REACTION SCOPE  
3.3.1 Exploration of the reaction scope with respect to allyl electrophile 
With optimized conditions in hand, the scope of substrates tolerated in the 
reaction was explored.  We found that cinnamyl-derived carbonates bearing either 
electron-donating (–OMe) or electron-withdrawing (–Br, –CF3) groups on the aromatic 
ring gave remarkably high dr, ee and yields (99% ee and 20:1 dr, Table 3.3.1.1, entries 1–
4). The branched to linear ratio (i.e., 100:101) tended to decrease as the electron 
deficiency of the aryl substituents increased (from 95:5 to 71:29, with 4-OMe-C6H4 to 4-
CF3-C6H4, respectively, entries 2–4). Heteroaryl substituents, such as 3-pyridyl, 2-thienyl 
and 2-furanyl, were also installed with uniformly excellent enantioselectivities and high 
diastereoselectivities (95–98% ee and 10:1–17:1 dr, entries 5–7).  In addition to aromatic 
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substituents, methyl sorbyl carbonate was also well tolerated in the chemistry providing 
diene 100h, although with a slight decrease in dr and ee (8:1 dr and 90% ee, entry 8).89  
Moreover, the reaction proceeded smoothly with ethyl β-ketoester 97i, providing the α-
allyl β-ketoester 100i with excellent yield and selectivity (entry 9).  
 
Figure 3.3.1.1.  Substrate scope of Ir-catalyzed allylic alkylation of β-ketoestersa  
 
 
a Reactions performed under the conditions of Table 1, entry 10.  b Determined by 1H NMR analysis 
of the crude mixture.  c Isolated yield of 100 and 101.  d Determined by chiral HPLC or SFC analysis 
of the major diastereomer. 
 
3.3.2 Exploration of the reaction scope with respect to ketoester nucleophile 
Gratifyingly, aliphatic mono cyclic ketones also proved to be excellent 
participants in the reaction.  Cyclopentanone and cyclohexanone based substrates 
delivered the products 103a and 103b in 98–99% ee and 8:1–20:1 dr, respectively (Figure 
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3.3.2.1, entries 1–2). Vinylogous ester, tetrahydropyran-4-one, and 4-piperidinone 
derivatives furnished the corresponding products (103d–103f) in high yields (85–99%), 
good diastereoselectivites (13:1–20:1), and enantioselectivities (97–99%, entries 4–6).  
The absolute stereochemistry of the product 103f (>99% ee) was determined as (R,R) by 
single-crystal X-ray analysis.90  
 
Figure 3.3.2.1.  Substrate scope of Ir-catalyzed allylic alkylation of β-ketoesters 
 
 
a Reactions performed under the conditions of Table 1, entry 10.  b Determined by 1H NMR analysis 
of the crude mixture.  c Isolated yield of 103 and 104.  d Determined by chiral HPLC or SFC analysis 
of the major diastereomer. 
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During the course of our investigations, we became intrigued by the possibility of 
developing a sequential allylic alkylation reaction, in which allylation of a dicarbonyl-
stabilized enolate would be followed by palladium-catalyzed decarboxylative allylic 
alkylation and, thus, engender the ability to select among all four possible stereochemical 
outcomes.91,92  In order to realize such a consecutive allylic alkylation, we deployed our 
novel oxycarbonyl-protected enolate, TMSE β-ketoester 88, which we hypothesized 
would successfully undergo Ir-catalyzed allylic alkylation and be poised to subsequently 
participate in Pd catalysis. Specifically, we envisioned that subsequent to Ir-catalyzed 
allylic alkyaltion TMSE β-ketoester 103c could be triggered with fluoride, and the 
resulting prochiral enolate then intercepted and engaged in Pd-catalyzed allylic alkylation 
to deliver α-quaternary ketone 106 or 107 (Figure 3.4.1).  In the case at hand, where β-
ketoester 103c contains a chiral branched R group at the a position, we anticipated that 
with careful choice of catalyst, we could potentially control the newly generated 
stereocenter independent of the absolute stereochemistry of the side chain. 
 
Figure 3.4.1.  Conceptualization of sequential catalysis 
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We were pleased to find that TMSE β-ketoester 88 is a highly competent 
substrate for Ir-catalyzed allylic alkylation and, under standard conditions, gave the 
desired product (103c) with excellent yield and selectivity (Figure 3.3.2.1, entry 3).  
Moreover, exposure of 103c to catalytic Pd2(dba)3/L8 (Figure 3.4.2) in the presence of 
allyl methylcarbonate and tetrabutylammonium difluorotriphenylsilicate (TBAT) 
generated the desired diallylated α-quaternary ketones 106 and 107 in good yield. The 
use of achiral PHOX ligand L8 revealed that substrate 103c displays inherent selectivity 
under Pd catalysis, furnishing 106a93 as the major diastereomer in a 2:1 ratio with 107a 
(Figure 3.4.2, entry 1).  Use of (S)-t-BuPHOX ligand (S)-L1 resulted in modest reversal 
of the inherent diastereoselectivity to generate 107a predominantly (entry 2).  
Furthermore, we were interested to find that use of ligand (S)-L14, possessing both an 
electronically modified phosphine and a smaller i-Pr substituent on the oxazoline ring in 
contrast to the more standard t-Bu, produced 107a with improved diastereoselectivity 
(106a:107a, 1:8 dr) and 91% yield (entry 3).  Alternatively, through judicious choice of 
ligand (e.g., (R)-L15), the inherent selectivity of the system could be enhanced to afford 
106a:107a with up to 18:1 dr favoring 106a (entries 4–5).  Cursory investigation revealed 
that 2-aryl and 2-alkyl substitutions at the allyl carbonate are well tolerated: allylic 
alkylation products 106b and 106c were obtained in good yields and with excellent 
diastereoselectivities. 
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Figure 3.4.2. Development of Pd-catalyzed diastereoselective decarboxylative allylic alkylation of 
TMSE-β-ketoestersa  
 
a Reactions performed with 1.2 equiv of TBAT, and 1.2 equiv of allyl methylcarbonate at 0.03 M.b 
Isolated yield of 106 and 107. c Determined by 1H NMR analysis of the crude mixture and 
confirmed by GC analysis. d 10 mol % ligand was used.   
 
3.5 CONCLUDING REMARKS  
In summary, a highly regio-, diastereo-, and enantio-selective method for the 
synthesis of vicinal tertiary and all-carbon quaternary centers was realized through the 
use of an [Ir(cod)Cl]2/N-aryl-phosphoramidite (L12) catalyst system.  Varied 
substitutions were well tolerated on both the β-ketoester and allyl carbonate fragments.  
A sequential Ir/Pd-catalyzed dialkylation protocol was also established to deliver bis-
allylated α-quaternary ketones with excellent stereoselectivity, while affording access to 
either product diastereomer with catalyst control.  Further studies exploring the 
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mechanisms of these reactions and exploiting their applications in the total synthesis of 
complex natural products are underway in our laboratory. 
 
3.6 EXPERIMENTAL SECTION 
3.6.1 Materials and Methods 
Unless otherwise stated, reactions were performed in flame-dried glassware under 
an argon or nitrogen atmosphere using dry, deoxygenated solvents.  Solvents were dried 
by passage through an activated alumina column under argon.61 Reaction progress was 
monitored by thin-layer chromatography (TLC) or Agilent 1290 UHPLC-LCMS.  TLC 
was performed using E. Merck silica gel 60 F254 precoated glass plates (0.25 mm) and 
visualized by UV fluorescence quenching, p-anisaldehyde, or KMnO4 staining.  Silicycle 
SiliaFlash® P60 Academic Silica gel (particle size 40–63 nm) was used for flash 
chromatography.  1H NMR spectra were recorded on Varian Inova 500 MHz and 600 
MHz spectrometers and are reported relative to residual CHCl3 (δ 7.26 ppm) or C6HD5 (δ 
7.16 ppm).  13C NMR spectra were recorded on a Varian Inova 500 MHz spectrometer 
(125 MHz) and are reported relative to CHCl3 (δ 77.16 ppm) or C6HD5 (δ 128.06 ppm). 
31P and 19F NMR spectra were recorded on a Varian Mercury 300 MHz (at 121 MHz and 
282 MHz, respectively).  19F NMR spectra were reported relative to CFCl3 (δ 0.0 ppm). 
31P NMR spectra were reported relative to external H3PO4 (δ 0.0 ppm).  Data for 1H NMR 
are reported as follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), 
integration).  Multiplicities are reported as follows: s = singlet, d = doublet, t = triplet, q = 
quartet, p = pentet, sept = septuplet, m = multiplet, br s = broad singlet, br d = broad 
doublet, app = apparent.  Data for 13C NMR are reported in terms of chemical shifts 
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(δ ppm).  IR spectra were obtained by use of a Perkin Elmer Spectrum BXII spectrometer 
using thin films deposited on NaCl plates and reported in frequency of absorption (cm-1).  
Optical rotations were measured with a Jasco P-2000 polarimeter operating on the 
sodium D-line (589 nm), using a 100 mm path-length cell and are reported as: [α]DT 
(concentration in g/100 mL, solvent).  Analytical HPLC was performed with an Agilent 
1100 Series HPLC utilizing a Chiralpak (AD-H or AS) or Chiralcel (OD-H, OJ-H, or 
OB-H) columns (4.6 mm x 25 cm) obtained from Daicel Chemical Industries, Ltd.  
Analytical SFC was performed with a Mettler SFC supercritical CO2 analytical 
chromatography system utilizing Chiralpak (AD-H, AS-H or IC) or Chiralcel (OD-H, OJ-
H, or OB-H) columns (4.6 mm x 25 cm) obtained from Daicel Chemical Industries, Ltd.  
High resolution mass spectra (HRMS) were obtained from Agilent 6200 Series TOF with 
an Agilent G1978A Multimode source in electrospray ionization (ESI+), atmospheric 
pressure chemical ionization (APCI+), or mixed ionization mode (MM: ESI-APCI+). 
Reagents were purchased from Sigma-Aldrich, Acros Organics, Strem, or Alfa 
Aesar and used as received unless otherwise stated.  Ligands L12–L13,87 ligands L8–L9 
and L14–L15,94 allyl carbonates,95 and β-ketoesters96 were prepared by known methods.   
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3.6.2  Optimization of reaction parameters  
Table 3.6.2.1. Optimization of reaction parameters 
 
 
a  Reactions performed with 0.1 mmol of 98a, 0.2 mmol of 97a in 1 mL of solvent.  b  Determined by 1H 
NMR or UHPLC-MS analysis of the crude reaction mixture.  d  (Ee) of the alternate diasteromer.  e 
Measured on the minor isomer and the number in the parenthesis is ee of the major isomer. f 1 mol % of 
[Ir(cod)Cl]2 and 2 mol % of L12 were used.  g  0.5 mol % of [Ir(cod)Cl]2 and 1 mol % of L12 were used. 
 
General Procedure for Optimization Reaction (Table 3.6.2.1): All experiments 
were preformed in a nitrogen-filled glove box.  [Ir(cod)Cl]2 (1.4 mg, 0.002 mmol, 2 
mol%), ligand (0.004 mmol, 4 mol%), and TBD (1.4 mg, 0.01 mmol, 10 mol%) were 
entrya base/additive(equiv)
dr of 
100a b100a:101a b
ee of
 100a (%)c
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
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24f
25g
NaH (2)
NaH (2)
NaH (2)
—
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TBD (2)
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LiBr (1)
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LiBr (1)
1:1.4
1:1.9
>20:1
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11:1
11:1
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13:1
>20:1
14:1
>20:1
>20:1
nd
nd
12:1
nd
>20:1
11:1
9.0:1
>20:1
>20:1
>20:1
>95:5
>95:5
95:5
80:20
72:28
74:26
77:23
63:37
63:37
75:25
86:14
95:5
88:12
95:5
72:28
nd
nd
80:20
12:88
95:5
76:24
68:32
>95:5
95:5
92:8
  96 (99)d
  32 (3)e
  98
  96
  96
  95
  97
  93
  90
  93
  96
  99
  98
>99
  97
   nd
   nd
  96
   nd
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  96
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THF
THF
THF
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THF
THF
THF
THF
THF
THF
THF
THF
THF
THF
THF
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L12
L12
t  (h)
24
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8
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12
12
1
1
1
1
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60
1
3
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>95
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added to a vial equipped with a magnetic stirring bar.  The vial was then charged with 
solvent (0.5 mL) and stirred at 20 °C for 10 min, generating an orange solution.  
Cinnamyl carbonate 98a (19.2 mg, 0.1 mmol, 1.0 equiv), β-ketoester 97a (40.4 mg, 0.2 
mmol, 2.0 equiv), base or additive (as indicated below) and another 0.5 mL of solvent 
were added.  The vial was sealed and stirred at 20 °C until allylic carbonate 98a was fully 
consumed, as indicated by TLC or UHPLC-MS anaylsis.  The reaction mixture was 
filtered through a celite pad, rinsed with CH2Cl2, and concentrated under reduced 
pressure.  The ratios of constitutional isomers (branched product to linear product: 
100a:101a) and diastereomers (dr) were determined by 1H NMR or UHPLC-MS.   
 
3.6.3. General procedure for the Ir-catalyzed asymmetric allylic alkylation of β-
ketoesters 
 
Note: the absolute configuration was determined only for compound 100f via X-ray 
analysis (vide infra, Appendix 4).  The absolute configuration for all other products 100 
has been inferred by analogy.  Isolated yields are reported in Figures 3.3.1.1 and 3.3.2.1 
(vida infra).  For respective HPLC or SFC conditions, please refer to Table 3.6.8.1. 
 
 
(R)-methyl 1-oxo-2-((S)-1-phenylallyl)-1,2,3,4-tetrahydronaphthalene-2-carboxylate 
(100a). In a nitrogen-filled glove box, [Ir(cod)Cl]2 (2.7 mg, 0.004 mmol, 2 mol%), ligand 
L12 (3.7 mg, 0.008 mmol, 4 mol%), and TBD (2.8 mg, 0.02 mmol, 10 mol%) were 
O
Ph OCO2Me
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added to a 2 dram scintillation vial equipped with a magnetic stirring bar.  The vial was 
then charged with THF (1 mL) and stirred at 20 °C for 10 min, generating an orange 
solution.  Cinnamyl carbonate (98a) (38.3 mg, 0.2 mmol, 1.0 equiv), LiBr (17.3 mg, 0.2 
mmol, 1.0 equiv), β-ketoester 97a (80.8 mg, 0.4 mmol, 2.0 equiv) and another 1 mL of 
THF were added.  The vial was sealed and stirred at 20 °C until allylic carbonate 98a was 
fully consumed, as indicated by TLC or UHPLC-MS analysis.  THF was evaporated and 
the crude mixture was then dissolved in CH2Cl2, filtered through a celite pad, rinsed with 
CH2Cl2, and concentrated under reduced pressure.  The regioselectivity (branched 
product to linear product: b:l = 95:5) and diastereoselectivity (dr >20:1) were determined 
by 1H NMR or UHPLC-MS.  The residue was purified by silica gel flash chromatography 
(gradient elution, 2→5% EtOAc in hexanes) to afford 100a and 101a (62.6 mg, 98% 
combined yield).  Allylation product 100a was isolated as a white solid by silica gel 
chromatography (gradient elution, 0→2% EtOAc in hexanes).  >99% ee, [α]D25 +26.3 (c 
1.11, CHCl3); Rf = 0.3 (5% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 8.03 (dd, J 
= 7.9, 1.2 Hz, 1H), 7.42– 7.39 (m, 3H), 7.28–7.23 (m, 3H), 7.19–7.13 (m, 2H), 6.36 (dt, J 
= 16.8, 10.0 Hz, 1H), 5.21–5.12 (m, 2H), 4.46 (d, J = 10.0 Hz, 1H), 3.56 (s, 3H), 3.23 
(ddd, J = 17.1, 12.1, 4.7 Hz, 1H), 2.88 (ddd, J = 17.6, 5.0, 3.0 Hz, 1H), 2.60 (ddd, J = 
13.7, 4.7, 3.0 Hz, 1H), 2.10 (ddd, J = 13.6, 12.1, 5.0 Hz, 1H); 13C NMR (126 MHz, 
CDCl3) δ 193.2, 170.0, 143.1, 139.8, 136.6, 133.6, 132.5, 130.2, 128.8, 128.4, 128.2, 
126.9, 126.7, 117.9, 62.7, 53.9, 52.6, 28.8, 26.4; IR (Neat Film, NaCl) 3066, 3028, 2948, 
1731, 1685, 1636, 1599, 1491, 1453, 1433, 1358, 1298, 1283, 1238, 1214, 1169, 1108, 
1080, 1032, 1001, 980, 926, 892, 808, 743 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d 
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for C21H21O3 [M+H]+: 321.1485, found 321.1489; HPLC conditions: 2% IPA, 0.6 
mL/min, Chiralcel OD-H column, λ = 254 nm, tR (min): major = 13.80, minor = 17.89. 
 
3.6.4. Spectroscopic data for Ir-catalyzed allylic alkylation products 
 
(R)-methyl 2-((S)-1-(4-methoxyphenyl)allyl)-1-oxo-1,2,3,4-tetrahydronaphthalene-2-
carboxylate (100b) 
 
 
Ketoester 100b was isolated by silica gel chromatography (gradient elution, 0→5% 
EtOAc in hexanes) as a white solid.  >99% ee, [α]D25 +38.5 (c 0.93, CHCl3); Rf = 0.3 (5% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 8.03 (dd, J = 7.9, 1.4 Hz, 1H), 7.41 
(td, J = 7.5, 1.5 Hz, 1H), 7.37–7.31 (m, 2H), 7.31–7.21 (m, 1H), 7.21–7.12 (m, 1H), 
6.86–6.75 (m, 2H), 6.32 (dt, J = 16.8, 10.0 Hz, 1H), 5.20–5.09 (m, 2H), 4.41 (d, J = 9.9 
Hz, 1H), 3.75 (s, 3H), 3.56 (s, 3H), 3.23 (ddd, J = 17.1, 12.2, 4.6 Hz, 1H), 2.88 (ddd, J = 
17.6, 4.9, 2.9 Hz, 1H), 2.58 (ddd, J = 13.6, 4.7, 3.0 Hz, 1H), 2.11 (ddd, J = 13.6, 12.2, 5.0 
Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 193.3, 170.1, 158.4, 143.2, 136.8, 133.6, 132.5, 
131.8, 131.2, 128.8, 128.4, 126.7, 117.6, 113.5, 62.8, 55.3, 53.2, 52.6, 28.7, 26.4; IR 
(Neat Film, NaCl) 3073, 3003, 2950, 2836, 1732, 1687, 1636, 1608, 1601, 1581, 1511, 
1454, 1442, 1435, 1357, 1337, 1303, 1242, 1215, 1181, 1114, 1078, 1033, 1000, 981, 923, 
893, 834, 808, 749 cm-1; HRMS (ESI+) m/z calc’d for fragment C10H11O [M-
O CO2Me
100b
OMe
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C11H12O3+H]+: 147.0804, found 147.0807; HPLC conditions: 2% IPA, 0.6 mL/min, 
Chiralpak AD-H column, λ = 254 nm, tR (min): minor = 27.44, major = 37.29. 
 
(R)-methyl 2-((S)-1-(4-bromophenyl)allyl)-1-oxo-1,2,3,4-tetrahydronaphthalene-2-
carboxylate (100c) 
 
 
Ketoester 100c was isolated by silica gel chromatography (gradient elution, 0→3% 
EtOAc in hexanes) as a colorless oil.  99% ee, [α]D25 +49.1 (c 1.18, CHCl3); Rf = 0.4 (5% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 8.02 (dd, J = 8.0, 1.4 Hz, 1H), 7.43 
(td, J = 7.5, 1.5 Hz, 1H), 7.39–7.35 (m, 2H), 7.32–7.27 (m, 2H), 7.27–7.25 (m, 1H), 7.15 
(dt, J = 7.7, 0.9 Hz, 1H), 6.29 (dt, J = 16.7, 10.0 Hz, 1H), 5.32–5.03 (m, 2H), 4.37 (d, J = 
9.9 Hz, 1H), 3.54 (s, 3H), 3.29–3.15 (m, 1H), 2.88 (ddd, J = 17.5, 4.9, 2.8 Hz, 1H), 2.57 
(ddd, J = 13.6, 4.7, 2.9 Hz, 1H), 2.09 (ddd, J = 13.5, 12.3, 4.9 Hz, 1H); 13C NMR (126 
MHz, CDCl3) δ 193.2, 169.9, 143.0, 139.0, 136.1, 133.8, 132.4, 132.0, 131.2, 128.8, 
128.4, 126.8, 121.0, 118.5, 62.5, 53.7, 52.7, 29.1, 26.4; IR (Neat Film, NaCl) 3074, 3025, 
2949, 1732, 1687, 1683, 1633, 1601, 1488, 1454, 1435, 1403, 1357, 1297, 1240, 1215, 
1170, 1141, 1112, 1075, 1032, 1010, 981, 925, 892, 831, 808, 750, 741 cm-1; HRMS 
(MM: ESI-APCI+) m/z calc’d for C21H2079BrO3 [M+H]+: 399.0590, found 399.0585; 
HPLC conditions: 2% IPA, 0.6 mL/min, Chiralpak AD-H column, λ = 254 nm, tR (min): 
minor = 19.71, major = 23.59.  
O CO2Me
100c
Br
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(R)-methyl 1-oxo-2-((S)-1-(4-(trifluoromethyl)phenyl)allyl)-1,2,3,4-tetrahydronaph-
thalene-2-carboxylate (100d) 
 
 
Ketoester 100d was isolated by silica gel chromatography (gradient elution, 0→5% 
EtOAc in hexanes) as a colorless oil.  >99% ee, [α]D25 +32.4 (c 1.51, CHCl3); Rf = 0.3 
(5% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 8.03 (dd, J = 7.9, 1.4 Hz, 1H), 
7.57 (d, J = 8.4 Hz, 2H), 7.52 (d, J = 8.3 Hz, 2H), 7.44 (td, J = 7.5, 1.4 Hz, 1H), 7.28 (t, J 
= 7.5, 1H), 7.16 (d, J = 7.7 Hz, 1H), 6.34 (dt, J = 16.7, 10.1 Hz, 1H), 5.33–5.08 (m, 2H), 
4.45 (d, J = 10.0 Hz, 1H), 3.54 (s, 3H), 3.29–3.16 (m, 1H), 2.90 (ddd, J = 17.6, 4.9, 2.7 
Hz, 1H), 2.60 (ddd, J = 13.6, 4.7, 2.8 Hz, 1H), 2.11 (ddd, J = 13.5, 12.3, 5.0 Hz, 1H); 13C 
NMR (126 MHz, CDCl3) δ 193.1, 169.9, 144.1, 143.0, 135.8, 133.8, 132.4, 130.6, 129.1 
(q, 2JCF = 32.4 Hz), 128.8, 128.4, 126.8, 125.0 (q, 3JCF = 3.8 Hz), 124.3 (q, 1JCF = 272.0 
Hz), 118.8, 62.5, 54.1, 52.7, 29.3, 26.4; IR (Neat Film, NaCl) 3074, 2952, 1736, 1733, 
1689, 1683, 1616, 1601, 1454, 1435, 1413, 1327, 1241, 1217, 1166, 1123, 1070, 1019, 
927, 846, 809, 751, 742 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C22H2019F3O3 
[M+H]+: 389.1359, found 389.1346;  SFC conditions: 5% IPA, 4.0 mL/min, Chiralpak 
AD-H column, λ = 254 nm, tR (min): minor = 3.38, major = 3.91.  
 
O CO2Me
100d
CF3
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(R)-methyl 1-oxo-2-((S)-1-(pyridin-3-yl)allyl)-1,2,3,4-tetrahydronaphthalene-2-
carboxylate (100e) 
 
 
Ketoester 100e was isolated by silica gel chromatography (gradient elution 20→50% 
EtOAc in hexanes) as a white solid.  98% ee, [α]D25 +64.6 (c 0.46, CHCl3); Rf = 0.4 (50% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 8.60 (s, 1H), 8.43 (dd, J = 5.0, 1.7 Hz, 
1H), 8.02 (dd, J = 8.3, 1.3 Hz, 1H), 7.93 (dt, J = 8.0, 2.0 Hz, 1H), 7.44 (td, J = 7.5, 1.5 
Hz, 1H), 7.28 (t, J = 7.6 Hz, 1H), 7.23 (dd, J = 8.0, 4.8 Hz, 1H),  7.17 (d, J = 7.7 Hz, 1H), 
6.36–6.29 (m, 1H), 5.22–5.18 (m, 2H), 4.31 (d, J = 9.8 Hz, 1H), 3.53 (s, 3H), 3.21 (ddd, J 
= 17.2, 12.3, 4.7 Hz, 1H), 2.91 (ddd, J = 17.5, 4.9, 2.7 Hz, 1H), 2.60 (ddd, J = 13.5, 4.7, 
2.8 Hz, 1H), 2.17 (ddd, J = 13.4, 12.3, 4.9 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 
193.3, 170.0, 150.9, 147.9, 142.9, 138.4, 136.0, 135.5, 133.9, 132.5, 128.8, 128.4, 126.9, 
123.3, 119.2, 62.4, 52.7, 52.5, 29.7, 26.5; IR (Neat Film, NaCl) 3029, 2950, 2848, 1732, 
1687, 1599, 1573, 1479, 1454, 1429, 1356, 1295, 1274, 1241, 1216, 1171, 1122, 1077, 
1025, 999, 979, 926, 807, 749, 716 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for 
C20H20NO3 [M+H]+: 322.1438, found 322.1442; HPLC conditions: 10% IPA, 1.0 
mL/min, Chiralpak AD-H column, λ = 254 nm, tR (min): minor = 13.45, major = 15.72. 
 
O CO2Me
100e
N
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(R)-methyl 1-oxo-2-((R)-1-(thiophen-2-yl)allyl)-1,2,3,4-tetrahydronaphthalene-2-
carboxylate (100f) 
 
 
Ketoester 100f was isolated by silica gel chromatography (gradient elution, 0→3% 
EtOAc in hexanes) as a white solid. 95% ee, [α]D25 –14.2 (c 0.86, CHCl3); Rf = 0.4 (5% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 8.08 (dd, J = 7.9, 1.2 Hz, 1H), 7.44 
(td, J = 7.5, 1.4 Hz, 1H), 7.29 (t, J = 7.6 Hz, 1H), 7.17 (d, J = 7.7 Hz, 1H), 7.14 (dd, J = 
5.1, 1.2 Hz, 1H), 6.93 (ddd, J = 3.6, 1.2, 0.7 Hz, 1H), 6.88 (dd, J = 5.1, 3.5 Hz, 1H), 6.23 
(dt, J = 16.8, 10.0 Hz, 1H), 5.26–5.12 (m, 2H), 4.76 (d, J = 10.0 Hz, 1H), 3.59 (s, 3H), 
3.25 (ddd, J = 17.2, 12.0, 4.8 Hz, 1H), 2.89 (ddd, J = 17.5, 5.0, 3.1 Hz, 1H), 2.55 (ddd, J 
= 13.7, 4.8, 3.1 Hz, 1H), 2.12 (ddd, J = 13.6, 12.0, 5.0 Hz, 1H); 13C NMR (126 MHz, 
CDCl3) δ 193.2, 169.7, 143.2, 142.3, 135.9, 133.8, 132.3, 128.9, 128.4, 126.9, 126.8, 
126.4, 124.9, 118.3, 62.9, 52.7, 49.5, 28.0, 26.2; IR (Neat Film, NaCl) 3071, 2949, 2925, 
2853, 1731, 1686, 1639, 1599, 1484, 1453, 1433, 1354, 1293, 1272, 1240, 1214, 1170, 
1119, 1078, 1032, 979, 924, 891, 853, 807, 749 cm-1; HRMS (MM: ESI-APCI+) m/z 
calc’d for C19H19SO3 [M+H]+: 327.1049, found 327.1048; SFC conditions: 10% IPA, 4.0 
mL/min, Chiralcel OJ-H column, λ = 254 nm, tR (min): major = 2.96, minor = 3.63. 
 
O CO2Me
100f
S
Chapter 3 – Construction of Vicinal Tertiary and Quaternary Stereocenters via Ir-
Catalyzed Allylic Alkylation and Applications in Sequential Pd-Catalysis  
 
 
247 
(R)-methyl 2-((R)-1-(furan-2-yl)allyl)-1-oxo-1,2,3,4-tetrahydronaphthalene-2-
carboxylate (100g) 
 
 
Ketoester 100g was isolated by silica gel chromatography (gradient elution, 0→3% 
EtOAc in hexanes) as a colorless oil.  95% ee, [α]D25 +22.5 (c 1.17, CHCl3); Rf = 0.4 (5% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 8.06 (dd, J = 8.0, 1.4 Hz, 1H), 7.45 
(td, J = 7.5, 1.5 Hz, 1H), 7.28 (t, J = 7.6 Hz, 1H), 7.25 (dd, J = 1.9, 0.9 Hz, 1H), 7.17 (d, 
J = 7.7 Hz, 1H), 6.25 (dd, J = 3.2, 1.8 Hz, 1H), 6.19–6.09 (m, 2H), 5.26–5.18 (m, 2H), 
4.63 (d, J = 9.8 Hz, 1H), 3.63 (s, 3H), 3.24 (ddd, J = 17.3, 12.2, 4.8 Hz, 1H), 2.88 (ddd, J 
= 17.5, 4.9, 3.1 Hz, 1H), 2.57 (ddd, J = 13.8, 4.8, 3.1 Hz, 1H), 1.99 (ddd, J = 13.8, 12.1, 
5.0 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 192.7, 169.7, 153.4, 143.3, 141.6, 133.7, 
133.6, 132.1, 128.9, 128.4, 126.7, 119.2, 110.3, 108.4, 62.2, 52.7, 47.9, 28.1, 26.1; IR 
(Neat Film, NaCl) 3116, 3075, 3024, 2950, 2848, 1734, 1731, 1689, 1639, 1600, 1500, 
1485, 1453, 1433, 1356, 1293, 1271, 1243, 1216, 1172, 1155, 1120, 1110, 1078, 1012, 
981, 965, 928, 905, 892, 806, 745, 736 cm-1; HRMS (ESI+) m/z calc’d for C19H19O4 
[M+H]+: 311.1278, found 311.1275; SFC conditions: 10% IPA, 2.5 mL/min, Chiralpak 
AD-H column, λ = 254 nm, tR (min): major = 5.21, minor = 6.03.  
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(R)-methyl 2-((S,E)-hexa-1,4-dien-3-yl)-1-oxo-1,2,3,4-tetrahydronaphthalene-2-
carboxylate (100h) 
 
 
Ketoester 100h was isolated by silica gel chromatography (gradient elution, 0→2% 
EtOAc in hexanes) as a colorless oil.  90% ee, [α]D25 +46.4 (c 1.02, CHCl3); Rf = 0.5 (5% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 8.05 (dd, J = 7.9, 1.2 Hz, 1H), 7.45 
(td, J = 7.5, 1.5 Hz, 1H), 7.30 (t, J = 7.6 Hz, 1H), 7.19 (d, J = 7.7 Hz, 1H), 5.98–5.87 (m, 
1H), 5.74 (ddd, J = 15.3, 8.0, 1.6 Hz, 1H), 5.57–5.48 (m, 1H), 5.08–5.03 (m, 2H), 3.61 (s, 
3H), 3.47 (t, J = 8.4 Hz,  1H), 3.12 (ddd, J = 17.0, 12.0, 4.7 Hz, 1H), 2.91 (dt, J = 17.4, 
4.1 Hz, 1H), 2.45 (ddd, J = 13.7, 4.7, 3.3 Hz, 1H), 2.25 (ddd, J = 13.7, 11.9, 4.9 Hz, 1H), 
1.65 (ddd, J = 6.4, 1.7, 0.7 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 194.2, 171.0, 143.1, 
136.7, 133.6, 132.8, 129.8, 128.8, 128.2, 128.2, 126.8, 117.6, 62.0, 53.2, 52.4, 29.5, 26.5, 
18.2; IR (Neat Film, NaCl) 3075, 3028, 2951, 2854, 1732, 1688, 1600, 1454, 1438, 1356, 
1300, 1272, 1235, 1214, 1169, 1122, 1090, 999, 974, 917, 890, 803, 747 cm-1; HRMS 
(ESI+) m/z calc’d for C18H21O3 [M+H]+: 288.1485, found 288.1489; SFC conditions: 2% 
MeOH, 2.5 mL/min, Chiralpak IC column, λ = 254 nm, tR (min): minor  = 8.23, major = 
8.87. 
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(R)-ethyl 1-oxo-2-((S)-1-phenylallyl)-1,2,3,4-tetrahydronaphthalene-2-carboxylate 
(100i) 
 
 
Ketoester 100i was isolated by silica gel chromatography (gradient elution, 0→5% 
EtOAc in hexanes) as a white solid, >99% ee, [α]D25 +42.7 (c 1.09, CHCl3); Rf = 0.3 (5% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 8.03 (dd, J = 7.9, 1.4 Hz, 1H), 7.46–
7.39 (m, 3H), 7.29–7.23 (m, 3H), 7.20–7.12 (m, 2H), 6.37 (dt, J = 16.8, 10.0 Hz, 1H), 
5.20–5.07 (m, 2H), 4.40 (d, J = 9.9 Hz, 1H), 4.07–3.94 (m, 2H), 3.22 (ddd, J = 17.3, 12.2, 
4.8 Hz, 1H), 2.88 (ddd, J = 17.5, 5.0, 2.9 Hz, 1H), 2.58 (ddd, J = 13.6, 4.7, 3.0 Hz, 1H), 
2.12 (ddd, J = 13.6, 12.1, 5.0 Hz, 1H), 1.06 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, 
CDCl3) δ 193.4, 169.7, 143.0, 140.0, 136.7, 133.5, 132.7, 130.3, 128.7, 128.3, 128.1, 
126.9, 126.7, 117.9, 62.3, 61.6, 54.1, 29.2, 26.4, 14.0; IR (Neat Film, NaCl) 3063, 3027, 
2978, 2934, 1727, 1699, 1689, 1685, 1599, 1490, 1452, 1363, 1298, 1282, 1235, 1212, 
1157, 1107, 1080, 1018, 926, 899, 787, 773, 743 cm-1; HRMS (MM: ESI-APCI+) m/z 
calc’d for C22H23O3 [M+H]+: 335.1642, found 335.1651; SFC conditions:  5% IPA, 2.5 
mL/min, Chiralpak AD-H column, λ = 254 nm, tR (min): minor = 13.82, major = 16.53. 
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(R)-ethyl 2-oxo-1-((S)-1-phenylallyl)cyclopentanecarboxylate (103a) 
 
 
Ketoester 103a was isolated by silica gel chromatography (gradient elution, 0→5% 
EtOAc in hexanes) as a colorless oil.  99% ee, [α]D25 –52.5 (c 1.04, CHCl3); Rf = 0.3 (5% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.31–7.15 (m, 5H), 6.14–6.03 (m, 
1H), 5.20–5.10 (m, 2H), 4.37 (d, J = 8.9 Hz, 1H), 4.22–4.09 (m, 2H), 2.67 (dddd, J = 
13.4, 7.1, 3.5, 1.7 Hz, 1H), 2.24–2.14 (m, 1H), 2.13–2.02 (m, 1H), 1.84–1.71 (m, 1H), 
1.69–1.59 (m, 1H), 1.59–1.49 (m, 1H), 1.24 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, 
CDCl3) δ 213.4, 169.2, 139.3, 136.3, 129.9, 128.4, 127.1, 117.8, 65.9, 61.9, 52.8, 38.9, 
28.5, 19.7, 14.2; IR (Neat Film, NaCl) 3083, 3062, 3030, 2979, 2891, 1752, 1719, 1639, 
1601, 1493, 1465, 1452, 1405, 1365, 1315, 1223, 1138, 1105, 1026, 1003, 923, 864, 826, 
757, 707 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C17H21O3 [M+H]+: 273.1485, 
found 273.1483; HPLC conditions:  2% IPA, 0.6 mL/min, Chiralcel OD-H column, λ = 
210 nm, tR (min): major = 11.23, minor = 12.73. 
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(R)-ethyl 2-oxo-1-((S)-1-phenylallyl)cyclohexanecarboxylate (103b) 
 
Ketoester 103b was isolated by silica gel chromatography (gradient elution, 0→5% 
EtOAc in hexanes) as a white solid.  98% ee, [α]D25 +140.6 (c 1.25, CHCl3); Rf = 0.4 (5% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.36–7.30 (m, 2H), 7.29–7.22 (m, 
2H), 7.21–7.15 (m, 1H), 6.33 (ddd, J = 16.9, 10.2, 9.2 Hz, 1H), 5.13–4.99 (m, 2H), 4.11–
3.96 (m, 2H), 3.93 (d, J = 9.2 Hz, 1H), 2.47–2.39 (m, 2H), 2.36–2.29 (m, 1H), 1.92 
(dddd, J = 9.5, 4.8, 2.7, 1.5 Hz, 1H), 1.79–1.47 (m, 3H), 1.12 (t, J = 7.1 Hz, 3H); 13C 
NMR (126 MHz, CDCl3) δ 206.7, 170.8, 140.0, 137.5, 130.3, 128.0, 126.8, 117.4, 65.5, 
61.4, 54.6, 42.1, 35.0, 27.2, 22.8, 14.0; IR (Neat Film, NaCl) 3077, 3028, 2977, 2939, 
2865, 1714, 1635, 1600, 1491, 1452, 1388, 1365, 1340, 1309, 1262, 1231, 1204, 1133, 
1085, 1020, 1002, 919, 854, 756, 704 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for 
C18H23O3 [M+H]+: 287.1642, found 287.1639; SFC conditions: 10% IPA, 4.0 mL/min, 
Chiralpak IC column, λ = 210 nm, tR (min): minor = 1.69, major = 1.94. 
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(R)-2-(trimethylsilyl)ethyl 2-oxo-1-((S)-1-phenylallyl)cyclohexanecarboxylate (103c) 
 
 
Ketoester 103c was isolated by silica gel chromatography (gradient elution, 0→2% i-
BuOAc in hexanes) as a colorless oil.  >99% ee, [α]D25 +91.6 (c 0.45, CHCl3); Rf = 0.4 
(10% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.37–7.32 (m, 2H), 7.24 (ddd, J 
= 8.2, 6.9, 1.4 Hz, 2H), 7.21–7.15 (m, 1H), 6.34 (ddd, J = 16.9, 10.2, 9.2 Hz, 1H), 5.21–
4.86 (m, 2H), 4.05 (dddd, J = 58.0, 11.8, 10.8, 5.9 Hz, 2H), 3.92 (d, J = 9.2 Hz, 1H), 
2.46–2.40 (m, 2H), 2.38–2.28 (m, 1H), 1.98–1.87 (m, 1H), 1.80–1.71 (m, 1H), 1.72–1.47 
(m, 3H), 0.82 (qdd, J = 13.6, 11.7, 5.7 Hz, 2H), 0.01 (s, 9H); 13C NMR (126 MHz, 
CDCl3) δ 206.6, 170.9, 139.9, 137.4, 130.2, 127.9, 126.7, 117.3, 65.4, 63.7, 54.5, 42.0, 
34.9, 27.0, 22.7, 17.2, –1.6; IR (Neat Film, NaCl) 2950, 1712, 1452, 1250, 1231, 1133, 
921, 859, 837 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C21H30NaO3Si [M+Na]+: 
381.1856, found 381.1865; SFC conditions: 3% IPA, 2.5 mL/min, Chiralcel OJ–H 
column, λ = 210 nm, tR (min): minor = 1.93, major = 2.24. 
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(R)-methyl 4-isobutoxy-2-oxo-1-((S)-1-phenylallyl)cyclohex-3-enecarboxylate (103d) 
 
 
Ketoester 103d was isolated by silica gel chromatography (gradient elution, 0→10% 
EtOAc in hexanes) as a colorless oil.  >99% ee, [α]D25 +31.5 (c 1.88, CHCl3); Rf = 0.4 
(10% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.34–7.29 (m, 2H), 7.27–7.20 
(m, 2H), 7.20–7.13 (m, 1H), 6.24 (dt, J = 16.7, 10.2 Hz, 1H), 5.28 (s, 1H), 5.18 (ddd, J = 
16.8, 1.9, 0.8 Hz, 1H), 5.12 (dd, J = 10.0, 1.8 Hz, 1H), 4.62 (d, J = 10.4 Hz, 1H), 3.64 (s, 
3H), 3.53–3.45 (m, 2H), 2.79 (dddd, J = 18.3, 11.8, 5.1, 1.6 Hz, 1H), 2.43 (ddd, J = 13.4, 
5.1, 2.4 Hz, 1H), 2.26 (ddd, J = 18.2, 5.5, 2.4 Hz, 1H), 1.94 (dt, J = 13.3, 6.7 Hz, 1H), 
1.83 (ddd, J = 13.4, 11.8, 5.5 Hz, 1H), 0.91 (d, J = 6.8 Hz, 6H); 13C NMR (126 MHz, 
CDCl3) δ 192.8, 177.2, 170.0, 139.7, 136.1, 130.2, 128.1, 126.8, 118.0, 102.9, 74.9, 61.1, 
52.6, 52.1, 27.7, 26.7, 25.2, 19.11, 19.08; IR (Neat Film, NaCl) 3073, 3029, 2958, 2874, 
1727, 1664, 1607, 1582, 1491, 1470, 1452, 1443, 1431, 1406, 1384, 1369, 1316, 1298, 
1231, 1193, 1177, 1140, 1116, 1079, 1012, 987, 921, 903, 844, 817, 788, 764, 724 cm-1; 
HRMS (MM: ESI-APCI+) m/z calc’d for C21H27O4 [M+H]+: 343.1904, found 343.1905; 
SFC conditions: 10% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 254 nm, tR (min): 
major = 3.71, minor = 6.24. 
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(S)-methyl 4-oxo-3-((S)-1-phenylallyl)tetrahydro-2H-pyran-3-carboxylate (103e) 
 
 
Ketoester 103e was isolated by silica gel chromatography (gradient elution, 5→10% 
EtOAc in hexanes) as a colorless oil.  98% ee, [α]D25 +71.1 (c 0.88, CHCl3); Rf = 0.2 
(10% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.35–7.30 (m, 2H), 7.31–7.25 
(m, 2H), 7.24–7.19 (m, 1H), 6.43 (ddd, J = 16.9, 10.2, 9.4 Hz, 1H), 5.19–5.03 (m, 2H), 
4.28 (dd, J = 11.9, 1.2 Hz, 1H), 4.03 (dddd, J = 11.1, 6.2, 4.9, 1.3 Hz, 1H), 3.98 (d, J = 
9.4 Hz, 1H), 3.82 (dddd, J = 11.3, 9.0, 4.5, 0.6 Hz, 1H), 3.67 (d, J = 11.8 Hz, 1H), 3.61 
(s, 3H), 2.70 (ddd, J = 14.5, 8.9, 6.2 Hz, 1H), 2.57 (dt, J = 14.5, 4.7 Hz, 1H); 13C NMR 
(126 MHz, CDCl3) δ 202.8, 169.7, 138.6, 136.7, 129.8, 128.4, 127.4, 118.0, 73.2, 68.6, 
67.1, 52.4, 51.6, 41.9; IR (Neat Film, NaCl) 3063, 3029, 2973, 2951, 2863, 1746, 1716, 
1635, 1600, 1492, 1472, 1454, 1433, 1378, 1360, 1310, 1290, 1229, 1212, 1176, 1140, 
1112, 1085, 1033, 1001, 978, 925, 826, 763, 741 cm-1; HRMS (ESI+) m/z calc’d for 
C16H19O4 [M+H]+: 275.1278, found 275.1282; SFC conditions: 5% IPA, 2.5 mL/min, 
Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 4.65, major = 4.95.  
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(S)-methyl 1-benzyl-4-oxo-3-((S)-1-phenylallyl)piperidine-3-carboxylate (103f) 
 
 
Ketoester 103f was isolated by silica gel chromatography (gradient elution, 5→10% 
EtOAc in hexanes) as a colorless oil.  97% ee, [α]D25 +34.3 (c 0.87, CHCl3); Rf = 0.3 
(10% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.39–7.29 (m, 5H), 7.28–7.24 
(m, 2H), 7.24–7.14 (m, 3H), 6.44 (ddd, J = 16.9, 10.2, 9.3 Hz, 1H), 5.12–5.04 (m, 2H), 
4.03 (d, J = 9.4 Hz, 1H), 3.59 (s, 3H), 3.64–3.54 (m, 2H), 3.15 (dd, J = 11.9, 2.0 Hz, 1H), 
2.82–2.75 (m, 1H), 2.71 (ddd, J = 14.1, 8.5, 5.7 Hz, 1H), 2.65–2.56 (m, 2H), 2.53 (ddd, J 
= 13.9, 5.4, 4.3 Hz, 1H);  13C NMR (126 MHz, CDCl3) δ 205.3, 170.6, 139.4, 138.0, 
137.4, 129.9, 129.2, 128.5, 128.2, 127.5, 127.1, 117.6, 66.1, 62.0, 60.2, 53.4, 53.0, 52.0, 
40.9; IR (Neat Film, NaCl) 3060, 3027, 2949, 2811, 2765, 1718, 1631, 1600, 1584, 1493, 
1468, 1452, 1432, 1364, 1345, 1310, 1286, 1228, 1194, 1138, 1073, 1047, 1028, 1001, 
973, 922, 821, 740 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C23H26NO3 [M+H]+: 
364.1907, found 364.1908; SFC conditions: 10% IPA, 4.0 mL/min, Chiralpak AD-H 
column, λ = 210 nm, tR (min): major = 2.49, minor = 2.94. 
 
 
 
 
 
N
Bn
O Ph
CO2Me
103f
Chapter 3 – Construction of Vicinal Tertiary and Quaternary Stereocenters via Ir-
Catalyzed Allylic Alkylation and Applications in Sequential Pd-Catalysis  
 
 
256 
3.6.5. General procedure for Pd-catalyzed allylic alkylation 
 
 
(R)-2-allyl-2-((S)-1-phenylallyl)cyclohexanone (106a). To a 0.5 dram scintillation vial 
equipped with a magnetic stir bar were added Pd2(dba)3 (1.3 mg, 0.0014 mmol), L8 (1.2 
mg, 0.0035 mmol), TBAT (16.6 mg, 0.031 mmol) and THF (0.9 mL) in a nitrogen-filled 
glove box. The dark purple mixture was stirred at ambient glove box temperature (ca. 30 
°C) for 35 minutes at which point the mixture had become red-orange.  Ketoester 103c 
(10.0 mg, 0.028 mmol) and allyl methylcarbonate (4.1 mg, 0.035 mmol) were then added 
neat to the reaction mixture.  The resulting yellow-green reaction mixture was stirred at 
20 °C until full conversion of the starting material was indicated by TLC analysis 
(reaction times typically ranged from 24 to 36 hours).  The vial was removed from the 
glove box, uncapped and diluted with 2 ml of hexanes.  Filtration through a celite pad 
afforded the crude residue, which was concentrated in vacuo and analyzed by 1H NMR to 
determine the diastereomeric ratio of 106a and 107a (2:1).  The residue was purified by 
silica gel flash chromatography (gradient elution, 0→2% EtOAc in hexanes) to afford 
106a and 107a (6.5 mg, 91% combined yield) as a colorless oil. 99% ee (The 
enantiomeric excesses of the products 106a and 107a are inferred from the corresponding 
Ir-catalyzed allylic alkylation products (103c)). Spectroscopic data for compound 106a is 
as follows: [α]D25 –1.9 (c 0.48, CHCl3); Rf = 0.3 (0.4% EtOAc in hexanes); 1H NMR (300 
MHz, CDCl3) δ 7.33–7.28 (m, 2H), 7.25–7.20 (m, 3H), 6.20 (dt, J = 16.8, 10.1 Hz, 1H), 
Pd2(dba)3 (5 mol %)
L1 (12.5 mol %),
TBAT, THF, 25 °C
MeO2CO
(1.2 equiv)
PhO
106a
OPh
O
O
TMS
PhO
107a
+
103c
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5.68 (dddd, J = 17.1, 10.1, 8.8, 5.4 Hz, 1H), 5.09 (ddd, J = 10.1, 1.6, 0.4 Hz, 1H), 5.08 
(ddd, J = 16.7, 1.7, 0.8 Hz, 1H), 4.98 (dddd, J = 10.2, 2.3, 1.3, 0.7 Hz, 1H), 4.92–4.86 (m, 
1H), 3.92 (d, J = 9.9 Hz, 1H), 2.75 (dd, J = 13.7, 5.4 Hz, 1H), 2.56–2.10 (m, 2H), 2.11–
1.59 (m, 7H); 13C NMR (126 MHz, CDCl3) δ  212.9, 140.1, 136.3, 134.9, 130.0, 128.1, 
126.8, 117.9, 117.4, 55.7, 52.8, 40.5, 37.6, 31.9, 26.2, 21.1; IR (Neat Film, NaCl) 3073, 
3028, 2937, 2864, 1833, 1701, 1636, 1600, 1452, 1432, 1313, 1219, 1125, 1056, 1002, 
916, 849, 787, 765 cm–1; HRMS (MM: ESI-APCI+) m/z calc'd for C18H23O [M+H]+: 
255.1754; found 255.1743.  Spectroscopic data for compound 107a is as follows: [α]D25 
+6.1 (c 0.75, CHCl3); Rf = 0.3 (0.4% EtOAc in hexanes); 1H NMR (300 MHz, CDCl3) δ 
7.33–7.28 (m, 2H), 7.25–7.20 (m, 3H), 6.19 (dt, J = 16.8, 10.1 Hz, 1H), 5.65 (dddd, J = 
17.1, 10.1, 8.8, 5.4 Hz, 1H), 5.17 (dd, J = 1.7, 1.0, 1H), 5.15 (dd, J = 1.7, 1.0, 1H) 5.07–
5.02 (m, 2H) 3.95 (d, J = 8.5, 1H), 2.75 (dd, J = 13.7, 5.4 Hz, 1H), 2.56–2.10 (m, 2H), 
2.11–1.59 (m, 7H); 13C NMR (126 MHz, CDCl3) δ  213.2, 140.3, 138.0, 134.1, 129.8, 
128.3, 126.8, 118.0, 117.8, 55.6, 53.4, 40.6, 38.6, 32.2, 25.6, 20.8; IR (Neat Film, NaCl) 
3073, 3028, 2937, 2864, 1833, 1701, 1636, 1600, 1452, 1432, 1313, 1219, 1125, 1056, 
1002, 916, 849, 787, 765 cm–1; HRMS (MM: ESI-APCI+) m/z calc'd for C18H23O 
[M+H]+: 255.1754; found 255.1750.  
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(R)-2-((S)-1-phenylallyl)-2-(2-phenylallyl)cyclohexanone (106b) 
 
 
Ketone 106b was isolated by silica gel chromatography (gradient elution, 0→1% Et2O in 
hexanes) as a colorless oil.   [α]D25 –50.9 (c 0.22, CHCl3); Rf = 0.5 (10% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 7.32–7.13 (m, 10H), 6.24 (dt, J = 16.8, 10.1 Hz, 
1H), 5.29 (d, J = 1.8 Hz, 1H), 5.22–5.02 (m, 3H), 3.92 (d, J = 10.0 Hz, 1H), 2.95 (ddd, J 
= 377.8, 13.8, 0.9 Hz, 2H), 2.15–2.00 (m, 2H), 1.76–1.57 (m, 4H), 1.54–1.43 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 212.8, 145.6, 142.8, 140.3, 136.2, 129.9, 128.1, 128.0, 
127.0, 126.7, 126.5, 118.2, 117.7, 56.6, 54.4, 40.6, 37.6, 30.6, 24.8, 21.4; IR (Neat Film, 
NaCl) 2937, 2859, 1701, 1624, 1597, 1451, 1310, 1256, 1207, 1125 910, 779 cm-1; 
HRMS (MM: ESI-APCI+) m/z calc’d for C24H26O [M+H]+: 331.2056, found 331.2065. 
 
(R)-2-(2-methylallyl)-2-((S)-1-phenylallyl)cyclohexanone (106c) 
 
 
Ketone 106c was isolated by silica gel chromatography (gradient elution, 0→2% EtOAc 
in hexanes) as a colorless oil.  [α]D25 –41.7 (c 0.46, CHCl3); Rf = 0.4 (5% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 7.33–7.28 (m, 2H), 7.25–7.19 (m, 3H), 6.19 (dt, 
PhO
106b
Ph
PhO
106c
Me
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J = 16.8, 10.1 Hz, 1H), 5.08 (dd, J = 10.2, 1.6 Hz, 1H), 5.03 (ddd, J = 16.8, 1.6, 0.8 Hz, 
1H), 4.74 (ddt, J = 2.7, 1.8, 0.9 Hz, 1H), 4.52 (ddt, J = 2.4, 1.6, 0.9 Hz, 1H), 3.86 (d, J = 
10.0 Hz, 1H), 2.90 (d, J = 13.1 Hz, 1H), 2.37 (dtd, J = 16.2, 4.9, 1.6 Hz, 1H), 2.25 (ddd, J 
= 15.9, 11.3, 6.0 Hz, 1H), 2.00 (d, J = 13.7 Hz, 1H), 1.93–1.78 (m, 2H), 1.74–1.63 (m, 
4H), 1.59 (dt, J = 1.4, 0.7 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 212.8, 143.0, 140.3, 
136.5, 130.1, 128.2, 126.9, 117.4, 115.3, 55.5, 54.2, 40.7, 40.2, 30.8, 25.5, 25.1, 21.4; IR 
(Neat Film, NaCl) 3071, 3030, 2940, 2865, 1704, 1637, 1599, 1452, 1375, 1314, 1209, 
1124, 994, 916, 893, 756 cm–1; HRMS (MM: ESI-APCI+) m/z calc'd for C19H25O 
[M+H]+: 269.1920; found 269.1920. 
 
3.6.6. Determination of the relative configuration of compound 106a 
 
The relative configuration of compound 106a was determined via NOE analysis 
of the corresponding spirocycle, 108, obtained via ring-closing metathesis.  The 
experimental procedure by which 108 was generated is as follows:   
 
 
(1S,5R)-1-phenylspiro[4.5]dec-2-en-6-one (108). To a flask charged with Grubbs-
Hoveyda second generation catalyst (1.85 mg, 0.0030 mmol) under an atmosphere of 
argon was added a solution of cyclohexanone 106a (15.0 mg, 0.059 mmol) in 6 mL 
benzene. The reaction mixture was heated to 50 °C and stirred for 4 hours, at which point 
the reaction was determined to be complete by TLC analysis.  The reaction vessel was 
PhO
106a
PhH, 50 °C
(5 mol %)
O
108
Ph
Grubbs-Hoveyda 2
94% yield
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cooled to 25 °C and 0.5 mL of ethyl vinyl ether was added. After 30 minutes of stirring, 
the crude mixture was purified directly by silica gel chromatography (gradient elution, 
0→3% EtOAc in hexanes) to afford spirocycle 108 (12.7 mg, 0.056 mmol, 94% yield) as 
a colorless oil.  [α]D25 –133.6 (c 0.25, CHCl3); Rf = 0.5 (10% EtOAc in hexanes); 1H 
NMR (500 MHz, CDCl3)  δ 7.32–7.24 (m, 2H), 7.24–7.18 (m, 1H), 7.18–7.12 (m, 2H), 
6.01–5.52 (m, 1H), 4.75 (p, J = 2.1 Hz, 1H), 2.66–2.56 (m, 2H), 2.56–2.44 (m, 2H), 
1.95–1.85 (m, 1H), 1.64–1.49 (m, 3H), 1.42 (dtd, J = 14.66, 3.6, 2.3 Hz, 1H), 1.35–0.72 
(m, 1H), 1.01 (ddd, J = 13.9, 11.3, 4.5 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ  212.9, 
140.6, 133.8, 129.3, 128.0, 127.4, 126.4, 59.8, 53.7, 42.8, 39.6, 35.5, 26.8, 22.2; IR (Neat 
Film, NaCl) 3944, 3693, 3053, 2986, 2941, 2866, 2685, 2305, 1698, 1422, 1264, 1129, 
896, 756 cm–1; HRMS (MM: ESI-APCI+) m/z calc'd for C16H19O [M+H]+: 227.1430; 
found 227.1431. 
 
 
3.6.7. Spectroscopic data for new phosphinooxazoline ligands 
 
Phosphinooxazoline ligands L14 and L15 employed in these studies were 
generously donated by Dr. Robert A. Craig. They were generated following the method 
reported by McDougal and Stoltz. Comprehensive preparatory detail can be found in the 
Thesis of Dr. Craig.   
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(S)-2-(2-(bis(4-(trifluoromethyl)phenyl)phosphino)phenyl)-4-isopropyl-5,5-diphenyl-
4,5-dihydrooxazole (L14) 
 
 
 [α]D25 –163.33 (c 0.75, CHCl3,); Rf = 0.3 (4:1 hexanes in dichloromethane); 1H NMR 
(500 MHz, C6D6)  δ 8.22 (ddd, J = 7.8, 3.9, 1.4 Hz, 1H), 7.29 (ddd, J = 49.4, 8.4, 1.4 Hz, 
4H), 7.21–7.14 (m, 5H), 7.10–7.02 (m, 7H), 7.02–6.94 (m, 3H), 6.89 (td, J = 7.6, 1.4 Hz, 
1H), 6.81 (ddd, J = 7.9, 3.4, 1.3 Hz, 1H), 4.66 (d, J = 4.5 Hz, 1H), 1.74 (td, J = 6.6, 4.6 
Hz, 1H), 0.83 (d, J = 6.7 Hz, 3H), 0.59 (d, J = 6.5 Hz, 3H);  13C NMR (126 MHz, C6D6) δ 
160.1 (d, JCP = 3.2 Hz), 145.8 , 144.4–143.9 (m) 141.2 , 137.9 (d, JCP = 27.4 Hz), 134.9, 
134.5 (dd, JCP = 70.9, 20.8 Hz), 132.6 (d, JCP = 21.4 HZ), 131.3 , 130.6 (dd, JCP = 32.3, 
18.4 Hz), 130.3 (d, JCP = 3.2 Hz), 129.1, 127.5 (d, JCF = 11.2 Hz), 126.8,  125.3 (ddt, JCF 
= 14.7, 7.6, 3.8 Hz), 124.8 (d, JCF = 273.5 Hz), 93.1, 81.1 (d JCP = 2.0 Hz), 30.60, 22.0; 
19F NMR (282 MHz, C6D6) δ –62.44, –62.53; 31P NMR (121MHz, C6D6) δ –7.59; IR 
(Neat Film, NaCl) 3060, 2961, 1654, 1605, 1493, 1470, 1448, 1396, 1323, 1166, 1127, 
1060, 1016, 954, 832, 756 cm–1; HRMS (MM: ESI-APCI+) m/z calc'd for 
C28H3019F6NOP [M+H]+: 662.2042, found 662.2080.  
 
P N
O
CF3
Ph
PhF3C
L14
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(R)-2-(2-(bis(4-(trifluoromethyl)phenyl)phosphino)-5-(trifluoromethyl)phenyl)-4-
isopropyl-5,5-dimethyl-4,5-dihydrooxazole (L15) 
 
 
 
[α]D25 +9.45 (c 3.20, CHCl3,); Rf = 0.3 (4:1 hexanes in dichloromethane); 1H NMR (500 
MHz, C6D6)  δ 8.57 (dd, J  = 3.3, 2.0 Hz, 1H), 7.41–7.36 (m, 4H), 7.21–7.15 (m, 4H), 
7.10 (dd, J = 8.2, 2.0 Hz, 1H), 6.78 (dd, J = 8.0, 3.0 Hz, 1H), 3.22 (d, J = 8.4 Hz, 1H), 
1.55 (ddt, J = 13.0, 8.3, 6.5 Hz, 1H), 1.21 (s, 3H), 1.08 (s, 3H), 0.99 (d, J = 6.5 Hz, 3H), 
0.75 (d, J = 6.5 Hz, 3H);  13C NMR (126 MHz, C6D6) δ  159.1 (d, JCP = 4.0 Hz), 143.5 (t, 
JCP = 14.8 Hz), 142.7 (d, JCP = 30.6 Hz), 134.5 (dd, JCP = 21.3, 15.7 Hz), 133.7 (d, JCP = 
19.5 Hz), 131.1 (q, JCF = 3.6 Hz), 126.4–126.1 (m), 125.9 (d, JCF = 3.2 Hz), 126.5–125.0 
(m), 123.8 (d, JCF = 3.3 Hz), 123.3, 87.2, 81.7 (d, JCP = 1.5 Hz), 29.1, 28.8, 21.1, 20.8, 
20.8 (d, JCP = 1.8 Hz); 19F NMR (282 MHz, C6D6) δ –62.63, –62.85; 31P NMR (121MHz, 
C6D6) δ –7.10; IR (Neat Film, NaCl) 2974, 1652, 1397, 1323, 1165, 1128, 1060, 1017, 
832, 756 cm–1; HRMS (FAB+) m/z calc'd for C29H26O19F9NP [M+H]+: 606.1608, found 
606.1585.  
P N
O
CF3
F3C
CF3
L15
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3.6.8 Determination of enantiomeric excess 
 
Table 3.6.8.1. Determination of enantiomeric excess 
 
O CO2Me OMe
O Ph
CO2Me
O CO2Me Br
O CO2Me CF3
O CO2Me
S
O CO2Me
O
O CO2Me
N
O CO2Me
entry compound analytic conditions ee (%)
1
2
3
4
5
6
7
8
HPLC
Chiralcel OD-H, ∈≈ = 254 nm
2% IPA/hexanes, 0.6 mL/min
tR (min): major 13.80, minor 17.89
HPLC
Chiralpak AD-H, ∈≈ = 254 nm
2% IPA/hexanes, 0.6 mL/min
tR (min): minor 27.44, major 37.29
>99
>99
99
>99
98
95
95
90
HPLC
Chiralpak AD-H, ∈≈ = 254 nm
2% IPA/hexanes, 0.6 mL/min
tR (min): minor 19.71, major 23.59
SFC
Chiralpak AD-H, ∈≈ = 254 nm
5% IPA/CO2, 4.0 mL/min
tR (min): minor 3.38, major 3.91
HPLC
Chiralpak AD-H, ∈≈ = 254 nm
90% IPA/hexanes, 1.0 mL/min
tR (min): minor 13.45, major 15.72
SFC 
Chiralcel OJ-H, ∈≈ = 254 nm
10% IPA/CO2, 4.0 mL/min, 
tR (min): major 2.96, minor 3.63
SFC 
Chiralpak AD-H, ∈≈ = 254 nm
10% IPA/CO2, 2.5 mL/min, 
tR (min): major 5.21, minor 6.03
SFC
Chiralpak IC, ∈≈ = 254 nm
2% MeOH/CO2, 2.5 mL/min,
tR (min): minor 8.23, major 8.87
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Table 3.6.8.2 Determination of enantiomeric excess continued 
 
 
 
 
 
 
 
 
O Ph
CO2Et
O Ph
CO2CH2CH2TMS
O Ph
CO2Me
i-BuO
O
O Ph
CO2Me
O Ph
CO2Et
CO2Et
O Ph
N
Bn
O Ph
CO2Me
9
10
11
12
13
14
15
>99
99
98
>99
>99
98
97
SFC
Chiralpak AD-H, ∈≈ = 254 nm
5% IPA/CO2, 2.5 mL/min,
tR (min): minor 13.82, major 16.53
HPLC
Chiralcel OD-H, ∈≈ = 220 nm
2% IPA/hexanes, 0.6 mL/min
tR(min): major 11.23, minor 12.73
SFC
Chiralpak IC,  ∈≈ = 210 nm
10% IPA/CO2, 4.0 mL/min
tR (min): minor 1.69, major 1.94
SFC
Chiralcel OD-H, ∈≈ = 254 nm
10% IPA/CO2, 2.5 mL/min
tR (min): major 3.71, minor 6.24
SFC
Chiralpak AD-H, ∈≈ = 210 nm
5% IPA/CO2, 2.5 mL/min
tR (min): minor 4.65, major 4.95
SFC
Chiralpak AD-H, ∈≈ = 210 nm
10% IPA/CO2, 4.0 mL/min
tR (min): major 2.49, minor 2.94
SFC
Chiralcel OJ-H,  ∈≈ = 210 nm
3% IPA/CO2, 2.5 mL/min
tR (min): minor 1.93, major 2.24
entry compound analytic conditions ee (%)
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Figure A3.2  Infrared spectrum (thin film/NaCl) of compound 100a. 
Figure A3.3  13C NMR (125 MHz, CDCl3) of compound 100a. 
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Figure A3.6  Infrared spectrum (thin film/NaCl) of compound 100b. 
Figure A3.6  13C NMR (125 MHz, CDCl3) of compound 100b. 
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Figure A3.8  Infrared spectrum (thin film/NaCl) of compound 100c. 
Figure A3.9  13C NMR (125 MHz, CDCl3) of compound 100c. 
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Figure A3.11  Infrared spectrum (thin film/NaCl) of compound 100d. 
Figure A3.12  13C NMR (125 MHz, CDCl3) of compound 100d. 
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Figure A3.14  Infrared spectrum (thin film/NaCl) of compound 100e. 
Figure A3.15  13C NMR (125 MHz, CDCl3) of compound 100e. 
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Figure A3.17  Infrared spectrum (thin film/NaCl) of compound 100f. 
Figure A3.18  13C NMR (125 MHz, CDCl3) of compound 100f. 
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Figure A3.20  Infrared spectrum (thin film/NaCl) of compound 100g. 
Figure A3.21  13C NMR (125 MHz, CDCl3) of compound 100g. 
286
Appendix 3 – Spectra Related to Chapter 3 
 


	
 



(

)



  
Fi
gu
re
 A
3.
22
  1
H
 N
M
R
 (5
00
 M
H
z,
 C
D
C
l 3)
 o
f c
om
po
un
d 
10
0h
. 
O
CO
2M
e
10
0h
287
Appendix 3 – Spectra Related to Chapter 3 
 
	 
()

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A3.23  Infrared spectrum (thin film/NaCl) of compound 100h. 
Figure A3.24  13C NMR (125 MHz, CDCl3) of compound 100h. 
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Figure A3.26  Infrared spectrum (thin film/NaCl) of compound 100i. 
Figure A3.27  13C NMR (125 MHz, CDCl3) of compound 100i. 
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Figure A3.29  Infrared spectrum (thin film/NaCl) of compound 103a. 
Figure A3.30  13C NMR (125 MHz, CDCl3) of compound 103a. 
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Figure A3.32  Infrared spectrum (thin film/NaCl) of compound 103b. 
Figure A3.33  13C NMR (125 MHz, CDCl3) of compound 103b. 
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Figure A3.35  Infrared spectrum (thin film/NaCl) of compound 103c. 
Figure A3.36  13C NMR (125 MHz, CDCl3) of compound 103c. 
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Figure A3.38  Infrared spectrum (thin film/NaCl) of compound 103d. 
Figure A3.39  13C NMR (125 MHz, CDCl3) of compound 103d. 
298
Appendix 3 – Spectra Related to Chapter 3 
 


	
 



(

)



  
Fi
gu
re
 A
3.
40
  1
H
 N
M
R
 (5
00
 M
H
z,
 C
D
C
l 3)
 o
f c
om
po
un
d 
10
3e
. 
OO
Ph CO
2M
e
10
3e
299
Appendix 3 – Spectra Related to Chapter 3 
 
  

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A3.41  Infrared spectrum (thin film/NaCl) of compound 103e. 
Figure A3.42  13C NMR (125 MHz, CDCl3) of compound 103e. 
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Figure A3.44  Infrared spectrum (thin film/NaCl) of compound 103f. 
Figure A3.44  13C NMR (125 MHz, CDCl3) of compound 103f. 
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Figure A3.47  Infrared spectrum (thin film/NaCl) of compound 106a and 107a. 
Figure A3.48  13C NMR (125 MHz, CDCl3) of compound 106a and 107a. 
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Figure A3.50  Infrared spectrum (thin film/NaCl) of compound 106b. 
Figure A3.51  13C NMR (125 MHz, CDCl3) of compound 106b. 
306
Appendix 3 – Spectra Related to Chapter 3 
 
1
2
3
4
5
6
7
8
9
10
pp
m
  
Fi
gu
re
 A
3.
52
  1
H
 N
M
R
 (5
00
 M
H
z,
 C
D
C
l 3)
 o
f c
om
po
un
d 
10
6c
. 
Ph
O
10
6c
M
e
307
Appendix 3 – Spectra Related to Chapter 3 
 
020406080100120140160180200220
ppm
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A3.53  Infrared spectrum (thin film/NaCl) of compound 106c. 
Figure A3.54  13C NMR (125 MHz, CDCl3) of compound 106c. 
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Figure A3.56  Infrared spectrum (thin film/NaCl) of compound 108. 
Figure A3.57  13C NMR (125 MHz, CDCl3) of compound 108. 
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Figure A3.59  Infrared spectrum (thin film/NaCl) of compound L14. 
Figure A3.60  13C NMR (125 MHz, C6D6) of compound L14. 
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Figure A3.64  Infrared spectrum (thin film/NaCl) of compound L15. 
Figure A3.65  13C NMR (125 MHz, C6D6) of compound L15. 
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                          APPENDIX 4 
X-ray Crystallography Reports 
Relevant to Chapter 3 
 
A4.1 CRYSTAL STRUCTURE ANALYSIS FOR COMPOUND 100f 
 Ketoester 100f (>99% ee) was recrystallized from i-PrOH/hexanes (liquid/liquid 
diffusion) to provide suitable crystals for X-ray analysis, mp = 98-99 °C. NOTE: 
Crystallographic data have been deposited in the Cambridge Database (CCDC), 12 Union 
Road, Cambridge CB2 1EZ, UK, and copies can be obtained on request, free of charge, by 
quoting the publication citation and the deposition number CCDC 939243. 
 
Appendix 4 — X-ray Crystallography Reports Relevant to Chapter 3 320 
Figure A4.1.1. ORTEP drawing of 100f.  
 
 
 
 
 
Table A4.1. Crystal Data and Structure Analysis Details for allylation ketoester 100f. 
 
Empirical formula  C19 H18 O3 S 
Formula weight  326.39 
Crystallization solvent  i-PrOH/hexanes 
Crystal shape  block 
Crystal color  colourless  
Crystal size 0.13 x 0.23 x 0.29 mm 
 
 Data Collection  
Preliminary photograph(s)  rotation  
Type of diffractometer  Bruker SMART 1000 ccd 
Wavelength  0.71073 Å MoK 
Data collection temperature  100 K 
Theta range for 9849 reflections used 
in lattice determination  2.30 to 30.92° 
Unit cell dimensions a = 8.4853(3) Å a= 90° 
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 b = 10.8613(4) Å b= 90° 
 c = 17.6979(6) Å g = 90° 
Volume 1631.06(10) Å
3
 
Z 4 
Crystal system  orthorhombic 
Space group  P 21 21 21   (# 19) 
Density (calculated) 1.329 g/cm
3
 
F(000) 688 
Theta range for data collection 2.2 to 36.7° 
Completeness to theta = 25.000° 99.9%  
Index ranges -14 £ h £ 14, -18 £ k £ 18, -29 £ l £ 29 
Data collection scan type  and scans 
Reflections collected 49310 
Independent reflections 7841 [Rint= 0.0476] 
Reflections > 2s(I) 6228  
Average s(I)/(net I) 0.0436 
Absorption coefficient 0.21 mm-1 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.0000 and 0.9025  
 
 Structure Solution and Refinement  
Primary solution method  dual 
Secondary solution method  ? 
Hydrogen placement  difmap 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7841 / 0 / 303 
Treatment of hydrogen atoms  refall 
Goodness-of-fit on F2 1.55 
Final R indices [I>2s(I), 6228 reflections] R1 = 0.0483, wR2 = 0.0806 
R indices (all data) R1 = 0.0694, wR2 = 0.0846 
Type of weighting scheme used calc 
Weighting scheme used   
Max shift/error  0.000 
Average shift/error  0.000 
Absolute structure parameter 0.01(3) 
Extinction coefficient n/a 
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Largest diff. peak and hole 0.37 and -0.24 e·Å-3 
 
_refine_ls_abs_structure_details; 
Flack x determined using 2400 quotients [(I+)-(I-)]/[(I+)+(I-)]; 
(Parsons and Flack (2004), Acta Cryst. A60, s61). 
_refine_ls_abs_structure_Flack    0.01(3) 
_refine_ls_abs_structure_Hooft    0.02(3) 
 Programs Used  
Cell refinement   SAINT V8.27B (Bruker-AXS, 2007) 
Data collection   Bruker SMART v5.054 (Bruker-AXS, 2007) 
Data reduction   SAINT V8.27B (Bruker-AXS, 2007) 
Structure solution   SHELXT (Sheldrick, 2012) 
Structure refinement   SHELXL-2013/2 (Sheldrick, 2013) 
Graphics  DIAMOND 3 (Crystal Impact, 1999) 
 
 
 
 
 
Table A4.2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for 100f.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.  
_______________________________________________________________________ 
 x y z Ueq 
_______________________________________________________________________ 
S(1) 9499(4) 3027(2) 9424(2) 26(1) 
S(1A) 7396(4) 1194(2) 8920(1) 26(1) 
O(1) 10909(1) 3864(1) 7769(1) 20(1) 
O(2) 6712(1) 3819(1) 6298(1) 22(1) 
O(3) 8198(1) 5196(1) 6915(1) 20(1) 
C(1) 8415(2) 3108(1) 7316(1) 14(1) 
C(2) 10216(2) 3266(1) 7292(1) 14(1) 
C(3) 11064(2) 2667(1) 6651(1) 14(1) 
C(4) 12665(2) 2961(1) 6537(1) 18(1) 
C(5) 13491(2) 2453(2) 5941(1) 21(1) 
C(6) 12737(2) 1641(2) 5451(1) 21(1) 
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C(7) 11165(2) 1346(1) 5556(1) 18(1) 
C(8) 10300(2) 1842(1) 6161(1) 14(1) 
C(9) 8605(2) 1477(1) 6273(1) 16(1) 
C(10) 7999(2) 1793(1) 7062(1) 17(1) 
C(11) 7676(2) 4054(1) 6775(1) 15(1) 
C(12) 7433(2) 6145(2) 6468(1) 27(1) 
C(13) 7740(2) 3432(1) 8120(1) 16(1) 
C(14) 8255(2) 2565(1) 8741(1) 19(1) 
C(15) 9443(3) 1759(2) 9876(1) 44(1) 
C(16) 8455(3) 892(2) 9630(1) 42(1) 
C(17) 7757(14) 1354(11) 8921(7) 51(4) 
C(17A) 9366(19) 2793(11) 9301(7) 45(3) 
C(18) 5962(2) 3506(2) 8090(1) 18(1) 
C(19) 5128(2) 4517(2) 8192(1) 25(1) 
______________________________________________________________________  
 
 
Table A4.3.  Bond lengths [Å] and angles [°] for 100f. 
_______________________________________________________________________  
S(1)-C(14)  1.681(3) 
S(1)-C(15)  1.594(4) 
S(1A)-C(14)  1.688(3) 
S(1A)-C(16)  1.579(3) 
O(1)-C(2)  1.2177(17) 
O(2)-C(11)  1.2030(18) 
O(3)-C(11)  1.3403(17) 
O(3)-C(12)  1.452(2) 
C(1)-C(2)  1.538(2) 
C(1)-C(10)  1.539(2) 
C(1)-C(11)  1.539(2) 
C(1)-C(13)  1.5733(19) 
C(2)-C(3)  1.492(2) 
C(3)-C(4)  1.409(2) 
C(3)-C(8)  1.406(2) 
C(4)-H(4)  0.967(17) 
C(4)-C(5)  1.380(2) 
C(5)-H(5)  0.950(19) 
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C(5)-C(6)  1.394(2) 
C(6)-H(6)  0.958(18) 
C(6)-C(7)  1.385(2) 
C(7)-H(7)  0.963(16) 
C(7)-C(8)  1.405(2) 
C(8)-C(9)  1.505(2) 
C(9)-H(9A)  0.942(17) 
C(9)-H(9B)  1.013(17) 
C(9)-C(10)  1.527(2) 
C(10)-H(10A)  0.977(17) 
C(10)-H(10B)  0.966(18) 
C(12)-H(12A)  0.96(2) 
C(12)-H(12B)  1.03(2) 
C(12)-H(12C)  1.02(2) 
C(13)-H(13)  0.996(18) 
C(13)-C(14)  1.511(2) 
C(13)-C(18)  1.511(2) 
C(14)-C(17)  1.418(11) 
C(14)-C(17A)  1.391(12) 
C(15)-H(15)  0.90(3) 
C(15)-C(16)  1.334(3) 
C(15)-C(17A)  1.517(15) 
C(16)-H(16)  0.98(3) 
C(16)-C(17)  1.476(12) 
C(17)-H(17)  1.04(4) 
C(17A)-H(17A)  0.97(5) 
C(18)-H(18)  0.950(18) 
C(18)-C(19)  1.319(2) 
C(19)-H(19A)  0.97(2) 
C(19)-H(19B)  1.01(2) 
 
C(15)-S(1)-C(14) 94.87(18) 
C(16)-S(1A)-C(14) 95.02(18) 
C(11)-O(3)-C(12) 114.07(12) 
C(2)-C(1)-C(10) 108.86(12) 
C(2)-C(1)-C(11) 108.20(11) 
C(2)-C(1)-C(13) 111.27(11) 
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C(10)-C(1)-C(13) 112.89(12) 
C(11)-C(1)-C(10) 110.12(12) 
C(11)-C(1)-C(13) 105.36(11) 
O(1)-C(2)-C(1) 121.30(13) 
O(1)-C(2)-C(3) 121.79(13) 
C(3)-C(2)-C(1) 116.91(12) 
C(4)-C(3)-C(2) 118.41(13) 
C(8)-C(3)-C(2) 121.60(13) 
C(8)-C(3)-C(4) 119.98(13) 
C(3)-C(4)-H(4) 118.7(10) 
C(5)-C(4)-C(3) 120.59(14) 
C(5)-C(4)-H(4) 120.7(10) 
C(4)-C(5)-H(5) 120.4(11) 
C(4)-C(5)-C(6) 119.70(15) 
C(6)-C(5)-H(5) 119.9(11) 
C(5)-C(6)-H(6) 119.0(11) 
C(7)-C(6)-C(5) 120.27(15) 
C(7)-C(6)-H(6) 120.7(11) 
C(6)-C(7)-H(7) 121.4(10) 
C(6)-C(7)-C(8) 121.19(15) 
C(8)-C(7)-H(7) 117.4(10) 
C(3)-C(8)-C(9) 121.84(13) 
C(7)-C(8)-C(3) 118.25(13) 
C(7)-C(8)-C(9) 119.90(13) 
C(8)-C(9)-H(9A) 108.3(10) 
C(8)-C(9)-H(9B) 109.8(10) 
C(8)-C(9)-C(10) 112.49(12) 
H(9A)-C(9)-H(9B) 104.7(14) 
C(10)-C(9)-H(9A) 108.8(10) 
C(10)-C(9)-H(9B) 112.4(9) 
C(1)-C(10)-H(10A) 107.6(10) 
C(1)-C(10)-H(10B) 109.6(10) 
C(9)-C(10)-C(1) 113.53(12) 
C(9)-C(10)-H(10A) 109.2(10) 
C(9)-C(10)-H(10B) 109.8(10) 
H(10A)-C(10)-H(10B) 106.8(14) 
O(2)-C(11)-O(3) 123.43(13) 
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O(2)-C(11)-C(1) 124.93(13) 
O(3)-C(11)-C(1) 111.60(12) 
O(3)-C(12)-H(12A) 113.2(14) 
O(3)-C(12)-H(12B) 106.2(11) 
O(3)-C(12)-H(12C) 110.2(11) 
H(12A)-C(12)-H(12B) 109.9(18) 
H(12A)-C(12)-H(12C) 106.8(18) 
H(12B)-C(12)-H(12C) 110.5(16) 
C(1)-C(13)-H(13) 106.6(10) 
C(14)-C(13)-C(1) 114.33(12) 
C(14)-C(13)-H(13) 107.1(10) 
C(18)-C(13)-C(1) 110.12(12) 
C(18)-C(13)-H(13) 108.2(10) 
C(18)-C(13)-C(14) 110.28(13) 
C(13)-C(14)-S(1) 121.21(15) 
C(13)-C(14)-S(1A) 124.16(14) 
C(17)-C(14)-S(1) 107.6(5) 
C(17)-C(14)-C(13) 131.0(5) 
C(17A)-C(14)-S(1A) 108.4(6) 
C(17A)-C(14)-C(13) 127.1(6) 
S(1)-C(15)-H(15) 120.9(19) 
C(16)-C(15)-S(1) 117.68(19) 
C(16)-C(15)-H(15) 121.4(19) 
C(16)-C(15)-C(17A) 106.1(5) 
C(17A)-C(15)-H(15) 132(2) 
S(1A)-C(16)-H(16) 113.9(17) 
C(15)-C(16)-S(1A) 118.07(19) 
C(15)-C(16)-H(16) 128.0(17) 
C(15)-C(16)-C(17) 106.8(5) 
C(17)-C(16)-H(16) 125.0(17) 
C(14)-C(17)-C(16) 112.8(8) 
C(14)-C(17)-H(17) 116(2) 
C(16)-C(17)-H(17) 131(2) 
C(14)-C(17A)-C(15) 112.1(9) 
C(14)-C(17A)-H(17A) 124(3) 
C(15)-C(17A)-H(17A) 124(3) 
C(13)-C(18)-H(18) 118.4(11) 
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C(19)-C(18)-C(13) 125.07(16) 
C(19)-C(18)-H(18) 116.5(11) 
C(18)-C(19)-H(19A) 121.1(14) 
C(18)-C(19)-H(19B) 119.8(11) 
H(19A)-C(19)-H(19B) 119.1(17) 
 _______________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
 Table A4.4.  Anisotropic displacement parameters  (Å2x 104 ) for 100f.  The anisotropic displacement 
factor exponent takes the form: -2p2 [ h2 a*2U 11  + ... + 2 h k a* b* U12 ] 
_______________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
_______________________________________________________________________ 
S(1) 360(9)  243(10) 173(5)  5(6) -83(5)  58(8) 
S(1A) 335(10)  229(6) 231(7)  93(6) -46(6)  -2(6) 
O(1) 198(5)  189(5) 197(5)  -39(4) -40(4)  -28(4) 
O(2) 242(6)  202(5) 213(5)  -7(4) -87(5)  5(4) 
O(3) 220(6)  136(5) 253(6)  36(4) -82(5)  -16(4) 
C(1) 145(6)  132(6) 130(6)  -2(5) -6(5)  -11(5) 
C(2) 168(7)  127(6) 140(6)  26(5) -27(5)  -4(5) 
C(3) 151(6)  139(6) 138(6)  19(5) -17(5)  -6(5) 
C(4) 166(7)  188(7) 188(7)  24(5) -23(6)  -20(6) 
C(5) 160(7)  267(8) 204(7)  46(6) -2(6)  -6(6) 
C(6) 232(8)  258(8) 146(7)  24(6) 23(6)  39(6) 
C(7) 223(8)  188(7) 143(6)  4(5) -6(6)  3(6) 
C(8) 168(7)  131(6) 136(6)  23(5) -18(5)  4(5) 
C(9) 185(7)  142(6) 153(6)  -24(5) -2(5)  -32(5) 
C(10) 191(7)  139(7) 170(7)  -10(5) 10(5)  -36(5) 
C(11) 149(7)  150(6) 157(6)  4(5) 14(5)  -6(5) 
C(12) 330(10)  151(7) 333(9)  58(7) -107(8)  5(7) 
C(13) 197(7)  140(6) 136(6)  -6(5) -7(5)  4(5) 
C(14) 215(7)  198(7) 152(7)  4(5) 7(6)  34(6) 
C(15) 537(14)  571(14) 214(9)  -26(9) -113(9)  224(12) 
C(16) 451(13)  329(11) 469(12)  186(9) 150(10)  127(10) 
C(17) 480(60)  540(60) 500(50)  -210(40) -180(40)  20(40) 
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C(17A) 510(50)  330(50) 510(70)  90(40) 70(50)  -90(40) 
C(18) 185(7)  194(7) 163(7)  6(6) 6(6)  -3(6) 
C(19) 262(9)  251(9) 244(8)  -56(7) -34(7)  49(7) 
 
 
Table A4.5. Hydrogen coordinates ( x 103) and isotropic  displacement parameters (Å2x 103) for 100f. 
_______________________________________________________________________ 
 x  y  z  Uiso 
_______________________________________________________________________  
H(4) 1318(2) 350(2) 689(1) 11(4) 
H(5) 1457(2) 265(2) 587(1) 23(5) 
H(6) 1331(2) 131(2) 503(1) 18(4) 
H(7) 1063(2) 79(1) 522(1) 12(4) 
H(9A) 852(2) 62(2) 620(1) 14(4) 
H(9B) 793(2) 185(2) 586(1) 14(4) 
H(10A) 846(2) 122(2) 743(1) 14(4) 
H(10B) 687(2) 168(2) 708(1) 17(4) 
H(12A) 766(3) 608(2) 594(1) 44(6) 
H(12B) 784(2) 697(2) 667(1) 32(5) 
H(12C) 624(3) 608(2) 652(1) 32(5) 
H(13) 815(2) 426(2) 825(1) 17(4) 
H(15) 1003(3) 165(3) 1030(2) 72(8) 
H(16) 827(3) 7(3) 985(2) 80(9) 
H(17) 689(4) 98(3) 857(2) 10(8) 
H(17A) 1003(5) 352(4) 932(2) 9(11) 
H(18) 539(2) 277(2) 799(1) 20(4) 
H(19A) 564(3) 531(2) 828(1) 40(6) 
H(19B) 394(2) 448(2) 818(1) 27(5) 
_______________________________________________________________________  
 
Table A4.6.  Hydrogen bonds for 100f  [Å and °]. 
 ______________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
_______________________________________________________________________   
 C(12)-H(12B)...O(1)#1 1.03(2) 2.52(2) 3.539(2) 173.4(16) 
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Symmetry transformations used to generate equivalent atoms:  
#1 -x+2,y+1/2,-z+3/2       
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CHAPTER 4 
Enantio-, Diastereo- and Regioselective Iridium-Catalyzed Asymmetric 
Allylic Alkylation of Acyclic β-Ketoesters1 
 
4.1 INTRODUCTION  
4.1.1 State of the art in the asymmetric construction of vicinal quaternary and 
tertiary carbon centers 
As outlined in Chapter 3 (vide supra), the generation of enantioenriched all-
carbon quaternary centers is complicated by the presence of vicinal tertiary stereocenters 
due to increased steric demands and the introduction of requisite diastereocontrol.  
Modern strategies for accessing these highly-congested stereochemical dyads have relied 
primarily on transition-metal catalysis, notably Pd-catalyzed enolate alkylation 
cascades,30 Pd-catalyzed trimethylenemethane cycloadditions,73b,e Cu-catalyzed 
asymmetric Claisen rearrangements,73f and Mo-73c,d and Ir-catalyzed83 allylic alkylations.  
Common to the majority of these reports is the constraint that the nascent quaternary 
center be formed at a cyclic nucleophile.  At the outset of our studies in this area, only 
two groups had reported success in employing linear nucleophiles to produce vicinal 
 
1 This work was performed in collaboration with Wen-Bo Lui, postdoctoral researcher in the Stoltz group. This 
work has been published. See: Liu, W. -B.; Reeves, C. M.; Stoltz, B. M. J. Am. Chem. Soc. 2013, 135, 17298.  
. 
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quaternary/tertiary arrays.  Namely, Trost’s communication on the molybdenum-
catalyzed allylic alkylation of β-cyanoesters73d and Carreira’s recent report on the allylic 
alkylation of aldehydes using stereodivergent dual catalysis.83  To address these 
limitations, we initiated studies investigating the asymmetric allylic alkylation of linear 
β-ketoesters.   
As described above, we have shown iridium-N-arylphosphoramidite catalysis87 to 
be a powerful tool for accessing vicinal all-carbon quaternary and tertiary stereocenters. 
The success of our protocol for the regio-, diastereo- and enantioselective asymmetric 
allylic alkylation of cyclic β-ketoesters (Figure 4.1.1.1A)82, 88, 97 combined with the virtual 
absence of reports describing the application of this transformation to acyclic β-
ketoesters encouraged our further exploration of iridium catalysts in the domain of this 
important substrate class. In this chapter, we detail the development of the first highly 
regio-, diastereo- and enantioselective allylic alkylation of acyclic β-ketoesters to forge 
vicinal tertiary, quaternary centers (Figure 4.1.1.1B).   
 
Figure 4.1.1.1.  Representative Ir-catalyzed asymmetric allylic alkylation 
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4.2 DEVELOPMENT AND OPTIMIZATION OF AN IRIDIUM-CATALYZED 
ALLYLIC ALKYLATION OF LINEAR β-KETOESTERS 
Our initial investigations in the domain of Ir-catalyzed allylic alkylation of linear 
β-ketoesters focused on identifying conditions that would afford both reaction efficiency 
and selectivity.  We chose ethyl 2-methyl-3-oxo-3-phenylpropanoate (111a) and 
cinnamyl carbonate (98a) as standard coupling partners, and investigated several 
iridacycle complexes84 at the outset of our studies.  The result of these studies are shown 
in Table 4.2.1 (entries 1–6).  We found that exposure of standard coupling components 
(111a) and (98a) to a combination of catalytic phosphoramidite ligand L10•[Ir(cod)Cl]2 
complex86 and two equivalents of  NaH in THF at ambient temperature afforded the 
desired product with good conversion, ee and regioselectivity, but low levels of 
diastereoselectivity (1:2) (entry 1).  Use of either L11 or L16 under these conditions 
favored instead the reaction pathway yielding the undesired, linear allylic alkylation 
product (113a) in only modest conversion (entries 2 and 4).  Ligands L13 and L1787,98 
gave the desired branched product in good conversion but with diminished 
diastereoselectivity and enantioselectivity and protracted reaction times (entries 5 and 6).  
We were pleased to find that tetrahydroquinoline based ligand L1287 rapidly furnished the 
desired α-quaternary β-ketoester (112a) in greater than 95% conversion, 95:5 
regioselectivity, 13:1 dr and 99% enantiomeric excess (entry 3).  Previous reports 
demonstrating the marked effect of metal cations over regio-99 and diastereoselectivity100 
in iridium-catalyzed allylic alkylations prompted further investigation of both bases and 
additives (entries 7–15).  Contrary to our previous findings (vide infra, Chapter 3), a 
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sluggish reaction was observed when LiBr was used in place of NaH (entry 7), 
presumably due to the decreased α-acidity of acyclic β-ketoesters relative to cyclic 
substrates.  While amine and organic bases did not perform well in the chemistry, the use 
of alkoxide bases resulted in considerably reduced reaction times (entries 8–9).  
Ultimately, it was found that the use of LiOt-Bu as base was optimal, delivering β-
ketoester 112a with an exceptional branched to linear ratio (93:7), >20:1 
diastereoselectivity, and 98% enantioselectivity in only two hours (entry 8). 
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Table 4.2.1.  Optimization of the Ir-catalyzed asymmetric allylic alkylationa     
 
 
a Reactions performed with 0.1 mmol of 98a, 0.2 mmol of 111a at 0.1 M in THF at 20 °C.  b 
Determined by 1H NMR and UHPLC-MS analysis of the crude mixture.  c Determined by chiral SFC 
analysis; parenthetical value is the ee of the alternate diastereomer.  d Not determined. 
 
4.3 EXPLORATION OF THE REACTION SCOPE AND SUBSTITUENT EFFECTS 
4.3.1 Exploration of the iridium-catalyzed allylic alkylation of linear β-ketoesters 
with respect to allyl electrophile 
With optimized conditions identified, the scope of the reaction with respect to the 
electrophile was next explored.  A highly selective reaction was observed between β-
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ketoester 111a and various cinnamyl carbonate-derived electrophiles (98) bearing 
electron-donating substitutents about the aryl group, R (Table 4.3.1.1, entries 2–4).  4-
Me- (98i), 4-MeO- (98b), and 3-MeO-substitutions (98j) about the aryl ring gave the 
corresponding α-quaternary β-ketoesters (products 112b-112d) in good to excellent 
yield, dr, ee and branched to linear ratio (Table 4.3.1.1).  Electron deficient aryl 
substituents at the allyl group (entries 5–7) were also well tolerated, delivering the 
branched products 112e–112g101 in good to excellent yield, outstanding ee and dr, and 
with only slightly diminished regioselectivies.  Interestingly, (4-nitro)-aryl substitution at 
the allyl carbonate (entry 8, substrate 98l) led to loss of regioselectivity in the reaction, 
giving equal amounts of products 112h (14:1 dr, 93% ee) and 113h (23% ee).  We were 
pleased to discover, however, that heteroaryl-substituted allyl carbonates (substrates 98j 
and 98g) resulted in smooth reactions and delivered the alkylated products 112i and 112j 
with excellent yield, ee and regioselectivity and with good to excellent dr (entries 9–10).  
Finally, we found that sorbyl carbonate 98h was also a suitable participant in the reaction, 
giving the corresponding β-ketoester product (112k) in good yield and dr and with 
excellent regio- and enantioselectivities (entry 11).    
 
 
 
 
 
Chapter 4 – Enantio-, Diastereo- and Regioselective Iridium-Catalyzed Asymmetric Allylic 
Alkylation of Acyclic β-Ketoesters 
 
 
336 
Table 4.3.1.1.  Exploration of the reaction scope with respect to allyl electrophilea    
 
 
a Reactions performed under the conditions of Table 1, entry 8.  b Combined isolated yield of 112 
and 113.  c Determined by 1H NMR analysis of the crude mixture.  d Determined by chiral SFC 
analysis of the major diastereomer.  e Conditions of  Table 1, entry 7.   f 23% ee for the linear 
product.  
 
4.3.2 Investigation of allyl electrophile substituent effects on reaction selectivity 
During the course of this investigation, a trend relating regioselectivity and 
electrophile electron deficiency began to emerge.  Specifically, the regioselectivity of the 
reaction diminished as the electron deficiency of the allyl substituent increased.  In order 
to identify the linear free energy relationship governing the reaction, we performed a 
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Hammett analysis relating the log of the ratio of branched to linear products, which is 
proportional to the relative rates of product formation, to the corresponding Hammett σ-
values.  The negative ρ value observed from this plot suggests that as the magnitude of 
electropositive charge generated at the putative allyl-Ir intermediate8b increases, the 
reaction pathway yielding the branched allylation product becomes more favorable.  This 
analysis can be extended to account, in part, for the poor regioselectivity observed in the 
case of p-nitro substituted allyl component 98. 
 
Figure 4.3.2.1. Hammett plot of the log of product ratios (112:113) from Table 2 versus Hammett 
σ-values 
 
 
4.3.3 Exploration of the iridium-catalyzed allylic alkylation of linear β-ketoesters 
with respect to β-ketoester nucleophile 
Having investigated reaction substrate scope with respect to the allyl electrophile, 
we next examined the diversity of nucleophilic coupling partners permitted in the 
chemistry (Table 4.3.3.1).  β-Ketoesters (111) bearing either electron-donating or 
electron-withdrawing aryl substituents (R1) at the ketone fared very well in the reaction, 
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delivering products 112l and 112m in excellent yield, dr, ee and branched to linear ratio 
(entries 1 and 2).  Gratifyingly, a wide variety of functional groups are readily permitted 
at the α-position (R2), including alkyl, benzyl, allyl, propargyl, heteroaryl and keto 
groups (substrates 111d–111i, entries 3–8, respectively).  The products of these reactions 
(products 112n–112s, respectively) were obtained with excellent ee and 
regioselectivities, and in good to excellent dr and yield.  To the best of our knowledge, 
substrate 111g represents the first example of a terminal propargyl-substituted 
nucleophile to undergo Ir-catalyzed allylic substitutions. 102   Nitrile-containing 
substituents were tolerated in the reaction as well (substrate 111j), and α-quaternary β-
ketoester 112t was furnished in excellent yield, ee and regioselectivity, albeit with a 
diminished dr of 3:1.  We were pleased to learn that use of certain of α-halogenated 
nucleophiles (substrates 111k and 111l) also resulted in an efficient and selective reaction 
as α-fluoro and α-chloro β-ketoesters 112u and 112v were obtained in excellent yields, 
dr, ee and regioselectivity.  In addition to aryl ketones, cyclohexenyl β-ketoester 111m 
was found to deliver the corresponding product 112w in excellent yield, dr, ee and 
branched to linear ratio with no detectable products resulting from competitive 
bimolecular Michael addition.  Although the use of alkyl β-ketoesters 111n and 111o 
provided the desired products (112x and 112y, respectively) with excellent yields, ee’s 
and regioselectivities, we were disappointed to find that the diastereoselectivities were 
diminished considerably.  Lastly, we found that the use of a sterically-hindered ester 
moiety  (substrate 111p) gave an efficient and highly enantioselective reaction but with a 
concurrent loss in regio- and diastereoselectivity (entry 15).  
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Table 4.3.3.1.  Exploration of the reaction scope with respect to β-ketoester nucleophilea  
 
 
a Reactions performed under the conditions of Table 1, entry 8.  b Combined isolated yield of 112 
and 113.  c Determined by 1H NMR analysis of the crude mixture.  d Determined by chiral SFC 
analysis of the major diastereomer.  e 4 mol % of [Ir(cod)Cl]2 and 8 mol % of L12 were used.  
f The 
reaction was run at 0.5 mmol scale.  g ee for the minor diastereomer.  
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products obtained in the course of our studies (Scheme 4.4.1).  Aldol condensation of β-
ketoester 112r gave γ-quaternary cyclohexenone 114 in excellent yield.  Ring-closing 
metathesis of diallyl β-ketoester 112p cleanly furnished cyclohexene 115 in excellent 
yield.  Finally, Pauson–Khand cyclization of progaryl-substituted β-ketoester 112q 
smoothly delivered bicycle 116 in outstanding 99% yield.  
 
Scheme 4.4.1.  Rapid generation of molecular and stereochemical complexity employing allylic 
alkylation products 
 
 
 
4.5 CONCLUDING REMARKS 
In summary, the first enantioselective catalytic allylic alkylation of linear β-
ketoesters to generate vicinal quaternary and tertiary stereocenters in high yield, dr, ee 
and regioselectivity has been developed.  The process hinges on the use of an Ir•N-aryl-
phosphoramidite catalyst (L12).  A variety of substitution patterns at the allyl electrophile 
and β-ketoester are well tolerated in the chemistry.  A number of transformations were 
carried out on reaction products to demonstrate the value this method holds for the rapid 
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generation of highly functionalized chiral building blocks.  Studies utilizing this method 
toward the synthesis of complex biologically active natural products are underway in our 
laboratory and will serve to showcase the utility of the method in synthetic setting.  
Moreover, studies to extend the scope of functionality tolerated about the electrophile in 
the chemistry, in particular non-aromatic substituents, should greatly expand the potential 
applications of this method to total synthesis.     
 
4.6 EXPERIMENTAL SECTION 
4.6.1 Materials and Methods 
Unless otherwise stated, reactions were performed in flame-dried glassware under 
an argon or nitrogen atmosphere using dry, deoxygenated solvents.  Solvents were dried 
by passage through an activated alumina column under argon.61 Reaction progress was 
monitored by thin-layer chromatography (TLC) or Agilent 1290 UHPLC-MS.  TLC was 
performed using E. Merck silica gel 60 F254 precoated glass plates (0.25 mm) and 
visualized by UV fluorescence quenching, p-anisaldehyde, or KMnO4 staining.  Silicycle 
SiliaFlash® P60 Academic Silica gel (particle size 40–63 nm) was used for flash 
chromatography.  1H NMR spectra were recorded on Varian Inova 500 MHz and 600 
MHz spectrometers and are reported relative to residual CHCl3 (δ 7.26 ppm) or C6HD5 (δ 
7.16 ppm).  13C NMR spectra were recorded on a Varian Inova 500 MHz spectrometer 
(125 MHz) and are reported relative to CHCl3 (δ 77.16 ppm) or C6HD5 (δ 128.06 ppm). 
31P and 19F NMR spectra were recorded on a Varian Mercury 300 MHz (at 121 MHz and 
282 MHz, respectively).  19F NMR spectra were reported relative to CFCl3 (δ 0.0 ppm). 
31P NMR spectra were reported relative to external H3PO4 (δ 0.0 ppm).  Data for 1H NMR 
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are reported as follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), 
integration).  Multiplicities are reported as follows: s = singlet, d = doublet, t = triplet, q = 
quartet, p = pentet, sept = septuplet, m = multiplet, br s = broad singlet, br d = broad 
doublet, app = apparent.  Data for 13C NMR are reported in terms of chemical shifts 
(δ ppm).  IR spectra were obtained by use of a Perkin Elmer Spectrum BXII spectrometer 
or Nicolet 6700 FTIR spectrometer using thin films deposited on NaCl plates and 
reported in frequency of absorption (cm-1).  Optical rotations were measured with a Jasco 
P-2000 polarimeter operating on the sodium D-line (589 nm), using a 100 mm path-
length cell and are reported as: [a]DT (concentration in g/100 mL, solvent).  Analytical 
HPLC was performed with an Agilent 1100 Series HPLC utilizing a Chiralpak (AD-H or 
AS) or Chiralcel (OD-H, OJ-H, or OB-H) columns (4.6 mm x 25 cm) obtained from 
Daicel Chemical Industries, Ltd.  Analytical SFC was performed with a Mettler SFC 
supercritical CO2 analytical chromatography system utilizing Chiralpak (AD-H, AS-H or 
IC) or Chiralcel (OD-H, OJ-H, or OB-H) columns (4.6 mm x 25 cm) obtained from 
Daicel Chemical Industries, Ltd.  High resolution mass spectra (HRMS) were obtained 
from Agilent 6200 Series TOF with an Agilent G1978A Multimode source in 
electrospray ionization (ESI+), atmospheric pressure chemical ionization (APCI+), or 
mixed ionization mode (MM: ESI-APCI+). 
Reagents were purchased from Sigma-Aldrich, Acros Organics, Strem, or Alfa 
Aesar and used as received unless otherwise stated.  Ligands L12, L13, L16 and L1787 
allyl carbonates 98,95 and β-ketoesters 111103 were prepared by known methods.   
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4.6.2  Optimization of reaction parameters 
Table 4.6.2.1 Optimization of reaction parameters 
 
  
a  Reactions performed with 0.1 mmol of 98a, 0.2 mmol of 111a in 1 mL of THF.  b  Determined 
by 1H NMR or UHPLC-MS analysis of the crude reaction mixture.  c Isolated yield.  d (ee) of the 
alternative diastereomer. 
General Procedure for Optimization Reaction (Table 4.6.2.1): All experiments were 
performed in a nitrogen-filled glove box.  
 Procedure A (for entries 1-9): [Ir(cod)Cl]2 (1.4 mg, 0.002 mmol, 2 mol%), ligand 
L (0.004 mmol, 4 mol%), and TBD (1.4 mg, 0.01 mmol, 10 mol%) were added to a 2 
dram scintillation vial (vial A) equipped with a magnetic stirring bar.  The vial was then 
charged with THF (0.5 mL) and stirred at 25 °C for 10 min, generating an orange 
solution.  To another 2 dram scintillation vial (vial B) was added base (0.2 mmol, 2 
equiv), 0.5 mL of THF and β-ketoester 111a (41.2 mg, 0.2 mmol, 2.0 equiv).  After 
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stirring for 10 min at 25 °C, the pre-formed catalyst solution (vial A) was transferred to 
vial B, and cinnamyl carbonate (98a) (19.2 mg, 0.1 mmol, 1.0 equiv) was added.  The 
vial was sealed and stirred at 25 °C until allylic carbonate 98a was fully consumed, as 
indicated by UHPLC-MS analysis.  Upon completion of the reaction the vial was 
removed from the glove-box and uncapped.  Saturated NH4Cl aqueous solution was 
added and the mixture was extracted with CH2Cl2 (10 mL x 3), the combined organic 
phase was washed with brine, dried over Mg2SO4, filtered and concentrated in vacuo.  
The regioselectivity (branched product to linear product, b:l) and diastereoselectivity (dr) 
were determined by 1H NMR. The residue was purified by silica gel flash 
chromatography (gradient elution, 0→1→2% EtOAc in hexanes) to afford the desired 
product.  
Procedure B (for entries 10-15): [Ir(cod)Cl]2 (1.4 mg, 0.002 mmol, 2 mol%), 
ligand L (0.004 mmol, 4 mol%), and TBD (1.4 mg, 0.01 mmol, 10 mol%) were added to 
a 2 dram scintillation vial equipped with a magnetic stirring bar.  The vial was then 
charged with THF (0.5 mL) and stirred at 25 °C for 10 min, generating an orange 
solution.  Cinnamyl carbonate (98a) (19.2 mg, 0.1 mmol, 1.0 equiv), β-ketoester 111a 
(41.2 mg, 0.2 mmol, 2.0 equiv), base (0.2 mmol, 2 equiv) or additive (0.1 mmol, 1.0 
equiv) and an additional 0.5 mL of THF were added.  The vial was sealed and stirred at 
25 °C until allylic carbonate 98a was fully consumed, as indicated by UHPLC-MS 
analysis.  Upon completion of the reaction the vial was removed from the glove-box and 
uncapped and THF evaporated under reduced pressure.  Et2O was added to the crude 
mixture and the resulting precipitate was filtered through a celite pad, rinsed with Et2O 
and the filtrate was concentrated under reduced pressure. The regioselectivity (branched 
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product to linear product: b:l) and diastereoselectivity (dr) were determined by 1H NMR.  
The residue was purified by silica gel flash chromatography (gradient elution, 0→1→2% 
EtOAc in hexanes) to afford the desired product. 
 
4.6.3. General procedure for the Ir-catalyzed asymmetric allylic alkylation of 
acyclic β-ketoesters 
Note that the absolute configuration was determined only for compound 112f via X-ray 
analysis of its derivative (vide infra).  The absolute configuration for all other products 3 
has been inferred by analogy.  Isolated yields are reported in Tables 2 and 3 (see 
manuscript).  For respective SFC conditions, please refer to Table 4.6.8.1. The relative 
configuration of product derivative 116 was determined by 2D NMR studies, see 
appendix A6 for details.  The relative configurations of all other products determined by 
anaolgy.  
 
 
 
      In a nitrogen-filled glove box, [Ir(cod)Cl]2 (1.4 mg, 0.002 mmol, 2 mol%), ligand 
L12 (1.8 mg, 0.004 mmol, 4 mol%), and TBD (1.4 mg, 0.01 mmol, 10 mol%) were 
added to a 2 dram scintillation vial equipped with a magnetic stirring bar.  The vial was 
then charged with THF (0.5 mL) and stirred at 25 °C for 10 min, generating an orange 
solution. To another 2 dram scintillation vial was added LiOt-Bu (16.0 mg, 0.2 mmol, 2 
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equiv) and 0.5 mL of THF, then β-ketoester 111a (41.2 mg, 0.2 mmol, 2.0 equiv) was 
added.  After stirring for 10 min, the above pre-formed catalyst solution was transferred 
to this vial, followed by cinnamyl carbonate (98a) (19.2 mg, 0.1 mmol, 1.0 equiv).  The 
vial was sealed and stirred at 25 °C until allylic carbonate 98a was fully consumed, as 
indicated by UHPLC-MS analysis.  Upon completion of the reaction the vial was 
removed from the glove-box and uncapped and saturated NH4Cl aqueous solution was 
added.  The mixture was extracted with CH2Cl2 (10 mL x 3), the combined organic layers 
washed with brine, dried over Mg2SO4, filtered and concentrated under reduced pressure.  
The regioselectivity (branched product to linear product: b:l = 93:7) and 
diastereoselectivity (dr >20:1) were determined by 1H NMR of the crude reaction 
mixture. The residue was purified by silica gel flash chromatography (gradient elution, 
0→1→2% EtOAc in hexanes) to afford product (31.2 mg, 97% yield) as a colorless oil. 
 
Ethyl-(2R,3S)-2-benzoyl-2-methyl-3-phenylpent-4-enoate (112a).  
Ketoester 112a was isolated by silica gel chromatography (gradient elution, 0→1→2% 
EtOAc in hexanes) as a colorless oil. >99% ee, [α]D25 +76.6 (c 0.77, CHCl3); Rf = 0.4 
(5% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.69–7.60 (m, 2H), 7.52–7.43 (m, 
1H), 7.38–7.33 (m, 2H), 7.26–7.15 (m, 5H), 6.35 (ddd, J = 17.0, 10.3, 8.3 Hz, 1H), 5.13 
(ddd, J = 10.2, 1.7, 0.9 Hz, 1H), 5.07 (ddd, J = 17.0, 1.8, 1.2 Hz, 1H), 4.39 (dd, J = 8.3, 
1.1 Hz, 1H), 4.09 (qd, J = 7.2, 0.6 Hz, 2H), 1.53 (s, 3H), 1.04 (t, J = 7.1 Hz, 3H); 13C 
NMR (126 MHz, CDCl3) δ 198.0, 173.0, 139.5, 137.8, 137.2, 132.3, 130.1, 128.4, 
128.20, 128.17, 127.1, 117.5, 61.8, 61.6, 54.8, 21.0, 13.8; IR (Neat Film, NaCl) 3062, 
3028, 2981, 2939, 2902, 1731, 1686, 1682, 1597, 1582, 1493, 1452, 1446, 1377, 1311, 
Chapter 4 – Enantio-, Diastereo- and Regioselective Iridium-Catalyzed Asymmetric Allylic 
Alkylation of Acyclic β-Ketoesters 
 
 
347 
1243, 1218, 1186, 1096, 1018, 1001, 962, 920, 860, 758 cm-1; HRMS (ESI+) m/z calc’d 
for C21H23O3 [M+H]+: 323.1642, found 323.1647; SFC conditions: 5% IPA, 2.5 mL/min, 
Chiralpak IC column, λ = 254 nm, tR (min): major = 4.12, minor = 6.14. 
 
4.6.4. Spectroscopic data for Ir-catalyzed allylic alkylation products 
 
Ethyl (2R,3S)-2-benzoyl-2-methyl-3-(p-tolyl)pent-4-enoate (112b). 
 
 
Ketoester 112b was isolated by silica gel chromatography (gradient elution, 0→1→2% 
EtOAc in hexanes) as a colorless oil.  99% ee, [α]D25 +80.4 (c 1.82, CHCl3); Rf = 0.4 (5% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.69–7.65 (m, 2H), 7.47 (ddt, J = 8.6, 
7.0, 1.3 Hz, 1H), 7.39–7.33 (m, 2H), 7.11–7.02 (m, 4H), 6.33 (ddd, J = 16.9, 10.2, 8.3 Hz, 
1H), 5.11 (ddd, J = 10.3, 1.8, 1.0 Hz, 1H), 5.07 (ddd, J = 17.0, 1.9, 1.2 Hz, 1H), 4.38 (dd, 
J = 8.3, 1.2 Hz, 1H), 4.09 (qd, J = 7.1, 2.6 Hz, 2H), 2.29 (s, 3H), 1.54 (s, 3H), 1.05 (t, J = 
7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 198.1, 173.0, 137.9, 137.2, 136.6, 136.4, 
132.3, 129.9, 128.9, 128.4, 128.2, 117.3, 61.8, 61.5, 54.3, 21.1, 20.9, 13.8;  IR (Neat Film, 
NaCl) 3058, 3023, 2981, 2938, 1736, 1732, 1682, 1687, 1636, 1597, 1580, 1513, 1446, 
1376, 1310, 1243, 1219, 1186, 1115, 1104, 1021, 1001, 963, 919, 820, 793 cm-1; HRMS 
(MM: ESI-APCI+) m/z calc’d for C22H25O3 [M+H]+:  337.1798, found 337.1805; SFC 
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conditions: 5% IPA, 2.5 mL/min, Chiralpak IC column, λ = 254 nm, tR (min): major = 
6.71, minor = 9.45. 
 
Ethyl (2R,3S)-2-benzoyl-3-(4-methoxyphenyl)-2-methylpent-4-enoate (112c). 
 
 
Ketoester 112c was isolated by silica gel chromatography (gradient elution, 2→5% 
EtOAc in hexanes) as a colorless oil.  >99% ee, [α]D25 +81.5 (c 2.02, CHCl3); Rf = 0.2 
(5% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.70–7.63 (m, 2H), 7.52–7.43 (m, 
1H), 7.38–7.32 (m, 2H), 7.15–7.08 (m, 2H), 6.85–6.74 (m, 2H), 6.32 (ddd, J = 17.0, 10.3, 
8.2 Hz, 1H), 5.11 (ddd, J = 10.3, 1.8, 1.0 Hz, 1H), 5.05 (ddd, J = 17.0, 1.8, 1.2 Hz, 1H), 
4.37 (d, J = 8.2 Hz, 1H), 4.09 (qd, J = 7.1, 0.9 Hz, 2H), 3.76 (s, 3H), 1.51 (s, 3H), 1.05 (t, 
J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 198.1, 173.0, 158.5, 138.0, 137.3, 132.3, 
131.4, 131.1, 128.4, 128.2, 117.2, 113.5, 61.9, 61.5, 55.3, 53.9, 20.8, 13.9;  IR (Neat Film, 
NaCl) 3067, 2981, 2937, 2904, 2835, 1731, 1686, 1682, 1610, 1597, 1581, 1511, 1446, 
1376, 1302, 1245, 1218, 1181, 1114, 1101, 1034, 963, 922, 830 cm-1; HRMS (ESI+) m/z 
calc’d for fragment C10H11O [M-C11H12O3+H]+: 147.0804, found 147.0808;  SFC 
conditions: 5% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 254 nm, tR (min): minor 
= 11.17, major = 12.67. 
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Ethyl (2R,3S)-2-benzoyl-3-(-methoxyphenyl)-2-methylpent-4-enoate (112d). 
 
 
Ketoester 112d was isolated by silica gel chromatography (gradient elution, 0→1→2% 
EtOAc in hexanes) as a colorless oil.  >99% ee, [α]D25 +85.1 (c 1.21, CHCl3); Rf = 0.3 
(5% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.70–7.63 (m, 2H), 7.52–7.43 (m, 
1H), 7.42–7.32 (m, 2H), 7.23–7.11 (m, 1H), 6.82–6.71 (m, 3H), 6.32 (ddd, J = 16.9, 10.3, 
8.3 Hz, 1H), 5.13 (ddd, J = 10.3, 1.8, 0.9 Hz, 1H), 5.09 (ddd, J = 17.0, 1.8, 1.2 Hz, 1H), 
4.37 (dt, J = 8.3, 1.1 Hz, 1H), 4.09 (qd, J = 7.2, 1.3 Hz, 2H), 3.74 (s, 3H), 1.53 (s, 3H), 
1.05 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 198.0, 172.9, 159.3, 141.0, 137.6, 
137.3, 132.3, 129.1, 128.4, 128.2, 122.4, 117.6, 116.0, 112.4, 61.8, 61.6, 55.2, 54.8, 21.0, 
13.8; IR (Neat Film, NaCl) 3078, 2982, 2940, 2835, 1731, 1683, 1598, 1583, 1488, 1454, 
1377, 1315, 1245, 1217, 1186, 1162, 1096, 1049, 1019, 1001, 963, 922, 861, 781 cm-1; 
HRMS (ESI+) m/z calc’d for C22H25O4 [M+H]+:  353.1747, found 353.1761; SFC 
conditions: 2% MeOH, 2.5 mL/min, Chiralpak IC column, λ = 254 nm, tR (min): major = 
12.24, minor = 13.50. 
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Ethyl (2R,3S)-2-benzoyl-3-(3-chlorophenyl)-2-methylpent-4-enoate (112e). 
 
 
Ketoester 112e was isolated by silica gel chromatography (gradient elution, 0→1→2% 
EtOAc in hexanes) as a colorless oil.  99% ee, [α]D25 +99.1 (c 1.13, CHCl3); Rf = 0.3 (5% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.70–7.63 (m, 2H), 7.48 (ddt, J = 7.8, 
6.9, 1.2 Hz, 1H), 7.41–7.33 (m, 2H), 7.22–7.19 (m, 1H), 7.19–7.14 (m, 2H), 7.14–7.08 
(m, 1H), 6.30 (ddd, J = 17.0, 10.2, 8.4 Hz, 1H), 5.15 (ddd, J = 10.3, 1.6, 0.9 Hz, 1H), 
5.07 (dt, J = 17.0, 1.4 Hz, 1H), 4.34 (d, J = 8.4 Hz, 1H), 4.10 (q, J = 7.2 Hz, 2H), 1.52 (s, 
3H), 1.06 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 197.6, 172.6, 141.7, 137.0, 
136.9, 133.9, 132.5, 130.3, 129.3, 128.5, 128.4, 128.3, 127.2, 118.1, 61.7, 61.7, 54.5, 20.9, 
13.8;  IR (Neat Film, NaCl) 3068, 2982, 2943, 1732, 1682, 1595, 1574, 1475, 1446, 1378, 
1301, 1245, 1218, 1194, 1095, 1018, 1001, 963, 924, 784 cm-1; HRMS (MM: ESI-APCI+) 
m/z calc’d for C21H22ClO3 [M+H]+: 357.1252, found 357.1260; SFC conditions: 10% IPA, 
4.0 mL/min, Chiralpak IC column, λ = 254 nm, tR (min): major = 1.59, minor = 1.77. 
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 Ethyl (2R,3S)-2-benzoyl-3-(4-bromophenyl)-2-methylpent-4-enoate (112f). 
 
 
Ketoester 112f was isolated by silica gel chromatography (gradient elution, 0→1→2% 
EtOAc in hexanes) as a colorless oil.  >99% ee, [α]D25 +89.0 (c 1.42, CHCl3); Rf = 0.3 
(5% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.70–7.63 (m, 2H), 7.50–7.45 (m, 
1H), 7.40–7.33 (m, 4H), 7.13–7.08 (m, 2H), 6.29 (ddd, J = 16.9, 10.2, 8.2 Hz, 1H), 5.16–
5.11 (m, 1H), 5.05 (dt, J = 17.0, 1.4 Hz, 1H), 4.36 (d, J = 8.2 Hz, 1H), 4.08 (q, J = 7.1 Hz, 
2H), 1.51 (s, 3H), 1.05 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 197.6, 172.7, 
138.6, 137.2, 136.9, 132.5, 131.9, 131.2, 128.5, 128.3, 121.1, 117.9, 61.7, 61.6, 54.1, 20.8, 
13.8;  IR (Neat Film, NaCl) 3077, 2981, 2938, 1728, 1683, 1597, 1488, 1446, 1377, 1305, 
1243, 1217, 1186, 1099, 1076, 1010, 963, 922, 822, 802, 716 cm-1; HRMS (MM: ESI-
APCI+) m/z calc’d for C21H22BrO3 [M+H]+:  401.0747, found 401.0754; SFC conditions: 
10% IPA, 4.0 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 2.95, 
major = 3.47. 
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Ethyl (2R,3S)-2-benzoyl-2-methyl-3-(4-(trifluoromethyl)phenyl)pent-4-enoate (112g). 
 
 
Ketoester 112g was isolated by silica gel chromatography (gradient elution, 0→1→2% 
EtOAc in hexanes) as a colorless oil.  >99% ee, [α]D25 +77.4 (c 0.94, CHCl3); Rf = 0.3 
(5% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.69–7.63 (m, 2H), 7.53–7.45 (m, 
3H), 7.39–7.35 (m, 4H), 6.33 (ddd, J = 16.9, 10.2, 8.4 Hz, 1H), 5.16 (ddd, J = 10.2, 1.6, 
0.9 Hz, 1H), 5.07 (dt, J = 17.0, 1.4 Hz, 1H), 4.44 (d, J = 8.4 Hz, 1H), 4.09 (q, J = 7.1 Hz, 
2H), 1.53 (s, 3H), 1.04 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 197.5, 172.6, 
143.9, 136.9, 136.8, 132.6, 130.6, 129.2 (q, J = 32.4 Hz), 128.5, 128.3, 125.0 (q, J = 3.7 
Hz), 124.3 (d, J = 271.8 Hz), 118.3, 61.8, 61.6, 54.6, 20.8, 13.8;  IR (Neat Film, NaCl) 
3070, 2984, 2941, 1732, 1687, 1682, 1617, 1597, 1581, 1446, 1413, 1379, 1327, 1245, 
1220, 1166, 1123, 1069, 1018, 964, 924, 846 cm-1; HRMS (ESI+) m/z calc’d for 
C22H22F3O3 [M+H]+: 391.1516, found 391.1517;  SFC conditions: 2% IPA, 2.5 mL/min, 
Chiralpak AD-H column, λ = 254 nm, tR (min): minor = 5.20, major = 6.68. 
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Ethyl (2R,3S)-2-benzoyl-2-methyl-3-(4-nitrophenyl)pent-4-enoate (112h). 
 
 
Ketoester 112h was isolated by silica gel chromatography (5% EtOAc in hexanes) as a 
colorless oil.  93% ee, [α]D25 +96.8 (c 0.64, CHCl3); Rf = 0.3 (10% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3) δ 8.13–8.09 (m, 2H), 7.70–7.63 (m, 2H), 7.52–7.48 (m, 1H), 
7.46–7.43 (m, 2H), 7.40–7.35 (m, 2H), 6.31 (ddd, J = 16.9, 10.2, 8.5 Hz, 1H), 5.23–5.16 
(m, 1H), 5.08 (dt, J = 17.0, 1.3 Hz, 1H), 4.50 (d, J = 8.5 Hz, 1H), 4.10 (qd, J = 7.1, 2.4 
Hz, 2H), 1.54 (s, 3H), 1.05 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 197.0, 
172.3, 147.4, 146.8, 136.3, 136.1, 132.6, 131.0, 128.4, 128.2, 123.1, 118.8, 61.8, 61.4, 
54.3, 20.5, 13.7;  IR (Neat Film, NaCl) 3080, 2982, 2942, 1731, 1686, 1682, 1597, 1523, 
1519, 1446, 1379, 1346, 1245, 1219, 1111, 1001, 1015, 964, 926, 853 cm-1; HRMS (MM: 
ESI-APCI+) m/z calc’d for C21H22O5N [M+H]+: 368.1492, found 368.1508;  SFC 
conditions: 5% MeOH, 3.0 mL/min, Chiralpak AD-H column, λ = 254 nm, tR (min): 
minor = 4.47, major = 5.71.  
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Ethyl (E)-2-benzoyl-2-methyl-5-(4-nitrophenyl)pent-4-enoate (113h). 
 
 
Ketoester 113h was isolated by silica gel chromatography (5% EtOAc in hexanes) as a 
yellow solid.  23% ee, [α]D25 +4.7 (c 0.96, CHCl3); Rf = 0.3 (10% EtOAc in hexanes); 1H 
NMR (500 MHz, CDCl3) δ 8.15 (dt, J = 9.0, 2.5 Hz, 2H), 7.86 (dt, J = 8.5, 2.0 Hz, 2H), 
7.59–7.49 (m, 1H), 7.47–7.40 (m, 4H), 6.45 (dt, J = 15.9, 1.2 Hz, 1H), 6.32 (dt, J = 15.7, 
7.5 Hz, 1H), 4.12 (qd, J = 7.2, 1.1 Hz, 2H), 3.00 (ddd, J = 14.2, 7.3, 1.3 Hz, 1H), 2.90 
(ddd, J = 14.2, 7.7, 1.2 Hz, 1H), 1.58 (s, 3H), 1.05 (t, J = 7.1 Hz, 3H); 13C NMR (126 
MHz, CDCl3) δ 197.0, 173.6, 146.9, 143.6, 135.4, 133.1, 132.1, 130.0, 128.7, 126.8, 
124.1, 61.7, 57.3, 40.6, 21.6, 14.0;  IR (Neat Film, NaCl) 2981, 2936, 1732, 1686, 1682, 
1596, 1519, 1515, 1446, 1342, 1298, 1267, 1239, 1184, 1108, 973, 857 cm-1; HRMS 
(MM: ESI-APCI+) m/z calc’d for C21H22O5N [M+H]+: 368.1492, found 368.1499;  SFC 
conditions: 10% MeOH, 3.0 mL/min, Chiralpak AD-H column, λ = 254 nm, tR (min): 
major = 7.13, minor = 8.06.  
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Ethyl (2R,3R)-2-benzoyl-2-methyl-3-(thiophen-2-yl)pent-4-enoate (112i). 
 
 
Ketoester 112i was isolated by silica gel chromatography (gradient elution, 0→1→2% 
EtOAc in hexanes) as a colorless oil.  95% ee, [α]D25 +53.0 (c 1.63, CHCl3); Rf = 0.4 (5% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.74–7.68 (m, 2H), 7.51–7.47 (m, 1H), 
7.42–7.35 (m, 2H), 7.16 (dd, J = 5.1, 1.2 Hz, 1H), 6.89 (dd, J = 5.1, 3.5 Hz, 1H), 6.84 
(ddd, J = 3.5, 1.2, 0.7 Hz, 1H), 6.23 (ddd, J = 16.4, 10.6, 9.0 Hz, 1H), 5.23–5.16 (m, 2H), 
4.77 (d, J = 9.0 Hz, 1H), 4.11 (q, J = 7.1 Hz, 2H), 1.52 (s, 3H), 1.09 (t, J = 7.2 Hz, 3H); 
 13C NMR (126 MHz, CDCl3) δ 197.5, 172.3, 142.1, 136.8, 136.6, 132.5, 128.5, 128.4, 
126.9, 126.2, 124.9, 118.2, 62.2, 61.9, 49.8, 19.4, 13.9;  IR (Neat Film, NaCl) 3069, 2981, 
2937, 1732, 1687, 1682, 1597, 1580, 1446, 1383, 1298, 1246, 1221, 1107, 1018, 1001, 
968, 924, 851, 795, 747 cm-1; HRMS (ESI+) m/z calc’d for C19H21O3S [M+H]+: 329.1206, 
found 329.1214;  SFC conditions: 5% IPA, 2.5 mL/min, Chiralpak IC column, λ = 254 
nm, tR (min): major = 7.92, minor = 11.24.  
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Ethyl (2R,3R)-2-benzoyl-3-(furan-2-yl)-2-methylpent-4-enoate (112j). 
 
 
Ketoester 112j was isolated by silica gel chromatography (gradient elution, 0→1→2% 
EtOAc in hexanes) as a colorless oil.  >99% ee, [α]D25 +67.3 (c 1.34, CHCl3); Rf = 0.4 
(5% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.73–7.67 (m, 2H), 7.52–7.45 (m, 
1H), 7.40–7.35 (m, 2H), 7.27 (dd, J = 1.8, 0.9 Hz, 1H), 6.25 (dd, J = 3.3, 1.8 Hz, 1H), 
6.17 (ddd, J = 17.0, 10.2, 8.5 Hz, 1H), 6.11 (dt, J = 3.3, 0.7 Hz, 1H), 5.19 (ddd, J = 10.2, 
1.7, 0.8 Hz, 1H), 5.14 (ddd, J = 17.0, 1.7, 1.1 Hz, 1H), 4.62 (dd, J = 8.5, 0.9 Hz, 1H), 
4.12 (q, J = 7.1 Hz, 2H), 1.52 (s, 3H), 1.10 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, 
CDCl3) δ 196.9, 172.1, 152.9, 141.5, 136.6, 134.4, 132.2, 128.3, 128.2, 118.3, 110.1, 
108.7, 61.6, 61.4, 47.9, 19.3, 13.8; IR (Neat Film, NaCl) 3081, 2983, 2941, 2904, 1732, 
1686, 1597, 1581, 1501, 1446, 1378, 1301, 1246, 1222, 1149, 1096, 1013, 968, 926, 885, 
860, 797, 736 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C19H21O4 [M+H]+: 
313.1431, found 313.1438;  SFC conditions: 5% IPA, 2.5 mL/min, Chiralpak IC column, 
λ = 254 nm, tR (min): major = 5.09, minor = 9.14. 
 
Ph
Me
O
CO2Et
112j
O
Chapter 4 – Enantio-, Diastereo- and Regioselective Iridium-Catalyzed Asymmetric Allylic 
Alkylation of Acyclic β-Ketoesters 
 
 
357 
Ethyl (2R,3S,E)-2-benzoyl-2-methyl-3-vinylhex-4-enoate (112k). 
 
 
Ketoester 112k was isolated by silica gel chromatography (gradient elution, 0→1→2% 
EtOAc in hexanes) as a colorless oil.  91% ee, [α]D25 +43.5 (c 1.86, CHCl3); Rf = 0.4 (5% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.80–7.71 (m, 2H), 7.52–7.46 (m, 1H), 
7.42–7.36 (m, 2H), 5.98 (ddd, J = 16.9, 10.5, 7.5 Hz, 1H), 5.47–5.27 (m, 2H), 5.15–5.00 
(m, 2H), 4.09 (qd, J = 7.1, 1.5 Hz, 2H), 3.73–3.69 (m, 1H), 1.65–1.58 (m, 3H), 1.48 (s, 
3H), 1.07 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 197.4, 173.0, 137.2, 136.8, 
132.4, 129.0, 128.5, 128.4, 128.3, 117.1, 61.4, 60.5, 51.6, 19.2, 18.2, 14.0; IR (Neat Film, 
NaCl) 3077, 2981, 2939, 2913, 1732, 1687, 1682, 1597, 1580, 1446, 1377, 1299, 1245, 
1221, 1100, 1018, 1001, 970, 921, 859 cm-1; HRMS (ESI+) m/z calc’d for C18H23O3 
[M+H]+:  287.1642, found 287.1654; SFC conditions: 2% IPA, 2.5 mL/min, Chiralpak 
AD-H column, λ = 210 nm, tR (min): minor = 4.40, major = 5.52. 
 
Ethyl (2R,3S)-2-(4-methoxybenzoyl)-2-methyl-3-phenylpent-4-enoate (112l). 
 
 
Ketoester 112l was isolated by silica gel chromatography (4% EtOAc in hexanes) as a 
colorless oil.  99% ee, [α]D25 +53.9 (c 1.51, CHCl3); Rf = 0.3 (10% EtOAc in hexanes); 
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1H NMR (500 MHz, CDCl3) δ7.76–7.69 (m, 2H), 7.25–7.17 (m, 5H), 6.87–6.82 (m, 2H), 
6.36 (ddd, J = 17.0, 10.3, 8.1 Hz, 1H), 5.12 (ddd, J = 10.3, 1.8, 1.0 Hz, 1H), 5.05 (ddd, J 
= 17.0, 1.8, 1.2 Hz, 1H), 4.39 (dt, J = 8.1, 1.2 Hz, 1H), 4.10 (q, J = 7.1 Hz, 2H), 3.84 (s, 
3H), 1.53 (s, 3H), 1.07 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 195.8, 173.4, 
162.9, 139.6, 138.0, 130.8, 130.2, 129.5, 128.1, 127.0, 117.3, 113.6, 61.5, 61.3, 55.5, 54.7, 
21.0, 13.9; IR (Neat Film, NaCl) 3083, 2981, 2940, 2842, 1727, 1677, 1600, 1576, 1513, 
1454, 1417, 1376, 1310, 1247, 1221, 1176, 1118, 1031, 964, 842 cm-1; HRMS (ESI+) 
m/z calc’d for C22H25O4 [M+H]+:  353.1747, found 353.1752; SFC conditions: 10% IPA, 
4.0 mL/min, Chiralpak IC column, λ = 254 nm, tR (min): major = 2.67, minor = 3.51. 
 
Methyl (2R,3S)-2-(4-bromobenzoyl)-2-methyl-3-phenylpent-4-enoate (112m). 
 
  
Ketoester 112m was isolated by silica gel chromatography (gradient elution, 1→2 Et2O 
in hexanes) as a colorless oil.  >99% ee, [α]D25 +65.9 (c 0.50, CHCl3); Rf = 0.3 (10% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.51–7.48 (m, 4H), 7.29–7.09 (m, 5H), 
6.31 (ddd, J = 16.9, 10.3, 8.4 Hz, 1H), 5.21–4.96 (m, 2H), 4.37 (d, J = 8.5 Hz, 1H), 3.62 
(s, 3H), 1.51 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 196.6, 173.3, 139.1, 137.3, 135.7, 
131.7, 130.0, 129.7, 128.2, 127.5, 127.1, 117.7, 61.8, 54.7, 52.5, 20.8; IR (Neat Film, 
NaCl) 3355, 3028, 2997, 2948, 1735, 1685, 1584, 1484, 1452, 1395, 1245, 1221, 1117, 
1073, 966, 922, 841, 756 cm-1; HRMS (ESI+) m/z calc’d for C20H20BrO3 [M+H]+: 
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387.0590, found 387.0612; SFC conditions: 5% IPA, 2.5 mL/min, Chiralpak AD-H 
column, λ = 254 nm, tR (min): major = 5.35, minor = 5.88.  
 
Ethyl (2R,3S)-2-benzoyl-2-ethyl-3-phenylpent-4-enoate (112n). 
 
 
Ketoester 112n was isolated by silica gel chromatography (gradient elution, 0→2 Et2O in 
hexanes) as a colorless oil.  >99% ee, [α]D25 +77.4 (c 0.25, CHCl3); Rf = 0.4 (10% EtOAc 
in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.61–7.51 (m, 2H), 7.48–7.38 (m, 1H), 7.35–
7.11 (m, 7H), 6.33 (ddd, J = 17.0, 10.3, 7.8 Hz, 1H), 5.07 (ddd, J = 10.3, 1.8, 1.1 Hz, 1H), 
4.96 (dt, J = 17.1, 1.5 Hz, 1H), 4.38 (dd, J = 7.9, 1.4 Hz, 1H), 4.06 (qd, J = 7.2, 3.3 Hz, 
2H), 2.15 (dq, J = 15.0, 7.5 Hz, 1H), 1.89 (dq, J = 14.9, 7.5 Hz, 1H), 0.99 (t, J = 7.1 Hz, 
3H), 0.78 (t, J = 7.5 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 198.1, 172.9, 139.5, 138.4, 
137.9, 132.0, 129.8, 128.2, 128.1, 127.9, 127.0, 116.6, 65.2, 61.0, 52.2, 27.6, 13.6, 8.5; 
IR (Neat Film, NaCl) 3061, 3028, 2980, 1729, 1679, 1597, 1446, 1386, 1303, 1228, 1208, 
1097, 1028, 993, 917, 759 cm-1; HRMS (ESI+) m/z calc’d for C22H25O3 [M+H]+: 
337.1798, found 337.1813; SFC conditions: 5% MeOH, 2.5 mL/min, Chiralpak AD-H 
column, λ = 254 nm, tR (min): major = 2.48, minor = 2.20.  
 
Ethyl (2R,3S)-2-benzoyl-2-benzyl-3-phenylpent-4-enoate (112o). 
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Ketoester 112o was isolated by silica gel chromatography (gradient elution, 1→2 EtOAc 
in hexanes) as a white solid.  >99% ee, [α]D25 +37.1 (c 1.29, CHCl3); Rf = 0.4 (5% EtOAc 
in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.33–7.29 (m, 1H), 7.29–7.21 (m, 4H), 7.17–
7.10 (m, 8H), 7.04–7.00 (m, 2H), 6.37 (ddd, J = 17.0, 10.3, 8.1 Hz, 1H), 5.13 (ddd, J = 
10.2, 1.8, 1.0 Hz, 1H), 5.02 (dt, J = 17.0, 1.5 Hz, 1H), 4.42 (d, J = 7.9 Hz, 1H), 3.99 (dq, 
J = 10.7, 7.1 Hz, 1H), 3.80 (dq, J = 10.7, 7.1 Hz, 1H), 3.28 (AB, J = 15.5, 13.5 Hz, 2H), 
0.82 (t, J = 7.2 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 200.5, 172.0, 139.7, 139.3, 138.3, 
136.8, 131.4, 131.2, 130.0, 128.4, 128.1, 127.7, 127.6, 127.4, 126.9, 117.6, 67.5, 61.0, 
56.8, 42.1, 13.4; IR (Neat Film, NaCl) 3063, 3029, 2982, 2929, 1729, 1673, 1600, 1582, 
1496, 1448, 1367, 1299, 1241, 1209, 1082, 1066, 1025, 925, 757 cm-1; HRMS (ESI+) 
m/z calc’d for C27H27O3 [M+H]+: 399.1955, found 399.1956; SFC conditions: 4% IPA, 
4.0 mL/min, Chiralpak AD-H column, λ = 254 nm, tR (min): major = 5.06, minor = 8.94.  
 
Ethyl (2R,3S)-2-allyl-2-benzoyl-3-phenylpent-4-enoate (112p). 
 
 
Ketoester 112p was isolated by silica gel chromatography (2% EtOAc in hexanes) as a 
colorless oil.  >99% ee, [α]D25 +80.7 (c 0.31, CHCl3); Rf = 0.4 (5% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3) δ 7.54–7.49 (m, 2H), 7.43 (ddt, J = 7.7, 7.0, 1.2 Hz, 1H), 
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7.33–7.27 (m, 2H), 7.25–7.19 (m, 3H), 7.18–7.13 (m, 2H), 6.36 (ddd, J = 17.0, 10.3, 8.0 
Hz, 1H), 5.71 (dddd, J = 17.0, 10.2, 7.8, 7.0 Hz, 1H), 5.10 (ddd, J = 10.3, 1.8, 1.1 Hz, 
1H), 5.03 (ddt, J = 10.2, 2.1, 1.0 Hz, 1H), 4.99 (ddd, J = 17.0, 1.8, 1.2 Hz, 1H), 4.92 (dq, 
J = 17.1, 1.7 Hz, 1H), 4.35 (dt, J = 8.0, 1.2 Hz, 1H), 4.14–3.96 (m, 2H), 2.86 (ddt, J = 
14.6, 7.0, 1.3 Hz, 1H), 2.63 (ddt, J = 14.6, 7.7, 1.2 Hz, 1H), 0.99 (t, J = 7.2 Hz, 3H); 13C 
NMR (126 MHz, CDCl3) δ 198.0, 172.4, 139.4, 138.3, 138.2, 132.5, 132.1, 130.1, 128.3, 
128.14, 128.12, 127.2, 119.5, 117.2, 65.2, 61.2, 53.4, 39.4, 13.7; IR (Neat Film, NaCl) 
3079, 3029, 2981, 2933, 1728, 1679, 1638, 1597, 1581, 1493, 1446, 1367, 1257, 1216, 
1181, 1144, 1045, 1023, 1001, 921, 758 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for 
C23H25O3 [M+H]+: 349.1808, found 349.1808; SFC conditions: 3% IPA, 4.0 mL/min, 
Chiralpak IC column, λ = 254 nm, tR (min): major = 7.16, minor = 8.60.  
 
Ethyl (2R,3S)-2-benzoyl-3-phenyl-2-(prop-2-yn-1-yl)pent-4-enoate (112q). 
 
 
Ketoester 112q was isolated by silica gel chromatography (2% EtOAc in hexanes) as a 
colorless oil.  >99% ee, [α]D25 +57.7 (c 0.94, CHCl3); Rf = 0.3 (5% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3) δ 7.62–7.55 (m, 2H), 7.46 (ddt, J = 8.6, 7.0, 1.2 Hz, 1H), 
7.35–7.29 (m, 2H), 7.25–7.23 (m, 5H), 6.37 (ddd, J = 17.0, 10.3, 7.8 Hz, 1H), 5.15 (ddd, 
J = 10.3, 1.8, 1.2 Hz, 1H), 5.09 (dt, J = 17.0, 1.5 Hz, 1H), 4.58 (dt, J = 7.8, 1.3 Hz, 1H), 
4.19–4.05 (m, 2H), 2.97 (dd, J = 17.4, 2.7 Hz, 1H), 2.69 (dd, J = 17.4, 2.7 Hz, 1H), 2.09 
Ph
PhO
CO2Et
112q
Chapter 4 – Enantio-, Diastereo- and Regioselective Iridium-Catalyzed Asymmetric Allylic 
Alkylation of Acyclic β-Ketoesters 
 
 
362 
(t, J = 2.7 Hz, 1H), 1.05 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 196.0, 171.4, 
138.9, 137.6, 137.3, 132.5, 130.1, 128.4, 128.32, 128.27, 127.4, 117.6, 79.3, 72.9, 64.0, 
61.7, 52.5, 25.7, 13.8; IR (Neat Film, NaCl) 3288, 3060, 3030, 2981, 1728, 1682, 1597, 
1580, 1446, 1255, 1213, 1183, 1046, 1001, 925 cm-1; HRMS (ESI+) m/z calc’d for 
C23H23O3 [M+H]+: 347.1642, found 347.1647; SFC conditions: 5% IPA, 2.5 mL/min, 
Chiralcel OD-H column, λ = 254 nm, tR (min): minor = 5.67, major = 6.44.  
 
Ethyl (E)-2-benzoyl-5-phenyl-2-(prop-2-yn-1-yl)pent-4-enoate (113q). 
 
 
Ketoester 113q was isolated by silica gel chromatography (2% EtOAc in hexanes) as a 
colorless oil. 34% ee, [α]D25 -23.4 (c 0.42, CHCl3); Rf = 0.3 (5% EtOAc in hexanes); 1H 
NMR (500 MHz, CDCl3) δ 7.88–7.85 (m, 2H), 7.59–7.54 (m, 1H), 7.48–7.42 (m, 2H), 
7.30–7.24 (m, 4H), 7.21 (ddd, J = 8.7, 4.9, 3.8 Hz, 1H), 6.43 (dt, J = 15.6, 1.3 Hz, 1H), 
5.90 (dt, J = 15.5, 7.7 Hz, 1H), 4.20 (qq, J = 7.1, 3.6 Hz, 2H), 3.19 (ddd, J = 14.5, 7.9, 1.3 
Hz, 1H), 3.11 (ddd, J = 14.5, 7.5, 1.4 Hz, 1H), 2.98 (d, J = 2.7 Hz, 2H), 2.07 (t, J = 2.7 
Hz, 1H), 1.13 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 195.2, 171.7, 137.1, 
135.7, 134.9, 133.2, 128.8, 128.60, 128.57, 127.6, 126.4, 122.9, 79.0, 72.4, 62.1, 60.6, 
36.5, 23.9, 14.1; IR (Neat Film, NaCl) 3287, 3059, 3026, 2979, 2933, 1729, 1679, 1596, 
1580, 1446, 1367, 1285, 1270, 1239, 1192, 1180, 1094, 1064, 1023, 966, 937 cm-1; 
HRMS (ESI+) m/z calc’d for C23H23O3 [M+H]+: 347.1642, found 347.1651; SFC 
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conditions: 5% IPA, 2.5 mL/min, Chiralpak IC column, λ = 254 nm, tR (min): minor = 
9.81, major = 10.67.  
 
Ethyl (R)-2-benzoyl-5-oxo-2-((S)-1-phenylallyl)hexanoate (112r). 
 
 
Ketoester 112r was isolated by silica gel chromatography (gradient elution, 5→10% 
EtOAc in hexanes) as a colorless oil.  99% ee, [α]D25 +66.8 (c 1.20, CHCl3); Rf = 0.4 
(25% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.59–7.55 (m, 2H), 7.48–7.43 
(m, 1H), 7.37–7.30 (m, 2H), 7.26–7.14 (m, 5H), 6.34 (ddd, J = 17.0, 10.3, 8.1 Hz, 1H), 
5.09 (ddd, J = 10.3, 1.7, 1.0 Hz, 1H), 4.97 (ddd, J = 17.0, 1.7, 1.2 Hz, 1H), 4.36–4.32 (m, 
1H), 4.13–3.99 (m, 2H), 2.46–2.38 (m, 1H), 2.34–2.29 (m, 2H), 2.25–2.17 (m, 1H), 1.99 
(s, 3H), 1.00 (t, J = 7.2 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 206.9, 198.0, 172.4, 
139.1, 137.9, 137.8, 132.4, 129.7, 128.4, 128.3, 128.0, 127.3, 117.2, 64.2, 61.3, 53.2, 38.3, 
29.9, 28.0, 13.7; IR (Neat Film, NaCl) 3063, 3030, 2981, 2905, 1733, 1717, 1681, 1637, 
1596, 1582, 1495, 1446, 1419, 1367, 1243, 1214, 1137, 1093, 1029, 1002, 925, 860, 761 
cm-1; HRMS (ESI+) m/z calc’d for C24H27O3 [M+H]+: 379.1904, found 379.1911; SFC 
conditions: 5% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 254 nm, tR (min): minor = 
8.00, major = 10.08.  
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Ethyl (2R,3S)-2-((1H-indol-3-yl)methyl)-2-benzoyl-3-phenylpent-4-enoate (112s). 
 
 
Ketoester 112s was isolated by silica gel chromatography (gradient elution, 5→10% 
EtOAc in hexanes) as a colorless oil.  >99% ee, [α]D25 –7.7 (c 1.60, CHCl3); Rf = 0.4 
(25% EtOAc in hexanes); 1H NMR (300 MHz, C6D6) δ 7.70–7.65 (m, 1H), 7.36 (dd, J = 
7.2, 1.8 Hz, 2H), 7.24–7.16 (m, 2H), 7.08–6.93 (m, 5H), 6.90–6.63 (m, 6H), 6.56 (br s, 
1H), 5.17–5.12 (m, 1H), 5.10 (t, J = 1.0 Hz, 1H), 4.82 (d, J = 7.8 Hz, 1H), 3.82–3.63 (m, 
3H), 3.62–3.45 (m, 1H), 0.40 (td, J = 6.7, 1.3 Hz, 3H); 13C NMR (126 MHz, C6D6) δ 
199.7, 172.2, 139.7, 139.6, 138.9, 135.5, 130.8, 130.2, 128.4, 128.1, 127.9, 127.8, 127.6, 
126.9, 124.3, 121.6, 119.7, 119.2, 116.9, 110.5, 66.6, 60.4, 56.0, 31.9, 12.9; IR (Neat 
Film, NaCl) 3411, 3060, 1724, 1673, 1456, 1241, 1216, 1096, 1012, 923, 747 cm-1; 
HRMS (ESI+) m/z calc’d for C29H28NO3 [M+H]+: 438.2064, found 438.2070; SFC 
conditions: 10% MeOH, 2.5 mL/min, Chiralpak IC column, λ = 254 nm, tR (min): minor 
= 8.26, major = 9.30.  
 
Ethyl (2R,3S)-2-benzoyl-2-(2-cyanoethyl)-3-phenylpent-4-enoate (112t) and ethyl 
(2S,3S)-2-benzoyl-2-(2-cyanoethyl)-3-phenylpent-4-enoate (112t’).  
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Products 112t and 112t’ were isolated by silica gel chromatography (5% EtOAc in 
hexanes) as a mixture of diastereomers (3:1), which were separated by preparative HPLC 
(20% EtOAc in hexanes). 
 
     
The major diastereomer 112t was isolated as a white solid, >99% ee, [α]D25 +59.1 (c 
1.81, CHCl3); Rf = 0.2 (10% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.52–
7.44 (m, 3H), 7.36–7.30 (m, 2H), 7.26–7.20 (m, 3H), 7.15–7.11 (m, 2H), 6.33 (ddd, J = 
17.0, 10.2, 8.2 Hz, 1H), 5.14 (ddd, J = 10.2, 1.6, 1.0 Hz, 1H), 5.01 (dt, J = 17.0, 1.3 Hz, 
1H), 4.32 (dt, J = 8.0, 1.0 Hz, 1H), 4.15–4.06 (m, 2H), 2.50–2.36 (m, 2H), 2.28 (td, J = 
8.0, 0.8 Hz, 2H), 1.01 (t, J = 7.2 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 197.2, 171.8, 
138.3, 137.5, 137.1, 132.8, 129.7, 128.7, 128.5, 128.1, 127.7, 119.1, 118.1, 64.0, 61.9, 
53.6, 30.6, 13.7, 13.1; IR (Neat Film, NaCl) 3061, 3027, 2981, 2248, 1729, 1675, 1596, 
1580, 1446, 1243, 1214, 1185, 1085, 1017, 971, 924, 757 cm-1; HRMS (MM: ESI-APCI+) 
m/z calc’d for C23H24NO3 [M+H]+:  362.1751, found 362.1766; SFC conditions: 5% IPA, 
2.5 mL/min, Chiralpak AD-H column, λ = 254 nm, tR (min): major = 9.77, minor = 11.61. 
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The minor diastereomer was isolated as a white solid, >99% ee, [α]D25 +22.3 (c 0.11, 
CHCl3); Rf = 0.2 (10% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.69–7.63 (m, 
2H), 7.55–7.47 (m, 1H), 7.41–7.32 (m, 2H), 7.31–7.22 (m, 4H), 7.22–7.16 (m, 1H), 6.29 
(dt, J = 16.8, 10.2 Hz, 1H), 5.21–5.11 (m, 2H), 4.35 (d, J = 10.3 Hz, 1H), 4.03 (dq, J = 
10.8, 7.2 Hz, 1H), 3.84 (dq, J = 10.8, 7.2 Hz, 1H), 2.74–2.63 (m, 1H), 2.46–2.28 (m, 2H), 
2.14–2.02 (m, 1H), 0.81 (t, J = 7.2 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 196.0, 171.3, 
139.7, 136.7, 136.0, 133.0, 129.7, 128.7, 128.5, 128.3, 127.4, 119.2, 118.9, 63.8, 61.7, 
53.0, 30.7, 13.3, 12.9; IR (Neat Film, NaCl) 3062, 3029, 2982, 2248, 1728, 1678, 1596, 
1580, 1494, 1446, 1367, 1275, 1242, 1215, 1093, 1018, 972, 928, 757 cm-1; HRMS (MM: 
ESI-APCI+) m/z calc’d for C23H24NO3 [M+H]+:  362.1751, found 362.1757; SFC 
conditions: 5% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 254 nm, tR (min): major = 
10.65, minor = 12.02. 
 
Ethyl (2S,3S)-2-benzoyl-2-fluoro-3-phenylpent-4-enoate (112u). 
 
 
Ketoester 112u was isolated by silica gel chromatography (gradient elution, 1→2% 
EtOAc in hexanes) as a colorless oil.  95% ee, [α]D25 +82.0 (c 1.19, CHCl3); Rf = 0.4 (5% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.77 (ddt, J = 7.6, 2.0, 1.2 Hz, 2H), 
7.49 (ddt, J = 7.7, 7.0, 1.3 Hz, 1H), 7.38–7.30 (m, 4H), 7.31–7.14 (m, 3H), 6.20 (ddd, J = 
17.0, 10.2, 9.4 Hz, 1H), 5.27 (ddt, J = 17.0, 1.5, 0.8 Hz, 1H), 5.23 (ddd, J = 10.1, 1.5, 0.6 
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Hz, 1H), 4.65 (dd, J = 33.3 (JH-F), 9.4 Hz, 1H), 4.31 (ddq, J = 39.5, 10.8, 7.2 Hz, 2H), 
1.30 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 192.6 (d, J = 27.1 Hz), 166.3 (d, 
J = 26.4 Hz), 137.4, 134.9 (d, J = 3.5 Hz), 134.5 (d, J = 4.0 Hz), 133.6, 129.9 (d, J = 2.6 
Hz), 129.5 (d, J = 6.7 Hz), 128.5, 128.4, 127.4, 119.1, 103.1 (d, J = 208.4 Hz), 63.1, 54.4 
(d, J = 18.3 Hz), 14.2; 19F NMR (282 MHz, CDCl3) δ -169.39 (d, J = 33.2 Hz); IR (Neat 
Film, NaCl) 3062, 3030, 2982, 2934, 1749, 1694, 1597, 1454, 1447, 1367, 1230, 1187, 
1129, 1038, 929, 856, 743 cm-1; HRMS (ESI+) m/z calc’d for C20H20FO3 [M+H]+: 
327.1391, found 327.1401; SFC conditions: 5% IPA, 4.0 mL/min, Chiralpak IC column, 
λ = 254 nm, tR (min): major = 2.02, minor = 3.18.  
 
Ethyl (2S,3S)-2-benzoyl-2-chloro-3-phenylpent-4-enoate (112v). 
 
 
Ketoester 112v was isolated by silica gel chromatography (gradient elution, 2→3% 
EtOAc in hexanes) as a colorless oil.  >99% ee, [α]D25 +93.8 (c 1.43, CHCl3); Rf = 0.4 
(5% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.84–7.78 (m, 2H), 7.54–7.47 (m, 
1H), 7.47–7.40 (m, 2H), 7.40–7.33 (m, 2H), 7.33–7.18 (m, 3H), 6.36 (ddd, J = 16.9, 10.2, 
8.7 Hz, 1H), 5.20 (ddd, J = 10.2, 1.5, 0.8 Hz, 1H), 5.15 (ddd, J = 16.9, 1.6, 1.0 Hz, 1H), 
4.66 (d, J = 8.6 Hz, 1H), 4.18 (q, J = 7.1 Hz, 2H), 1.12 (t, J = 7.1 Hz, 3H); 13C NMR (126 
MHz, CDCl3) δ 189.8, 167.3, 138.0, 135.9, 134.8, 133.1, 130.7, 129.3, 128.3, 128.0, 
127.5, 118.7, 77.3, 63.4, 55.8, 13.8; IR (Neat Film, NaCl) 3062, 3029, 2982, 1754, 1696, 
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1597, 1581, 1446, 1367, 1299, 1239, 1207, 1186, 1094, 1075, 1025, 1007, 928, 749 cm-1; 
HRMS (ESI+) m/z calc’d for C20H20ClO3 [M+H]+: 343.1095, found 343.1099; SFC 
conditions: 10% MeOH, 2.5 mL/min, Chiralpak IC column, λ = 254 nm, tR (min): major 
= 2.52, minor = 2.77.  
 
Ethyl (2R,3S)-2-(cyclohex-1-ene-1-carbonyl)-2-methyl-3-phenylpent-4-enoate 
(112w). 
 
 
Ketoester 112w was isolated by silica gel chromatography (1% EtOAc in hexanes) as a 
colorless oil.  99% ee, [α]D25 +80.8 (c 1.00, CHCl3,); Rf = 0.3 (10% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3) δ 7.33–7.13 (m, 5H), 6.47 (td, J = 3.9, 2.0 Hz, 1H), 6.25 
(ddd, J = 16.8, 10.3, 8.0 Hz, 1H), 5.09 (dt, J = 10.2, 1.4 Hz, 1H), 5.00 (dt, J = 16.9, 1.4 
Hz, 1H), 4.29 (dd, J = 8.0, 1.4 Hz, 1H), 3.68 (d, J = 0.8 Hz, 3H), 2.24–2.03 (m, 3H), 
1.97–1.81 (m, 1H), 1.55 (tq, J = 7.0, 4.0, 2.3 Hz, 4H), 1.43 (s, 3H); 13C NMR (126 MHz, 
CDCl3) δ 198.1, 173.8, 139.4, 138.3, 137.9, 137.2, 130.0, 128.0, 126.8, 117.1, 61.1, 54.5, 
52.2, 25.9, 24.3, 22.0, 21.3, 20.7; IR (Neat Film, NaCl) 2938, 1732, 1671, 1636, 1452, 
1433, 1234, 1113, 984, 917, 703 cm-1; HRMS (ESI+) m/z calc’d for C20H25O3 [M+H]+: 
313.1798, found 313.1785; SFC conditions: 5% MeOH, 4.0 mL/min, Chiralpak IC 
column, λ = 254 nm, tR (min): minor = 5.83, major = 6.55.  
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Methyl (2R,3S)-2-(cyclohexanecarbonyl)-2-methyl-3-phenylpent-4-enoate (112x). 
 
 
Ketoester 112x was isolated by silica gel chromatography (5% EtOAc in hexanes) as a 
mixture of diastereomers (4:1 dr).  For the major isomer: 96% ee, [α]D25 +57.7 (c 1.54, 
CHCl3, measured with 4:1 dr mixture); Rf = 0.3 (5% EtOAc in hexanes); 1H NMR (500 
MHz, CDCl3) δ 7.29–7.18 (m, 5H), 6.26 (ddd, J = 17.0, 10.2, 8.5 Hz, 1H), 5.08 (ddd, J = 
10.2, 1.8, 0.9 Hz, 1H), 5.00 (ddd, J = 17.0, 1.8, 1.1 Hz, 1H), 4.18 (dt, J = 8.5, 1.0 Hz, 1H), 
3.71 (s, 3H), 2.50 (tt, J = 11.4, 3.2 Hz, 1H), 1.79–1.56 (m, 5H), 1.53–1.46 (m, 1H), 1.33 
(s, 3H), 1.32–1.11 (m, 4H); 13C NMR (126 MHz, CDCl3) δ 210.3, 172.4, 139.6, 137.8, 
129.9, 128.3, 127.0, 117.4, 64.7, 54.1, 52.2, 48.4, 30.3, 29.6, 25.8, 25.73, 25.71, 18.7; IR 
(Neat Film, NaCl) 2933, 2854, 1729, 1708, 1635, 1495, 1453, 1432, 1380, 1315, 1228, 
1144, 1101, 989, 919 cm-1; HRMS (ESI+) m/z calc’d for C20H26O3 [M+H]+: 315.1955, 
found 315.1955; SFC conditions: 100% CO2, 4.0 mL/min, Chiralcel OJ-H column, λ = 
210 nm, tR (min): minor = 7.28, major = 7.96.  
 
Methyl (2R,3S)-2-acetyl-2-ethyl-3-phenylpent-4-enoate (112y) and methyl (2S,3S)-2-
acetyl-2-ethyl-3-phenylpent-4-enoate (112y’). 
Ketoesters 112y and 112y’ were isolated by silica gel chromatography (gradient elution, 
0→4% EtOAc in hexanes) as mixture of two diastereomers (1.5:1 dr).  The diastereomers 
were separated by preparative HPLC (gradient elution, 60→70% MeCN in H2O).   
Me
PhO
CO2Me
112x
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The major diastereomer 112y was isolated as a colorless oil. 90% ee, [α]D25 +72.7 (c 
0.60, CHCl3); Rf = 0.4 (5% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.32–7.25 
(m, 2H), 7.25–7.18 (m, 1H), 7.17–7.07 (m, 2H), 6.28 (ddd, J = 17.0, 10.2, 8.4 Hz, 1H), 
5.08 (ddd, J = 10.2, 1.7, 0.9 Hz, 1H), 4.97 (ddd, J = 17.0, 1.7, 1.1 Hz, 1H), 4.03 (d, J = 
8.5 Hz, 1H), 3.76 (s, 3H), 2.06 (s, 3H), 1.86–1.68 (m, 2H), 0.77 (t, J = 7.5 Hz, 3H); 13C 
NMR (126 MHz, CDCl3) δ 205.8, 172.4, 139.5, 137.7, 129.3, 128.4, 127.3, 117.3, 68.2, 
53.5, 51.9, 29.8, 27.4, 9.1; IR (Neat Film, NaCl) 3083, 3029, 2978, 2950, 2883, 1709, 
1601, 1494, 1434, 1385, 1353, 1301, 1220, 1116, 1029, 993, 919, 755 cm-1; HRMS (MM: 
ESI-APCI+) m/z calc’d for C16H21O3 [M+H]+:  261.1485, found 261.1492; SFC 
conditions: 0.5% IPA, 2.5 mL/min, Chiralcel OJ-H column, λ = 210 nm, tR (min): minor 
= 4.79, major = 7.02. 
 
 
The minor diastereomer 112y’ was isolated as a colorless oil. 91% ee, [α]D25 +25.3 (c 
0.26, CHCl3); Rf = 0.4 (5% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.26–7.23 
(m, 2H), 7.21–7.17 (m, 1H), 7.17–7.13 (m, 2H), 6.31 (ddd, J = 16.9, 10.2, 9.3 Hz, 1H), 
5.15 (ddd, J = 10.2, 1.6, 0.7 Hz, 1H), 5.10 (ddd, J = 17.0, 1.7, 1.0 Hz, 1H), 4.11 (d, J = 
9.4 Hz, 1H), 3.63 (s, 3H), 2.12 (s, 3H), 2.09–1.98 (m, 1H), 1.80 (dq, J = 14.8, 7.5 Hz, 
1H), 0.77 (t, J = 7.5 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 205.3, 172.3, 140.1, 137.3, 
Me
Et
PhO
CO2Me
112y
Me
Et
PhO
CO2Me
112y'
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129.4, 128.2, 127.0, 117.6, 68.0, 52.5, 51.9, 30.1, 26.9, 8.8; IR (Neat Film, NaCl) 3063, 
3030, 2962, 2925, 2850, 1710, 1600, 1446, 1354, 1286, 1260, 1223, 1182, 1118, 1095, 
1023, 921, 864, 801 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C16H21O3 [M+H]+:  
261.1485, found 261.1494; SFC conditions: 0.5% IPA, 2.5 mL/min, Chiralcel OJ-H 
column, λ = 210 nm, tR (min): minor = 6.29, major = 7.02.  
 
tert-Butyl (2R,3S)-2-benzoyl-2-methyl-3-phenylpent-4-enoate (112z). 
 
 
Ketoester 112z was isolated by silica gel chromatography (gradient elution, 0→2→5% 
EtOAc in hexanes) as a colorless oil. >99% ee, [α]D25 +67.4 (c 1.54, CHCl3); Rf = 0.4 (5% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.74–7.70 (m, 2H), 7.49–7.46 (m, 1H), 
7.39–7.34 (m, 2H), 7.25–7.16 (m, 5H), 6.34 (ddd, J = 17.0, 10.3, 7.9 Hz, 1H), 5.12 (ddd, 
J = 10.3, 1.8, 1.1 Hz, 1H), 5.03 (dt, J = 17.0, 1.6 Hz, 1H), 4.42 (dt, J = 7.9, 1.2 Hz, 1H), 
1.50 (s, 3H), 1.29 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 198.1, 171.8, 139.7, 138.1, 
137.3, 132.2, 130.4, 128.5, 128.3, 128.1, 126.9, 117.1, 82.6, 62.1, 54.6, 27.8, 21.0; IR 
(Neat Film, NaCl) 3061, 3027, 2978, 2934, 1728, 1716, 1687, 1682, 1598, 1454, 1446, 
1251, 1155, 1115, 961, 918, 844 cm-1; HRMS (ESI+) m/z calc’d for C23H27O3 [M+H]+: 
351.1955, found 351.1955; SFC conditions: 5% IPA, 2.5 mL/min, Chiralpak IC column, 
λ = 254 nm, tR (min): major = 4.14, minor = 5.80.  
 
Ph
Me
PhO
CO2t-Bu
112z
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tert-Butyl (E)-2-benzoyl-2-methyl-5-phenylpent-4-enoate (113z). 
 
 
Ketoester 113z was isolated by silica gel chromatography (gradient elution, 0→2→5% 
EtOAc in hexanes) as a colorless oil. 38% ee, [α]D25 +3.9 (c 0.74, CHCl3); Rf = 0.4 (5% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.92–7.89 (m, 2H), 7.56–7.51 (m, 1H), 
7.46–7.41 (m, 2H), 7.33–7.27 (m, 4H), 7.23–7.18 (m, 1H), 6.39 (dt, J = 15.8, 1.3 Hz, 1H), 
6.16–6.06 (m, 1H), 2.93 (ddd, J = 14.2, 7.5, 1.4 Hz, 1H), 2.84 (ddd, J = 14.2, 7.7, 1.3 Hz, 
1H), 1.55 (s, 3H), 1.28 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 197.8, 172.8, 137.3, 135.9, 
133.9, 132.7, 128.8, 128.6, 128.5, 127.4, 126.3, 124.7, 82.2, 58.0, 40.7, 27.8, 21.5; IR 
(Neat Film, NaCl) 3058, 3026, 2977, 2933, 1728, 1686, 1682, 1597, 1579, 1447, 1368, 
1249, 1212, 1152, 1111, 970, 845 cm-1; HRMS (ESI+) m/z calc’d for C23H27O3 [M+H]+: 
351.1955, found 351.1949; SFC conditions: 5% IPA, 2.5 mL/min, Chiralpak IC column, 
λ = 254 nm, tR (min): major = 9.88, minor = 8.48.  
 
Ph
Me
O
CO2t-Bu
113z
Ph
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4.6.5 Procedures for derivatization of allylic alkylation products and 
spectroscopic data of derivatives 
Synthesis of cyclohexenone 114: 
 
 
    To a solution of ketoester 112r (60.4 mg, 0.6 mmol) in t-BuOMe (2 mL) was added 
pyrrolidine (13.7 mg, 0.19 mmol) and AcOH (11.6 mg, 0.19 mmol).  The mixture was 
stirred for 12 h at 25 °C then heated to reflux for 4 h.  The solvent was removed under 
reduced pressure and the residue was subjected to column chromatography on silica gel 
(gradient elution, 10→25% EtOAc in hexanes) to give cyclohexenone 114 (55.1 mg, 
95% yield) as a colorless oil.  [α]D25 +151.4 (c 1.19, CHCl3); Rf = 0.5 (25% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 7.34–7.28 (m, 1H), 7.25–7.19 (m, 2H), 7.13–
7.04 (m, 3H), 7.04–6.97 (m, 2H), 6.69–6.63 (m, 2H), 6.33 (ddd, J = 16.9, 10.2, 7.8 Hz, 
1H), 6.07 (s, 1H), 5.10 (ddd, J = 10.2, 1.6, 1.0 Hz, 1H), 4.87 (dt, J = 17.0, 1.5 Hz, 1H), 
4.31 (q, J = 7.1 Hz, 2H), 4.26 (dt, J = 7.5, 1.5 Hz 1H), 2.91–2.77 (m, 1H), 2.62–2.53 (m, 
3H), 1.32 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 198.5, 173.2, 161.6, 139.5, 
139.2, 138.0, 131.9, 129.8, 128.7, 128.2, 128.1, 128.0, 126.7, 118.1, 62.0, 54.0, 53.8, 
34.7, 30.9, 14.3; IR (Neat Film, NaCl) 3058, 3030, 2981, 1725, 1673, 1602, 1492, 1444, 
1326, 1240, 1214, 1170, 1016, 921, 882 cm-1; HRMS (ESI+) m/z calc’d for C24H25O3 
[M+H]+:  361.1798, found 361.1798. 
 
Ph
PhO
CO2Et
pyrrolidine
AcOH
t-BuOMe, 25 °C→reflux
O
PhEtO2C
O Ph
112r 114
95% yield
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Synthesis of bicyclic enone 116: 
 
 
    A dried flask was charged with a solution of enyne 112q (8.6 mg, 0.025 mmol) and 
Co2(CO)8 (11.8 mg, 0.034 mmol) in CH2Cl2 (2 mL) and the mixture was stirred at room 
temperature for 12 h under an atmosphere of argon. After full consumption of 112q was 
observed by TLC analysis, Me3NO•2H2O (7.6 mg, 0.068 mmol) was added.  The mixture 
was stirred for 20 min and an additional portion of Me3NO•2H2O (30.1 mg, 0.27 mmol) 
was added.  Stirring was continued until complete consumption of the cobalt-alkyne 
complex was observed by TLC analysis (about 4 h).  The mixture was filtered through a 
celite pad, washed with CH2Cl2, the solvent removed under reduced pressure, and the 
residue subjected to column chromatography on silica gel (25% EtOAc in hexanes) to 
give the bicyclic enone 116 (9.3 mg, 99% yield) as a colorless oil.  The relative 
stereochemistry of 116 was assigned by 2D-NOESY.  [α]D25 -178.8 (c 0.79, CHCl3); Rf = 
0.3 (25% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.33–7.26 (m, 1H), 7.26–
7.18 (m, 4H), 7.13–7.02 (m, 5H), 6.03 (td, J = 2.2, 1.1 Hz, 1H), 4.11–3.91 (m, 3H), 3.82 
(d, J = 12.3 Hz, 1H), 3.73–3.63 (m, 1H), 3.01 (dq, J = 18.2, 1.1 Hz, 1H), 2.54 (ddd, J = 
18.0, 6.4, 0.8 Hz, 1H), 2.14 (ddd, J = 18.0, 2.5, 1.7 Hz, 1H), 0.86 (t, J = 7.1 Hz, 3H); 13C 
NMR (126 MHz, CDCl3) δ 209.3, 197.1, 183.8, 173.3, 137.1, 136.7, 132.4, 129.5, 128.5, 
128.3, 127.9, 127.8, 126.1, 68.6, 62.0, 55.8, 50.4, 41.7, 39.2, 13.6; IR (Neat Film, NaCl) 
3034, 2979, 2927, 1733, 1714, 1668, 1636, 1600, 1583, 1449, 1409, 1255, 1211, 1183, 
Ph
O
O
EtO2C
Ph
116
H
Ph
PhO
CO2Et
112q
1) Co2(CO)8, CH2Cl2
    25 °C, 12 h
2) Me3NO•2H2O
99% yield
Chapter 4 – Enantio-, Diastereo- and Regioselective Iridium-Catalyzed Asymmetric Allylic 
Alkylation of Acyclic β-Ketoesters 
 
 
375 
1071, 1043, 927, 914, 819 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C24H23O4 
[M+H]+:  375.1596, found 375.1592. 
 
Synthesis of compound 115: 
 
    To a flame-dried Schlenk flask was added a solution of 112p (20.8 mg, 0.06 mmol in 
1.5 mL of CH2Cl2) and Hoveyda-Grubbs II catalyst (3.7 mg, 10 mol%).  The reaction 
mixture was stirred for 3 h at 40 °C, filtered through a short silica pad and purified by 
silica gel chromatography (gradient elution, 1→5% EtOAc in hexanes) to give ketoester 
115 (18.3 mg, 96% yield) as a white solid.  [α]D25 -613.7 (c 0.94, CHCl3); Rf = 0.4 (5% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.61–7.55 (m, 2H), 7.38 (ddt, J = 8.6, 
7.1, 1.2 Hz, 1H), 7.28–7.21 (m, 2H), 6.97–6.93 (m, 3H), 6.89–6.83 (m, 2H), 5.90 (ddt, J 
= 6.1, 2.6, 1.8 Hz, 1H), 5.75 (dtd, J = 5.5, 2.6, 1.5 Hz, 1H), 4.92 (q, J = 2.3 Hz, 1H), 4.11 
(q, J = 7.1 Hz, 2H), 4.03 (dtd, J = 18.0, 2.6, 1.9 Hz, 1H), 2.73 (ddd, J = 18.0, 2.6, 1.6 Hz, 
1H), 1.00 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 194.2, 174.4, 138.4, 136.6, 
133.8, 132.5, 129.5, 128.5, 128.1, 128.0, 127.4, 127.0, 68.3, 61.9, 58.0, 41.5, 13.8; IR 
(Neat Film, NaCl) 3060, 3028, 2959, 2932, 2871, 1736, 1732, 1686, 1682, 1598, 1582, 
1492, 1447, 1365, 1258, 1243, 1220, 1157, 1087, 1048, 1004, 966, 922, 876, 761 cm-1; 
HRMS (MM: ESI-APCI+) m/z calc’d for C21H21O3 [M+H]+:  321.1485, found 321.1489. 
 
Ph
PhO
CO2Et
Hoveyda-Grubbs II
 (10 mol%)
CH2Cl2, 40 °C, 3 h
115
EtO2C
Ph
Ph
O
112p
N N
Ru
MesMes
O
Cl
Cl
Hoveyda-Grubbs-II
96% yield
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4.6.6 Determination of the absolute confirmation of compound 112f 
 
 
    To a flame-dried flask was added 112f (98% ee, 62.1 mg, 0.16 mmol), CH2Cl2 (5 mL) 
and this solution was cooled to -78 °C.  DIBAL-H (0.62 mL, 1.0 M solution in hexane) 
was added dropwise by syringe.  The mixture was stirred for 2 h at -78 °C, then allowed 
to warm to 25 °C and stirred for an additional 12 h.  The reaction was then cooled to 0 °C, 
and another 0.62 mL of DIBAL-H solution was added, followed by stirring at 25 °C for 3 
h. The reaction mixture was then quenched with saturated aqueous Rochelle’s salt (20 
mL) and stirred for another 3 h.  The aqueous layer was partitioned with a total of 100 
mL of CH2Cl2 and the combined organic phases washed with brine, dried over MgSO4, 
filtered and concentrated under reduced pressure.  The crude product was purified by 
silica gel chromatography (gradient elution, 5→20% EtOAc in hexanes) to give 40.2 mg 
(72% yield) of 117 as white solid mixture (1:1 dr).  The diastereomers were separated by 
preparative HPLC (gradient elution, 60→90% MeCN in H2O).  For isomer a: white solid, 
[α]D25 +58.9 (c 0.47, CHCl3); Rf = 0.4 (25% EtOAc in hexanes); 1H NMR (500 MHz, 
CDCl3) δ7.46–7.39 (m, 4H), 7.36–7.31 (m, 2H), 7.31–7.27 (m, 1H), 7.27–7.23 (m, 2H), 
6.79 (dt, J = 16.9, 10.1 Hz, 1H), 5.20–5.10 (m, 2H), 5.07 (s, 1H), 3.67 (d, J = 10.1 Hz, 
1H), 3.34 (d, J = 11.2 Hz, 1H), 3.11 (dd, J = 11.1, 0.7 Hz, 1H), 1.56 (br s, 2H), 0.72 (s, 
3H); 13C NMR (126 MHz, CDCl3) δ 141.5, 141.0, 140.4, 131.6, 131.4, 128.04, 128.79, 
Ph
Me
O
CO2Et
112f
Br
DIBAL-H
CH2Cl2, -78 → 25 °C
Ph
Me
OH
CH2OH
117
Br
∼ 1:1 dr mixture
72% yield
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127.8, 120.5, 116.5, 76.0, 66.6, 55.8, 46.2, 15.3; IR (Neat Film, NaCl) 3423, 3070, 2969, 
2923, 1486, 1452, 1403, 1342, 1074, 1012, 916, 827 cm-1; HRMS (ESI+) m/z calc’d for 
fragment C19H18Br [M-H4O2+H]+:  325.0586, found 325.0585.  For isomer b: white solid, 
[α]D25 +53.4 (c 0.43, CHCl3); Rf = 0.4 (24% EtOAc in hexanes); 1H NMR (500 MHz, 
CDCl3) δ 7.50–7.45 (m, 2H), 7.35–7.27 (m, 5H), 7.25–7.20 (m, 2H), 6.30 (dt, J = 16.8, 
10.0 Hz, 1H), 5.35 (ddd, J = 16.8, 1.9, 0.8 Hz, 1H), 5.24 (ddd, J = 10.0, 1.9, 0.5 Hz, 1H), 
4.39 (d, J = 10.0 Hz, 1H), 4.26 (s, 1H), 3.64 (d, J = 11.6 Hz, 1H), 3.51 (dd, J = 11.6, 1.8 
Hz, 1H), 1.58 (br s, 2H), 0.48 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 141.0, 140.2, 137.2, 
131.7, 131.3, 128.02, 127.97, 127.8, 120.6, 118.3, 80.0, 65.6, 49.7, 44.5, 15.5; IR (Neat 
Film, NaCl) 3372, 2973, 2938, 2888, 1637, 1486, 1473, 1454, 1402, 1348, 1266, 1203, 
1101, 1077, 1024, 1010, 921, 894, 831, 782 cm-1; HRMS (ESI+) m/z calc’d for fragment 
C19H18Br [M-H4O2+H]+:  325.0586, found 325.0588. 
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4.6.7 Determination of enantiomeric excess 
Table 4.6.7.1. Determination of enantiomeric excess 
 
entry compound SFC analytic conditions ee (%)
1
2
3
4
5
6
Chiralpak IC, λ = 254 nm
5% IPA/CO2, 2.5 mL/min
tR (min): major 4.12, minor 6.14
Chiralpak IC, λ = 254 nm
5% IPA/CO2, 2.5 mL/min
tR (min): major 6.71, minor 9.45
98
>99
>99
>99
99
>99
Chiralcel OJ-H, λ = 254 nm
4% IPA/CO2, 2.5 mL/min
tR (min): minor 5.64, major 6.84
Chiralpak IC, λ = 254 nm
2% MeOH/CO2, 2.5 mL/min
tR (min): major 12.24, minor 13.50
Chiralpak IC, λ = 254 nm
10% IPA/CO2, 4.0 mL/min
tR (min): major 1.59, minor 1.77
Chiralpak AD-H, λ = 254 nm
10% IPA/CO2, 4.0 mL/min
tR (min): minor 2.95, major 3.17
Ph
Me
PhO
CO2Et
112a
Ph
Me
O
CO2Et
112b
Me
Ph
Me
O
CO2Et
112c
OMe
Ph
Me
O
CO2Et
112d
OMe
Ph
Me
O
CO2Et
112e
Cl
Ph
Me
O
CO2Et
112f
Br
7 >99
Chiralpak AD-H, λ = 254 nm
2% IPA/CO2, 2.5 mL/min
tR (min): minor 5.20, major 6.68Ph
Me
O
CO2Et
112g
CF3
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8
9
10
93
23
95
Chiralpak AD-H, λ = 254 nm
10% MeOH/CO2, 3.0 mL/min
tR (min): major 7.13, minor 8.06
Chiralpak IC, λ = 254 nm
5% IPA/CO2, 2.5 mL/min
tR (min): major 7.92, mino 11.24
Chiralpak AD-H, λ = 254 nm
5% MeOH/CO2, 3.0 mL/min
tR (min): minor 4.47, major 5.71Ph
Me
O
CO2Et
112h
NO2
Ph
Me
O
CO2Et
113h
NO2
Ph
Me
O
CO2Et
112i
S
Ph
Me
O
CO2Et
112j
O
Ph
Me
O
CO2Et
112k
Me
Chiralpak IC, λ = 254 nm
5% IPA/CO2, 2.5 mL/min
tR (min): major 5.09, minor 9.14
Chiralpak AD-H, λ = 210 nm
2% IPA/CO2, 2.5 mL/min
tR (min): minor 4.40, major 5.52
11 >99
9112
Chiralpak IC, λ = 254 nm
10% IPA/CO2, 4.0 mL/min
tR (min): major 2.67, minor 3.51
9913
Chiralpak AD-H, λ = 254 nm
5% IPA/CO2, 2.5 mL/min
tR (min): major 5.35, minor = 5.88
>9914
O Ph
CO2Et
112l
Me
MeO
O Ph
CO2Me
112m
Me
Br
entry compound SFC analytic conditions ee (%)
Chiralpak AD-H, λ = 254 nm,
5% MeOH/CO2, 2.5 mL/min,
 tR (min): major = 2.48, minor = 2.20
>9915 Ph
Et
PhO
CO2Et
112n
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Ph
PhO
CO2Et
112p
Chiralpak AD-H, λ = 254 nm
4% MeOH/CO2, 4.0 mL/min
tR (min): major 5.06, minor 8.94
>9916
Chiralpak IC, λ = 254 nm
3% IPA/CO2, 4.0 mL/min
tR (min): major 7.16, minor 8.60
>9917
Chiralcel OD-H, λ = 254 nm
5% IPA/CO2, 2.5 mL/min
tR (min): minor 5.67, major 6.44
>9918
Ph
Bn
PhO
CO2Et
112o
Ph
PhO
CO2Et
112q
Ph
PhO
CO2Et
112r
O
Chiralcel OD-H, λ = 254 nm
5% IPA/CO2, 2.5 mL/min
tR (min): minor 10.8, major 8.0
9920
Chiralpak AD-H, λ = 254 nm
5% IPA/CO2, 2.5 mL/min
tR (min): major 9.77, minor 11.60
>9922
Ph
PhO
CO2Et
NC
112t
Ph
PhO
CO2Et
NH
112s
Chiralpak IC, λ = 254 nm
10% MeOH/CO2, 2.5 mL/min
tR (min): major 8.26, minor 9.30
>9921
Chiralpak IC, λ = 254 nm
5% IPA/CO2, 2.5 mL/min
tR (min): major 10.67, minor 9.81
34
Ph
O
CO2Et
113q
Ph19
entry compound SFC analytic conditions ee (%)
Chiralpak AD-H, λ = 254 nm
5% IPA/CO2, 2.5 mL/min
tR (min): major 10.65, minor 12.00
>9923
Ph
PhO
CO2Et
112t'
NC
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Chiralpak IC, λ = 254 nm
5% IPA/CO2, 4.0 mL/min
tR (min): major 2.02, minor 3.18
9524
Chiralpak IC, λ = 254 nm
10% IPA/CO2, 2.5 mL/min
tR (min): major 2.52, minor 2.76
>9925
Chiralpak IC, λ = 254 nm
5% MeOH/CO2, 4 mL/min
tR (min): major 6.56, minor 5.83
9926
Ph
F
PhO
CO2Et
112u
Ph
Cl
PhO
CO2Et
112v
Me
PhO
CO2Me
112w
Chiralcel OJ-H, λ = 210 nm
100% CO2, 4.0 mL/min
tR (min): minor 7.28, major 7.96
9627
Chiralcel OJ-H, λ = 210 nm
0.5% IPA/CO2, 2.5 mL/min
tR (min): minor 4.79, major 5.33
9028
Chiralcel OJ-H, λ = 210 nm
0.5% IPA/CO2, 2.5 mL/min
tR (min): minor 6.29, major 7.02
9129
Me
PhO
CO2Me
112x
Me
Et
PhO
CO2Me
112y
Me
Et
PhO
CO2Me
112y'
Ph
Me
PhO
CO2t-Bu
112z
Chiralpak IC, λ = 254 nm
5% IPA/CO2, 2.5 mL/min
tR (min): major 4.14, minor 5.80
>9930
Chiralpak IC, λ = 254 nm
5% IPA/CO2, 2.5 mL/min
tR (min): major 9.88, minor 8.48
38Ph
Me
O
CO2t-Bu
113z
Ph31
entry compound SFC analytic conditions ee (%)
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APPENDIX 5 
Stereochemical Model and Mechanistic Discussion for Iridium-
Catalyzed Allylic Alkylation  
 
A5.1 INTRODUCTION  
Following the first reports of iridium-catalyzed allylic alkylation75 and amination78 
nearly two decades ago, myriad studies investigating the underlying mechanism of regio- 
and enantioselectivity in iridium-catalyzed allylic substitutions, and the nature of role of 
Ir-phosphoramidite complexes in these processes, have been conducted.79  Seminal 
contributions from Hartwig and Helmchen79 confirmed evidence that active species in Ir-
phosphoramidite catalyzed allylic substitution processes are in situ generated iridacycles, 
formed by C–H insertion into the amidite domain of a Feringa type ligand.79a  Moreover, 
Hartwig and coworkers went on the show that only the stereocenter β to the metal center 
is crucial in affecting enantioinduction and that only one such center is requisite for 
stereocontrol.79g, 79h  
Comparatively less investigation has been undertaken to unearth the source of 
diastereoselectivity in iridium-catalyzed allylic substitution processes, in part due to the 
lack of reports describing such findings.  Herein, we speculate as to the source of 
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diastereoselectivity in our iridium catalyzed regio-, diastereo- and enantioselective allylic 
alkylation, and present a plausible catalytic cycle.  
 
A5.2 STEREOCHEMICAL MODEL FOR DIASTEREOSELECTIVITY IN IRIDIUM-
CATALYZED ALLYLIC ALKYLATION 
Feringa-type phosphoramidite ligands have been shown to form iridacycles via 
iridium(I) insertion into the C(sp3)–H bond (118, Figure A5.2.1).  Investigations by You 
and coworkers87 led to the development and N-arylphosphoramidite ligand L12, which 
was then shown to form an active iridacycle via transition metal insertion into the C(sp2)–
H bond of the aryl group (119, Figure A5.2.1). DFT studies and single crystal X-ray 
diffraction analysis conducted by the You group87 revealed that the (π-allyl)-Ir complex 
formed upon oxidative addition of iridium(I) into cinnamyl derived allyl carbonates is 
predominately the exo isomer104 (120, Figure A5.2.1).  This is at odds from what is 
observed with Feringa ligand-derived iridacycles.  We speculate that both the ligand 
structure, in particular the aromatic amine moiety, and the unique allyl orientation may 
play a role in imparting L12 its selectivity profile.  
 
Figure A5.2.1.  Selected iridium-phosphoramidite complexes: 118 Feringa type; 119 N-
arylphosphoramidite (or You) type; 120 (π-allyl)-Ir complex with You type ligand.  
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In the course of our studies in iridium-catalyzed allylic alkylation, we were able to 
recrystallize β-Ketoester 112f from i-PrOH/hexanes such that crystals suitable for X-ray 
analysis were obtained.  Via single crystal X-ray diffraction studies, we were able to 
unambiguously assign the absolute stereochemistry of the products generated in studies 
presented in Chapter 4 (see Appendix 5 vide infra for detail).  With this data in hand, and 
with knowledge of the spatial orientation of (π-allyl)-Ir complex 120, we are able to 
begin speculation as to the origin of stereoselectivity in our allylic alkylation reaction.  
What we believe to be the two most likely approaches of linear enolate 
nucleophiles prior to the bond-forming event are depicted in Figure A5.2.2 (121 and 122).  
In this depiction, the diene ligand, BINOL backbone of the ligand and protruding 
tetrahydroquinoline methyl create a steric environment around the metal center in which 
approach of the nucleophile is necessarily via the bottom-right quadrant.  Our finding that 
aliphatic ketone substrates fare poorly with respect to diastereoselectivity leads us to 
hypothesize a potential π-π stacking interaction between the tetrahydroquinoline and 
ketone aryl group may be important in orienting the nucleophile.  Our finding that lithium 
is a crucial component of the reaction mixture leads us to suppose that rigidly enforced 
enolate geometry is also essential with respect to diastereomeric outcome.  Given these 
data, we believe that the approach shown to the left (121) is most plausible, in that both a 
π-stacking interaction is possible and enolate geometry is enforced.  
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Figure A5.2.2.  Approach of the enolate nucloephile in the Ir-catalyzed allylic alkylation.  
 
 
 
The catalytic cycle we propose to be operative is depicted below in Figure A5.2.3.  
Beginning with dissociation of the precatalyst dimer, and association of an equivalent of 
iridium with ligand, we arrive at species 123.  Base promoted C–H insertion followed by 
loss of an associated ligand delivers the active catalyst species  (119).105  This complex 
may then undergo oxidative addition into cinnamyl carbonate 98 to deliver exo (π-allyl)-
iridium complex 120, which may then be attacked by an enolate nucleophile to give 
olefin-bound iridium complex 126.  Finally, dissociation of the olefin gives the allylated 
product and regenerates the active catalyst species. 
While the cycle presented below is plausible, and is in line with what is known in 
the literature79 it is also conjecture.  More evidence is needed to confirm or support a 
variety of discreet steps; for example the reversibility of C–H insertion (i.e., 125 → 123, 
124 → 123).  Moreover, the discreet steps in such a cycle may change depending on the 
particular precatalyst, base and ligand that are employed.76d As such, further 
investigations to elucidate the mechanism of this iridium-catalyzed allylic alkylation are 
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warranted, and should serve to inform the development of new modes of reactivity for 
these iridium complexes.  
 
Figure A5.2.3.  Proposed catalytic cycle for iridium-N-arylphosphoramidite complex-catalyzed allylic 
alkylation 
 
 
A5.3 REFERENCES AND NOTES 
 
(104) The exo complex is defined as having the C2−H bond of the allylic moiety 
pointing toward diene, whereas the endo isomer places the C2−H bond of the 
allylic moiety pointing toward the amine part of the ligand. 
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(105) While this has been shown to be the case for Feringa type ligands, unpublished 
work by the You group indicate that in the case of N-aryl phosphoramidite 
ligands, the iridacycle does not coordinate a second equivalent of ligand.  
  
Appendix 6 – Spectra Related to Chapter 6 
 
 
APPENDIX 6 
Spectra Related to Chapter 4:  
Enantio-, Diastereo- and Regioselective Iridium-Catalyzed 
Asymmetric Allylic Alkylation of Acyclic β-Ketoesters 
 
 
 
 
390
Appendix 6 – Spectra Related to Chapter 4 
 
-
2
-
1
0
1
2
3
4
5
6
7
8
9
1
0
1
1
1
2
1
3
1
4
p
p
m
  
Fi
gu
re
 A
6.
1 
 1 H
 N
M
R
 (5
00
 M
H
z,
 C
D
C
l 3)
 o
f c
om
po
un
d 
11
2a
. 
Ph
M
e
Ph
O
CO
2E
t
11
2a
391
Appendix 6 – Spectra Related to Chapter 4 
 
020406080100120140160180200
ppm
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A6.2  Infrared spectrum (thin film/NaCl) of compound 112a. 
Figure A6.3  13C NMR (125 MHz, CDCl3) of compound 112a. 
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Figure A6.5 Infrared spectrum (thin film/NaCl) of compound 112b. 
Figure A6.6  13C NMR (125 MHz, CDCl3) of compound 112b. 
394
Appendix 6 – Spectra Related to Chapter 4 
 
0
1
2
3
4
5
6
7
8
9
10
pp
m
  
Fi
gu
re
 A
6.
7 
 1 H
 N
M
R
 (5
00
 M
H
z,
 C
D
C
l 3)
 o
f c
om
po
un
d 
11
2c
. 
Ph
M
eO
CO
2E
t
11
2cO
M
e
395
Appendix 6 – Spectra Related to Chapter 4 
 
020406080100120140160180200
ppm
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A6.8  Infrared spectrum (thin film/NaCl) of compound 112c. 
Figure A6.9  13C NMR (125 MHz, CDCl3) of compound 112c. 
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Figure A6.11  Infrared spectrum (thin film/NaCl) of compound 112d. 
Figure A6.12  13C NMR (125 MHz, CDCl3) of compound 112d. 
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Figure A6.14  Infrared spectrum (thin film/NaCl) of compound 112e. 
Figure A6.15  13C NMR (125 MHz, CDCl3) of compound 112e. 
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Figure A6.17  Infrared spectrum (thin film/NaCl) of compound 112f. 
Figure A6.18  13C NMR (125 MHz, CDCl3) of compound 112f. 
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Figure A6.20  Infrared spectrum (thin film/NaCl) of compound 112g. 
Figure A6.21  13C NMR (125 MHz, CDCl3) of compound 112g. 
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Figure A6.23  Infrared spectrum (thin film/NaCl) of compound 112h. 
Figure A6.24  13C NMR (125 MHz, CDCl3) of compound 112h. 
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Figure A6.26  Infrared spectrum (thin film/NaCl) of compound 113h. 
Figure A6.27  13C NMR (125 MHz, CDCl3) of compound 113h. 
408
Appendix 6 – Spectra Related to Chapter 4 
 
0
1
2
3
4
5
6
7
8
9
10
pp
m
  
Fi
gu
re
 A
6.
28
  1
H
 N
M
R
 (5
00
 M
H
z,
 C
D
C
l 3)
 o
f c
om
po
un
d 
11
2i
. 
Ph
M
eO
CO
2E
t
11
2i
S
409
Appendix 6 – Spectra Related to Chapter 4 
 
020406080100120140160180200
ppm
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A6.29  Infrared spectrum (thin film/NaCl) of compound 112i. 
Figure A6.30  13C NMR (125 MHz, CDCl3) of compound 112i. 
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Figure A6.32  Infrared spectrum (thin film/NaCl) of compound 112j. 
Figure A6.33  13C NMR (125 MHz, CDCl3) of compound 112j. 
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Figure A6.35  Infrared spectrum (thin film/NaCl) of compound 112k. 
Figure A6.36  13C NMR (125 MHz, CDCl3) of compound 112k. 
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Figure A6.38  Infrared spectrum (thin film/NaCl) of compound 112l. 
Figure A6.39  13C NMR (125 MHz, CDCl3) of compound 112l. 
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Figure A6.41  Infrared spectrum (thin film/NaCl) of compound 112m. 
Figure A6.42  13C NMR (125 MHz, CDCl3) of compound 112m. 
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Figure A6.44  Infrared spectrum (thin film/NaCl) of compound 112n. 
Figure A6.45  13C NMR (125 MHz, CDCl3) of compound 112n. 
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Figure A6.47  Infrared spectrum (thin film/NaCl) of compound 112o. 
Figure A6.48  13C NMR (125 MHz, CDCl3) of compound 112o. 
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Figure A6.50  Infrared spectrum (thin film/NaCl) of compound 112p. 
Figure A6.51  13C NMR (125 MHz, CDCl3) of compound 112p. 
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Figure A6.53  Infrared spectrum (thin film/NaCl) of compound 112q. 
Figure A6.54  13C NMR (125 MHz, CDCl3) of compound 112q. 
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Figure A6.56  Infrared spectrum (thin film/NaCl) of compound 113q. 
Figure A6.57  13C NMR (125 MHz, CDCl3) of compound 113q. 
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Figure A6.59  Infrared spectrum (thin film/NaCl) of compound 112r. 
Figure A6.60  13C NMR (125 MHz, CDCl3) of compound 112r. 
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Figure A6.62  Infrared spectrum (thin film/NaCl) of compound 112s. 
Figure A6.63  13C NMR (125 MHz, CDCl3) of compound 112s. 
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Figure A6.65  Infrared spectrum (thin film/NaCl) of compound 112t. 
Figure A6.66  13C NMR (125 MHz, CDCl3) of compound 112t. 
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Figure A6.68  Infrared spectrum (thin film/NaCl) of compound 112t’. 
Figure A6.69  13C NMR (125 MHz, CDCl3) of compound 112t’. 
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Figure A6.71  Infrared spectrum (thin film/NaCl) of compound 112u. 
Figure A6.72  13C NMR (125 MHz, CDCl3) of compound 112u. 
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Figure A6.74  Infrared spectrum (thin film/NaCl) of compound 112v. 
Figure A6.75  13C NMR (125 MHz, CDCl3) of compound 112v. 
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Figure A6.77  Infrared spectrum (thin film/NaCl) of compound 112w. 
Figure A6.78  13C NMR (125 MHz, CDCl3) of compound 112w. 
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Figure A6.80  Infrared spectrum (thin film/NaCl) of compound 112x. 
Figure A6.81  13C NMR (125 MHz, CDCl3) of compound 112x. 
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Figure A6.83  Infrared spectrum (thin film/NaCl) of compound 112y. 
Figure A6.84  13C NMR (125 MHz, CDCl3) of compound 112y. 
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Figure A6.86  Infrared spectrum (thin film/NaCl) of compound 112y’. 
Figure A6.87  13C NMR (125 MHz, CDCl3) of compound 112y’. 
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Figure A6.89  Infrared spectrum (thin film/NaCl) of compound 112z. 
Figure A6.90  13C NMR (125 MHz, CDCl3) of compound 112z. 
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Figure A6.92  Infrared spectrum (thin film/NaCl) of compound 113z. 
Figure A6.93  13C NMR (125 MHz, CDCl3) of compound 113z. 
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Figure A6.95  Infrared spectrum (thin film/NaCl) of compound 114. 
Figure A6.96  13C NMR (125 MHz, CDCl3) of compound 114. 
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Figure A6.98  Infrared spectrum (thin film/NaCl) of compound 116. 
Figure A6.99  13C NMR (125 MHz, CDCl3) of compound 116. 
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Figure A6.104  Infrared spectrum (thin film/NaCl) of compound 115. 
Figure A6.105  13C NMR (125 MHz, CDCl3) of compound 115. 
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Figure A6.107  Infrared spectrum (thin film/NaCl) of compound 117a. 
Figure A6.108  13C NMR (125 MHz, CDCl3) of compound 117a. 
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Figure A6.110  Infrared spectrum (thin film/NaCl) of compound 117b. 
Figure A6.111  13C NMR (125 MHz, CDCl3) of compound 117b. 
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APPENDIX 7 
X-ray Crystallography Reports 
Relevant to Chapter 4 
 
A7.1 CRYSTAL STRUCTURE ANALYSIS FOR COMPOUND 117  
The mixture of diastereomers 117 were recrystallized from i-PrOH/heptane (liquid/liquid 
diffusion) to provide crystals suitable for X-ray analysis. NOTE: Crystallographic data 
have been deposited in the Cambridge Database (CCDC), 12 Union Road, Cambridge 
CB2 1EZ, UK, and copies can be obtained on request, free of charge, by quoting the 
publication citation and the deposition number CCDC 959511. 
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Figure A7.1.1. ORTEP drawing of 117.  
 
Table A7.1. Crystal Data and Structure Analysis Details for diol 117. 
Empirical formula  C19 H21 Br O2 
Formula weight  361.27 
Crystallization solvent  i-PrOH/heptane 
Crystal shape  plate 
Crystal color  colourless  
Crystal size 0.06 x 0.16 x 0.45 mm 
 
 Data Collection  
Preliminary photograph(s)  rotation  
Type of diffractometer  Bruker APEX-II CCD 
Wavelength  0.71073 Å  MoK 
Data collection temperature  100 K 
Theta range for 9925 reflections used 
in lattice determination  2.31 to 24.19° 
Unit cell dimensions a = 11.871(3) Å 〈= 90° 
 b = 13.179(3) Å ®= 90° 
 c = 21.761(5) Å © = 90° 
Volume 3404.5(13) Å3 
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Z 8 
Crystal system  orthorhombic 
Space group  P 21 21 21   (# 19) 
Density (calculated) 1.410 g/cm3 
F(000) 1488 
Theta range for data collection 1.8 to 32.3° 
Completeness to theta = 25.000° 99.8%  
Index ranges -17 ″ h ″ 17, -19 ″ k ″ 19, -32 ″ l ″ 32 
Data collection scan type  and	  scans	  
Reflections collected 88198 
Independent reflections 11569 [Rint= 0.1174] 
Reflections > 2⌠(I) 8213  
Average ⌠(I)/(net I) 0.0905 
Absorption coefficient 2.42 mm-1 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.0000 and 0.6406  
 
Structure Solution and Refinement 
Primary solution method  dual 
Secondary solution method  ? 
Hydrogen placement  geom 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 11569 / 0 / 403 
Treatment of hydrogen atoms  constr 
Goodness-of-fit on F2 1.31 
Final R indices [I>2⌠(I), 8213 reflections] R1 = 0.0549, wR2 = 0.1052 
R indices (all data) R1 = 0.0967, wR2 = 0.1137 
Type of weighting scheme used calc 
Weighting scheme used w=1/[^2^(Fo^2^)+(0.0300P)^2^] where 
P=(Fo^2^+2Fc^2^)/3 
Max shift/error  0.000 
Average shift/error  0.000 
Absolute structure parameter 0.032(5) 
Extinction coefficient n/a 
Largest diff. peak and hole 1.70 and -0.98 e·Å-3 
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  Programs Used  
Cell refinement   SAINT V8.32B (Bruker-AXS, 2007) 
Data collection   APEX2 2013.6-2 (Bruker-AXS, 2007) 
Data reduction   SAINT V8.32B (Bruker-AXS, 2007) 
Structure solution   SHELXT (Sheldrick, 2012) 
Structure refinement   SHELXL-2013/2 (Sheldrick, 2013) 
Graphics  DIAMOND 3 (Crystal Impact, 1999) 
 
Table A7.2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 
103) for 117.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.  
________________________________________________________________________________  
 x y z Ueq 
________________________________________________________________________________   
Br(1) 6018(1) 702(1) 2623(1) 24(1) 
Br(1B) 2988(1) 6376(1) 6793(1) 29(1) 
O(1) 2594(3) 2303(2) 5173(1) 17(1) 
O(1B) 7801(3) 4619(2) 5244(2) 18(1) 
O(2B) 9886(3) 5315(3) 5428(2) 24(1) 
O(2) 1686(3) 4120(3) 5230(2) 24(1) 
C(12) 4092(4) 2845(3) 5863(2) 16(1) 
C(18) 2777(4) 4578(3) 5206(2) 18(1) 
C(9) 3015(5) 4701(4) 3852(2) 18(1) 
C(18B) 9487(4) 6230(4) 5137(2) 19(1) 
C(8B) 6117(4) 7301(3) 6134(2) 17(1) 
C(2B) 8002(4) 6397(4) 5956(2) 15(1) 
C(1B) 8221(4) 6404(4) 5243(2) 16(1) 
C(1) 3608(4) 3879(3) 4879(2) 15(1) 
C(15) 4893(5) 2837(4) 7069(2) 24(1) 
C(14) 3765(4) 3049(4) 6953(2) 22(1) 
C(11) 3668(4) 2816(4) 5202(2) 16(1) 
C(6) 5187(4) 1642(4) 3110(2) 18(1) 
C(17) 5219(4) 2643(4) 5991(2) 21(1) 
C(2) 3195(4) 3711(4) 4194(2) 16(1) 
C(7B) 4982(4) 7302(4) 6324(2) 18(1) 
C(8) 4928(4) 3307(4) 3522(2) 20(1) 
C(3) 3933(4) 2995(3) 3819(2) 14(1) 
C(13) 3366(4) 3055(4) 6356(2) 17(1) 
C(19B) 7923(4) 7429(4) 4952(2) 19(1) 
C(12B) 7652(4) 5450(4) 4243(2) 18(1) 
C(6B) 4508(4) 6393(4) 6517(2) 21(1) 
C(19) 4775(4) 4374(4) 4898(2) 20(1) 
C(16) 5615(4) 2644(4) 6592(2) 22(1) 
C(11B) 7514(4) 5552(3) 4936(2) 15(1) 
C(4) 3595(4) 1989(4) 3747(2) 16(1) 
C(5) 4218(4) 1308(4) 3397(2) 19(1) 
C(3B) 6758(4) 6422(4) 6135(2) 15(1) 
C(9B) 8651(4) 7213(4) 6288(2) 21(1) 
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C(7) 5550(4) 2637(4) 3168(2) 19(1) 
C(13B) 8529(4) 4866(4) 3986(2) 22(1) 
C(14B) 8635(5) 4779(4) 3355(2) 25(1) 
C(4B) 6236(4) 5523(4) 6338(2) 18(1) 
C(10B) 9604(4) 7033(4) 6590(2) 27(1) 
C(10) 2036(5) 4974(4) 3618(2) 27(1) 
C(15B) 7867(5) 5270(4) 2970(2) 28(1) 
C(17B) 6896(4) 5927(4) 3852(2) 22(1) 
C(5B) 5122(4) 5503(4) 6526(2) 21(1) 
C(16B) 7008(5) 5844(4) 3217(2) 28(1) 
________________________________________________________________________________  
 
Table A7.3.   Bond lengths [Å] and angles [°] for 117. 
___________________________________________________________________________________  
Br(1)-C(6)  1.906(5) 
Br(1B)-C(6B)  1.902(5) 
O(1)-H(1)  0.8400 
O(1)-C(11)  1.445(5) 
O(1B)-H(1B)  0.8400 
O(1B)-C(11B)  1.443(5) 
O(2B)-H(2B)  0.8400 
O(2B)-C(18B)  1.442(6) 
O(2)-H(2)  0.8400 
O(2)-C(18)  1.430(5) 
C(12)-C(11)  1.525(6) 
C(12)-C(17)  1.391(7) 
C(12)-C(13)  1.404(6) 
C(18)-H(18A)  0.9900 
C(18)-H(18B)  0.9900 
C(18)-C(1)  1.527(6) 
C(9)-H(9)  0.9500 
C(9)-C(2)  1.517(6) 
C(9)-C(10)  1.319(7) 
C(18B)-H(18C)  0.9900 
C(18B)-H(18D)  0.9900 
C(18B)-C(1B)  1.538(6) 
C(8B)-H(8B)  0.9500 
C(8B)-C(7B)  1.409(7) 
C(8B)-C(3B)  1.386(7) 
C(2B)-H(2BA)  1.0000 
C(2B)-C(1B)  1.574(6) 
C(2B)-C(3B)  1.527(6) 
C(2B)-C(9B)  1.507(7) 
C(1B)-C(19B)  1.532(6) 
C(1B)-C(11B)  1.553(6) 
C(1)-C(11)  1.568(6) 
C(1)-C(2)  1.585(6) 
C(1)-C(19)  1.531(6) 
C(15)-H(15)  0.9500 
C(15)-C(14)  1.391(7) 
C(15)-C(16)  1.369(7) 
C(14)-H(14)  0.9500 
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C(14)-C(13)  1.382(7) 
C(11)-H(11)  1.0000 
C(6)-C(5)  1.381(7) 
C(6)-C(7)  1.386(7) 
C(17)-H(17)  0.9500 
C(17)-C(16)  1.391(6) 
C(2)-H(2A)  1.0000 
C(2)-C(3)  1.524(6) 
C(7B)-H(7B)  0.9500 
C(7B)-C(6B)  1.389(7) 
C(8)-H(8)  0.9500 
C(8)-C(3)  1.408(6) 
C(8)-C(7)  1.385(7) 
C(3)-C(4)  1.394(7) 
C(13)-H(13)  0.9500 
C(19B)-H(19D)  0.9800 
C(19B)-H(19E)  0.9800 
C(19B)-H(19F)  0.9800 
C(12B)-C(11B)  1.522(6) 
C(12B)-C(13B)  1.411(7) 
C(12B)-C(17B)  1.387(7) 
C(6B)-C(5B)  1.381(7) 
C(19)-H(19A)  0.9800 
C(19)-H(19B)  0.9800 
C(19)-H(19C)  0.9800 
C(16)-H(16)  0.9500 
C(11B)-H(11B)  1.0000 
C(4)-H(4)  0.9500 
C(4)-C(5)  1.391(7) 
C(5)-H(5)  0.9500 
C(3B)-C(4B)  1.408(7) 
C(9B)-H(9B)  0.9500 
C(9B)-C(10B)  1.329(7) 
C(7)-H(7)  0.9500 
C(13B)-H(13B)  0.9500 
C(13B)-C(14B)  1.384(7) 
C(14B)-H(14B)  0.9500 
C(14B)-C(15B)  1.398(8) 
C(4B)-H(4B)  0.9500 
C(4B)-C(5B)  1.385(7) 
C(10B)-H(10C)  0.9500 
C(10B)-H(10D)  0.9500 
C(10)-H(10A)  0.9500 
C(10)-H(10B)  0.9500 
C(15B)-H(15B)  0.9500 
C(15B)-C(16B)  1.379(8) 
C(17B)-H(17B)  0.9500 
C(17B)-C(16B)  1.392(7) 
C(5B)-H(5B)  0.9500 
C(16B)-H(16B)  0.9500 
 
C(11)-O(1)-H(1) 109.5 
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C(11B)-O(1B)-H(1B) 109.5 
C(18B)-O(2B)-H(2B) 109.5 
C(18)-O(2)-H(2) 109.5 
C(17)-C(12)-C(11) 120.1(4) 
C(17)-C(12)-C(13) 118.4(4) 
C(13)-C(12)-C(11) 121.5(4) 
O(2)-C(18)-H(18A) 109.6 
O(2)-C(18)-H(18B) 109.6 
O(2)-C(18)-C(1) 110.3(4) 
H(18A)-C(18)-H(18B) 108.1 
C(1)-C(18)-H(18A) 109.6 
C(1)-C(18)-H(18B) 109.6 
C(2)-C(9)-H(9) 118.4 
C(10)-C(9)-H(9) 118.4 
C(10)-C(9)-C(2) 123.3(5) 
O(2B)-C(18B)-H(18C) 109.1 
O(2B)-C(18B)-H(18D) 109.1 
O(2B)-C(18B)-C(1B) 112.3(4) 
H(18C)-C(18B)-H(18D) 107.9 
C(1B)-C(18B)-H(18C) 109.1 
C(1B)-C(18B)-H(18D) 109.1 
C(7B)-C(8B)-H(8B) 119.2 
C(3B)-C(8B)-H(8B) 119.2 
C(3B)-C(8B)-C(7B) 121.7(4) 
C(1B)-C(2B)-H(2BA) 106.1 
C(3B)-C(2B)-H(2BA) 106.1 
C(3B)-C(2B)-C(1B) 114.3(3) 
C(9B)-C(2B)-H(2BA) 106.1 
C(9B)-C(2B)-C(1B) 112.5(4) 
C(9B)-C(2B)-C(3B) 110.9(4) 
C(18B)-C(1B)-C(2B) 108.0(4) 
C(18B)-C(1B)-C(11B) 110.8(4) 
C(19B)-C(1B)-C(18B) 107.2(4) 
C(19B)-C(1B)-C(2B) 112.0(4) 
C(19B)-C(1B)-C(11B) 109.6(4) 
C(11B)-C(1B)-C(2B) 109.3(4) 
C(18)-C(1)-C(11) 111.0(4) 
C(18)-C(1)-C(2) 108.8(4) 
C(18)-C(1)-C(19) 108.3(4) 
C(11)-C(1)-C(2) 108.1(4) 
C(19)-C(1)-C(11) 109.2(4) 
C(19)-C(1)-C(2) 111.4(4) 
C(14)-C(15)-H(15) 119.9 
C(16)-C(15)-H(15) 119.9 
C(16)-C(15)-C(14) 120.2(4) 
C(15)-C(14)-H(14) 120.0 
C(13)-C(14)-C(15) 120.1(4) 
C(13)-C(14)-H(14) 120.0 
O(1)-C(11)-C(12) 110.2(4) 
O(1)-C(11)-C(1) 111.0(3) 
O(1)-C(11)-H(11) 106.9 
C(12)-C(11)-C(1) 114.5(4) 
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C(12)-C(11)-H(11) 106.9 
C(1)-C(11)-H(11) 106.9 
C(5)-C(6)-Br(1) 118.3(4) 
C(5)-C(6)-C(7) 121.3(4) 
C(7)-C(6)-Br(1) 120.4(4) 
C(12)-C(17)-H(17) 119.6 
C(12)-C(17)-C(16) 120.8(4) 
C(16)-C(17)-H(17) 119.6 
C(9)-C(2)-C(1) 112.6(4) 
C(9)-C(2)-H(2A) 106.2 
C(9)-C(2)-C(3) 110.5(4) 
C(1)-C(2)-H(2A) 106.2 
C(3)-C(2)-C(1) 114.3(4) 
C(3)-C(2)-H(2A) 106.2 
C(8B)-C(7B)-H(7B) 120.8 
C(6B)-C(7B)-C(8B) 118.4(4) 
C(6B)-C(7B)-H(7B) 120.8 
C(3)-C(8)-H(8) 119.4 
C(7)-C(8)-H(8) 119.4 
C(7)-C(8)-C(3) 121.1(4) 
C(8)-C(3)-C(2) 123.2(4) 
C(4)-C(3)-C(2) 118.9(4) 
C(4)-C(3)-C(8) 117.8(4) 
C(12)-C(13)-H(13) 119.8 
C(14)-C(13)-C(12) 120.4(4) 
C(14)-C(13)-H(13) 119.8 
C(1B)-C(19B)-H(19D) 109.5 
C(1B)-C(19B)-H(19E) 109.5 
C(1B)-C(19B)-H(19F) 109.5 
H(19D)-C(19B)-H(19E) 109.5 
H(19D)-C(19B)-H(19F) 109.5 
H(19E)-C(19B)-H(19F) 109.5 
C(13B)-C(12B)-C(11B) 121.4(4) 
C(17B)-C(12B)-C(11B) 119.9(4) 
C(17B)-C(12B)-C(13B) 118.8(4) 
C(7B)-C(6B)-Br(1B) 119.3(4) 
C(5B)-C(6B)-Br(1B) 119.1(4) 
C(5B)-C(6B)-C(7B) 121.6(4) 
C(1)-C(19)-H(19A) 109.5 
C(1)-C(19)-H(19B) 109.5 
C(1)-C(19)-H(19C) 109.5 
H(19A)-C(19)-H(19B) 109.5 
H(19A)-C(19)-H(19C) 109.5 
H(19B)-C(19)-H(19C) 109.5 
C(15)-C(16)-C(17) 120.1(5) 
C(15)-C(16)-H(16) 120.0 
C(17)-C(16)-H(16) 120.0 
O(1B)-C(11B)-C(1B) 106.8(3) 
O(1B)-C(11B)-C(12B) 111.1(4) 
O(1B)-C(11B)-H(11B) 107.7 
C(1B)-C(11B)-H(11B) 107.7 
C(12B)-C(11B)-C(1B) 115.5(4) 
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C(12B)-C(11B)-H(11B) 107.7 
C(3)-C(4)-H(4) 119.2 
C(5)-C(4)-C(3) 121.5(4) 
C(5)-C(4)-H(4) 119.2 
C(6)-C(5)-C(4) 119.0(5) 
C(6)-C(5)-H(5) 120.5 
C(4)-C(5)-H(5) 120.5 
C(8B)-C(3B)-C(2B) 123.3(4) 
C(8B)-C(3B)-C(4B) 117.5(4) 
C(4B)-C(3B)-C(2B) 119.2(4) 
C(2B)-C(9B)-H(9B) 118.5 
C(10B)-C(9B)-C(2B) 123.0(5) 
C(10B)-C(9B)-H(9B) 118.5 
C(6)-C(7)-H(7) 120.4 
C(8)-C(7)-C(6) 119.2(4) 
C(8)-C(7)-H(7) 120.4 
C(12B)-C(13B)-H(13B) 119.8 
C(14B)-C(13B)-C(12B) 120.4(5) 
C(14B)-C(13B)-H(13B) 119.8 
C(13B)-C(14B)-H(14B) 120.1 
C(13B)-C(14B)-C(15B) 119.8(5) 
C(15B)-C(14B)-H(14B) 120.1 
C(3B)-C(4B)-H(4B) 119.0 
C(5B)-C(4B)-C(3B) 122.0(4) 
C(5B)-C(4B)-H(4B) 119.0 
C(9B)-C(10B)-H(10C) 120.0 
C(9B)-C(10B)-H(10D) 120.0 
H(10C)-C(10B)-H(10D) 120.0 
C(9)-C(10)-H(10A) 120.0 
C(9)-C(10)-H(10B) 120.0 
H(10A)-C(10)-H(10B) 120.0 
C(14B)-C(15B)-H(15B) 119.9 
C(16B)-C(15B)-C(14B) 120.2(5) 
C(16B)-C(15B)-H(15B) 119.9 
C(12B)-C(17B)-H(17B) 119.6 
C(12B)-C(17B)-C(16B) 120.8(5) 
C(16B)-C(17B)-H(17B) 119.6 
C(6B)-C(5B)-C(4B) 118.9(5) 
C(6B)-C(5B)-H(5B) 120.6 
C(4B)-C(5B)-H(5B) 120.6 
C(15B)-C(16B)-C(17B) 120.1(5) 
C(15B)-C(16B)-H(16B) 120.0 
C(17B)-C(16B)-H(16B) 120.0 
  ___________________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
Table A7.4.   Anisotropic displacement parameters  (Å2x 104 ) for 117.  The anisotropic 
displacement factor exponent takes the form 
-2π2 [ h2 a*2U 11  + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
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______________________________________________________________________________  
Br(1) 216(2)  209(2) 285(2)  -37(2) 36(2)  57(2) 
Br(1B) 176(2)  307(3) 382(3)  10(2) 76(2)  -18(2) 
O(1) 164(16)  123(16) 218(17)  -4(14) -13(13)  -28(13) 
O(1B) 158(17)  130(16) 254(17)  27(13) -4(14)  -4(13) 
O(2B) 144(17)  223(19) 340(20)  29(15) 19(15)  75(15) 
O(2) 149(16)  138(18) 430(20)  -13(16) 45(15)  28(13) 
C(12) 160(20)  120(20) 190(20)  -7(17) 17(18)  -13(19) 
C(18) 140(20)  120(20) 260(20)  -3(18) 8(18)  -9(17) 
C(9) 240(20)  120(20) 200(20)  -3(17) -10(20)  0(20) 
C(18B) 160(20)  150(20) 260(20)  20(20) 33(18)  -3(19) 
C(8B) 200(20)  110(20) 190(20)  -5(17) 5(19)  -20(20) 
C(2B) 131(19)  120(20) 200(20)  15(18) -1(18)  20(20) 
C(1B) 150(20)  110(20) 220(20)  21(19) -13(17)  0(18) 
C(1) 150(20)  120(20) 190(20)  -8(17) 0(17)  8(17) 
C(15) 360(30)  220(30) 130(20)  13(19) -30(20)  -30(20) 
C(14) 270(30)  200(20) 170(20)  11(18) 60(19)  -20(20) 
C(11) 120(20)  130(20) 210(20)  20(18) 20(17)  -36(17) 
C(6) 170(20)  190(20) 180(20)  10(18) -5(18)  56(18) 
C(17) 180(20)  240(30) 210(20)  10(20) 16(19)  10(20) 
C(2) 140(20)  140(20) 200(20)  10(18) 6(17)  13(18) 
C(7B) 180(20)  150(20) 210(20)  -17(18) 11(19)  20(20) 
C(8) 150(20)  190(20) 250(20)  -13(19) -1(19)  -20(19) 
C(3) 140(20)  150(20) 136(19)  -1(16) -2(17)  15(19) 
C(13) 140(20)  190(20) 200(20)  5(19) 37(18)  -7(19) 
C(19B) 200(20)  140(20) 230(20)  -3(18) 40(20)  10(20) 
C(12B) 180(20)  140(20) 220(20)  5(18) -18(18)  -6(18) 
C(6B) 170(20)  250(30) 200(20)  -10(20) 3(18)  0(20) 
C(19) 170(20)  240(30) 200(20)  0(20) -18(17)  -60(20) 
C(16) 200(20)  230(30) 240(30)  30(20) -33(19)  10(20) 
C(11B) 150(20)  130(20) 170(20)  20(17) -14(17)  10(18) 
C(4) 150(20)  160(20) 180(20)  0(18) -5(17)  -22(18) 
C(5) 210(20)  140(20) 210(20)  21(18) 0(17)  0(20) 
C(3B) 150(20)  140(20) 160(20)  -4(18) -8(16)  -5(18) 
C(9B) 190(20)  190(20) 240(20)  -40(20) 31(19)  -40(20) 
C(7) 150(20)  220(20) 200(20)  0(20) 13(19)  3(19) 
C(13B) 230(30)  170(20) 240(30)  -20(20) 0(20)  20(20) 
C(14B) 260(30)  220(30) 260(30)  -50(20) 40(20)  40(20) 
C(4B) 210(30)  140(20) 180(20)  2(17) 0(18)  10(19) 
C(10B) 210(30)  260(30) 330(30)  -50(20) -10(20)  -20(20) 
C(10) 330(30)  200(30) 280(30)  40(20) -30(20)  20(30) 
C(15B) 310(30)  330(30) 220(20)  -50(20) 20(20)  -10(30) 
C(17B) 190(20)  200(30) 270(20)  -9(19) -20(20)  40(20) 
C(5B) 230(30)  160(30) 240(20)  0(19) 30(20)  -50(20) 
C(16B) 280(30)  310(30) 230(20)  10(20) -30(20)  40(20) 
______________________________________________________________________________  
 
Table A7.5.   Hydrogen coordinates ( x 103) and isotropic  displacement parameters (Å2x 103) for 
117. 
________________________________________________________________________________  
 x  y  z  Uiso 
________________________________________________________________________________  
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H(1) 239 225 480 25 
H(1B) 849 462 533 27 
H(2B) 1057 523 535 36 
H(2) 175 351 533 36 
H(18A) 304 472 563 21 
H(18B) 273 523 498 21 
H(9) 364 515 380 22 
H(18C) 963 619 469 23 
H(18D) 991 682 530 23 
H(8B) 645 792 600 20 
H(2BA) 830 574 611 18 
H(15) 516 283 748 28 
H(14) 327 319 728 26 
H(11) 422 240 496 19 
H(17) 572 250 566 25 
H(2A) 244 338 422 19 
H(7B) 455 791 632 22 
H(8) 518 399 356 24 
H(13) 260 320 628 21 
H(19D) 838 796 514 29 
H(19E) 712 757 502 29 
H(19F) 808 740 451 29 
H(19A) 476 502 467 30 
H(19B) 533 392 471 30 
H(19C) 499 451 533 30 
H(16) 639 251 667 27 
H(11B) 670 570 502 18 
H(4) 292 176 394 20 
H(5) 398 62 336 23 
H(9B) 837 789 628 25 
H(7) 622 286 297 23 
H(13B) 905 453 425 26 
H(14B) 923 439 318 30 
H(4B) 666 491 635 21 
H(10C) 990 637 660 32 
H(10D) 998 757 679 32 
H(10A) 140 454 366 32 
H(10B) 197 560 341 32 
H(15B) 794 521 254 34 
H(17B) 630 632 402 26 
H(5B) 479 489 666 25 
H(16B) 649 618 295 33 
________________________________________________________________________________  
 
Table A7.6. Hydrogen bonds for 117  [Å and °]. 
 _______________________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
_______________________________________________________________________ 
 O(1B)-H(1B)...O(2B) 0.84 1.91 2.669(5) 150.6 
 O(2B)-H(2B)...O(2)#1 0.84 1.99 2.689(5) 140.2 
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 O(2)-H(2)...O(1) 0.84 1.91 2.629(5) 142.7 
_______________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1 x+1,y,z       
________________________________________________________________________________ 
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 Table A7.7. Torsion angles [°] for 117. 
________________________________________________________________  
Br(1)-C(6)-C(5)-C(4) -179.3(3) 
Br(1)-C(6)-C(7)-C(8) 179.6(3) 
Br(1B)-C(6B)-C(5B)-C(4B) -178.6(3) 
O(2B)-C(18B)-C(1B)-C(2B) 55.2(5) 
O(2B)-C(18B)-C(1B)-C(19B) 176.0(4) 
O(2B)-C(18B)-C(1B)-C(11B) -64.4(5) 
O(2)-C(18)-C(1)-C(11) -57.0(5) 
O(2)-C(18)-C(1)-C(2) 61.9(5) 
O(2)-C(18)-C(1)-C(19) -176.9(4) 
C(12)-C(17)-C(16)-C(15) 0.5(8) 
C(18)-C(1)-C(11)-O(1) 63.0(5) 
C(18)-C(1)-C(11)-C(12) -62.6(5) 
C(18)-C(1)-C(2)-C(9) 54.6(5) 
C(18)-C(1)-C(2)-C(3) -178.1(4) 
C(9)-C(2)-C(3)-C(8) 45.4(6) 
C(9)-C(2)-C(3)-C(4) -132.4(4) 
C(18B)-C(1B)-C(11B)-O(1B) 64.1(5) 
C(18B)-C(1B)-C(11B)-C(12B) -60.1(5) 
C(8B)-C(7B)-C(6B)-Br(1B) 178.6(3) 
C(8B)-C(7B)-C(6B)-C(5B) 0.0(7) 
C(8B)-C(3B)-C(4B)-C(5B) 0.6(7) 
C(2B)-C(1B)-C(11B)-O(1B) -54.8(5) 
C(2B)-C(1B)-C(11B)-C(12B) -179.0(4) 
C(2B)-C(3B)-C(4B)-C(5B) 177.8(4) 
C(1B)-C(2B)-C(3B)-C(8B) -79.4(5) 
C(1B)-C(2B)-C(3B)-C(4B) 103.6(5) 
C(1B)-C(2B)-C(9B)-C(10B) -100.3(5) 
C(1)-C(2)-C(3)-C(8) -83.0(5) 
C(1)-C(2)-C(3)-C(4) 99.3(5) 
C(15)-C(14)-C(13)-C(12) 0.1(7) 
C(14)-C(15)-C(16)-C(17) -1.0(8) 
C(11)-C(12)-C(17)-C(16) -178.5(4) 
C(11)-C(12)-C(13)-C(14) 178.2(4) 
C(11)-C(1)-C(2)-C(9) 175.3(4) 
C(11)-C(1)-C(2)-C(3) -57.4(5) 
C(17)-C(12)-C(11)-O(1) 137.1(4) 
C(17)-C(12)-C(11)-C(1) -97.0(5) 
C(17)-C(12)-C(13)-C(14) -0.6(7) 
C(2)-C(1)-C(11)-O(1) -56.4(5) 
C(2)-C(1)-C(11)-C(12) 178.1(4) 
C(2)-C(3)-C(4)-C(5) 178.2(4) 
C(7B)-C(8B)-C(3B)-C(2B) -177.6(4) 
C(7B)-C(8B)-C(3B)-C(4B) -0.6(6) 
C(7B)-C(6B)-C(5B)-C(4B) 0.0(7) 
C(8)-C(3)-C(4)-C(5) 0.3(7) 
C(3)-C(8)-C(7)-C(6) -0.2(7) 
C(3)-C(4)-C(5)-C(6) -0.6(7) 
C(13)-C(12)-C(11)-O(1) -41.8(6) 
C(13)-C(12)-C(11)-C(1) 84.2(5) 
C(13)-C(12)-C(17)-C(16) 0.3(7) 
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C(19B)-C(1B)-C(11B)-O(1B) -177.8(3) 
C(19B)-C(1B)-C(11B)-C(12B) 58.0(5) 
C(12B)-C(13B)-C(14B)-C(15B) -0.1(8) 
C(12B)-C(17B)-C(16B)-C(15B) 1.0(8) 
C(19)-C(1)-C(11)-O(1) -177.7(4) 
C(19)-C(1)-C(11)-C(12) 56.8(5) 
C(19)-C(1)-C(2)-C(9) -64.8(5) 
C(19)-C(1)-C(2)-C(3) 62.5(5) 
C(16)-C(15)-C(14)-C(13) 0.7(8) 
C(11B)-C(12B)-C(13B)-C(14B) 179.6(5) 
C(11B)-C(12B)-C(17B)-C(16B) 180.0(5) 
C(5)-C(6)-C(7)-C(8) 0.0(7) 
C(3B)-C(8B)-C(7B)-C(6B) 0.3(7) 
C(3B)-C(2B)-C(1B)-C(18B) -172.3(4) 
C(3B)-C(2B)-C(1B)-C(19B) 69.9(5) 
C(3B)-C(2B)-C(1B)-C(11B) -51.7(5) 
C(3B)-C(2B)-C(9B)-C(10B) 130.2(5) 
C(3B)-C(4B)-C(5B)-C(6B) -0.3(7) 
C(9B)-C(2B)-C(1B)-C(18B) 60.0(5) 
C(9B)-C(2B)-C(1B)-C(19B) -57.8(5) 
C(9B)-C(2B)-C(1B)-C(11B) -179.4(4) 
C(9B)-C(2B)-C(3B)-C(8B) 49.2(6) 
C(9B)-C(2B)-C(3B)-C(4B) -127.9(4) 
C(7)-C(6)-C(5)-C(4) 0.4(7) 
C(7)-C(8)-C(3)-C(2) -177.7(4) 
C(7)-C(8)-C(3)-C(4) 0.0(7) 
C(13B)-C(12B)-C(11B)-O(1B) -36.2(6) 
C(13B)-C(12B)-C(11B)-C(1B) 85.7(5) 
C(13B)-C(12B)-C(17B)-C(16B) -0.9(7) 
C(13B)-C(14B)-C(15B)-C(16B) 0.2(8) 
C(14B)-C(15B)-C(16B)-C(17B) -0.7(8) 
C(10)-C(9)-C(2)-C(1) -120.1(5) 
C(10)-C(9)-C(2)-C(3) 110.7(5) 
C(17B)-C(12B)-C(11B)-O(1B) 142.9(4) 
C(17B)-C(12B)-C(11B)-C(1B) -95.2(5) 
C(17B)-C(12B)-C(13B)-C(14B) 0.5(7) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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APPENDIX 8 
Development of an α-Arylation Reaction of TMSE β-Ketoesters 
 
A8.1 INTRODUCTION  
A8.1.1 Background and state of the art in the α-arylation of cyclic ketones 
The ubiquity of all-carbon quaternary stereocenters in natural products and other 
compounds that possess antibiotic, antimicrobial, antifungal, anti-tumor and other 
therapeutic properties provides a strong impetus for researchers to continue to seek out 
new methods for the construction of this important motif.106  Within this domain, benzylic 
quaternary ketones have received a significant amount of attention, owing in part to the 
presence of an excellent functional group handle (i.e. the carbonyl) as well as the 
prevalence of arylated quaternary centers in medicinally important compounds107 (Figure 
A8.1.1). 
 
Figure A8.1.1.1.  Natural products containing benzylic quaternary stereocenters 
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The development of methods for the preparation of arylated quaternary centers 
via the α-arylation of nonstabilized ketones has been a subject of intense research for the 
past two decades.108 Early reports of transition-metal catalysis in this reaction focused on 
the use of palladium catalysts bound by sterically encumbered, electron-rich phosphine 
ligands.  A milestone publication by Buchwald109 and coworkers demonstrated that 
Pd2(dba)3, bound with p-tol-Binap (L18) as ligand, serves as an efficient catalyst for the 
direct arylation of ketone enolates (Scheme A8.1.1.1A).  Concurrent this to publication, 
Hartwig 110  disclosed a report describing the use of a 1,1′-Bis(di-o-
tolylphosphino)ferrocene (L19, DTPF)/Pd2(dba)3 catalyst system for α-arylation that 
capably provided α-arylated α-quaternary ketones (Scheme A8.1.1.1B).  These two 
publications represent the first examples of direct catalytic α-arylations of nonstabilized 
ketones.  
 
Scheme A8.1.1.1.  Initial Reports of Direct α-Arylation of Ketones by Buchwald (A) and Hartwig (B) 
 
 
 
 
O
Ph
PhBr (0.95 equiv), Pd2(dba)3 (10 mol%) 
L19 (15 mol%),  KN(SiMe3)2 (1.2 equiv)
refluxing THF
55% yield
O
Ph Fe
P(o-tol)2
P(o-tol)2
DTPF
B.
A. O (4-t-Bu)PhBr (0.5 equiv), Pd2(dba)3 (1.5 mol%) 
Tol-Binap (3.6 mol%),  NaOt-Bu (1.3 equiv)
refluxing THF
83% yield
O
t-Bu
P(p-tol)2
P(p-tol)2
59
133 134
132
L18 tol-binap
L19
Appendix 8 – Development of an α-Arylation Reaction of TMSE β-Ketoesters 
 
 
482 
 Ensuing reports from a number of research groups, following these initial 
communications, revealed the superiority of extremely sterically bulky phosphine ligands 
in the formation of quaternary centers via this transformation.111 The Hartwig and 
Buchwald groups have remained at the forefront of these developments.  The reported 
improvements to their respective catalytic systems constitute the most successful α-
arylation of nonstabilized enolates in the absence of blocking groups to date (Scheme 
A8.1.1.2, A112 and B113). 
 
Scheme A8.1.1.2.  Improved Catalyst Systems for α-Arylation by Hartwig (A) and Buchwald (B) 
 
 
 
A8.1.2 State of the art in the asymmetric α-arylation of cyclic ketones 
The current state of the art in the catalytic asymmetric α-arylation of ketones to 
form all–carbon quaternary centers is exemplified, again, by the research efforts of the 
Hartwig and Buchwald groups.  Studies by Buchwald and co-workers have focused on 
the use of α’ blocked α-methylcyclopentanone derivatives (136) as substrates (Scheme 
A8.1.2.1A).114 Sterically encumbered mono-phosphine ligand (L20) has been shown to 
efficiently catalyze the transformation (Scheme A8.1.2.1A) in good yields and excellent 
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enantiomeric excess.  Unfortunately, the tolerance of the transformation to substrate 
variability has been highly limited and even seemingly innocuous adjustments to the 
substrate, such as employing the corresponding 6-membered α’-blocked α-
methylcyclohexanone derivative, results in substantially diminished selectivity with ee’s 
no higher than 70%.  All attempts by Buchwald and coworkers, thus far, to generalize 
this reaction have proven nonviable.  
Hartwig and co-workers obviated the need for an α’-blocking group by focusing 
their studies exclusively on substrates which inherently lack more than one enolizable 
proton, namely tetralone and indanone derivatives (138).  Their work has shown that the 
use of chiral phosphine difluorphos (L22) under palladium catalysis is highly effective in 
promoting the α-arylation of tetralone and indanone substrates, delivering the 
corresponding α-quaternary ketone products (139) in moderate to excellent yields and 
uniformly excellent ee’s (Scheme A8.1.2.1B).  More recently, Hartwig and co-workers 
have also shown pre-formed nickel complex [((R)-BINAP)Ni(η2-NC-Ph)] to be an 
effective metal source for the heteroarylation of tetralone and indanone substrates 
(Scheme A8.1.2.1C).  
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Scheme A8.1.2.1.  Current State of the Art in Catalytic Asymmetric α-Arylation to Form α-
Quaternary Ketones 
 
 
 
Although existing asymmetric α-arylation methods are outstanding, considerable 
deficiency remains in the scope of compatible substrates.  Indeed, catalytic asymmetric 
means to access the deceptively simple looking 2-alkyl-2-arylcyclohexanone (149) 
shown in Figure A8.2.2.1 (R = alkyl) are not known.  We believe that the use of prochiral 
enolates generated in situ, in the absence of exogenous base will be crucial in identifying 
a solution to this problem. 
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Considerable investigation by the Stoltz group has been devoted to advancing and 
extending the palladium-catalyzed asymmetric allylic alkylation methodology described 
in Chapters 1 and 2.15 Beginning with work by Behenna and Stoltz, it was shown that a 
variety of enolate precursors, including allyl enol carbonates (1), allyl β-ketoesters (2) 
and silyl enol ethers (3), are all amenable to asymmetric catalysis through the use of a 
chiral phosphinooxazoline ligand ((S)-t-BuPHOX, L1).9 All three of these substrate 
classes function well in the chemistry, to provide α–quaternary ketones (7) in good to 
excellent yields and enantioselectivities.10 The striking uniformity in enantiomeric excess 
between these substrate classes suggested to us the possibility of a common mechanistic 
pathway; studies to elucidate the catalytic cycle of this reaction led by members of the 
Stoltz group resulted in an intriguing mechanistic picture (Scheme 5.2.1.1).35  
The catalytic cycle begins with the oxidative addition of a palladium(0) species 
into an allyl fragment (2) to generate an η1-palladium allyl species, which is also bound 
to the carboxylate in what has been shown to be the catalytic resting state species (140, 
Scheme A8.5.2.1.1).35a  Decarboxylation may then occur, to give Pd-bound prochiral 
enolate species (141).  The resulting complex may then undergo an alkylation event via a 
7-membered inner-sphere transition state to deliver the α-allylated product (7) and 
regenerate the catalyst (142). 
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Scheme A8.2.1.1.  Proposed catalytic cycle of asymmetric allylic alkylation  
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and tertiary stereocenters in excellent yields and good to excellent enantioselectivities 
(Scheme A8.2.1.2B).30a 
 
Scheme A8.2.1.2.  A. Asymmetric protonation of allyl β-ketoesters; B. Stereoselective conjugate 
addition–allylation cascade reaction.  
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 We reasoned that by eliminating allyl from the reaction mixture, we would 
obviate the problem of competing reaction pathways, and greatly expand the repertoire of 
in situ generated enolates of this type.  We envisioned that our TMSE β-ketoester 
substrate (see Chapter 2) would be an ideal candidate to enable an investigation of this 
hypothesis.  Specifically, we believed that electrophilic trapping of the enolate species 
(67) generated upon treatment of TMSE β-ketoester (66) with fluoride in the presence of 
a chiral catalyst may give rise to enantioenriched α–quaternary carbonyl products (68).    
 
Figure A8.2.2.1.  Proposed catalytic cycle for the α-arylation of cyclic ketones using in situ 
generated enolates 
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cycle and furnish the desired α-quaternary ketone product (149) and regenerate palladium 
(0) intermediate 150.  
 
Figure A8.2.2.2.  Proposed catalytic cycle for the α-arylation of cyclic ketones using in situ 
generated enolates 
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Pd2(dba)3 was used as the metal source, an equivalent of TBAT served to activate our 
substrate for deprotection and a slight molar excess of phenyl bromide was supplied as 
the aryl coupling partner.  In our first such screen, a variety of phosphine ligands were 
employed at several temperatures against a number of solvents ranging broadly in 
polarity, dielectric constant and σ-donor ability.  As this screening approach is 
combinatorial, the number of reactions per screen is easily calculated by multiplying the 
number of variables: in the case of Scheme A8.3.1.1, the product of 6 ligands, 4 solvents 
and 3 temperatures gives 72 reactions total.  The best results for these experiments were 
obtained for reactions held at 60 °C, and the data for that screen are shown in Figure 
A8.3.1.1. 
As can be seen in the Figure A8.3.1.1, very modest yields were seen in the first 
screen.  While most reactions resulted in deprotection and protonation of starting β-
ketoester 74 the combination of DMF as solvent and tricyclohexylphosphine (P(Cy)3) 
yielded the best result – a 5% yield of the desired α-quaternary ketone 149a.  These 
results indicated to us the importance of highly polar solvents and electron-rich 
phosphine ligands.      
Scheme A8.3.1.1.  Initial screens for α-arylation reactivity 
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Figure A8.3.1.1.  Summarized resultsa of screen 1 at 60 °C 
 
a. yield determined by GC analysis of tridecane internal standard 
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that sterically bulky, electron-rich phosphine ligand and polar solvents perform well in 
the reaction.  
 
Scheme A8.3.2.1.  Revised screens for α-arylation reactivity 
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Figure A8.3.2.1.  Summarized resultsa of screen 2 at 60 °C 
 
a. yield determined by GC analysis of tridecane internal standard 
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experiments were uniformly disappointing, with poor yields observed in the best cases.  
Ligands that Buchwald and coworkers have shown to be effective in palladium catalyzed 
α-arylation chemistry, such as the Brett–, John– and XPhos ligands (L23–L25), as well 
as t-Bu-JosiPhos (L29), delivered minimal amounts of the desired product.114   Likewise, 
ligands that Hartwig and coworkers have employed in the α-arylation of tetralone 
derivatives, such as SegPhos (L28) also failed to deliver the desired product.112   In 
addition to mono- and bisphosphine ligands, P,N type phosphinooxazoline ligands were 
also explored to no fruitful end.  
To tease out the relative importance of sterics and electronics in the ligand 
scaffold, a series of mono-phosphine of varying polarity and steric encumbrance were 
investigated.  The observation that tripentafluorophenylphosphine (L30), which is both 
electron-poor and sterically large, possessing a ligand cone angle115 of greater than 180°, 
was not a proficient ligand suggests that excess electron density about palladium is a 
prerequisite feature of successful catalyst systems for this transformation.  Steric 
hindrance about the ligand also proved to be essential to reaction efficiency, inasmuch as 
substituting one phosphine tert-butyl substituent with a cyclohexyl  (i.e., ligand L33) 
resulted in a halving of the best previously observed yield.  
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Figure A8.4.1.  Elaborated ligand searcha 
 
a. yield determined by GC analysis of tridecane internal standard 
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time and temperature, as well, only served to demonstrate that the conditions that we had 
previously identified worked best in the chemistry.  
Figure A8.4.2.  Optimization of fluoride donor, reaction time and temperature  
 
 
a. yield determined by GC analysis of tridecane internal standard; b. isolated yield. 
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Figure A8.4.3.  Further optimization of ligand, solvent and temperature  
 
 
a. yield determined by GC analysis of tridecane internal standard 
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Figure A8.4.4.  Further optimization of ligand, solvent and temperature  
 
 
a. yield determined by GC analysis of tridecane internal standard 
 
One screen that produced results meriting discussion was that which explored 
reaction efficiency with respect to varying ratios of ligand and metal source (Figure 
A8.4.5).  Interestingly, when the ratio of P(t-Bu)3 to palladium was 1:1, a considerable 
amount of starting material remain in the product mixture, even in the presence of excess 
fluoride source (Figure A8.4.5, entry 1).  As we increased the ligand loading, we 
t-Bu3P dioxane 80 PhBr/ 1.05 24 2.5 4.8
t-Bu3P dioxane 60 PhBr/ 1.05 24 5.0 31.1
t-Bu3P dioxane 80 PhBr/ 1.05 24 5.0 20.6
t-Bu3P 60 PhBr/ 1.05 24 5.0 64.0DMF
t-Bu3P 80 PhBr/ 1.05 24 5.0 44.5DMF
t-Bu3P 80 PhBr/ 2.0 24 5.0 34.7DMF
t-Bu3P 80 PhBr/ 3.0 24 5.0 44.1DMF
t-Bu3P 60 PhBr/ 1.05 24 5.0 12.6THF
t-Bu3P 80 PhBr/ 1.05 24 5.0 3.8THF
t-Bu3P 60 PhCl/ 1.05 24 5.0 1.5DMF
t-Bu3P 80 PhCl/ 1.05 24 5.0 4.6DMF
t-Bu3P dioxane 60 PhCl/ 1.05 24 5.0 --
t-Bu3P dioxane 80 PhCl/ 1.05 24 5.0 0.4
t-Bu3P toluene 80 PhCl/ 1.05 24 5.0 0.4
t-Bu3P 25 PhI/ 1.05 12 5.0 1.9DMF
t-Bu3P 40 PhI/ 1.05 12 5.0 37.9DMF
t-Bu3P 60 PhI/ 1.05 12 5.0 45.9DMF
t-Bu3P dioxane 60 PhI/ 1.05 12 5.0 --
t-Bu3P dioxane 80 Phl/ 1.05 12 5.0 18.8
t-Bu3P toluene 25, 40, 60 Phl/ 1.05 12 5.0 --
t-Bu2MeP 25, 40, 60 PhBr/ 1.05 24 5.0 --DMF
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60
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observed a sharp decline in the amount of starting material remaining until the ratio of 
palladium to ligand surpassed 2:1.  Noting the stability of the palladium carboxylate 
species formed in our allylic alkylation reaction, we believe it is plausible that the correct 
stoichiometry of palladium and ligand is needed for the formation of a catalyst complex 
capable of chelating the β-dicarbonyl, which in turn may be required to activate our (2-
TMS)ethyl β-ketoester substrate for deprotection by TBAT.  
 
Figure A8.4.5.  Importance of metal source to ligand ratio 
 
 
a. yield determined by GC analysis of tridecane internal standard 
 
A8.5 OUTLOOK AND FUTURE DIRECTIONS FOR CARBOXYLATE PROTECTED 
ENOLATES IN α -ARYLATION 
A8.5.1 Hypotheses that remain to be tested in α-arylation of TMSE β-ketoesters 
We have, at this point, a number of unanswered questions regarding our catalyst 
system and reaction as developed thus far.  For example, we would like to determine the 
role of our catalyst in promoting the deprotection of our substrate.  We would like to 
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devise a method to determine the particular mode of reductive elimination operative in 
our reaction.  Our inability to make direct comparisons between the reaction we have 
developed and existing methods for α-arylation, due to the nature of our substrate, is an 
unfortunate limitation of the TMSE β-ketoester substrate class, elimination of which we 
believe would help to answer a number of our questions.  For instance, every example of 
asymmetric α-arylation published to date employs toluene as solvent; however, TBAT is 
insoluble in toluene to the point of being completely ineffectual.  In view of work by 
Rawal116 and others,117 demonstrating the importance of the presence or absence of metal 
salts in determining α-arylation reaction outcomes, we would like to examine the 
efficiency of our reaction in the absence of fluoride salts.  However, successful solvents 
for our reaction, DMF and 1,4-dioxane in particular, also ensure that salts generated in 
the course of the reaction remain soluble.  We believe that the use of an alternative 
substrate may afford us the opportunity to better dissect our reaction and determine the 
relative importance of the factors enumerated above.  In particular, we envision that 
substrates that follow a deacylative pathway into catalysis may be highly valuable in this 
regard.   
 
A8.5.2 Deacylative in situ access to prochiral enolates  
Recent reports by Tunge and co-workers118 inspired us to consider a deacylative 
pathway into catalysis.  Tunge has shown that treatment of α-electron withdrawing acetyl 
compounds (Scheme A8.5.2.1, 151) with sodium allyloxide produces a molecule of allyl 
acetate (153) and generates the α-stabilized carbanion (152).  In the presence of a 
palladium catalyst, an equivalent of acetate ion is liberated in the formation of a 
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palladium π-allyl species, which are labile to attack by 152, and results in allylic 
alkylation to generate an α-quaternary carbon stereocenter (7).  
We envisioned a deacylative allylic alkylation scenario (Scheme A8.5.2.1) in 
which to test our substrate.  Upon combining catalytic palladium (0) and an alkyl allyl 
carbonate, the co-catalytic amount of alkoxide generated would attack substrate 156 and 
generate the desired prochiral enolate and byproduct ester 157.  Trapping of the enolate 
with an allyl palladium species would complete the catalytic cycle to deliver 7 (Scheme 
A8.5.2.1B).  In the case of α-arylation, we imagined that subjecting substrate 156 to a 
nucleophile like sodium ethoxide would provide access to a prochiral enolate, which 
could subsequently participate in palladium catalysis and afford α-arylated products (149, 
Scheme A8.5.2.1C). 
 
Scheme A8.5.2.1.  Conceptual schemes for deacylative enolate formation: A. previous research by 
Tunge and coworkers; B. proposed allylic alkylation via deacylative pathway; C. proposed  α-
arylation via deacylative pathway 
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A number of potential benefits are inherent in this substrate class.  The 
commercial starting materials needed to make derivatives of 156 (e.g., acetic anhydride, 
trichloroacetyl chloride or trifluoroethyl acetate) all cost less than one dollar per gram, 
whereas the 2-TMS-ethanol needed to make our (2-TMS)ethyl β-ketoester substrate is 
priced at nine dollars per gram.  Furthermore, these substrates will allow us to investigate 
the conditions we have developed in a broader range of solvents, such as toluene, in the 
absence of fluoride salts and explore a catalytic cycle in which the decarboxylation step is 
absent.  However, synthesis of substrate 156 has thus far proven challenging, and our 
attempts to make any such substrate following the procedure of Tunge and coworkers 
have failed.  
 
A8.6 CONCLUDING REMARKS 
This appendix details our development of an α-arylation reaction of carboxylate-
protected enolates, which makes use of the TMSE β-ketoester substrate class that we 
have developed.  The best observed results for this transformation occurred with a 
combination of Pd2(dba)3 as metal source and P(t-Bu)3 as ligand, phenyl bromide the aryl 
source, TBAT the fluoride source, DMF as solvent,  and at 60 °C, with a 45% isolated 
yield of the racemic desired product.  Notably, arylation occurs strictly at the site of 
deprotection to afford α-quaternary arylated compounds, despite the presence of other 
enolizable protons.  This constitutes a significant inroad to a highly challenging, unsolved 
problem–the efficient and enantioselective α-arylation of carbonyl compounds bearing 
more than one enolizable proton.  Given this promising beginning, it is our hope that 
further investigation of alternative ligand (for example N-heterocarbene ligands), 
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alternative metal sources (including an exhaustive investigation of nickel catalysts) and 
alternative substrate classes (such as the 1,3-diketones discussed above) will reveal 
conditions that confer synthetic utility to this potentially valuable transformation.  
 
A8.7 EXPERIMENTAL SECTION 
A8.7.1 Materials and Methods 
Unless otherwise stated, reactions were performed in flame-dried glassware under 
an argon or nitrogen atmosphere using dry, deoxygenated solvents.  Solvents were dried 
by passage through an activated alumina column under argon.61 Reaction progress was 
monitored by thin-layer chromatography (TLC) or Agilent 1290 UHPLC-MS.  TLC was 
performed using E. Merck silica gel 60 F254 precoated glass plates (0.25 mm) and 
visualized by UV fluorescence quenching, p-anisaldehyde, or KMnO4 staining.  Silicycle 
SiliaFlash® P60 Academic Silica gel (particle size 40–63 nm) was used for flash 
chromatography.  All reagents were purchased from Sigma-Aldrich, Acros Organics, 
Strem, or Alfa Aesar and used as received unless otherwise stated.  Reaction 
temperatures were controlled by an IKAmag temperature modulator unless otherwise 
indicated. Stirring was accomplished with Teflon® coated magnetic stir bars.  Glove-box 
manipulations were performed under a N2 atmosphere.  1H NMR spectra were recorded 
on Varian Inova 500 MHz and 600 MHz spectrometers and evaluated relative to residual 
CHCl3 (δ 7.26 ppm) or C6HD5 (δ 7.16 ppm).  13C NMR spectra were recorded on a 
Varian Inova 500 MHz spectrometer (125 MHz) and evaluated relative to CHCl3 (δ 77.16 
ppm) or C6HD5 (δ 128.06 ppm).  Analytical chiral GC analysis was performed with an 
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Agilent 6850 GC using a GT-A column (0.25 m × 30.00 m) employing a 130 °C isotherm 
and a flow rate of 1.0 mL/min. 
 
A8.6.2  Procedure for Symyx assisted screening of α-arylation 
 
 
This description will use the screen described in Scheme A8.3.1.1 as a 
representative example.  All Symyx reaction screenings were conducted in a nitrogen-
filled glove-box at the Caltech Center for Catalysis and Chemical Synthesis using 
solvents that were degassed with nitrogen after passage through an activated alumina 
column under argon.  Overall screen design was predicated by the desired individual 
reaction volume (in the case at hand 0.33 mL with a 0.1 M substrate concentration), and 
by the number of reactions to be conducted.  All stock solutions were prepared in ca. 1.5 
times excess to the exact amount of compound required for screening. 
First, a stock solution of Pd2(dba)3 was prepared by combining 0.1448 g of  
Pd2(dba)3 with 20 mL of THF in a 20 mL scintillation vial.119  The Symyx robot arm was 
then used to dispense 0.208 mL of this stock solution into each of the 72 half-dram 
reaction vials.  Using the Symyx Automation Studios program a sequence for the robot 
arm was loaded, the arm was initialized and flushed with 7 mL of the backing solvent, 
THF.  Multi-dispense mode was used and a 10 µL airgap, source overshoot of 5%, draw 
speed of 20 µL/second (lowered from the normal draw speed due to viscosity), dispense 
speed of 150 µL/second (again, due to viscosity),  1 mm draw distance from bottom 
O O
O
Me Pd2(dba)3 5 mol %, ligand 12.5 mol %
electrophile, TBAT (1 equiv)
solvent
O
Me
TMS
74 149a
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(calibrated prior to each screen) and 1 mL rinse of backing solvent prior to each draw 
were employed. Upon completion of the addition, the dispense needle was flushed with 
an additional 5 mL of THF.  The 72 reaction vials were then separated onto 2 36 reaction 
well plates and stripped of solvent by vacuum centrifugation using a Thermo Electro 
Corporation SDP 121P vacuum centrifuge until a pressure of 1.5 torr was reached (ca. 1 h 
under vacuum).  Thus, each vial then contained 1.51 mg (0.00165 mmol) of Pd2(dba)3.  
 Stock solutions for all other compounds were prepared according to the amount 
of volume to be dispensed and the number of reactions planned.  For example, for the 
screen at hand, 8.5 mg of TMSE β-ketoester substrate (74, 0.033 mmol) were to be 
dispensed in 0.08325 mL of solvent to each reaction vessel.  Total masses to be used in 
each stock solution were calculated by multiplying (mass per reaction) x (total number of 
planned reactions per solvent) x 1.5; in the present case, 0.0085 g x 18 x 1.5 = 0.23 g of 
74 per stock solution.  Stock solutions of 74 were prepared thusly by combining 0.1956 g, 
0.2126 g, 0.2275 g and 0.2313 g of 74 with 1.916 mL, 2.080 mL, 2.228 mL and 2.265 
mL of dioxane, toluene, DMF and DMSO, respectively.  For each of these stock 
solutions, 0.08325 mL of solution contains 8.5 mg of compound.  TBAT stock solutions 
were then prepared in the same fashion, such that TBAT could be dispensed in 0.1665 
mL of solvent.  Finally, ligand stock solutions were prepared in the same fashion, such 
that the ligand could be dispensed in 0.08325 mL of solvent.  Phenyl bromide and 
tridecane (internal standard) would be added neat, and their volumes considered 
negligible.  Therefore, each reaction vessel would contain 0.33 mL of solvent total 
(0.08325 mL + 0.08325 mL + 0.1665 mL) once all reaction components had been added 
to the reaction vessel.  As the Symyx robot is only capable of dispensing homogenous 
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liquid solutions, and some of the reaction components are only sparingly soluble in the 
desired solvents, some compounds had to be added manually, by hand.  This proved to be 
the case for BINAP, as BINAP is minimally soluble in all solvents other than THF.  
Once all of the stock solutions were prepared and compounds for which stock 
solutions could not be prepared had been added manually, the reactions were split evenly 
onto 3 plates (24 reactions per plate).  For bookkeeping, the reactions were each given a 
number according to the position on the plate, and organized accordingly.  For example, 
reactions contained in the plate held at 60 °C are given the following designations: 
 
 
 
In a similar fashion, number values are assigned to all other reactions in 
increasing order, such that a similar chart depicting plate number 3 (held at 110 °C) 
would put reaction number 72 in the bottom right hand corner. 
The robot arm was then used to dispense compounds to the individual reaction 
vials.  Using the same sequence, the robot arm was again initialized and flushed with 5 
mL of the backing solvent, THF.  Multi-dispense mode was used and a 10 µL airgap, 
source overshoot of 5%, draw speed of 20 µL/second (lowered from the normal draw 
speed of 50 µL, due to viscosity), dispense speed of 150 µL/second (again, due to 
viscosity),  1 mm draw distance from bottom (calibrated prior to each screen) and 1 mL 
rac-BINAP
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rinse of backing solvent prior to each draw were employed.  The compounds were then 
added in the following order: ligand (solution), substrate (74, solution), bromobenzene 
(neat), TBAT (solution), tridecane (neat).  Teflon® coated magnetic stirring bars were 
then added to each vial and each vial was fitted with a Teflon® lined screw cap.  The 
plates were then set into heated stirring wells set to 60, 80 and 110 °C, and stirred at a 
rate of 400 rpm.  
After stirring at the indicated temperatures for 24 hours the reactions were 
removed from the glovebox, and processed manually.  The workup procedure for 
reactions run in dioxane and toluene is as follows: each reaction is diluted to a total 
volume of 2 mL with hexanes and then pushed through a plug of silica with compressed 
air and collected in a 20 mL scintillation vial.  Silica plugs were made by crushing one 
forth of a Watman fiberglass pad (1” diameter) into a 6” pipette and then filling the 
pipette with ca. 1 mL of silica.  After passing the reaction solution through the pipette 
plug, it was rinsed with 3 mL of hexanes and the collected eluents diluted further with 
hexanes until 10 mL total volume was reached.  1.5 mL of this solution is then used to 
prepare a sample for GC analysis.  For reactions run in DMF or DMSO, each reaction 
was first transferred to a 20 mL scintillation vial, diluted with 5 mL hexanes, washed 
thoroughly with water, extracted and then passed through a pipette plug of silica.  These 
samples were diluted with hexanes to 10 mL volume total and analytical samples 
prepared by taking ca. 1.5 mL of this solution.     
GC analysis was of the analytical samples was then carried out. Retention time 
(tR) for tridecane – 3.3l min, tR for 74 – 27.04, 27.79 min, tR for 149a – 17.097, 17.33 
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min. All other screening experiments discussed in the text that were carried using the 
Symyx automation system, were conducted by adaptation of the above procedure.  
 
A8.6.3 Procedure for manual screening of α-arylation 
 
 
To a 2 mL scintillation vial with a stir bar were added Pd2(dba)3 (16.4 mg, 0.015 mmol), 
P(t-Bu)3 (21.9 mg, 0.037 mmol) and DMF (9 mL) in a nitrogen-filled glove-box. The 
dark purple mixture was stirred at ambient glove-box temperature (ca. 30 °C) for 35 
minutes at which point the mixture had become red-orange.  TBAT (80.0 mg, 0.31 mmol) 
was added to the reaction mixture, followed by phenyl bromide (80.0 mg, 0.31 mmol) 
and tridecane (80.0 mg, 0.31 mmol).  Finally, TMSE β-ketoester 74 (80.0 mg, 0.31 
mmol) was added as a solution in DMF (x.x M).  The resulting yellow-green reaction 
mixture was stirred at 60 °C until full conversion of the starting material was indicated by 
TLC analysis (reaction times typically ranged 18 to 36 hours).  The vial was removed 
from the glove-box, diluted with 3 mL of Et2O, extracted with 3 mL H2O (x3), dried over 
Mg2SO4 directly purified by flash column chromatography (SiO2, 2% EtOAc in hexanes 
to 10% EtOAc in hexanes) afforded 149a (41 mg, 45% yield) as colorless oil.  Rf = 0.3 
(15% Et2O in pentane); Spectroscopic data for this compound matched that reported in 
the literature. 
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APPENDIX 9 
Studies Toward the Enantioselective Total Synthesis of (+)-Lingzhiol 
 
A9.1 INTRODUCTION  
A9.1.1 Isolation studies of the lingzhiols 
The Ganoderma genus of mushrooms is native to southern China and contains 
around 80 species of mushrooms, many of which have long been used in traditional 
eastern medicine for ailments of the kidneys.120  Recently, investigation into this genus 
led to the isolation of (+)-lingzhiol (158) and (–)-lingzhiol (159) from the Ganoderma 
lucidum mushroom (commonly called the Lingzhi mushroom) (Figure A9.1.1.1).121  (+)-
Lingzhiol (158) and (–)-lingzhiol (159) are a pair of enantiomeric meroterpenoids, or 
natural products bearing both polyketide and terpenoid sub-units.  Vicinal all-carbon 
quaternary stereocenters (C-3’–C-7’) define a common axis about which three of the four 
rings in the novel 5/5/6/6 rotor-like structure of the lingzhiols hinge.  Extensive NMR 
studies and single crystal X-ray diffraction studies of 158 and 159 enabled the 
unambiguous assignment of the stereochemistry of the compounds.121   To date, only one 
total synthesis of lingzhiol has been reported.122 
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Figure A9.1.1.1.  The structures of (+)-lingzhiol and (–)-lingzhiol 
 
 
 
 
A9.1.2 Biological studies on and bioactivity profile of lingzhiol 
Studies conducted subsequent to the isolation lingzhiol have shown it to possess a 
swath of biological activity against pathogenesis in diabetic nephropathy and renal 
fibrosis.  Diabetic nephropathy and renal fibrosis are prevalent complications that arise in 
longstanding cases of diabetes and may lead to liver failure, which is usually life-
threatening.123  Pathogenic factors contributing to diabetic nephropathy and renal fibrosis 
include oxidative stress,124 extra cellular matrix (ECM) buildup, chronic inflammation 
and associated disorder of the TGF-β/Smads signaling pathways.125  Lingzhiol has been 
shown to both inhibit ROS directly and to induce nuclear factor erythroid 2-related factor 
2 (Nrf2), which up-regulates the production of protective antioxidant species in instances 
of high oxidative stress.126  Chronic inflammation and buildup of ECM in chronic kidney 
disease have been linked to the deregulation of TGF-β/Smad signaling pathway; in 
particular, the hyper-phosphorylation of Smad2/3 and loss of Smad 7 have been 
implicated in the renal scar formation, diabetic nephropathy and renal fibrosis. 127  
Lingzhiol has been shown to selectively inhibit Smad3 phosphorylation, while allowing 
Smad 2 phosphorylation, which, when taken alone, may have a renal protective role.121  
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This striking biological profile has prompted our investigation into the total synthesis of 
lingzhiol.  
 
A9.2 RETROSYNTHETIC ANALYSIS OF (+)-LINGZHIOL 
 Retrosynthetically, we envisioned that (+)-lingzhiol (158) could originate from 
tetracycle 160 via oxidative manipulation.  Tetracycle 160 could arise from the 
intramolecular (3+2) dipolar cycloaddition of a pendant nitrile oxide across the exocyclic 
olefin bourn by tetralone derivative 161.  The oxime precursor to tetralone derivative 
161, 162, would then be obtained by simple condensation subsequent to oxidation of 
alcohol 163.  Alcohol 163, in turn, would arise from elaboration of α-quaternary ketone 
164.  α-Quaternary ketone 164 would be derived in enantioselective fashion from the 
decarboxylative allylic alkylation of β-ketoester 165, which may be prepared by the 
acylation and aldol reaction of tetralone derivative 166.  Bicycle 166 would be generated 
via benzylic oxidation of known tetralone derivative 167, which may be prepared from 
Fries rearrangement of benzannulated lactone 168.  Finally, lactone 168 may be prepared 
via the Baeyer-Villiger oxidation of commercially available 7-methoxy tetralone 169.  
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Scheme A9.2.1.  First-generation retrosynthetic analysis for (+)-lingzhiol 
 
 
 
A9.3 MODEL STUDIES TO INVESTIGATE KEY (3+2) CYCLOADDITION IN THE 
SYNTHESIS (+)-LINGZHIOL 
A9.3.1 Retrosynthetic plan for lingzhiol model system 
In order to rapidly evaluate the viability of our proposed key (3 + 2) 
cycloadditions, we began our investigation into the total synthesis of (+)-lingzhiol in the 
context of a somewhat simplified model system.  We reasoned that by eliminating much 
of the oxidation about the core of lingzhiol we could streamline access to the carbocyclic 
core (170) and, thereby, rapidly arrive at a capable (3+2) cycloaddition substrate such as 
nitrile oxide 171 (Figure A9.3.1.1).  Oxime 172 could arise from the condensation of 
hydroxylamine onto aldehyde 173, which could be accessed via the oxidation of primary 
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alcohol 174.  Carefully orchestrated hydroboration/oxidation and Grignard 
addition/elimination sequences of known tetralone derivative 176 were planned to access 
styrenyl alcohol 175.  Tetralone derivative 176 could then be delivered via a palladium 
catalyzed allylic alkylation.  
 
Scheme A9.3.1.1.  First-generation retrosynthetic analysis for (+)-lingzhiol model system 
 
 
 
A9.3.2 Synthesis of lingzhiol model system and testing of key (3+2) cycloaddition 
 Known α-quaternary ketone was accessed in a racemic fashion via the palladium-
catalyzed allylic alkylation of allyl β-ketoester 176 (see Chapter 1, vide infra).  Although 
ketone to olefin transposition is known to proceed via methyl Grignard 
addition/elimination, we decided to first explore a Peterson olefination as opposed to 
something less exotic: our reasoning was twofold (Figure A9.3.2.1A).  On one hand, we 
believed that simple methyl Grignard addition to α-quaternary ketone 176 followed by 
elimination would give diene 177 and require a subsequent regioselective 
hydroboration/oxidation.  On the other hand, if hydroboration oxidation was carried out 
prior to methyl Grignard addition, elimination of the tertiary alcohol would be 
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complicated by the presence of the primary alcohol, 179, and require an additional 
protection/deprotection sequence.  Peterson olefination, however, would obviate these 
issues, and allow for simultaneous olefin formation and oxidation.  After some 
optimization we found that the desired tertiary alcohol 181 could be prepared in 90% 
yield from addition of the Grignard of (chloromethyl)trimethylsilane to ketone 176 
(Figure A9.3.2.1B). 
 
Scheme A9.3.2.1 A. Foreseeable difficulties in advancing methyl Grignard addition to ketone 176; 
B. Synthesis of olefin 181 
 
 
 
With tertiary alcohol 181 in hand, we began studies to identify effective 
hydroboration/oxidation conditions to access primary alcohol 174.  We were encouraged 
to find that treatment of olefin 181 with BH3•THF complex, followed by aqueous 
hydrogen peroxide and sodium hydroxide, delivered the primary alcohol with concurrent 
elimination of trimethylsilyl alcohol to afford the desired styrenyl alcohol in 86% yield, 
when performed on 0.05 g scale (Scheme A9.3.2.2, entry 1).  Unfortunately, this result 
proved difficult to replicate when carried out on larger scale, or when newly purchased 
reagents were employed (entry 2).  Similarly, BH3•DMS complex proved to be less 
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efficient than the THF complex.  To our delight, we discovered that conditions for the 
iridium-catalyzed regioselective hydroboration/oxidation developed by Crudden and 
coworkers,128 delivered the desired product in excellent and consistent yields irrespective 
of reaction scale (entries 4–6).  
 
Scheme A9.3.2.2.  Optimization studies for the tandem hydroboration/oxidation elimination of 181 
 
 
 
Dess-Martin periodinane (DMP) oxidation of primary alcohol 174 proceeded 
smoothly, to give aldehyde 173, which was observed by 1H NMR, and without rigorous 
isolation subjected conditions for oxime formation (Scheme A9.3.2.3).  When crude 
aldehyde 173 was treated with hydroxylamine hydrochloride (5 equiv), pyridine (15 
equiv), in EtOH a 25% yield (over 2 steps) of oxime 172 was observed.  However, by 
changing the base employed to sodium acetate and reducing the equivalents of 
hydroxylamine hydrochloride (below, Scheme A9.3.2.3), an 88% yield was observed for 
the formation of oxime 172.  Pleased with these results, we next attempted to affect our 
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key (3+2) cycloaddition addition reaction, via the in situ formation of the corresponding 
nitrile oxide.129  Attempts using chloramine-T130 in ethanol at a variety of temperature 
failed to deliver anything other than complex mixtures.  Likewise, attempts at nitrile 
oxide formation/(3+2) cycloaddition using N-chlorosuccinamide (NCS) and other 
oxidants131 also delivered complex mixtures of products, none of which appeared to be 
the desired tetracycle.  
 
Scheme A9.3.2.3.  Synthesis of oxime 172 and attempts at (3+2) cycloaddition 
 
 
 
While we were discouraged by these results, we reasoned that the styrene 
functionality of oxime 172 may be unstable, and that attempting a (3+2) cycloaddition 
via the corresponding nitrone might be less harsh and limit the degree of undesired 
reactivity observed.  We therefore subjected aldehyde 173 to N-methylhydroxylamine 
hydrochloride and sodium acetate in benzene at increasing temperature and, finally, 
observed a (3+2) cycloaddition in 61% yield.  Unfortunately, the regioselectivity by 
which the cycloaddition proceeded afforded the undesired, albeit interesting bridged 
product (183, Scheme A9.3.2.4).  
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Scheme A9.3.2.4.  The intramolecular (3+2) cycloaddition of nitrone 182 to form tetracycle 183 
 
 
a Unless otherwise noted, full characterization data for compounds depicted in this scheme have not 
been collected. 
 
A9.4 REVISED MODEL STUDIES TO INVESTIGATE KEY (3+2) CYCLOADDITION 
IN THE SYNTHESIS (+)-LINGZHIOL 
A9.4.1 Rationale and revised plan for (+)-lingzhiol model system 
 With the disappointing results described in Section A9.3 in mind, we returned to 
our model system with the goal of biasing the electronics of the styrene olefin, such that 
we could invert the regioselectivity observed in the (3+2) cycloaddition.  We believe that, 
due to inductive donation from the aryl group, a partial positive charge is present at the 
terminal position of the exocyclic olefin and that this was, in part, the source of 
regioselectivity we observed in the intramolecular cycloaddition of nitrone 182 (Figure 
A9.4.1.1).  We reasoned that by introducing the ketone present in the natural product at 
an earlier stage, the benzylogous enolate resonance contributor might serve to invert the 
electronics of the exocyclic olefin in 184 (Figure A9.4.1.1).  By this rationale, we 
hypothesized that we might affect an inversion in the regioselectivity of the (3+2) 
cycloaddition in favor of the desired pathway.  Therefore, we set about constructing a 
new model compound with which we would test our key cycloaddition.  
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Figure A9.4.1.1.  A hypothesis regarding the electronics of exocyclic olefin 182 
 
 
 
A9.4.2 Synthesis of the revised model system for (+)-lingzhiol 
 As we wished to install the requisite ketone via late stage benzylic oxidation, our 
early experiments towards a revised model system involved attempts to directly oxidize 
substrates generated in our previous model system.  However, as most benzylic oxidation 
processes involve the formation of a benzylic radical, the presence of an exocyclic 
styrenyl olefin or allyl group in the benzylic oxidation substrate proved troublesome.  As 
a consequence of this, a new route in which formation of the styrenyl olefin and 
hydroboration were reordered was required.  
Ultimately we chose to pursue the route shown below in Scheme A9.4.2.1.  
Beginning with acylated tetralone derivative 186, aldol reaction with formaldehyde, 
palladium catalyzed allylic alkylation, and silyl protection of the primary alcohol 
proceeded smoothly to give silyl ether 188 in 56% yield over the three steps.  The 
reaction of ketone 188 with methyl Grignard reagent furnished tertiary alcohol 189 in 
90% yield.  This alcohol was then elaborated to bicycle 190 by iridium-catalyzed 
hydroboration, oxidation with sodium perborate and, finally, acetate protection, all of 
which proceeded in 58% yield overall.  
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Scheme A9.4.2.1.  Synthesis of revised model for (3+2) cycloaddition studies 
 
 
 
 
With acetate 190 in hand, we were poised to explore benzylic oxidation strategies.  
After numerous failed attempts to first brominate and then affect a Kornblum-type 
oxidation, we turned to a report from Doyle and co-workers,132 in which benzylic 
oxidation is catalyzed by dirhodium tetracaprolactamate.  This strategy proved successful 
in the event, and we were pleased to isolate benzylic ketone 192 in 96% yield in just a 
single step from bicycle 191 (Scheme A9.4.2.2).  An uneventful deprotection of the 
primary acetate under standard conditions liberated primary alcohol 193, which was 
oxidized to a 2.7:1 mixture of lactol 194 and aldehyde 195 and via Swern oxidation.  This 
mixture was then subjected directly to the conditions for oxime formation with which we 
had previous success.  In the present case, these conditions furnished oxime 196 in 81% 
yield overall from primary alcohol 193.  
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Scheme A9.4.2.2.  Synthesis of revised model for (3+2) cycloaddition studies 
 
 
 
With a reliable route to access oxime 196 in place, we set about attempting to 
affect the formation of our desired (3+2) cycloaddition precursor.  Concerned over the 
stability of the pendant oxime, we began our investigation by employing relatively mild 
dehydrating agents such as Martin sulfurane133 and Burgess reagent.134  Unfortunately, 
neither of these experiments nor experiments employing harsher reagents such as thionyl 
chloride proved fruitful, and in all cases resulted in complex mixtures of products, none 
of which were believed to be the desired styrene (Scheme A9.4.2.3).  We believe these 
disappointing results may be, in part, accounted for by the incompatibility of an 
electrophilic styrene moiety and nucleophilic oxime oxygen both present in the desired 
product.  Efforts to first form the α-chloro oxime using NCS129 and subsequently affect 
simultaneous olefin and nitrile oxide formation were also met with failure.  Noting the 
relative instability of the oxime moiety to the conditions required for dehydration, we 
attempted to preclude these difficulties by dehydrating at an earlier point in the synthesis.  
However, efforts to advance styrenyl compounds in which the protected alcohol had yet 
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to be oxidized were met with what we believe to be hetero-Michael addition processes by 
the alcohol oxygen into the styrene olefin.  
 
Scheme A9.4.2.3.  Studies toward the dehydration of tertiary alcohol 196 
 
 
 
A9.5 REVISED STRATEGY FOR THE SYNTHESIS OF (+)-LINGZHIOL 
Disappointed with the failure of our model system, we sought to take advantage 
of the lessons learned in our attempts to model (+)-lingzhiol in a revised overall strategy.  
One thing that became apparent over the course of our revised model system studies was 
the high electrophilicity of the styrene moiety once the benzylic ketone was in place.  
Indeed, this system could also aptly be described as a benzylogous enone.  We believe 
that this reactivity can be exploited and efforts toward a new route to do so are underway.  
A revised retrosynthetic analysis detailing how such reactivity may be harnessed is 
depicted below in Scheme A9.5.1.  
While much of our initial retrosynthesis (Scheme A9.1.1.2, vide infra) is survived 
in the revised version shown below, the benzylogous enone moiety (i.e., 162) is unveiled 
later in the synthesis, such that oxidative manipulation of the primary alcohol formed 
from hydroboration/oxidation (198) of the allyl fragment is already complete (Scheme 
A9.5.1).  We believe this reordering to be crucial to the success of the route.   
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Scheme A9.5.1.  Second-generation retrosynthetic analysis toward the synthesis of (+)-lingzhiol 
 
 
 
An additional benefit inherent to the revised synthetic plan is that it will enable 
our exploration of alternative endgame strategies that exploit the high electrophilicity of 
the benzylogous enone moiety.  In particular, we believe that by simultaneously 
deprotecting both the silyl enol ether and primary silyl (PG = SiR3) in bicycle 197, we 
may be able to affect a conjugate addition/aldol cascade, wherein alkoxide 204 acts as a 
nucleophile and undergoes intramolecular conjugate addition to afford benzylogous 
enolate 205 (Scheme A9.5.2).  Intramolecular aldol addition of the benzylogous enolate 
205 to the pendent aldehyde may then take place to furnish tetracycle 206.  Tetracycle 
206 may then undergo oxidative manipulation to furnish the natural product.  
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Scheme A9.5.2.  Second-generation retrosynthetic analysis toward the synthesis of (+)-lingzhiol 
 
 
 
A9.6 CONCLUDING REMARKS 
 Described herein is our progress toward the asymmetric total synthesis of marine 
natural product (+)-lingzhiol.  Two iterations of model systems were explored in order to 
evaluate the feasibility of a proposed key intramolecular (3+2) cycloaddition, which 
would furnish vicinal quaternary carbons and two rings in a single step.  Key discoveries 
uncovered in our model systems include the use of interrupted Peterson olefination to 
install a sterically-hindered exocyclic olefin and the successful employment of dirhodium 
tetracaprolactamate catalysis to affect the benzylic oxidation of highly functionalized 
intermediate 191.  Finally, a new retrosynthetic analysis, which makes use of information 
gained in our model studies, is presented.   
 
A9.7 EXPERIMENTAL SECTION 
A9.7.1 Materials and Methods 
Unless otherwise stated, reactions were performed in flame-dried glassware under 
an argon or nitrogen atmosphere using dry, deoxygenated solvents.  Solvents were dried 
by passage through an activated alumina column under argon.61 Reaction progress was 
monitored by thin-layer chromatography (TLC).  TLC was performed using E. Merck 
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silica gel 60 F254 precoated glass plates (0.25 mm) and visualized by UV fluorescence 
quenching, p-anisaldehyde, or KMnO4 staining.  Silicycle SiliaFlash® P60 Academic 
Silica gel (particle size 40–63 nm) was used for flash chromatography.  1H NMR spectra 
were recorded on Varian Inova 300 MHz and 500 MHz spectrometers and are reported 
relative to residual CHCl3 (δ 7.26 ppm) or C6HD5 (δ 7.16 ppm).  13C NMR spectra were 
recorded on a Varian Inova 500 MHz spectrometer (125 MHz) and are reported relative 
to CHCl3 (δ 77.16 ppm) or C6HD5 (δ 128.06 ppm). Data for 1H NMR are reported as 
follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), integration).  
Multiplicities are reported as follows: s = singlet, d = doublet, t = triplet, q = quartet, p = 
pentet, sept = septuplet, m = multiplet, br s = broad singlet, br d = broad doublet, app = 
apparent.  Data for 13C NMR are reported in terms of chemical shifts (δ ppm).  IR spectra 
were obtained by use of a Perkin Elmer Spectrum BXII spectrometer or Nicolet 6700 
FTIR spectrometer using thin films deposited on NaCl plates and reported in frequency 
of absorption (cm-1). Reagents were purchased from Sigma-Aldrich, Gelest, Strem, or 
Alfa Aesar and used as received unless otherwise stated. 
 
A9.7.2 Procedures for the preparation of and spectroscopic data for compounds in 
scheme A9.3.2.1 
 
To a 25 mL 3-neck round bottom flask was added 0.122 g (5.0 mmol) of 
magnesium turnings.  The central neck of the flask was fitted with a reflux condenser, 
which was fitted with a rubber septum, and the remaining two necks of the flask were 
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also capped rubber septa.  The flask was put under vacuum and vigorously flame dried 
for ca. 5 min.  The flask was allowed to cool under vacuum for 15 min, at which point it 
was back filled with Ar2 (x3).  0.05 mL of 1,2-dibromoethane was added, along with a 
minimal amount of Et2O, ca. 0.5 mL.  A syringe containing 2.5 mL of Et2O was fitted 
through one septum where it remained until the addition of reagents was complete.  A 
second syringe containing 0.7 mL (chloromethyl)trimethylsilane (5.0 mmol) was fitted 
through another septum and added in a drop-wise fashion until an exotherm was 
perceptible by touching the bottom of the flask.  Shortly after the generation of heat had 
become perceptible, the reaction mixture began to boil.  Additional 
(chloromethyl)trimethylsilane was added to the flask at a rate that maintained a gentle 
reflux.  If ever the exotherm went beyond that of a gentle boil, additional Et2O was added 
to slow the exotherm.  This process was continued until the addition of 
(chloromethyl)trimethylsilane was complete, at which point the reaction was heated to 
40 °C via oil bath and allowed to stir for 2 hours.  At this point only trace magnesium 
turnings remained in the reaction mixture.  The reaction vessel was removed from the oil 
bath, and placed in a water ice bath and an additional 2 mL of Et2O were added.  Finally, 
0.10 g of α-quaternary ketone 176 (0.5 mmol) in 0.5 mL of Et2O was added drop-wise 
and the reaction was allowed to warm to 25 °C and stirred for an hour.  The reaction was 
then judged to be complete by TLC analysis and then carefully quenched with saturated 
aqueous NH4Cl, acidified to pH 5 by the addition of 1 N aqueous HCl, and extracted with 
EtOAc (10 mL x3).  The combined organic washings were dried over MgSO4, filtered 
and concentrated in vacuo.  0.13 g of tertiary alcohol 181 (0.4 mmol) in a 6:1 ratio of 
diastereomers was then isolated by flash column chromatography (SiO2, 5% EtOAc in 
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hexanes to 15% EtOAc in hexanes) as a colorless oil. 90% yield. Rf = 0.4 (10% EtOAc in 
hexanes); 1H NMR for minor diastereomer (300 MHz, CDCl3) δ 8.05 (dd, J = 7.8, 1.4 
Hz, 1H), 7.46 (td, J = 7.4, 1.4 Hz, 1H), 7.34–7.28 (m, 1H), 7.23 (d, J = 7.7 Hz, 1H), 5.79 
(ddt, J = 15.2, 10.8, 7.4 Hz, 1H), 5.13 (d, J = 9.9 Hz, 1H), 5.09–5.06 (m, 1H), 2.99 (q, J = 
5.7 Hz, 2H), 2.28 (dd, J = 13.9, 7.6 Hz, 1H), 2.13–2.08 (m, 1H), 1.96–1.90 (m, 1H), 
1.73–1.69 (m, 1H), 1.20 (s, 3H), -0.12 (s, 17H); 1H NMR for major diastereomer (300 
MHz, CDCl3) δ 7.63 (dd, J = 7.6, 1.7 Hz, 1H), 7.20–7.10 (m, 2H), 7.07–7.00 (m, 1H), 
6.06–5.87 (m, 1H), 5.10 (td, J = 4.9, 3.7, 1.8 Hz, 1H), 5.04–4.86 (m, 1H), 2.79 (td, J = 
8.8, 4.6 Hz, 2H), 2.27 (ddd, J = 207.5, 13.6, 7.8 Hz, 1H), 1.86 (ddd, J = 14.4, 9.0, 5.9 Hz, 
2H), 1.74–1.62 (m, 2H), 1.37 (dd, J = 14.9, 1.3 Hz, 1H), 1.10 (s, 2H), 1.05 (dd, J = 14.9, 
1.3 Hz, 1H), 0.81 (s, 1H), -0.11 (d, J = 2.2 Hz, 9H); 13C NMR for minor diastereomer (75 
MHz, CDCl3) δ 144.6, 136.3, 134.7, 128.3, 126.3, 125.7, 125.6, 117.2, 41.4, 41.1, 33.3, 
30.6, 28.5, 25.2, 21.9, 18.9, 0.3; 13C NMR for major diastereomer (75 MHz, CDCl3) δ  
144.7, 136.6, 135.0, 128.4, 126.3, 125.6, 125.4, 117.4, 41.4, 41.2, 39.0, 30.2, 29.4, 24.9, 
20.2, 0.3. 
  
A9.7.3 Procedures for the preparation of and spectroscopic data for compounds in 
scheme A9.3.2.2 
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General procedure for the hydroboration/oxidation of tertiary alcohol 181 by 
borane•THF complex: To a solution of 0.05 g of tertiary alcohol 181  (0.173 mmol) in 1.7 
mL of Et2O was added 0.21 mL of 1 M BH3•THF complex solution (0.21 mmol, 1.2 
equiv) in a drop-wise fashion over 5 min at 25 °C.  The reaction mixture was then 
allowed to stir for an additional 2 hours, at which point 0.020 mL of H2O2 (34% aqueous 
solution, 0.21 mmol, 1.2 equiv) and 0.692 mL of 1 N aqueous NaOH (0.692 mmol, 0.4 
equiv) were added sequentially.  This mixture was allowed to stir for 12 hours, at which 
point it was poured into 5 mL of H2O, acidified to pH 7 with 1 N aqueous HCl, and 
extracted with Et2O (5 mL x 4).  The combined organic fractions were dried over MgSO4, 
and concentrated in vacuo.  0.032 g of primary alcohol 174 (0.4 mmol) was then isolated 
by flash column chromatography (SiO2, 1% EtOAc in hexanes to 25% EtOAc in 
hexanes) as a colorless oil. 86% yield. Rf = 0.3 (25% EtOAc in hexanes); 1H NMR (300 
MHz, CDCl3) δ 7.56 (dd, J = 7.3, 2.0 Hz, 1H), 7.22–7.12 (m, 2H), 7.12–7.01 (m, 1H), 
5.49 (s, 1H), 5.03 (s, 1H), 3.60–3.50 (m, 2H), 2.99–2.71 (m, 2H), 1.80–1.66 (m, 2H), 
1.65–1.37 (m, 5H), 1.30–1.20 (m, 2H), 1.19 (s, 3H). 
 
 
The general procedure for the hydroboration/oxidation of tertiary alcohol 181 by 
iridium catalysis was adapted from a procedure reported by Crudden and coworkers: In a 
nitrogen-filled glove box, a previously flame dried 50 mL round bottom flask charged 
with magnetic stirring bar was charged with 0.062 g of [Ir(cod)Cl]2 (0.093 mmol, 0.025 
equiv), and 0.08 g of 1,4-bis(diphenylphosphino)butane (0.186 mmol, 0.05 equiv) and 
1) [Ir(cod)Cl]2, HBPin, THF
HO
TMS
92% yield
OH
181 174
2) NaBO3, THF/H2O
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dissolved in 4 mL of THF.  To this solution, 1.07 g of tertiary alcohol 181  (3.71 mmol, 1 
equiv) in 6 mL of THF was added and the mixture was allowed to stir at 25 °C for 15 min.  
0.63 g of pinacolborane (4.34 mmol, 1.2 equiv) was then added, the reaction vessel 
capped with a rubber septum and the mixture allowed to stir for an additional 24 hours. 
At this point the reaction mixture was removed from the glove-box and concentrated in 
vacuo.  The crude reaction mixture was subject then taken up in 17 mL of THF, and 
combined with 17 mL of H2O, 1.58 g of NaBO3•4H2O (10.3 mmol, 3 equiv) and stirred 
for an additional 12 hours.  This mixture was then extracted with EtOAc (10 mL x 3), the 
combined organic fractions were dried over MgSO4, and concentrated in vacuo.  0.74 g 
of primary alcohol 174 (0.4 mmol) was then isolated by flash column chromatography 
(SiO2, 10% EtOAc in hexanes to 25% EtOAc in hexanes) as a colorless oil. 92% yield.  
 
A9.7.4 Procedures for the preparation of and spectroscopic data for compounds in 
scheme A9.3.2.3 
 
 
 
Dess-Martin periodinane (DMP) was prepared following literature procedure.135  
0.185 g of primary alcohol 174 (0.856 mmol, 1 equiv) was transferred to a 25 mL round 
bottom flask with 0.93 mL of CH2Cl2 containing 0.417 g of DMP (0.984 mmol, 1.15 
equiv) in 2.5 mL of CH2Cl2.  The reaction was judged to be complete in 10 min, at which 
point the reaction mixture was poured into 7 mL of saturated aqueous NaHCO3 
DMP, DCM
dark,10 min
not isolated
HONH3•Cl (2 equiv)
NaOAc (3 equiv)
EtOH/H2O
88% yield
over two steps
172173174
O N
OH
OH
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containing 10 weight % Na2S2O3 (1.85 g), and this mixture stirred for 5 min. The mixture 
was then extracted with 7 mL of Et2O, and the organic fraction was washed with 3 mL of 
saturated aqueous NaHCO3, dried over MgSO4, filtered and concentrated in vacuo.  The 
crude reaction mixture was >95% pure by 1H NMR, and taken on without further 
purification.  1H NMR for aldehyde 173 (300 MHz, CDCl3) δ 9.78–9.51 (m, 1H), 7.55 
(dd, J = 7.0, 2.2 Hz, 1H), 7.24–7.02 (m, 3H), 5.53 (s, 1H), 5.03 (s, 1H), 3.06–2.71 (m, 
3H), 2.55–2.25 (m, 2H), 2.01–1.60 (m, 5H), 1.18 (s, 3H). 
To 0.055 g of freshly prepared aldehyde 173 (0.259 mmol, 1 equiv), in 1.7 mL of 
H2O and 3.3 mL of EtOH was added 0.036 g of H3NO•HCl (0.518 mmol, 2 equiv), and 
the reaction mixture was cooled to 0 °C using an ice water bath.  To the cooled reaction 
mixture, 0.064 g of NaOAc (0.777 mmol, 3 equiv) was added portion-wise over 15 min 
and the mixture was allowed to warm to room temperature and stir for 12 hours, at which 
point the reaction was judged to be complete by TLC analysis. The EtOH was removed in 
vacuo and the remaining aqueous mixture was extracted with EtOAc (5 mL x 3).  The 
combined organic fractions were dried over MgSO4, concentrated in vacuo, and the 
resulting crude oil was purified by flash column chromatography (SiO2, 3% EtOAc in 
hexanes to 4% EtOAc in hexanes) to give 0.052 g of oxime 172 as a colorless oil. 88% 
yield over two steps. Rf = 0.5 (25% EtOAc in hexanes); 1H NMR (300 MHz, CDCl3) δ 
7.56 (dd, J = 7.3, 2.0 Hz, 1H), 7.34 (t, J = 5.9 Hz, 1H), 7.21–7.13 (m, 2H), 7.09 (ddd, J = 
6.3, 2.7, 0.9 Hz, 1H), 6.78 (s, 1H), 5.51 (s, 1H), 5.03 (s, 1H), 2.99–2.74 (m, 2H), 2.31–
1.98 (m, 2H), 1.84–1.70 (m, 2H), 1.68–1.58 (m, 1H), 1.20 (s, 3H); 13C NMR (75 MHz, 
CDCl3) δ  152.7, 150.4, 135.9, 135.0, 128.7, 127.5, 126.1, 125.5, 108.2, 37.4, 35.4, 34.2, 
25.9, 25.6, 24.8. 
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A9.7.5 Procedures for the preparation of and spectroscopic data for compounds in 
scheme A9.3.2.4 
 
 
To a flame dried 5 mL microwave vial was charged 0.015 g of crude aldehyde 
172 (0.07 mmol, 1 equiv), 0.006 g of MeH2NOH•HCl (0.07 mmol, 1 equiv), 0.0193 g of 
K2CO3 (0.14 mmol, 2 equiv), and 1 mL of benzene.  The microwave vial was capped 
with a rubber septum and stirred for 6 hours at room temperature, at which point all 
starting materials had by consumed by TLC analysis.  The reaction mixture was then 
heated to 100 °C for 24 hours.  The mixture was then concentrated in vacuo, and the 
crude oil was purified directly by flash column chromatography (SiO2, 12% EtOAc in 
hexanes to 60% EtOAc in hexanes) to give 0.0103 g of tetracycle 183 as a colorless oil. 
61% yield.  Rf = 0.3 (25% EtOAc in hexanes); 1H NMR (300 MHz, CDCl3) δ 7.50 (dd, J 
= 7.3, 1.9 Hz, 1H), 7.24–7.17 (m, 2H), 7.13–7.09 (m, 1H), 3.44 (t, J = 4.7 Hz, 1H), 2.93–
2.82 (m, 1H), 2.81 (s, 3H), 2.79–2.66 (m, 2H), 2.17 (d, J = 12.2 Hz, 1H), 2.07 (td, J = 
13.2, 5.8 Hz, 1H), 1.92–1.79 (m, 2H), 1.78–1.68 (m, 1H), 1.37–1.29 (m, 2H), 0.95 (t, J = 
0.7 Hz, 3H); 13C NMR (75 MHz, CDCl3) 138.9, 133.7, 129.7, 127.7, 127.1, 126.3, 66.0, 
64.8, 53.6, 47.7, 36.9, 34.5, 33.7, 32.9, 28.3, 25.9. 
 
MeONH3•Cl (1 equiv)
NaOAc (2 equiv)
PhH, 23 –> 100 °C 61% yield
O NMe
173 182 183
N
OO
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A9.7.6 Procedures for the preparation of and spectroscopic data for compounds in 
scheme A9.4.2.1 
 
To a 100 mL round bottom flask containing a magnetic stirring bar was added 3.8 
g of β-ketoester 186 (16.5 mmol, 1 equiv), 4.95 g of KHCO3 (49.5 mmol, 3 equiv) and 47 
mL of THF.  The mixture was cooled to 0 °C via an ice water bath, and 9.24 mL of 37 
wt. % formaldehyde in H2O (113.9 mmol, 6.9 equiv) was added slowly over 5 min.  The 
mixture was then allowed to warm to room temperature and stirred for 12 hours, at which 
point the reaction was judged to be complete by TLC analysis.  The crude reaction 
mixture was diluted with H2O (50 mL), and CH2Cl2 (100 mL) and extracted with CH2Cl2 
(30 mL x 4).  The combined organic fractions were dried over MgSO4, filtered and 
concentrated in vacuo.  The crude oil was then purified by flash column chromatography 
(SiO2, 20% EtOAc in hexanes to 25% EtOAc in hexanes) to give 3.96 g of alcohol 187 as 
a colorless oil. 92% yield. Rf = 0.2 (33% EtOAc in hexanes); 1H NMR (300 MHz, 
CDCl3) δ 8.07 (ddd, J = 7.9, 1.6, 0.5, 1H), 7.51 (td, J = 7.5, 1.5, 1H), 7.34 (dddd, J = 8.0, 
7.3, 1.4, 0.7, 1H), 7.24 (dd, J = 7.2, 1.2, 1H), 5.80 (ddt, J = 17.5, 10.2, 5.5, 1H), 5.21–
5.15 (m, 1H), 5.14–5.10 (m, 1H), 4.68–4.57 (m, 2H), 4.06–3.85 (m, 2H), 3.42–3.25 (m, 
1H), 3.00 (dt, J = 9.6, 4.8, 2H), 2.46 (dt, J = 13.6, 4.5, 1H), 2.18 (ddd, J = 13.6, 10.6, 5.6, 
1H). 
 
O
O
O HCOH, 
KHCO3
O
O
O
92% yield
OH
187186
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In a nitrogen-filled glove-box at 27 °C, a 250 mL round bottom flask containing a 
magnetic stirring bar was charged with 0.156 g of Pd2(dba)3 (0.171 mmol, 0.025 equiv), 
0.107 g of PPh3 (0.41 mmol, 0.06 equiv) and 100 mL of THF, and allowed to stir for 30 
min.  To this mixture was added 1.78 g of β-ketoester 187 as a solution in 35 mL THF, 
the flask was capped with a rubber septum, the lip of the septum sealed with electrical 
tape, and the flask removed from the glove-box.  After stirring for 12 hours, the reaction 
was judged to be complete by TLC analysis.  The crude reaction mixture was 
concentrated in vacuo and the resulting oil was passed through a silica plug (SiO2, 20% 
EtOAc in hexanes to 30% EtOAc in hexanes), to give 1.47 g of crude product.  This oil 
was then taken on without further purification. Rf = 0.2 (25% EtOAc in hexanes). 
To a 200 mL round bottom flask containing a magnetic stirring bar was added 
1.47 of the crude ketone, 1.54 g of TBSCl (10.25 mmol, 1.5 equiv based on previous 
reaction),  2.32 g of imidizole (34.15 mmol, 5 equiv based on previous reaction),  and 70 
mL of CH2Cl2, at 25 °C and the reaction mixture wa allowed to stir for 12 hours, at which 
point the reaction was judged to be complete by TLC analysis. The crude reaction 
mixture was poured into 100 mL of H2O and extracted with CH2Cl2 (50 mL x 4), washed 
with saturated aqueous NH4Cl (50 mL), washed with brine (50 mL), and then 
concentrated in vacuo.  The crude oil was then purified by flash column chromatography 
(SiO2, 3% EtOAc in hexanes to 10% EtOAc in hexanes) to give 1.38 g of silyl ether 188 
(4.18 mmol) as a colorless oil. 61% yield over two steps. Rf = 0.4 (10% EtOAc in 
hexanes); 1H NMR data for the precursor alcohol 188’ (300 MHz, CDCl3) δ δ 8.01 (dd, J 
O
O
O
OH
1) Pd2(dba)3 (2.5 mol%)
PPh3 (6 mol %), THF
O OTBS
2) TBSCl, imidizole
CH2Cl2
61% yield over two steps 188187
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= 7.9, 1.4 Hz, 1H), 7.48 (td, J = 7.5, 1.4 Hz, 1H), 7.35–7.27 (m, 1H), 7.26–7.22 (m, 1H), 
5.95–5.66 (m, 1H), 5.25–5.14 (m, 1H), 5.13 (q, J = 1.1 Hz, 1H), 3.70 (qd, J = 11.5, 1.0 
Hz, 2H), 3.24–3.03 (m, 1H), 2.94 (t, J = 4.6 Hz, 1H), 2.88 (t, J = 4.6 Hz, 1H), 2.58–2.26 
(m, 2H), 2.14–1.98 (m, 1H), 1.98–1.84 (m, 1H). 
 
 
Tertiary alcohol 188 was prepared following the same procedure as that which 
was employed to prepare tertiary alcohol 181 (vide supra).  Compound 189 was isolated 
by flash column chromatography (SiO2, 5% EtOAc in hexanes to 10% EtOAc in 
hexanes) as a colorless oil. 90% yield. Rf = 0.4 (10% EtOAc in hexanes); 1H NMR (300 
MHz, CDCl3) δ 7.74 (dd, J = 7.6, 1.6 Hz, 1H), 7.65 (dd, J = 7.8, 1.5 Hz, 2H), 6.01–5.71 
(m, 2H), 5.23–5.03 (m, 5H), 4.15 (s, 2H), 3.69–3.65 (m, 3H), 3.61 (d, J = 10.3 Hz, 1H), 
3.54–3.50 (m, 2H), 3.47 (t, J = 7.0 Hz, 4H), 3.06–2.50 (m, 9H), 2.16 (dd, J = 13.7, 7.3 
Hz, 1H), 1.96 (dd, J = 14.7, 6.9 Hz, 2H), 1.82–1.65 (m, 2H), 1.53 (s, 5H), 1.48–1.40 (m, 
2H), 1.37 (s, 3H), 1.21 (t, J = 7.0 Hz, 8H), 0.96 (s, 15H), 0.81 (s, 9H), 0.13 (d, J = 5.6 Hz, 
10H), -0.11 (d, J = 31.4 Hz, 6H). 
 
 
Hydroboration and oxidation of olefin 189 was accomplished following the 
general procedure detailed above for the synthesis of alcohol 174 (vide supra), beginning 
O OTBS
188
HO
189
0 °C to rt 12 h
90% yield
MeI, Mg, Et2O
OTBS
HO
189
OTBS
HO
OTBS
OAc
1) [Ir(cod)Cl]2, HBPin, THF 
2) NaBO3, THF/H2O
3) acetic anhydride 
Hunig's base, DMAP 
CH2Cl2 190/191
58% yield over three steps
Appendix 9 – Studies Toward the Enantioselective Total Synthesis of (+)-Lingzhiol 
 
 
536 
with 1.3 g of olefin 189.  The crude reaction mixture was extracted with EtOAc, the 
combined organic  fractions were dried over MgSO4, and concentrated in vacuo to give 
1.35 g of the intermediate diol as a colorless oil. Rf = 0.4 (10% EtOAc in hexanes); 1H 
NMR for diastereomer 1 of boronate intermediate (300 MHz, CDCl3) δ 7.63 (dd, J = 7.7, 
1.5 Hz, 1H), 7.18 (ddd, J = 8.8, 7.5, 1.4 Hz, 1H), 7.10 (td, J = 7.3, 1.5 Hz, 1H), 7.03–6.98 
(m, 1H), 4.13 (s, 1H), 3.69 (s, 2H), 2.91 (dt, J = 18.6, 9.7 Hz, 1H), 2.69 (dt, J = 17.5, 3.9 
Hz, 1H), 1.92 (ddd, J = 14.0, 11.3, 5.6 Hz, 1H), 1.58 (d, J = 5.3 Hz, 1H), 1.52 (s, 3H), 
1.50–1.42 (m, 2H), 1.41–1.31 (m, 1H), 1.29–1.17 (m, 3H), 1.13 (d, J = 6.8 Hz, 12H), 
0.94 (s, 9H), 0.85 (d, J = 19.9 Hz, 1H), 0.77–0.65 (m, 1H), 0.13 (d, J = 4.1 Hz, 5H).  1H 
NMR for diastereomer 2 of boronate intermediate (300 MHz, CDCl3) δ 7.72 (dd, J = 7.7, 
1.6 Hz, 1H), 7.15 (dtd, J = 18.9, 7.3, 1.7 Hz, 2H), 7.03–6.96 (m, 1H), 4.79 (s, 1H), 3.62 
(s, 2H), 2.90–2.61 (m, 2H), 2.06–1.91 (m, 1H), 1.89–1.78 (m, 1H), 1.77–1.65 (m, 1H), 
1.58 (dd, J = 7.6, 3.6 Hz, 1H), 1.54–1.38 (m, 2H), 1.35 (s, 3H), 1.23 (s, 12H), 1.14 (d, J = 
4.7 Hz, 2H), 0.92 (s, 1H), 0.81 (s, 10H), 0.13 (s, 1H), -0.09 (d, J = 32.0 Hz, 6H). 
A 25 mL round bottom flask was charged with 1.35 g of the crude diol, 0.77 g of 
Hunig’s base (4.44 mmol, 1.2 equiv based on previous reactions),  0.045 g of DMAP 
(0.37 mmol, 0.1 equiv based on previous reactions),  and 5.3 mL of CH2Cl2, and cooled 
to 0 °C. 0.378 mL of acetic anhydride was then added drop-wise to the cooled solution 
and the mixture was stirred for 3 hours, at which point the reaction was judged to be 
complete by TLC analysis.  The crude reaction mixture was quenched with 5 wt. % HCl 
in H2O, neutralized with 1 N NaOH (ca. 5 mL) and washed with brine.  The organic 
fraction was dried over MgSO4 and then concentrated in vacuo.  The crude oil was then 
purified by flash column chromatography (SiO2, 5% EtOAc in hexanes to 10% EtOAc in 
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hexanes) and the diastereomers separated.  0.5 g of diastereomer A (190) and 0.380 g of 
diastereomer B (191) were isolated as colorless oils.  58% yield over three steps. Rf = 0.3 
(10% EtOAc in hexanes); 1H NMR for diastereomer 1 (190) (300 MHz, CDCl3) δ 7.73–
7.59 (m, 1H), 7.23–7.09 (m, 2H), 7.08–7.00 (m, 1H), 2.91–2.64 (m, 3H), 1.74 (ddd, J = 
8.1, 6.7, 2.8 Hz, 2H), 1.58 (d, J = 3.6 Hz, 3H), 1.44 (d, J = 1.2 Hz, 3H), 1.41–1.18 (m, 
3H), 1.01 (d, J = 0.5 Hz, 2H), 0.98–0.92 (m, 2H), 0.91–0.86 (m, 2H).; 1H NMR for 
diastereomer 2 (191) (300 MHz, CDCl3) δ 7.74 (dd, J = 7.7, 1.6 Hz, 1H), 7.25–7.07 (m, 
2H), 7.07–6.95 (m, 1H), 4.61 (s, 1H), 4.19–4.03 (m, 2H), 3.69–3.49 (m, 2H), 2.90–2.60 
(m, 2H), 2.23–2.09 (m, 1H), 2.05 (d, J = 0.6 Hz, 3H), 1.70 (dddd, J = 15.4, 12.0, 8.1, 5.0 
Hz, 4H), 1.48–1.36 (m, 1H), 1.34 (s, 3H), 1.28–1.24 (m, 3H), 0.98–0.84 (m, 3H), 0.81 (d, 
J = 0.6 Hz, 9H), -0.10 (d, J = 34.0 Hz, 5H); 13C NMR for diastereomer 2 (191) (75 MHz, 
CDCl3) δ  171.2, 145.3, 133.6, 127.8, 126.3, 126.3, 126.1, 126.1, 125.5, 66.2, 65.4, 65.2, 
41.4, 27.4, 27.0, 26.7, 26.0, 25.9, 25.8, 25.8, 25.7, 25.6, 24.6, 23.2, 21.0, 17.9, -6.0, -6.1 
   
A9.7.7 Procedures for the preparation of and spectroscopic data for compounds in 
scheme A9.4.2.2 
 
 
To a 1 mL microwave vial containing a magnetic stirring bar 25 °C, was charged 
with 0.05 g of diastereomer A of tertiary alcohol 191 (0.123 mmol, 1 equiv), 0.0004 g or 
Rh2(cap)4 (0.0006 mmol, 0.005 equiv), 0.005 g of NaHCO3 (0.0615 mmol, 0.5 equiv) and 
0.5 mL of DCE.  This mixture was then allowed to stir for 30 min until all of tertiary 
HO OTBS
OAc Rh2cap4
TBHP, NaHCO3
DCE
HO OTBS
OAc
O96% yield191 192
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alcohol 191 was solubilized.  To this mixture was added 0.06 mL of TBHP (0.615 mmol, 
5 equiv), and the flask was fitted with a balloon filled with Ar2 and heated to 40 °C.  
After stirring for 3 hours, an additional 0.0004 g or Rh2(cap)4 (0.0006 mmol, 0.005 equiv) 
and 0.06 mL of TBHP (0.615 mmol, 5 equiv) were added.  The reaction was stirred for 
36 hours, at which point it was judged to be complete by TLC analysis.  The crude 
reaction mixture was adsorbed into 0.1 g SiO2 by concentration in vacuo and the resulting 
fine particulate was then purified by flash column chromatography (SiO2, 2% EtOAc in 
hexanes to 25% EtOAc in hexanes), to give 0.05 g of ketone 192 as a colorless oil. 96% 
yield.  Rf = 0.3 (25% EtOAc in hexanes); 1H NMR (300 MHz, CDCl3) δ 7.92 (dddd, J = 
9.1, 7.9, 1.4, 0.6 Hz, 2H), 7.65 (ddd, J = 7.9, 7.3, 1.4 Hz, 1H), 7.38 (td, J = 7.5, 1.2 Hz, 
1H), 5.06 (d, J = 1.7 Hz, 1H), 4.14 (dt, J = 7.9, 6.3 Hz, 2H), 3.74–3.50 (m, 2H), 2.62 (d, J 
= 18.5 Hz, 1H), 2.46 (d, J = 18.5 Hz, 1H), 2.29 (td, J = 12.8, 4.4 Hz, 1H), 2.08 (s, 3H), 
1.75–1.59 (m, 3H), 1.51 (d, J = 61.1 Hz, 12H), 0.82 (s, 9H), -0.10 (d, J = 67.5 Hz, 5H). 
 
 
To 0.350 g of ketone 192 (0.832 mmol, 1 equiv) was added 0.138 g of K2CO3 (1.0 
mmol, 1.2 equiv), 3 mL of THF and 1 mL of MeOH.  The mixture was stirred at 25 °C 
for 12 hours and then judged to be complete by TLC analysis.  The crude mixture was 
diluted with 20 mL EtOAc, washed with 10 mL H2O, 10 mL brine, dried over MgSO4, 
and concentrated in vacuo.  The resulting crude oil was then purified by flash column 
chromatography (SiO2, 20% EtOAc in hexanes to 60% EtOAc in hexanes), to give 3.14 g 
of primary alcohol 193 as a colorless oil. 99% yield.  Rf = 0.3 (50% EtOAc in hexanes); 
HO OTBS
OAc
O 192
HO OTBS
OH
O
K2CO3
THF/MeOH
99% yield 193
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1H NMR for diastereomer 1 (500 MHz, CDCl3) δ 7.90 (d, J = 7.8 Hz, 1H), 7.74 (d, J = 
7.9 Hz, 1H), 7.58 (t, J = 7.7 Hz, 1H), 7.30 (t, J = 7.6 Hz, 1H), 3.87 (d, J = 10.4 Hz, 1H), 
3.61 (d, J = 10.4 Hz, 1H), 3.43 (t, J = 6.7 Hz, 2H), 2.43 (d, J = 17.3 Hz, 1H), 2.32 (d, J = 
17.4 Hz, 1H), 1.99 (ddd, J = 14.3, 12.2, 4.8 Hz, 1H), 1.61 (s, 3H), 1.48–1.32 (m, 2H), 
1.28–1.18 (m, 1H), 0.93 (d, J = 1.6 Hz, 9H), 0.14 (d, J = 13.7 Hz, 5H); 13C NMR for 
diastereomer 1 (75 MHz, CDCl3) δ  195.5, 149.9, 134.6, 129.7, 127.0, 125.9, 125.8, 76.1, 
65.9, 63.0, 45.3, 41.5, 28.5, 27.1, 25.7, 18.0, -5.7, -5.8; 1H NMR for diastereomer 2 (193) 
(500 MHz, CDCl3) δ 7.91 (dddd, J = 13.3, 8.0, 1.4, 0.6 Hz, 2H), 7.64 (ddd, J = 7.8, 7.3, 
1.4 Hz, 1H), 7.38 (td, J = 7.5, 1.2 Hz, 1H), 5.09 (s, 1H), 3.80–3.70 (m, 2H), 3.70–3.59 
(m, 2H), 2.61 (d, J = 18.6 Hz, 1H), 2.50 (d, J = 18.6 Hz, 1H), 2.29–2.19 (m, 1H), 1.60 
(dddd, J = 15.7, 12.2, 8.6, 6.2 Hz, 3H), 1.46 (s, 3H), 0.81 (s, 9H), -0.10 (d, J = 64.7 Hz, 
5H); 13C NMR for diastereomer 2 (193) (75 MHz, CDCl3) δ  196.1, 151.1, 134.5, 130.1, 
127.2, 126.3, 125.4, 66.7, 63.4, 44.5, 44.0, 27.2, 26.8, 26.6, 25.5, 17.8, -6.0, -6.2. 
 
 
To a septum capped 1 mL microwave vial containing a magnetic stirring bar was 
added 5.43 µL of oxalyl chloride (0.06 mmol, 1.48 equiv) in 0.25 mL of CH2Cl2.  The 
mixture was cooled to –78 °C and 7.5 µL of DMSO (0.1056 mmol, 2 equiv) in 0.25 mL 
CH2Cl2 was added drop-wise over 20 min and the mixture was stirred for an additional 30 
min.  0.02 g of diastereomer 1 of primary alcohol 193 (0.053 mmol, 1 equiv) in 0.5 mL 
CH2Cl2 was then added drop-wise over 45 min and the mixture was stirred for an 
HO
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O
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additional 30 min.  30.0 µL of Et3N was then added neat over 1 minute, and the mixture 
was stirred vigorously for 30 min as it was allowed to warm to 0 °C.  1 mL of H2O was 
then added , the mixture was washed with 0.5 M HCl (1 mL), H2O (1 mL), saturated 
aqueous NaHCO3 (1 mL) and brine (1 mL).  The organic fraction was dried over MgSO4, 
and concentrated in vacuo to give 0.0197 g of lactol 194 and aldehyde 195 as a 2.7:1 
mixture.  Lactol 194 and aldehyde 195 were taken on without further purification. 1H 
NMR for lactol 194 (300 MHz, CDCl3) δ 8.08–7.93 (m, 1H), 7.67–7.52 (m, 2H), 7.38 
(ddd, J = 7.8, 6.5, 2.0 Hz, 1H), 6.37 (ddd, J = 6.2, 2.4, 1.5 Hz, 1H), 4.56 (td, J = 5.6, 5.0, 
2.2 Hz, 1H), 3.87–3.61 (m, 2H), 2.81 (d, J = 2.1 Hz, 2H), 2.10 (ddd, J = 17.9, 5.1, 1.5 Hz, 
1H), 1.69–1.58 (m, 2H), 1.54 (s, 3H), 0.89 (s, 11H), 0.05 (d, J = 3.8 Hz, 6H); 1H NMR 
for aldehyde 195 (300 MHz, CDCl3) δ 8.01 (ddd, J = 7.9, 1.4, 0.6 Hz, 1H), 7.74–7.61 (m, 
2H), 7.50–7.40 (m, 1H), 3.91–3.71 (m, 2H), 2.79 (d, J = 3.2 Hz, 2H), 2.53 (dt, J = 18.1, 
8.9 Hz, 1H), 2.21 (ddd, J = 18.5, 8.5, 3.6 Hz, 1H), 2.07–1.94 (m, 1H), 1.75 (dt, J = 14.3, 
8.9 Hz, 1H), 1.67 (d, J = 0.6 Hz, 3H), 0.91 (d, J = 0.6 Hz, 10H), 0.10 (d, J = 2.3 Hz, 6H); 
13C NMR for aldehyde 195 (75 MHz, CDCl3) δ  194.9, 170.5, 147.0, 135.3, 129.7, 128.5, 
126.8, 125.6, 84.4, 64.6, 44.7, 27.1, 26.4, 25.8, 24.8, 18.2, -5.6, -5.7. 
 
 
0.01 g of the mixture of crude diastereomer 2 of lactol 194 and diastereomer 2 of 
aldehyde 195 were combined with 0.0037 g of HONH2•HCl (0.053 mmol, 2 equiv from 
previous reaction), 0.0065 g NaOAc (0.0797 mmol, 3 equiv), 0.18 mL H2O and 0.35 mL 
HONH3•Cl (2 equiv)
NaOAc (3 equiv)
EtOH/H2O
O
O
OTBS +
O
OTBS
OH
OH O
HO OTBS
N
O
81% yield over two steps
OH
196195194
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EtOH in a 1 mL microwave containing a magnetic stirring bar and stirred at 25 °C for 12 
hours.  The crude reaction mixture was adsorbed into 0.1 g SiO2 by concentration in 
vacuo and the resulting fine particulate was then purified by flash column 
chromatography (SiO2, 10% EtOAc in hexanes to 40% EtOAc in hexanes), to give 0.085 
g of a mixture of E and Z oximes 196 as a colorless oil. 81% yield over two steps.  Rf = 
0.2 (33% EtOAc in hexanes); 1H NMR (300 MHz, CDCl3) δ 7.99–7.82 (m, 2H), 7.64 (td, 
J = 7.6, 1.5 Hz, 1H), 7.49 (t, J = 5.7 Hz, 0H), 7.45–7.31 (m, 1H), 6.82 (s, 1H), 5.06 (s, 
1H), 3.75–3.54 (m, 2H), 3.53–3.43 (m, 0H), 2.66 (d, J = 3.2 Hz, 0H), 2.60 (d, J = 3.1 Hz, 
1H), 2.51 (d, J = 7.4 Hz, 1H), 2.48–2.41 (m, 1H), 2.33–2.23 (m, 1H), 2.10 (s, 1H), 2.04 
(s, 1H), 1.84–1.63 (m, 1H), 1.44 (s, 3H), 1.33–1.13 (m, 2H), 0.96–0.85 (m, 0H), 0.80 (d, 
J = 0.8 Hz, 9H), -0.05 (d, J = 1.1 Hz, 3H), -0.19 (s, 3H). 
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